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1. INTRODUCTION
1.1Uracil Residues in DNA
1.1.1Incorporation of dUMP During DNA Synthesis
Low levels of deoxyuridine triphosphate (dUMP) are normally
incorporated into the genomic DNA of a variety of organisms, including
Escherichia coli (279, 281), Bacillus subtilis (154, 262), and mammalian cells (22,
86). Incorporation occurs because deoxyuridine triphosphate (dUTP) can be
efficiently utilized as a precursor for DNA replication in place of
deoxythymidine triphosphate (dTTP) by both prokaryotic and eukaryotic
DNA polymerases (59, 195, 281). Incorporation of dUMP in place of dTMP
culminates in the formation of a UA base pair (195). The ability of DNA
polymerases to incorporate dUMP into newly synthesized DNA suggests that
dUTP and dTTP are not readily discriminated within the nucleotide binding
pocket of the enzyme. In vitro experiments have demonstrated that E. coli
DNA polymerases I, II, and III are all capable of substituting dUTP in place of
dTTP during DNA synthesis (19, 82, 307). The Km values for incorporation of
dTTP and dUTP by DNA polymerase I were observed to be 4.1 and 5.4
respectively (279). DNA polymerase III exhibited similar Km values of 2.4 and
2.6 p.M for incorporation of dTTP and dUTP (279). Mammalian DNA
polymerase a (pol a) and DNA polymerase 13 (pol (3) also efficiently employed
dUTP as a nucleotide precursor in place of dTTP and yielded Km values of 18
and 10 1.1,M for dTTP and 20 and 8 }IM for dUTP, respectively (59, 68, 316).
Conversely, porcine liver DNA polymerase(pol y) preferentially2
incorporated dTMP over dUMP by a factor of -3-fold (170). Since DNA
polymerases do not discriminate efficiently between dUTP and dTTP during
DNA replication, it is of the utmost importance for the cell to minimize the
size of the intracellular dUTP pool available for DNA synthesis if the uracil
content of DNA is to remain at low levels.
The frequency of dUMP incorporation by DNA polymerases is
principally dictated by the relative pool sizes of dTTP versus dUTP (279).
Based on the estimate that intracellular levels of dUTP and dTTP in E. coli are
0.5 µM and 150 tiM, respectively, approximately 1 uracil residue would be
incorporated into DNA for every 300 thymine nucleotides polymerized (245).
In E. coli, intracellular dUTP accumulates following phosphorylation of dUDP
to yield dUTP or by the conversion of dCTP to dUTP by deoxycytidine
triphosphate (dCTP) deaminase (194). In bacteria, uracil incorporation into
DNA is minimized by the enzymatic activities of deoxyuridine 5'-
triphosphate nucleotidohydrolase (dUTPase) and uracil-DNA glycosylase
(Ung). The enzyme dUTPase hydrolyzes dUTP to dUMP and pyrophosphate
(PP;), and provides a source of dUMP for de novo dTTP biosynthesis (245). The
small amount of dUTP remaining may be incorporated into DNA by DNA
polymerases but it is rapidly eliminated by the uracil-initiated base excision
repair (BER) pathway (245, 279, 280). E. coli mutants defective in Ung
incorporated approximately 1 dUMP residue per 2,000 to 3,000 nucleotides
polymerized (279). Mutants defective in dUTPase exhibited approximately 5
% replacement of thymine by uracil in DNA, displayed reduced growth rates,
and were eventually inviable, presumably due to double-strand breaks which
occur when both strands of the DNA are repaired (297). Double mutants
defective in both Ung and dUTPase incorporated uracil into DNA at a
frequency of 1 per 100 nucleotides polymerized (279). These mutants also
exhibited a reduced growth rate after replacing -20 % of thymine residues in
DNA with uracil (297). Thus, dUTPase plays a significant role in lowering the
level of uracil incorporation into DNA in E. coli.3
Steady-state levels of dUTP in mammalian cells are significantly lower
than those of E. co/i. The absence of a mammalian counterpart to the E. co/i
dCTP deaminase or the presence of an abundant dUTPase could account for
the difference in the molar ratio of dUTP to dTTP between mammalian and
bacterial cells (37, 188). Human lymphoid cells maintain a dUTP
concentration of less than 0.3 fmol /106 cells whereas the dTTP concentration
is sustained at approximately 40 fmol /106 cells (85, 86). The ratio of dUTP to
dTTP in mammalian cells indicates that less than 1 dUMP is incorporated
into DNA for every 105 dTMP polymerized (85, 86). As a result, a lower
frequency of uracil residues would be expected to accumulate in human
genomic DNA as compared to E. coli.
Although eukaryotic mutants lacking uracil-DNA glycosylase or
dUTPase are unavailable at present, drugs that inhibit thymidylate synthetase
have been used to increase intracellular levels of dUTP in order to study the
toxic effects of increased uracil incorporation into DNA (85, 86). Thymidylate
synthase catalyzes the reductive methylation of dUMP to dTMP with
concomitant conversion of 5,10-methylenetetrahydrofolate to 7,8-
dihydrofolate following transfer of its methylgroup to dUMP (233).
Regeneration of 5,10-methylenetetrahydrofolate by dihydrofolate reductase is
inhibited by methotrexate, which reduces the utilization of dUMP by
thymidylate synthase, ultimately decreasing the dTTP pool and increasing the
dUTP pool (233). Methotrexate reduced the level of dTTP from -40 pmol /106
cells to -1 pmol /106 cells and increased the ratio of dUTP/dTTP from 510-5 to
0.2 (85). As expected, the level of dUMP in genomic DNA increased from <1
fmol/limol of DNA (nucleotides) to 0.8 pmol/innol of DNA in human
lymphoid cells (86). An increased level of intracellular dUTPwas
accompanied by DNA fragmentation due to excessive degradation of the
DNA (31, 202, 277). Thus, the toxic effects observed for cells treated with
agents that depress thymidylate synthase activity and increase uracil4
incorporation appear to be associated with removal of dUMP from DNA by
the uracil-initiated BER pathway.
1.1.2Cytosine Deamination
1.1.2.1 Spontaneous/Hydrolytic Cytosine Deamination
The spontaneous deamination of cytosine is the second route for the
introduction of uracil into DNA and results in the formation of GU mispairs
from pre-existing GC base pairs (241). There are two proposed chemical
mechanisms for the deamination of cytosine in solution (241).(1) The direct
mechanism involves alkali-catalyzed hydrolysis at the C4-position of the
pyrimidine ring by a water molecule or a hydroxyl ion to release ammonia
and requires protonation of the base at the N3-position. (2) The addition-
elimination mechanism involves addition of a water molecule across the 5,6
double bond of protonated cytosine to form 5,6-dihydrocytosine. Addition of
a second water molecule results in the loss of the ammonia group
(deamination) to yield dihydrouracil which is followed by the elimination of
water to produce uracil. By using the cytosine analogue N3 -methyl-2'-
deooxycytidine, Sowers et al. (254) experimentally determined that the
deamination rate was proportional to the concentration of hydroxide ion
concentration and the protonated state of cytosine. Previously, the
spontaneous rate of cytosine deamination had been determined at extremes
of temperature or pH (147, 242). By using a sensitive genetic assay under
physiological conditions (37°C, pH 7.4), the deamination rate constants for
cytosine in single- and double-stranded DNA were calculated to be 1 x 1010
and 7 x 10' sec
1,respectively (71). The calculated half-life for cytosine in
single- and double-stranded DNA obtained by using these deamination rate
constants translates to -200 years and -30,000 years, respectively, under
conditions of temperature and ionic strength that approximate those in vivo.5
The latter figure translates into -100 cytosine deamination events per human
duplex DNA genome per day (286).
Several studies have suggested that cytosine deamination events in
genomic DNA contribute to the overall spontaneous mutation frequency of
the cell (61, 63, 165). A pre-mutagenic GU mispair will producea GC>AT
transition mutation if repair does not occur prior to replication (61). For
example, E. coli ung mutant strains exhibited a 30-fold stimulation of
GC>AT transition mutations relative to that of wild-type E. coli (63). Thus,
uracil-DNA glycosylase helps reduce the spontaneous mutation rate caused by
cytosine deamination. In a related study, analysis of spontaneous mutations
observed in the E. coli lad gene revealed that -75 % of the mutations resulted
in GC>AT transitions that were potential sites for cytosine deamination
(47, 164). By utilizing an identical target for mammalian cells, base
substitution mutations induced in transfected plasmid vector DNA
containing the lad gene uniquely occurred at GC base pairs and involved
GC>AT transitions (165). Presumably, these mutational events involved
deamination of both cytosine and 5-methylcytosine, (66). Deamination of 5-
methylcytosine in a Gm5C base pair generates a TG mispair which produces
GC-->AT transition mutations following DNA replication (66).
As the rate of cytosine deamination in single-stranded DNA is more
than two orders of magnitude greater than that of double-stranded DNA, it is
likely that the accessibility of the N3 and C4 positions of cytosine to protons,
hydroxyl ions, and water leads to the enhancement of deamination events
(71). Thus, double-stranded DNA would sterically interfere with compounds
that protonate the N3 position or hydrolyze the C4 position of cytosine to
induce deamination. Watson-Crick-type pairing involves a hydrogen bond
between the N1 of guanine and the N3 of cytosine, thus making protonation
of cytosine more difficult. Aberrant base-pair formationor base modification
of cytosine or its cross-strand pairing partner, however, has been shownto6
result in accelerated protonation and deamination of cytosine within double-
stranded DNA (66, 72, 255). For example, 5-methylcytosine exhibits a
spontaneous deamination rate that is 4-5-fold higher than that observed for
cytosine under identical conditions (66). In addition, cytosine residues within
a CC or CT mispair were found to deaminate at 10-100 times the rate of
cytosine within a normal CG base pair, closely approaching the rate of
cytosine deamination in single-stranded DNA (72). These results support the
notion that stabilization/protection of cytosine by Watson-Crick base-pairing
apparently accounted for the -100-fold difference in the rate of deamination
between single- and double-stranded DNA (71, 72). On the other hand, stable
base pairing between 06-methylguanine and cytosine required protonation of
cytosine at the N3 position and promoted cross-strand deamination of
cytosine to produce uracil (255). Thus, improper Watson-Crick base pairing
interactions and accessibility of cytosine to protonation are detrimental factors
in maintaining the genetic integrity of DNA and indicate that the secondary
structure dramatically influences the rate of deamination.
The deamination of cytosine in double-stranded DNA is thought to
occur via a single-stranded intermediate (21). This suggests that processes
such as transcription, replication, or "breathing" transiently transforms
double-stranded DNA into regions of single-stranded character that are more
susceptible to deamination (21, 147).In support of this idea, the rate of
spontaneous deamination in S. cerevisiae was observed to be 40-fold greater
than that in E. coli, possibly due to the slower rate of eukaryotic transcription,
which maintains DNA in a single-stranded format for longer periods of time
(110).
1.1.2.2 Chemical Modification of Cytosine
Deamination of cytosine can also be enhanced by certain intercalating
agents (175) or by chemical modification with nitrous acid (161, 239) or
sodium bisulfite (42, 43, 100). Incubation of double-stranded M13mp2 DNA7
with the bis-intercalating antitumor drug, echinomycin, resulted in a 3-fold
greater increase in GC-->AT transition mutations than in untreated DNA
(175). Previous observations indicated that echinomycin bound at CpG sites
and unwound the DNA helix by -48° (79). These results suggested that an
open (single-stranded) DNA structure induced by intercalation of
echinomycin into DNA increased the cytosine deamination rate at nearby
sites (175). Nitric oxide treatment of gapped M13mp2 DNA has been shown
to increase levels of cytosine deamination as compared to untreated DNA and
almost exclusively (-98 %) produced C-*T transition mutations (161). Unlike
sodium bisulfite, nitrous oxide also reacted nonspecifically and induced
deamination of adenine and guanine residues (142). Selective deamination
of cytosine can be achieved using high concentrations of sodium bisulfite (-2
M) under acidic conditions (pH -5) (100). The reaction proceeds by an acid-
catalyzed addition-elimination mechanism, beginning with the addition of
bisulfite across the 5,6 double bond of cytosine to form the reaction
intermediate, 5,6-dihydrocytosine-6-sulfonate (100). This unstable
intermediate undergoes hydrolytic deamination of the C4 amino group to
produce 5,6-dihydrouracil-6-sulfonate. Elimination of bisulfite from the C6
position of 5,6-dihydrouracil-6-sulfonate ultimately generates uracil. At
physiological pH and temperature, the sodium bisulfite-induced deamination
rate for cytosine in single-stranded DNA was calculated to be 3.5 x 10-1° sec -1 as
compared to 0.6 x 1040 sec -1 for untreated DNA (42). When low levels of
sodium bisulfite (10 mM) were used under physiologically relevant
conditions, C-*T transition mutations were detected (42). Under identical
reaction conditions, the rate of cytosine deamination within a four-base target
in a double-stranded DNA substrate ranged between 0.06 x 10-10 and 0.36 x 10-1°
sec-1 and also showed a sequence context effect (43). Sequencing of revertants
showed that all mutations were C--->T point mutations and CC -.TT tandem
double mutations (43). The presence of tandem double mutations suggested
that bisulfite-induced deamination can occur by a concerted mechanism8
promoting deamination events between two neighboring cytosine residues,
an event previously attributed to UV-damage (43). These events were found
to be time and bisulfite concentration-dependent (43).
1.1.2.3 UV-induced Deamination of Cytosine
Ultraviolet (UV) irradiation (<300 nm) of DNA produces multiple
cytosine photoproducts, including monomeric species such as cytosine
hydrate (6-hydroxy-5,6-dihydrocytosine) and cytosine glycol (90, 199) and
dimeric species such as cyclobutyl pyrimidine-pyrimidine dimers (C<>T,
T<>C, C<>C) and the pyrimidine-pyrimidone 6-4 photoadducts (199).
Although the quantum yield of cytosine photohydrates is lower (-1-2 %) than
that of dimeric cytosine photoproducts, both lesions are potentially mutagenic
when formed in DNA (166).
Cytosine hydrate is potentially mutagenic because it forms a base pair
with thymine or cytosine rather than the complementary guanine during
DNA replication (136). Cytosine hydrates are removed from E. coli and
mammalian genomic DNA by the pyrimidine hydrate-DNA glycosylase
activities of E. coli endonuclease III and the related mammalian homologue
(4, 23). If left unrepaired, the intrinsic instability of this cytosine derivative
for deamination can produce a uracil hydrate that forms a base pair with
adenine during DNA replication (136). Elimination of a water molecule from
uracil hydrates ultimately generates uracil (23). UV-induced cytosine hydrates
were shown to persist in irradiated poly(dG-dC) for extended periods of time,
resulting in the formation of uracil hydrate and uracil at neutral pH (24). A
later study demonstrated that formation of uracil hydrate was greatest at
acidic pH (pH 3.1>5.4>7.4) at 37°C and dehydration of uracil hydrate to uracil
was a rare event (193). This result suggested that the mutagenic properties
associated with UV-induced cytosine hydration is a consequence of its
mispairing properties and its propensity to deaminate to the uracil hydrate.9
The mode of UV-induced mutagenesis associated with cyclobutyl
pyrimidine-pyrimidine dimers (CPDs) is a controversial issue and several
models have been proposed. One model involvesa misincorporation/bypass
DNA synthesis reaction, involving replication across a UV lesion by DNA
polymerase (28). In this model, an incorrect nucleotide is incorporated
opposite the damage (usually adenine) and bypass replication fixes the
mutation, precipitating C -T transitions (28). A sensitive bioassay system
using the X cro reporter gene in E. co/i indicated that cytosine deamination in
CPDs following UV-irradiation follows first order kinetics witha rate
constant of 3.9 x 10-5 sec-1, or a half-life of -5 hours, and -93 % of the
mutations were C-IT transitions (8). This half-life was increased to -12 hours
under physiological salt conditions (8). These results suggested that at least in
E. co/i, the rate of deamination of cytosine-containing dimerswas too slow to
contribute to UV-induced mutagenesis and suggested mutation fixation bya
replication bypass mechanism (8).
The second model suggests that the high rate of cytosine deamination
to uracil within CPDs results in a high degree of GC-->A0T transition
mutations (201, 227, 240). Early studies demonstrated that cytosine residues in
cyclobutyl pyrimidine-pyrimidine dimers could rapidly deaminate to form
uracil (240). Irradiated poly dI:dC containing cytosine dimerswas shown to
deaminate to uracil with a half-life of -2 hours at 37°C (240). By usinga
natural DNA substrate, the rate constant for cytosine deamination ina C<>C
cyclobutane pyrimidine dimer was 1.5x 10' sec-1, corresponding to a half life
of -5 days (201). In a separate study, the deamination rateconstants for
cytosine in a C<>T dimer at two different sites were 5x 10-6 and 11 x 10' sec-1
and corresponded to half-lives of 38 and 17 hours, respectively (67).
Following deamination and subsequent photoreactivation of the uracil-
containing dimer, accurate replication past the uracil could fix the C -T
transition mutation by incorporation of an adenine opposite the uracil. This10
model was later amended because the delayed appearance of C-->T transition
mutations in E. coli suggested that the DNA polymerase is blocked at cytosine-
containing dimers (267, 268). Tessman and co-workers suggested that
following deamination, however, the replication machinery was able to
correctly replicate past the uracil-containing dimers (267, 268). Another study
by Jiang and Taylor showed that UV-induced C-->T mutations at pyrimidine
dimer sites could be introduced by replicative bypass of cyclobutane dimers or
their deaminated products (113).
1.2Uracil-DNA Glycosylases
Uracil-DNA glycosylase is ubiquitously distributed in nature and
provides the first catalytic step of the uracil-DNA BER pathway (38, 121, 135,
146). The catalytic mechanism of the enzyme involves hydrolysis of the N-
glycosylic bond linking the uracil base to the deoxyribose phosphate backbone
of DNA (146). The substrate specificity of uracil-DNA glycosylase includes
removal of uracil residues that arise in DNA by dUMP incorporation or
cytosine deamination in both prokaryotes and eukaryotes. The biological
importance of this enzyme is underscored by its high degree of evolutionary
conservation, as indicated by the -56 % amino acid sequence homology
between proteins isolated from E. coli and humans (196). These similarities
suggest a degree of conservation that interrelates the structural and functional
elements of this enzyme.
1.2.1Escherichia coli Uracil-DNA Glycosylase
Uracil-DNA glycosylase (Ung) was the first DNA glycosylase to be
discovered and was purified to apparent homogeneity from E. coli (146). As
determined by hydrodynamic properties and sodium dodecyl sulfate
polyacrylamide gel electrophoresis, the active monomeric enzyme was
calculated to have a molecular weight of -24,500 daltons (146). Subsequently,11
the uracil-DNA glycosylase gene (ung) was cloned and overexpressed in E. coli
to more than 100-fold above the levels in a wild-type cell (60). The open
reading frame of the ung gene encoded a protein of 229 amino acids with a
molecular weight of 25,664 daltons (284). N-terminal sequence analysis
indicated that the N-terminal methionine residue was post-translationally
removed, a phenomenon common to many prokaryotic proteins (284).
Cloning and overexpression of large quantities of E. coli Ung have helped to
enable a more complete characterization of its biochemical properties.
Uracil-DNA glycosylase does not require divalent metal ions or other
cofactors for activity and catalyzes the hydrolytic removal of uracil from
single-stranded DNA or double-stranded DNA containing UA base pairs and
UG mispairs (16, 146). The reaction products following hydrolysis are free
uracil and an apyrimidinic site in the DNA (146). Unlike dUMP in long
stretches of DNA, free uracil is not hydrolyzed from RNA, dUMP, or
deoxyuridine (146). E. coli Ung also catalyzes the removal of 5-fluorouracil
from DNA (159) and the cytosine-derived oxidative DNA damage products, 5-
hydroxyuracil and 5,6-dihydroxyuracil (95, 317). The modifying groups at the
C5 or C6 position of these uracil base analogues apparently do not exclude
binding in the uracil-binding pocket of the enzyme. However, larger
modifying groups at the C5 position of uracil, such as those present on
thymine, 5-methylcytosine, or 5-bromouracil, sterically hinder binding in the
uracil-binding pocket and thus cannot be positioned for enzyme-catalyzed
hydrolysis (143, 168).
Uracil-DNA glycosylase utilizes single-stranded DNA substrates -2-fold
more efficiently than double-stranded substrates (16, 146). On the subject of
double-stranded DNA substrates, the enzyme preferentially excises uracil
residues mispaired opposite guanine (UG) -2-fold more efficiently than
uracil residues base paired opposite adenine (UA) (16, 124, 286). The
sequence context surrounding the uracil was found to be another important
determinant for the rate of uracil removal from UA base pairs or UG12
mispairs (192). For example, uracil removal from the consensus sequence 5'-
(A/T)UA(A/T)-3' was -17-fold greater than removal from the consensus
sequence 5'-(G/C)U(T/G/C)-3' in an analysis that involved 70 different
nucleotide sequences (192). In general, sequences that were GC-rich or
contained a T located to the 3' side of U were poorly repaired although a few
exceptions deviated from this rule (192). Good consensus sequences notably
were AT-rich (192). Although Ung prefers single-stranded DNA substrates,
excision of uracil from loop regions of hairpins was shown to be inefficient,
probably because the conformation of the sugar-phosphate backbone is not
conducive for efficient binding by the enzyme (124). This phenomenon
might provide an explanation as to why some dUMP residues in single
stranded. M13 DNA are poorly cleaved and result in areas of higher mutation
frequency (51). In the presence of single-stranded DNA binding protein, the
hairpin structures are melted and Ung can efficiently remove the uracil
residue (125). Together, both sequence context and DNA structure potentially
influence the efficiency of uracil excision which can directly impact the
mutation frequency at specific sites in genomic DNA.
The Km value for dUMP residues in DNA has been reported to be 40 nM
and the turnover number of uracil-DNA glycosylase is -800 uracil residues
released per minute (146). Ung was shown to be noncompetitively inhibited
by free uracil for single-stranded (Ki = 2 mM) and double-stranded (K, = 0.12
mM) DNA substrates. A limited number of uracil derivatives, such as 6-
aminouracil, 5-azauracil, and 5-fluorouracil but not deoxyuridine, dUMP,
thymine, 5-bromouracil, 5-aminouracil, 2-thiouracil, and orotic acid, also
inhibited the enzyme activity when tested at concentrations of 4 mM (146).
Ung is competitively inhibited by its other reaction product, the AP site, at
concentrations approximately 2-3 orders of magnitude lower than that of
uracil (58).
Several studies have investigated the minimum substrate size required
for DNA binding and catalysis by uracil-DNA glycosylase. Ung was shown to
remove a 5'-terminal uracil residue from synthetic oligonucleotides only if13
the 5'-end was phosphorylated (285). This suggested that amino acid residues
near the active site pocket of the enzyme might specifically interact with the
5'-phosphate group of uracil in DNA during hydrolysis of the N-glycosyl
bond. Oligonucleotides containing uracil at the 3'-terminus or at the second
position from the 3'-OH end were not excised (285). However, a uracil
residue in the second position from the 3'-terminus could be hydrolyzed if a
3!-PO4 group was present, suggesting another important protein-DNA contact
point required for efficient uracil removal (285). These results suggested that
an oligonucleotide trimer with uracil located at the phosphorylated 5'-
terminus provides the minimum substrate requirement for uracil excision by
uracil-DNA glycosylase. A recent study demonstrated that the
phosphodiester bond 3' to a deoxyuridine residue was crucial for substrate
binding by uracil-DNA glycosylase (217). Together, these studies have
provided initial information concerning potential contact points on a uracil-
containing substrate involved in Ung binding or catalysis.
Several conflicting reports have addressed the mechanism by which
uracil-DNA glycosylase locates and hydrolyzes the N-glycosylic bond at uracil
target sites (16, 101, 216). A distributive mechanism for locating the next
uracil residue following catalysis requires dissociation from the DNA and
random three-dimensional diffusion whereas a processive mechanism is
established when the enzyme remains bound to the DNA and locates
sequential uracil residues by facilitated diffusion (18). Thus, a processive
mechanism substantially increases the likelihood of locating the next uracil
target due to decreased dimensionality in the search.
Higley and Lloyd (101) concluded that uracil-DNA glycosylase acted
with partial processivity at50 mM NaC1 on a covalently-closed circular
duplex uracil-containing DNA substrate when treated simultaneously with E.
coli Ung and T4 endonuclease V. In these experiments, processivitywas
determined by measuring the conversion of Form I DNA to linear Form III
DNA. Form III DNA was produced only following removal of closely spaced14
uracil residues on opposite DNA strands followed by AP-site cleavage by T4
endonuclease V to produce two single-strand breaks. Significant
accumulation of Form III DNA accompanied by unreacted Form I DNA was
observed, which was indicative of a processive "search" mechanism. The
processivity of Ung was also shown to decrease with increasing salt
concentrations, a phenomenon observed for other processive DNA
metabolizing enzymes (91, 266). However, the interpretation of these results
was complicated due to the simultaneous use of T4 endonuclease V during
Ung treatment of the substrate. As demonstrated previously, T4
endonuclease V is a processive enzyme (149)
Contrary to these observations, Purmal and co-workers proposed a
distributive mode of action for uracil-DNA glycosylase (216). This study
utilized a linear double-stranded concatemeric polynucleotide with
deoxyuridine located at every 20th nucleotide along both DNA strands.
Following incubation with Ung, apyrimidinic sites were thermally cleaved
which eliminated the need for the T4 endonuclease V. A rapid accumulation
of larger fragments (>20-mers) was taken to be indicative of a distributive
mechanism. Their interpretation, however, was somewhat compounded
since the uracil residues were closely spaced on both sides of the double-
stranded concatemeric polynucleotide, the uracil targets were located in a
poor consensus sequence (5'-CUT-3') for efficient catalysis, and the analysis
was performed after significant levels of uracil (>95 %) had been hydrolyzed
from the substrate as argued by Bennett et al. (16, 216).
Utilizing a concatemeric polynucleotide substrate with uracil residues
located at intervals of 25 nucleotides on one DNA strand, Bennett, Sanderson,
and Mosbaugh (16) demonstrated that both E. coli and rat liver mitochondrial
uracil-DNA glycosylases located successive uracil residues bya processive
mechanism in the absence of NaCl. These results were identical for both of
the UA- and UG-containing DNA substrates and indicated that the nature
of the uracil target site did not influence the search mechanism. At low ionic15
strength, a rapid accumulation of 25-mers and reduced levels of larger
fragments was observed, which suggested uracil-DNA glycosylase located
sequential uracil residues by a processive "search" mechanism. The addition
of NaCl (50 mM) reduced the processivity of the enzyme on both UA- and
UG-containing substrates (16). These results were consistent with those
previously reported by Higley and Lloyd (101).
1.2.2Mammalian
1.2.2.1 Nuclear and Mitochondrial Uracil-DNA Glycosylase
In mammalian cells, active uracil-DNA glycosylase (UDG) has been
isolated as a monomeric protein from both the mitochondria and the nucleus
(3, 57, 92, 121, 305). Nuclear UDG has been purified from rat liver (57, 58), calf
thymus (65, 260, 261), and human cells (121) and the mitochondrial form of
the enzyme has been extensively purified from rat liver (57, 58). The
biochemical properties of mammalian nuclear and mitochondrial UDGs are
similar to those observed for prokaryotes. Both enzymes hydrolyze uracil
from single-stranded DNA approximately 2-fold more efficiently than from
double-stranded DNA (38, 57, 121, 135), with an approximate 2-fold preference
for UG mispairs over UA base pairs (16, 286). Substrate specificity analysis
has indicated that free uracil was not released from deoxyuridine and dUMP
(57, 261). As demonstrated for E. coli Ung, both the nuclear and
mitochondrial UDG were noncompetitively inhibited by uracil (38, 58, 135)
and were competitively inhibited by apyrimidinic sites (58, 260). AP sites
inhibited mitochondrial UDG at a concentration approximately 3 orders of
magnitude lower than that of free uracil (1.2 11M versus 600 [iM) (58).
Initial reports suggested that the nucleotide sequence surrounding
dUMP residues in DNA were important for mammalian uracil-DNA
glycosylase binding and/or recognition of dUMP asa substrate (58). It was
later demonstrated that an approximate 10-fold difference in the rate of uracil16
excision existed between different DNA sequence contexts utilizing calf
thymus uracil-DNA glycosylase (65). Analysis of 40 different consensus
sequences showed that efficient repair occurred within the DNA sequence 5'-
(A/T)UA(A/T)-3' whereas inefficient repair was observed for the DNA
sequences 5'-(G/C)UT-3' and 5'-(G/C)U(G/C)-3' (65). These good and poor
consensus sequences were identical to those observed for E. coli Ung (65, 192).
Since this DNA sequence phenomenon was not observed in single-stranded
DNA, these results suggested that the stability provided by double-stranded
DNA surrounding the dUMP residues influenced the rate of uracil release
(65).
Mitochondrial and nuclear uracil-DNA glycosylase activities have been
jointly isolated from few biological systems and characterization has been
generally limited to partially purified preparations of each enzyme (92, 305).
An extensive comparison of homogeneous preparations of nuclear and
mitochondria' uracil-DNA glycosylase from rat liver indicated distinct
differences in molecular weight and catalytic properties (57, 58). The nuclear
and mitochondrial species of rat liver uracil-DNA glycosylase have apparent
molecular weights of -35,000 and -24,000, respectively (57). These results are
similar to those of other reports that suggested a high molecular weight
(30,000 to -37,000) for the nuclear enzyme and a lower molecular weight
(18,000 to -20,000) for the mitochondria' species (38, 92, 135, 305). For the rat
liver nuclear uracil-DNA glycosylase, the apparent K. for uracil in DNA was
reported to be 0.5 µM with a turnover rate of -10 uracil residues per minute
(58). In contrast, the rat liver mitochondrial uracil-DNA glycosylase was
shown to have an apparent Km for uracil in DNA of 1.1 RM with a turnover
number of -1000 uracil residues hydrolyzed per minute (58). Despite these
differences, the relatedness of the mitochondrial and nuclear enzymes was
demonstrated by antibody cross-reactivity which suggested that the two
enzymes shared similar polypeptide domains (181, 249, 250).
Immunofluorescence studies also demonstrated a similar relationship in
which the UNG gene product was shown to be translocated to both the17
nuclear and mitochondrial compartments (181, 250). Mitochondrial
translocation was dependent on the N-terminal 77-amino acid UNG
presequence (250). These observations were explicated after it was discovered
that both nuclear and mitochondrial enzymes were encoded by the same
UNG gene (96, 191).
The full length human uracil-DNA glycosylase gene (UNG) has been
isolated and cloned (191, 196). The gene consists of seven exons that encode a
nuclear (UNG2) and a mitochondrial (UNG1) form of uracil-DNA glycosylase
(191). The gene spans a region of approximately 13.5 kb and is located on
chromosome 12q23-q24.1 as determined by radiation hybrid mapping (97).
The mRNAs for both forms are generated from the UNG gene by alternative
transcription start points and alternative splicing (191). Promoter PA is
utilized to produce an mRNA transcript encoding UNG2 and requires
splicing of exon 1A into a consensus splice site located after codon 35 of exon
1B (191). Promoter PB initiates transcription of the UNG1 mRNA beginning
at codon 1 of exon 1B and does not require alternative splicing (191). Thus,
UNG2 (313 amino acids) differs from UNG1 (304 amino acids) in the first 44
amino acids of the N-terminus which are required for nuclear and
mitochondrial import, respectively (191). The remaining 269 amino acids are
identical between both species and constitute the catalytic domain of the
enzyme (191). This structural organization suggests that signals exist in the
divergent N-terminal regions of UNG1 and UNG2 in order to direct each
protein to its respective subcellular location.
A recent study has corroborated the presence of multiple forms of
uracil-DNA glycosylase (UNG1 and UNG2) in HeLa cells that are either
translocated to the mitochondria (UNG1) or the nucleus (UNG2) (178). To
investigate the signals involved in sub-cellular targeting, the N-terminal
regions of UNG1 (77 amino acids) and UNG2 (86 amino acids) were used to
create fusion proteins with a variant of green fluorescent protein (GFP) and
were shown to localize to the mitochondria and nucleus, respectively (178).
Deletion mutation analysis studies indicated that the first 20 amino acids of18
UNG2 contain the nuclear localization signal necessary for nuclear targeting
(178). Interestingly, purified UNG2 migrated as a group of at least three
proteins in the 35,000 to 37,000 molecular weight range when analyzed by
SDS-polyacrylamide gel electrophoresis (178). Transfection of the UNG1/GFP
and UNG2/GFP constructs (containing the N-terminal regions of UNG1 and
UNG2, respectively) into NIH 3T3 cells in the presence of [32P]orthophosphate
demonstrated that UNG2 is differentially phosphorylated on serine and
threonine residues whereas UNG1 is unphosphorylated (178). The
significance of in vivo phophorylation of UNG2 is unknown at present but
such phosphorylation might modulate enzymatic activity or protein-protein
interactions.
Early studies of cultured human cells demonstrated that the expression
of uracil-DNA glycosylase was regulated during the cell cycle (93, 252, 311).
This regulation was shown to occur at the transcriptional level (252). In
synchronized human fibroblasts, transcription of the UNG gene was
upregulated 8-12-fold in the late G1-phase and led to a 2-3-fold increase in
total uracil-DNA glycosylase activity in the early S-phase (252). A
corroborating study demonstrated that uracil-DNA glycosylase activity in the
G2-phase was 2.8-fold greater than that detected in early G1-phase (181).
Analysis of the PB promoter region of the UNG gene demonstrated the
presence of an E2F element, which is known to be involved in cell cycle
regulation of several genes induced in late G1-phase (98, 189). Additional cell-
cycle regulation elements, such as c-Myc and Yi, are also located in the PA and
PB promoter regions of the human UNG gene (98). Levels of both UNG2 and
UNG1 mRNA transcripts have been shown to be increased in late G1-
phase /early S-phase and were accompanied by an approximate 4-5-fold
increase in uracil-DNA glycosylase activity (96). Thus, the coordinated
expression of the uracil-DNA glycosylase gene and translation of the gene
product relative to the S-phase implicates its importance in maintaining the
genetic integrity of the genome prior to DNA replication.19
Crystal structure and mutational analysis of human (117, 167, 168, 251)
and herpes simplex virus type-I (197, 235) uracil-DNA glycosylases have
helped elucidate the DNA binding properties and catalytic mechanism for the
enzyme. The structure of human uracil-DNA glycosylase is closely related to
that of the herpes simplex virus type-I enzyme and consists of a singlea /(3
catalytic domain composed of a central four-stranded parallel and twisted 13-
sheet surrounded by eight a-helices (168). Sequence-conserved amino acids
within and around the UDG a /j3 fold createan active-site groove, with an
area of positive electrostatic potential, approximately equal to the diameter of
a DNA double helix (168, 251). The location of the uracil-binding pocket, deep
in the active-site groove, necessitates that the enzyme recognizes uracil that is
extrahelical or "flipped out" from the double-stranded DNA helix (168).
Structural data of the enzyme complexed with the free uracil analog base, 6-
aminouracil, has indicated that the C2, N3, and C4 positions of uracil interact
through hydrogen bonds with conserved active-site residues (Asn-204, Tyr-
147, and Phe-158) that form part of the uracil-binding pocket (168). These
hydrogen-bonding requirements are not achieved with cytosineso hydrolysis
of the N-glycosidic bond of cytosine does not occur (117, 168). The side chain
of Tyr-147 also helps to createa rigid pocket which discriminates against bases
substituted at the C5 position, such as thymine (168). Mutations at either
Asn-204 (Asn204Asp) or Tyr-147 (Tyr147Ala, Tyr147Cys, and Tyr147Ser)
perturbed ordered interactions within the uracil-binding pocket that normally
provide specific contacts for uracil-recognition and have resulted in mutant
enzymes that hydrolyze cytosine or thymine from DNA, respectively (117).
These studies have helped elucidate the structural mechanism by which
uracil-DNA glycosylase recognizes uracil in preference to the normal
pyrimidines in DNA.
Mutational studies of the uracil-binding pocket of human
mitochondrial UNG1 (lacking the 84 N-terminal amino acids) have been
conducted in order to understand the biochemistry of uracil release (168).20
Four amino acid residues (Asn-204, Gln-144, Asp-145, and His-268)are
absolutely required for catalysis (168). His-268 has been implicated in catalysis
and uracil recognition (168, 251). Two different mechanisms for uracil
hydrolysis by human uracil-DNA glycosylase have been proposed (168).His-
268 potentially could act as the active-site nucleophile (general base) for
cleavage of the N-C1' glycosylic bond and forma transient covalent enzyme-
DNA intermediate between the imidazole group of His-268 and the C1' of the
deoxyribose. Displacement of the uracil followed by hydrolysis of the
transient covalent intermediate would produce free uracil andan AP site in
the DNA (168). Alternatively, hydrolysis of the N-C1' bond could be achieved
by activation of a water molecule through His-268 actingas a general base
(168). Site directed mutagenesis of Ser-270 suggestedan important role for an
interaction with the 3' DNA sugar-phosphate backbone,necessary for
stabilizing the imidazolegroup of His-268 to achieve catalysis (168).
DNA-binding and kinetic analysis of wild-type and mutant uracil-DNA
glycosylases indicated that the Leu-272 residue playsan active role in uracil
recognition and base flipping (168, 251). Structural analysis of human uracil-
DNA glycosylase complexed with uracil-containing double-stranded DNA has
identified five components for uracil recognition and catalysis which has
been described as a "push and pull" mechanism (251). (1) Shape and
electrostatic charge complementarity properly orients DNA into the active-
site groove of the enzyme. (2) Upon encounteringa uracil residue, insertion
of the side chain of Leu-272 into the DNA minorgroove facilitates flipping
("pushing") of the uracil base out of the majorgroove. This is accompanied
by conformational changes in the Leu-272 loop thatpromote the formation of
a stable protein-DNA complex. (3) Specific contacts with the DNA sugar-
phosphate backbonecompresses the DNA to help stabilize the extrahelical
uracil residue. (4) The substrate specificity pocket of theenzyme establishes
required uracil-recognition contacts with the uracil base, thedeoxyribose
sugar, and phosphate groups ("pulling") and aligns the residue for final
productive binding. (5) Polarization of the uracil-deoxyribose N-C1'bond by21
active-site residues promotes hydrolysis of the N-glycosyl bond. Thus,
nucleotide flipping is the established mechanism by which uracil-DNA
glycosylase recognizes uracil residues within duplex DNA.
1.2.2.2 Cyclin-like Uracil-DNA Glycosylase
A human cDNA encoding a uracil-DNA glycosylase of -36,000
molecular weight has been isolated and cloned (176). The amino acid
sequence of the cloned DNA showed limited homology with other uracil-
DNA glycosylases, including those isolated from E. coli (284) and both of the
mitochondrial and nuclear species isolated from human cells (191, 196).
However, significant similarity was shown to exist with the cyclin A protein
family (25-30 % identity and 51 % similarity) (177). Thus, theenzyme has
been called cyclin-like uracil-DNA glycosylase. Transcription and translation
of this cDNA in vitro apparently generated uracil-DNA glycosylase activity
(176). Unfortunately, the biochemical characterization and substrate
specificities of this enzyme at present are relatively incomplete. Uracil-DNA
glycosylase activity is routinely assayed by using UA base pair-containing
native PBS2 [3H]DNA (176) or [3H]uracil- containing calf-thymus DNA (179)as
substrates.
The gene encoding the cyclin-like uracil-DNA glycosylase spans 4.2-kb
and is composed of 2 exons (177). Sequence analysis of the genomic DNA
indicated a 1.4-kb upstream promoter region that lacks TATA and CAAT
boxes but contains an AP2 consensussequence, which mediates
transcriptional activation in response to phorbol esters and cAMP. In
addition, two inverted SP1 consensus sites have been identified that might be
involved in mediating basal constitutive expression (177). Furthermore,a
consensus CCB element and an inverted CCB element are present within the
promoter region and could potentially be recognized as a "half-site by the
transcriptional regulator, E2F (177). Deletion ofan SP1-like binding site and
an inverted CCB element within the promoter region (nucleotides -812 to22
603) suggested this region was responsible for inhibitionor repression of
transcription (177). Analysis of the cyclin-like uracil-DNA glycosylasegene
expression as a function of the cell cycle indicated that mRNA levels
increased 3- to 4-fold during G1 phase andwas accompanied by elevated levels
of uracil-DNA glycosylase proteinas determined by an immunoprecipitation
assay (177). Complete turnover of the enzyme was observed during the
course of one cell cycle (177).
Affinity-purified uracil-DNA glycosylase from He La cellextracts
initially suggested that the cyclin-like uracil DNA glycosylase (termedUDG2
in this study) was the major uracil-DNA glycosylase activity associatedwith
the nucleus (36). Immunostaining with antibodies for the highlyconserved
uracil-DNA glycosylase (termed UDG1 in this study) indicatedit was not
associated with the uracil-DNA glycosylase activity detected in nuclear
extracts and thus was likely associated with the mitochondria (36). However,
earlier work by Slupphaug and co-workers suggested that both the
mitochondrial and nuclear forms of theenzyme were encoded by the same
gene (UNG) and post-translationally processed for subcellular targeting (249,
250). In fact, antibodies raised against the human recombinanturacil-DNA
glycosylase eliminated >98 % of the total uracil-DNA glycosylaseactivity in
He La cell extracts, indicating that the LINGgene encoded both the
mitochondrial and nuclear forms of theenzyme (249). A recent study has
demonstrated that nuclear uracil-DNA glycosylase obtained from HeLa cell
nuclear extracts has a unique 44-amino acid N-terminus anda C-terminal
region that is identical to the catalytic domain of uracil-DNAglycosylase
encoded by the UNG gene (178). Since the proteinsequence analysis did not
confirm the identity of the cyclin-like uracil-DNA glycosylase,it appears that
the major nuclear uracil-DNA glycosylase is encoded by theLING gene as
originally reported by Nilsen and co-workers (191).23
1.3Other Enzymes with UDG Activity
1.3.1Thymine-DNA Glycosylase
Correction of GT mispairs to GC base pairs in DNA following the
deamination of 5-methylcytosine involves excision of the thymine residue by
thymine-DNA glycosylase (TDG) (29, 301). This activity was originally
identified in simian cell extracts and later confirmed as a glycosylase activity
in human cell extracts. Purification of the mismatch-specific TDG activity
from He La cell extracts identified a 55,000 molecular weight protein capable of
hydrolyzing the N-glycosyl bond between the sugar-phosphate backbone and a
mispaired thymine opposite guanine, cytosine, and thymine in the order
GT>>CT>TT (185, 298). No detectable endonucleolytic/lyase activity
toward apyrimidinic sites or 5'-terminal deoxyribophosphate moieties was
observed (185). Interestingly, TDG was also shown to excise uracil froma GU
mispair but not from an AU base pair or uracil-containing single-stranded
DNA (186). Band-shift experiments demonstrated that thymine-DNA
glycosylase had a higher affinity for double-stranded oligonucleotides
containing a GIJ mispair than for those containing GT mispairs (186).
Activity assays demonstrated that uracil was removed from GU mispairs
more efficiently than thymine was removed from G.T mispairs (186). Thus,
aside from counteracting the mutagenic potential of 5-methylcytosine
deamination events within CpG dinucleotide repeats, the uracil-DNA
glycosylase activity of TDG might also function to remove uracil residues that
accumulate as a result of cytosine deamination (186). Since uracil residues
within a sequence context area rich in guanine and cytosine nucleotidesare
poor substrates for mammalian uracil-DNA glycosylase (65), it has been
suggested that thymine-DNA glycosylase could perform this dutymore
efficiently and in place of uracil-DNA glycosylase (186).24
The human cDNA for thymine-DNA glycosylase has been cloned and
contains an open reading frame encoding a 410-amino acid polypeptide (184).
Expression of the cDNA in rabbit reticulocyte lysates and in E. coli yieldeda
polypeptide with an apparent molecular weight of 60,000 that possessed the
same enzymatic activities and substrate specificities as thymine-DNA
glycosylase purified from He La cells (184, 186). Amino acid sequence analysis
did not reveal any regions of sequence homology between the recombinant
TDG and other characterized human DNA glycosylases (184). However, the
core region is homologous (30 % sequence identity) to a mismatch-specific
uracil-DNA glycosylase identified in Escherichia coli (80).
With respect to sequence context specificities, recombinant TDGwas
shown to preferentially hydrolyze thymine from GT mispairs within a CpG
dinucleotide but also processed thymine residues mispaired opposite 06-
methylguanine (m6G) (184) or S6-methylthioguanine (298). A detailed
analysis of the substrate specificity of the recombinant thymine-DNA
glycosylase confirmed that GT mispairs in a CpG context were incised atan
efficiency that was 3- to 12-fold greater than that observed for TpG, GpG, and
ApG sequence contexts (246). The rate of incision was greatest for GT
mispairs (0.7 fmol/min) followed by in6GT mispairs (0.38 fmol/min) and
then 2-amino-6-(methylamino)purineT mispairs (0.15 fmol/min) (246).
This was consistent with the proposal that the primary role of theenzyme
involves repairing GT mismatches that arise through the deamination of 5-
methylcytosine. Recent evidence indicated that the highly mutagenic adduct,
3,N4-ethenocytosine, was also processed by theenzyme (234).
A recent study has measured the kinetics of the action of TDGon Oa
and GI.J mispairs (298). In this report, the 5' flanking base pair next to the
GT mispair influenced the rate of thymine removal with Ica, values of 0.91,
0.023, 0.0046, and 0.0010 min-1 for the consensus sequences CpG, TpG, GpG,25
and ApG, respectively (298). In addition to removing uracil from GU
mispairs, thymine-DNA glycosylase was shown to hydrolyze uracil from
other uracil-containing mispairs in the order GU>CU> TU>> AU
although the kcat values for uracil hydrolysis from these substrateswere not
measured (298). The rate of uracil hydrolysis from an MU base pairwas
observed to be extremely slow. The kcat value for uracil hydrolysis from
double-stranded DNA by the mismatch-specific uracil-DNA glycosylase,a
homologue of thymine-DNA glycosylase, was measured at 0.4 mint (9). The
kcat value for the removal of uracil in double-stranded DNA by human uracil-
DNA glycosylase was measured at 2500 miff' (117). Interestingly, theenzyme
was found to bind tightly to apyrimidinic sites following thymine hydrolysis
and limited each thymine DNA glycosylase molecule toone hydrolysis event
(298). Sibghat-Ullah and co-workers previously observeda limited level of
TDG activity and attributed this phenomenon to enzyme inactivation (246).
Although the physiological significance of this AP-site inhibition is unknown
at present, it is possible that in vivo, the bound glycosylase could nucleate other
enzymes involved in the base excision repair process to facilitate efficient
repair (298). Alternatively, the bound glycosylase might act to block
replication past a potentially mutagenic AP site, a model thatwas previously
proposed for AP-site inhibition of uracil-DNA glycosylase (58).
Transition state destabilization studies using nonhydrolyzable uracil
analogs that preserve TDG binding to the substrate but prevent excision have
been conducted (238). The results of these experiments suggested that the
enzyme contacts a guanine base on the 3' side of the mismatched residue in
the 5'-CpG-373'-GpU-5' sequence context (238). Methylation interference
analysis suggested that the G residue mismatched opposite Uwas not
contacted at the N7 position (238). Thymine mispaired opposite 06-
methylguanine or 2-amino-6-methylaminopurineare efficiently hydrolyzed,
suggesting that the 6- and perhaps the 1-position of guanineare also not
contacted by the enzyme (246). Since the 6- and 7-positions of guanineare26
located in the major groove, it has been suggested that the enzyme recognizes
mismatched guanine residues through interactions in the minor groove
(238). At present, there is no published structural information for human
thymine-DNA glycosylase, although some comparisons have been made with
the structure of the mismatch-specific uracil-DNA glycosylase purified from
E. coli (9).
1.3.2Mismatch-Specific Uracil-DNA Glycosylase
A class of uracil-DNA glycosylases that specifically recognize uracil
residues in double-stranded DNA has been identified in E. coli (80). The E. coli
enzyme has strong amino acid sequence homology to the core region of
human thymine-DNA glycosylase enzyme (80). To distinguish thisenzyme
from the ubiquitous class of uracil-DNA glycosylase, it has been named
mismatch-specific uracil-DNA glycosylase (MUG) (9). The bacterial cDNA has
been cloned and contains an open reading frame encoding a 169-amino acid
polypeptide. Expression of the cDNA in E. coli or rabbit reticulocyte lysates
produced a polypeptide that could hydrolyze uracil from GU mispairs but
not thymine from GT mispairs (80). E. coli MUG was also found to be
inactive on uracil in UA base pairs and in single-stranded DNA (80). Inan
attempt to co-crystallize purified recombinant MUG with a GT mispair-
containing DNA substrate, very high concentrations of the enzymewere
observed to hydrolyze the mismatched thymine residue. This suggested that
MUG was a dual uracil /thymine -DNA glycosylase (9).
The crystal structures of E. coli MUG alone and in complex with AP
site-containing duplex DNA have recently been determined (9).Interestingly,
E. coli MUG shares several structural elements with HSV-1 and human
UDGs, even though significant regions of amino acidsequence homology do
not exist between these two classes of glycosylases (9, 168, 235). Thecore of the
enzyme consists of a central five-stranded I3-sheet surrounded by a-helices27
and a distinct DNA-binding groove with an area of high positive electrostatic
potential (9). This groove is connected to a pocket that penetrates into the
core of the enzyme (similar to that observed in human and HSV-1 UDGs),
suggesting that MUG might employ a nucleotide-flipping mechanism for
uracil removal when bound to DNA (9). The MUG uracil-binding pocket
appears similar to those of both human and HSV-1 UDG and defines the
substrate specificity of the enzyme. On one face of the binding pocket, the side
chain of Phe-30 (corresponding to human UDG Phe-158 and HSV-1 UDG Phe-
191 (283)) has been proposed to provide it -it stacking interactions with uracil,
as previously observed in UDG-base complexes (168, 235). On the opposite
face and along one edge of the pocket, the MUG sequence GINPG (residues 16-
20) displays significant homology to the human UDG sequence GQDPY
(residues 143-147) and the HSV-1 UDG sequence GQDPY (residues 176-180) (9,
168, 235, 283). For both human and HSV-1 UDG, base selection against
thymine is provided by the tyrosine side chain side in the GQDPY sequence
(Tyr-147 from human UDG and Tyr-180 from HSV-1 UDG) and is proposed to
involve steric exclusion of the methyl group at the C5 position of thymine
(168, 235, 283). The corresponding side chain (Gly-20) of E. coli MUG does not
allow for this selection (9). Thus, MUG is able to hydrolyze this base but only
at extremely high concentrations of enzyme (9). Both classes of glycosylase do
provide a mechanism for the prevention of cytosine hydrolysis on the basis of
specific hydrogen bonding interactions within the catalytic pocket (9, 168, 235).
Thus, the mechanism of substrate recognition by E. coli MUG dependson the
structural features of the uracil-binding pocket in a manner similar to that
proposed for uracil-DNA glycosylase.
The proposed catalytic mechanism of MUG involves nucleophilic
attack of the N-glycosidic bond by a water molecule poised between a main
chain carbonyl group and the amide side chain of Asn-18 (9). However,
abstraction of a proton to activate the water molecule toa hydroxyl ion by a
general-base mechanism cannot be provided by the amide side chain of Asn-28
18 (9). This results in a weakly nucleophilic water molecule. Additionally,
the catalytic histidine present in UDG (His-210 in HSV-1 UDG and His-268 in
human UDG), which protonates the 02 of the bound deoxyuridine to
promote hydrolysis, is replaced by an arginine in E. coli MUG and a
methionine in human TDG (9). Neither one of these residues can act as a
general acid. Thus, the MUG/TDG enzymes cannot initiate general base or
general acid-catalyzed hydrolysis and instead most likely relies on weak
nucleophilic attack by a coordinated water molecule (9). This may explain the
several order of magnitude slower rate of uracil excision by E. coli MUG as
compared to human UDG (9).
Unlike uracil-DNA glycosylase, MUG has an absolute requirement for
double-stranded DNA since substrate recognition relies on interactions with
the complementary strand (9). In the MUGDNA co-crystal, hydrogen bonds
are maintained between the enzyme and five phosphate groups of the uracil-
containing DNA strand, including the phosphate groups immediately 3' and
5' to the "flipped-out" uracil residue (9). The gap in the double-stranded helix
left by the extrahelical uracil residue appears to be occupied by a "wedge"
formed by Gly-143, Leu-144, and Arg-146 of the enzyme (9). This structure
provides a similar function to that observed for the conserved leucine "loop"
of UDGs (251). In both cases, this "wedge" enters the DNA base stack via the
minor groove (9). The MUG enzyme makes three absolutely specific
hydrogen bonds with the guanine residue after the uracil is "flipped-out" into
the active-site binding pocket (9). These specific interactions would
purportedly provide the enzyme with a strand discriminatory mechanism (9).
It has also been proposed that although thymine from a TA base pairor
uracil from a 1.1A base pair can fit into the active-site binding pocket, the
unpaired adenine residue does not provide the three required hydrogen
bonds that stabilize the extrahelical base for hydrolysis (9). These
interpretations provide an attractive model for the structural and mechanistic
basis of GU/GT mismatch specificity.29
1.3.3Glyceraldehyde-3-phosphate Dehydrogenase
A human uracil-DNA glycosylase cDNA isolated from human placenta
was reported to direct the synthesis of a fusion protein that exhibited uracil-
DNA glycosylase activity (162). The gene product was a protein of 335 amino
acids and did not exhibit amino acid sequence homology with either E. coli
Ung or human UNG1 or UNG2 (162). However, nucleotide sequence analysis
revealed complete homology with the 36,050-kDa subunit of human
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (162). Human
erythrocyte GAPDH reportedly contains uracil-DNA glycosylase activity but
only after subunit dissociation of the tetrameric form (162). This required
purifying monomeric GAPDH by SDS-polyacrylamide gel electrophoresis
followed by electroelution from the gel slice and renaturation. Some caution
must be noted since human nuclear uracil-DNA glycosylase (UNG2) also
migrates at a molecular weight of about 36,000 and potentially could have
been a contaminant in the GAPDH preparation. Characterization of the
biochemical properties and substrate requirements of the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH)/uracil-DNA glycosylase (UDG) gene
product are relatively incomplete. Uracil-DNA glycosylase activity is
routinely assayed by using a poly (dA[3fI]dU) substrate (162). In order to
determine the relative efficiency of uracil removal by GADPH, purified
GAPDH protein (1.5 p,g) was assayed by using poly (dArlildU) as a substrate
and was shown to exhibit 0.565 units of uracil-DNA glycosylase activity (10).
Based on these results, the specific activity of GAPDH was calculated to be
-377 units/mg of GAPDH. However, the unit definition used in this study to
define the specific activity of GAPDH was 1000-fold lower than that normally
used to define that of E. coli Ung. In order to make the direct comparison, the
specific activity of GAPDH was corrected according to the E. coli unit
definition. The specific activity of GAPDH was re-calculatedas 0.377
units/mg and compared to the specific activity of 2 x 106 units/mg defined for30
E. call Ung. Thus, the specific activity of GAPDH is -5.3 x 106-fold lower than
that of E. coli uracil-DNA glycosylase. Several investigators have reportedan
inability to detect uracil-DNA glycosylase activity associated with GAPDH
purified from human erythrocytes (36, 190, 232, 249). These results suggest
that either GAPDH is a highly inefficient enzyme or the purified GAPDH
preparation examined by Sirover and co-workers (159) may have been
contaminated with uracil-DNA glycosylase.
1.4Bacteriophage PBS2 Uracil-DNA Glycosylase Inhibitor Protein
1.4.1Bacteriophage PBS2
Bacillus subtilis bacteriophages PBS1 and. PBS2 are unique because their
double-stranded genomic DNA naturally contains uracil in place of thymine
residues (259). Nucleotide analysis of PBS1 and PBS2 DNA have indicated
that the guanine plus cytosine (G+C) content represent -28 % of thegenome
whereas the adenine plus uracil (A+U) content constitute the remaining -72
(108, 259). Following bacteriophage infection, the expression of several
early gene products facilitates the incorporation of uracil into the replicating
phage DNA by a phage-induced DNA polymerase (212). Induction of dUMP
kinase (115), dTMP phophohydrolase (213), and dCTP deaminase (273)
activities in addition to inactivation of the host dUTPase activity (214) act
collectively to increase the intracellular dUTP pool while decreasing the dTTP
pool. Preservation of the bacteriophage uracil-DNAgenome is facilitated by a
phage-encoded inhibitor of the host uracil-DNA glycosylase (74).
1.4.2PBS2 Uracil-DNA Glycosylase Inhibitor
The PBS2 phage-encoded uracil-DNA glycosylase inhibitor (Ugi)
protein was originally purified from crude extracts of PBS2-infected B. subtilis
and characterized as a heat-stable, acidic protein of -18,500 molecular weight,
as determined by gel-filtration chromatography (46). Ugi was demonstrated to31
specifically inhibit uracil-DNA glycosylases isolated from a diverse spectrum
of biological species, including Escherichia coli, Micrococcus luteus,
Saccharomyces cerevisiae, herpes simplex virus types 1 and 2, rat liver (nuclear
and mitochondrial), human placenta, and human KB cells, butwas inactive
against DNA glycosylases specific for 3-methyladenine, 2,6-diamino-4-
hydroxy-5-(N-methylformamido)pyrimidine, or hypoxanthine (116, 292, 304).
In retrospect, this would be expected since the amino acidsequence of uracil-
DNA glycosylase has conservatively evolved (-40-56 % identical residues)
between phylogenetically diverse species (196, 283) and showsno homology
with other classes of DNA glycosylases (284). To specifically address uracil-
DNA glycosylase activities in human cells, it has been demonstrated that Ugi
inhibits the nuclear (167), mitochondrial (292), and cyclin-like (36) uracil-
DNA glycosylase enzymes. In contrast, human erythrocyte glyceraldehyde-3-
phosphate dehydrogenase has not been found to bind Ugi, and neither He La
nor recombinant thymine-DNA glycosylase have been shown to be inhibited
by Ugi (80, 186).
The PBS2 ugi gene has been cloned and expressed in E. coli (291).
Expression of the ugi gene was found to reduce E. coli uracil-DNA glycosylase
activity by 14,000-fold but did not alter growth rate. E. coli that produced Ugi
also had a 10-fold-higher spontaneous mutation rate, and supported
productive infection of uracil-containing M13mp19 phage (291). These
physiological properties are consistent with those observed for E. coliung
mutants (62). The complete nucleotide sequence of the ugi gene has been
determined and encodes a highly acidic polypeptide (p1 =4.2) of 9,477 daltons
(84 amino acids) (15, 292). Previous studies had determined that the inhibitor
had a molecular weight of 18,500 daltons, suggesting that Ugi might existas a
homodimer in solution (46, 291). However,mass spectrometry and
sedimentation equilibrium centrifugation studies demonstrated that Ugi
exists as a monomeric protein of -9,475 daltons, whichwas in excellent
agreement with the deduced amino acid sequence of the cloned ugigene (15).32
Finally, Ugi was observed to migrate anomalously as an -3,500 molecular
weight protein during 20 `)/0 SDS-polyacrylamide gel electrophoresis (288).
Inconsistent molecular weight determinations among various analytical
techniques may have resulted from the extreme acidic nature, heat stability,
and/or unusual structural configuration of the inhibitor protein (15).
The secondary and tertiary structures of Ugi were determined by
solution state multidimensional nuclear magnetic resonance (7, 12).
Secondary structural features include two a-helices and five 13-strands
arranged contiguously as al-(31-a2-P2-(33-04-[35 to form an antiparallel (3-
sheet. The inhibitor protein contains 12 glutamic acid and 6 aspartic acid
residues. Seven acidic amino acid residues (Glu-38, Asp-40, Glu-49, Asp-52,
Asp-61, Glu-64, Glu-78), not directly involved in secondary structural
elements, appear in small loop or turn regions that sequentially connect the
I3-strands. In addition, four of the [3-strands contain terminal acidic residues
(Glu-20, Asp-48, Glu-53, Asp-74). The remaining seven negatively charged
residues are located in either the al-helix (Asp-6, Glu-9, Glu-11)or the a2-
helix (Glu-27, Glu-28, Glu-30, Glu-31). The a2-helix is partitioned intoa
hydrophobic face and a charged face where the four glutamic acid residues
project (12).
Several unique features of Ugi suggest that the negatively charged
amino acids of the Ugi protein play an important role in mediating the
Ung/Ugi interaction. First, the overall electronegative potential of the Ugi
protein, engendered by its high (21 %) Glu and Asp content, is quite unusual
(15, 292). Second, the NMR structure shows that 11 of the 18 Glu and Asp
residues terminate the (3-strands or are located in themore flexible loops in a
nonrandom distribution (7). Third, the tertiary structure brings together
seven of these residues (Glu-20, Asp-48, Glu-49, Asp-52, Glu-53, Asp-74, and
Glu-78) into close proximity on one surface of the Ugi protein, forminga
unique structural element (12). The negative electrostatic potential of this33
region is >6.6 kcal, similar to that generated by the phosphate backbone of
DNA (12). Fourth, both the al and a2 helices contain regions with similar
high electronegative potential (12). Involvement of these negatively charged
amino acids in UngUgi complex formation have been specifically addressed
by selective chemical modification techniques and site-directed mutagenesis
studies (152, 231).
The ugi gene from bacteriophage PBS1 has been cloned and reportedto
have an identical nucleotidesequence to that previously documented for the
ugi gene cloned from bacteriophage PBS2 (236). By inference, this indicated
that the PBS1 and PBS2 Ugi primary amino acidsequences should also be
identical. However, several discrepancies existed between the deduced amino
acid sequence reported for PBS1 Ugi (237) and that reported for PBS2 Ugi (292).
Savva and Pearl (237) have stated that the X-ray crystal structure of PBS1 Ugi,
observed in the UngUgi complex with HSV-1 uracil-DNA glycosylase,
consisted of 83 amino acid residues as would be expected if the N-terminal
Met was removed from an 84 amino acid polypeptide. However, the reported
amino acid sequence of PBS1 Ugi contained only 82 amino acids, including
three amino acid substitutions (237). These amino acid substitutions in PBS1
Ugi relative to PBS2 Ugi included Glu-30-4Ala -30, Glu- 38 --Gly -38, and Lys
66 -.Gly -66. The smaller size of the PBS1 Ugi was explained byan amino acid
deletion of Asn-35. Contrary to the published amino acidsequence of PBS1
Ugi (237), the amino acid spatial coordinates of PBS1 Ugi obtained from the
"UDI Protein Data Bank Full Table Release" database indicated complete
amino acid sequence homology between PBS1 and PBS2 Ugi. Thus, the
discrepancies in the literature for PBS1 must be incorrectly reported and PBS1
and PBS2 Ugi are identical proteins.34
1.4.3Mechanism of Uracil-DNA Glycosylase Inhibitor Action
Ugi physically associates with E. coli uracil-DNA glycosylase (25,664
daltons) to form a complex of -35,400 molecular weight thatwas shown to be
essentially irreversible under physiological conditions (15, 292). Free Ugiwas
unable to exchange with Ugi bound ina preformed UngUgi complex,
emphasizing the stability of this interaction (17). The UngUgi complex
exhibited a 1:1 stoichiometry of enzyme to inhibitor protein (15). Recovery of
Ung and Ugi from a dissociated complex followingurea treatment/SDS-
polyacrylamide gel electrophoresis revealed that the mechanism of inhibitor
action involved protein binding only and did not involve covalent protein
modification as a mode of inhibition (15). The association of Ugi with Ung
prevented enzyme binding to DNA and also dissociatedan UngDNA
complex, suggesting that Ugi binds ator near the DNA binding site of the
enzyme (15, 17). Several other observations have supported this
interpretation: (i) photochemical cross-linking of Ung to single-stranded
oligonucleotide dT20 prevented Ugi binding to Ung (14); (ii) inclusion of Ugi
in UV-induced cross-linking reactions prevented formation of the Ungx dT20
cross-link (14); and (iii) X-ray crystallographic studies of Ugi complexed to the
human (167, 168) and herpes simplex virus type-I (237) uracil-DNA
glycosylases revealed that Ugi binds within the DNA binding domain of the
enzyme and mimics the structure of DNA.
Stopped-flow kinetic analysis have indicated that the association of
Ugi with Ung involves a two-step kinetic mechanism (17). The firststep is
initiated by a reversible Ung/Ugi interaction to forma precomplex,
distinguished by a dissociation constant (Kd) of 1.3 RM. The second step
results in the formation of the final irreversible UngUgi complex
characterized by the rate constant k=195 sec-1. Thus, complex formation
involves a preliminary "docking" step followed bya "locking" reaction
through which the two proteins achieve optimal alignment and becomevery35
tightly bound. The slower transition to the locked configuration suggests that
one or both proteins experience a conformational change in structure (17).
Inhibition of Ung occurs, since the UngUgi complex fails to recognize the
DNA substrate (15, 17).
1.4.4Structure of UDG-Ugi Complex
The X-ray crystal structures of Ugi complexed with human placental
(167) and HSV-1 (237) UDGs have been determined. The structures of human
(251) and HSV-1 (235) UDG in complex with Ugi exhibit minor structural
changes when compared to the X-ray crystal structure of the respective free
enzymes. At this point in time, an X-ray crystal structure of uncomplexed Ugi
has not been published. The structure of PBS1 Ugi in complex with the HSV-
1 UDG is essentially identical to that observed for PBS2 Ugi in complex with
the human enzyme (237).
A comparison of the free and complexed tertiary solution structures of
Ugi, as determined by nuclear magnetic resonance, indicate that Ugi
undergoes a conformational change upon binding to E. co/i Ung (12, 152). All
of the secondary structural elements and the tertiary structure of the p2433-04-
05 portion of the antiparallel I3-sheet remain relatively unchanged. However,
the polypeptide segments containing the al- and a2-helix undergo structural
rearrangement. Other conformational changes include twisting of the (31-
strand and a reorientation of the loop between the (33- and I34-strands. The
occurrence of these structural transitions potentially mediate the "locking"
reaction involved in the kinetics of UngUgi complex formation.
1.5Uracil-Initiated Base Excision Repair in Escherichia coli
Initial evidence for delineating enzyme components of the uracil-
initiated BER pathway was obtained from studies utilizing various E. co/i36
mutants, particularly dut mutants which are defective in dUTPase (105).
Studies of dut ung double mutants indicated a requirement for uracil-DNA
glycosylase whereas dut xth, dut polA, and dut lig double mutants were
conditionally lethal under circumstances where any of the single mutations
were not (265, 280, 297). These results suggested that uracil-DNA glycosylase,
exonuclease III, DNA polymerase I, and DNA ligase, respectively, were
essential components of the base excision repair pathway for uracil-
containing DNA in E. coli.
The initial step of the uracil-initiated base excision repair pathway
requires hydrolysis of the N-glycosyl bond linking the uracil base to the DNA
deoxyribose phosphate backbone. This is catalyzed by uracil-DNA glycosylase,
which acts to release free uracil and generate an apyrimidinic site (146).
Subsequently, a class II AP endonuclease incises the phosphodiester backbone
on the 5'-side of the AP site (172). There are several endonucleases in E. coli
that could participate in the incision of AP site-containing DNA. In vitro
studies have demonstrated that exonuclease III represents 80-85 % of the AP
endonuclease activity in crude extracts (300), whereas endonuclease IV
constitutes approximately 10 % of this activity (148). Both exonuclease III and
endonuclease IV are class II endonucleases. Other potential participants
involved in processing AP sites are endonuclease III, which cleaves to the 3'-
side of the AP site, (296) and endonuclease V, which cleaves uracil-containing
DNA (81). Following AP-site incision by a class II AP endonuclease, the BER
substrate intermediate is a nick containing a 3'-OH terminus and a 5'-
terminal deoxyribose phosphate (dRp) moiety. The 31-0Hgroup provides an
appropriate primer-terminus for DNA polymerase I (173). However, the 5'-
dRp residue must be removed in order to complete the BER pathway.
Excision of the 5'-dRp moiety must be conducted in connection with
gap filling DNA synthesis. In vitro studies with E. coli DNA polymerase I
demonstrated that 5'-terminal dRp residues located at strand breaksare
subject to strand displacement synthesis rather than DNA polymerase-
catalyzed nick translation synthesis (173). This suggested that another37
enzyme was responsible for removing the dRp residue. In principle, the dRp
residue could be enzymatically excised in its free form or as part ofa small
oligonucleotide. While the previous observation suggested that DNA
polymerase I may not efficiently remove the terminal dRp residue priorto
conducting DNA synthesis, other studies have indicated that the 5'3'
exonuclease activity of DNA polymerase I may liberate dRpas part of a small
oligonucleotide (5). The AP lyase activity of endonuclease IIIwas also
considered as a candidate for the removal of dRp (70, 138). However, this
enzyme was found not to be capable of cleaving on the 3'-side of a dRp
residue following hydrolytic incision on the 5'-side by a class II endonuclease
(70, 138). Further studies have suggested that the most likely candidate isa
DNA deoxyribophosphodiesterase activity that actson dRp-containing
termini formed from endonucleolytically incised AP sites (70). The product
of this reaction is free dRp. This protein, termed dRpase, hasa molecular
weight of -50,000 and has no detectable intrinsic exonuclease, AP
endonuclease, or DNA phosphatase activity (70). The relationship between
purified dRpase and the red gene productwas recognized following
biochemical characterization of these two proteins (55). Thered gene encodes
an enzyme with a 5>3' single-strand specific exonuclease activity that has
previously been implicated in recombinational DNA repair (151). Similarly,
purified dRpase was found to containa 5'.-43' single-strand specific
exonuclease activity with identical properties to that of the purifiedred gene
product (56). Furthermore, the Rec J proteinwas shown to possess dRpase
activity (55). From this study, it was concluded that the redgene encoded the
dRpase enzyme. The BER substrate intermediate produced by the combined
action of uracil-DNA glycosylase, AP endonuclease, and dRpase/Rec J isa
one-nucleotide gap with 3'-OH and 5'-PO4 termini. This substrate
intermediate will support DNA repair synthesis and ligation by DNA
polymerase I and DNA ligase, respectively.38
The role of E. coli DNA polymerase I in excision repair was first
recognized in genetic analysis of E. coli mutants (52, 280, 281). It was observed
that the introduction of DNA polymerase I or DNA ligase mutations into E.
coli dut mutants reduced the rate of the joining of short Okazaki DNA
fragments (280). These results implied a role for DNA polymerase I and DNA
ligase in the excision repair of uracil-containing DNA.
The entire BER reaction has been reproduced by using cell extracts
derived from E. coli and the prevalent repair reaction productswere found to
contain repair patches of one nucleotide (54). This indicated that the 5'>3'
exonuclease or strand displacement activities of DNA polymerase I did not
significantly participate in the removal of the 5-terminal dRp moiety (54).
Specifically, more than 70 % of the repair patches involved the incorporation
of a single nucleotide (54). This suggested that the BER pathwaywas largely
conducted as a concerted series of reactions.
Reconstitution of the uracil-initiated BER pathway was achieved using
five purified enzymes from E. coli (uracil-DNA glycosylase, AP endonuclease
IV, Rec J, DNA polymerase I, and DNA ligase) (53). As observed for BER in
cell extracts, in vitro DNA repair synthesis primarily involved the
incorporation of a single nucleotide and was dependenton the Rec J protein
(54). Thus, it appeared that the 5'-terminal deoxyribose phosphatewas
released as a free dRp residue to generate a one-nucleotidegap for
subsequently acted upon by DNA polymerase I and DNA ligase (53). An
alternative pathway was proposed to explain the -30 `)/0 of the repair patches
that involved the incorporation of twoor more nucleotides. This pathway
involved excision of the dRp residueas part of a small oligonucleotide by the
structure-specific 5' nuclease activity of DNA Pol I and generated larger repair
patches due to strand displacement DNA synthesis (53). The resultswere
similar to those observed with E. coli crude cell extracts, suggesting thatno
additional proteins or cofactors are required for BER (54).39
1.6Eukaryotic DNA Polymerases
Six different polymerases have been identified in eukaryotic cells and
are designated DNA polymerase a, 13, 5, e, y, and(289). Three essential
replicative DNA polymerases, a, 5, and E, and two non-replicative
polymerases, 13 andare located in the nucleus whereas DNA polymerase 7 is
localized to the mitochondria. DNA polymerase y is responsible for
replication of the mitochondrial genome and presumably mitochondrial
DNA repair processes as well. DNA polymerases 5 and e appear to be linked
to BER in eukaryotic cells and DNA polymerase 13 has been strongly
implicated in mammalian BER. The evidence for the involvement of these
three DNA polymerases in BER will be described in a succeeding section of
the "Introduction". As eukaryotic cells displaya complex mixture of DNA
polymerases, general overview of each is described below.
The DNA polymerase a/primase complex is composed of a 165-180-
kDa "core" catalytic subunit (pol a),a 70-kDa subunit with no detectable
enzymatic activity, and two smaller subunits of 49- and 58-kDa that are
associated with the primase activity (289). The 70-kDa subunit appears to act
as a molecular tether between T antigen and the catalytic subunit of pol a and
it has been suggested that this interaction promotes DNA chain initiation at
the origin of replication and/or promotes DNA priming and synthesison the
lagging strand template (45). All subunits have been purified to apparent
homogeneity and cDNAs have been cloned and characterized froma wide
range of phylogenetic species (78, 289). The main function of the pol
a/primase complex is to synthesize short RNA primers and elongate them
into DNA primers (Okazaki fragments) for both leading and lagging strand
DNA synthesis during replication (287, 288). Pol a is the only DNA
polymerase with an associated primase activity and lacks associated40
endonuclease, 5'-->31 exonuclease, and 3'>5' proofreading exonuclease
activities (289).It is moderately processive and has surprisingly high fidelity,
even without an intrinsic 3'>5' exonuclease activity. Pol a is especially
sensitive to aphidicolin and butylphenyl dGTP but not dideoxynucleoside
triphosphates (ddNTPs).
DNA polymerase(pol (3) is the smallest naturally occurring
eukaryotic DNA polymerase and has been purifiedas a single polypeptide of
39- to 45-kDa from a variety of vertebrate sources (41, 257, 264, 290, 310).
Purified human pol 13 does not catalyze detectable levels of dNTPturnover,
pyrophosphate exchange, or pyrophosphorolysis and lacks intrinsic
endonuclease, 31-->5' exonuclease, and 5'>3' exonuclease activities. Recently,
it was demonstrated that rat pol 13 contained an intrinsic deoxyribophospho-
diestersase (dRpase) and AP lyase activity, both associated with the N-
terminal 8-kDa domain (157, 208). Pol 13 from human, rat, and Xenopus laevis
have been cloned and overexpressed in E. coil in order to accurately examine
biophysical properties and structure-function relationships of the purified
recombinant enzymes (1, 49, 220). Recombinant pol p, in allcases, was
virtually indistinguishable from the naturalsource of pol 13 in terms of size,
template-primer specificity, antigenicity, and lack of associatedexo- and
endonuclease activities. The recombinantenzymes were found to be fully
active as compared to purified enzymes from the originalsource. Pol 13 is not
inhibited by aphidicolin, is inhibited weakly by butylphenyl dGTP, and is
strongly inhibited by ddNTPs.
DNA polymerase 5 (pol 5) is a heterodimer with subunits of
approximately 125-kDa and 48-kDa (103). Both subunits have been purified to
apparent homogeneity and cDNAs have been cloned from mammalian cells
for characterization (44, 48, 102, 312, 318). In additionto the polymerase
activity, the 125-kDa catalytic subunit containsan intrinsic 3' -5' proofreading41
exonuclease activity which readily distinguishes it from Pol-a and Pol-f3 (308,
319). This activity hydrolyzes mismatched termini with significantly greater
efficiency than base-paired termini. As of yet, the function of the small
subunit is still unknown. The low processivity of pol 8 was stimulated in the
presence of PCNA on long stretches of single-stranded DNA templates (263).
Pol 5 has been implicated as the leading strand DNA polymerase during DNA
replication as well as completion of lagging strand DNA synthesis of each
Okazaki fragment (278, 288). Pol 6 also occupies important roles in nucleotide
excision repair, base excision repair, and VDJ recombination (103, 289).
The catalytic properties of pol 6 must be considered in the context of
two auxiliary proteins, called proliferating cell nuclear antigen (PCNA) and
replication factor C (RF-C). Non-specifically bound RF-C loads PCNA directly
onto double-stranded DNA in an ATP-dependent fashion to form a protein
complex clamp that tracks along the DNA untila 3'-OH primer-template
junction is encountered, where the complex is transformed intoa competent
clamp (206). Subsequently, pol 6 stably associates with the PCNA/RF-C
complex in a replication competent fashion (207) (34). PCNA stimulates the
activity and processivity of the heterodimer but hasno effect on the isolated
catalytic subunit, indicating that the -50 kDa subunitappears to be necessary
for the stimulation of processivity by PCNA (87).
DNA polymerase a (pol a) purified from human cells consists ofa
catalytic 255-kDa subunit and smaller 55-kDa subunit. Like pol 8, pola also
has an intrinsic 3'>5' proofreading exonuclease activity associated with the
255-kDa subunit (258). Pol a can be biochemically distinguished from pol 5 by
its moderate processivity in the absence of PCNA andan apparent low
stimulation of processivity in its presence (258). A role for pola in DNA
replication is presently unclear but several lines of evidence have indicated
that this polymerase has a role in DNA repair, including nucleotideexcision42
repair, base excision repair, and DNA double-strand break repair (289). Both
pol 8 and polare sensitive to aphidicolin but are resistant to ddNTPs.
DNA polymerase y (pol y) isolated from humans is a heterodimer
composed of a 140-kDa subunit and a 54-kDa subunit (89). Both subunits
have been purified and the cDNAs for the large subunit have been cloned
from a variety of organisms, including Drosophila melanogaster (139), Xenopus
laevis (314), and humans (226). Biochemical characterization of the large
subunit demonstrated the presence of both DNA polymerase activity and
3'-->5' exonuclease activity in the absence of anyaccessory factors (88, 139).
The small subunit has been proposed to enhance the interaction between the
catalytic subunit and the DNA and to increase processivity (88). Several
studies have documented repair ofsome types of damage in mitochondrial
DNA, including damage by purine base alkylating agents (180) and bleomycin
(243), and suggest a possible role fora BER mechanism in mitochondria.
Recently, a combination of a mitochondria' class II AP endonuclease, poly,
and mitochondria' DNA ligase purified from X. laevis mitochondriawere
found to be capable of conducting complete repair of AP site-containing DNA
(204). Thus, in addition to a role in mitochondrial DNA replication, pol
apparently participates in DNA repair synthesis. Poly is inhibited by ddNTPs
but is resistant to the inhibitory effects of aphidicolin.
DNA polymerase(pol C) was originally identified in S. cerevisiae as a
heterodimer composed of the REV3 and REV7gene products (187). The S.
cerevisiae REV3 and REV7 cDNAs have been cloned and encoded polypeptides
with predicted masses of -173-kDa and -29-kDa, respectively (169, 276).Pol
is thought to conduct error-prone translesion DNA synthesisacross damaged
DNA templates in yeast andwas demonstrated to replicate past a thymine-
thymine dimer, a lesion that inhibits DNA synthesis, withan efficiency of -10
% (187). It has also been implicated in mutagenesis associatedwith double-
strand break DNA repair (106). The polymerase activity associatedwith the43
REV3 subunit is nonprocessive and appears to lack 3'>5' proofreading
exonuclease activity (187). Recently, the human homologue of the REV3gene
has been cloned and found to encodea polypeptide with a predicted mass of
-- 353 -kDa (84). Further characterization of this gene product should promote
a better understanding of translesion DNA repair synthesis in human cells.
Pol C is insensitive to aphidicolin and ddNTPs but moderately sensitiveto
butylphenyl dGTP (187).
1.7Uracil-Initiated Base Excision Repair in Eukaryotes
The general strategy of the BER pathway in eukaryotic cells is similarto
that of E. coli and entails a multienzyme repairprocess involving base release,
phosphodiester bond incision, deoxyribose phosphate removal, DNA
synthesis, and DNA ligation (122, 171). Uracil-DNA BER is initiated bya
uracil-DNA glycosylase that releases the free uracil base togenerate an
apyrimidinic (AP) site (171). The AP-site produced during uracil-initiated
BER is also a common intermediate in the repair of several othertypes of
DNA damage involving N-glycosylic bond hydrolysisor spontaneous
depurination/depyrimidation events (142, 144). The second step of the
pathway requires hydrolysis of the phosphodiester bondon the 5' -side of the
AP site by a class II AP endonuclease (172). This generatesa 5'-terminal
deoxyribose-phosphate group that is subsequently removed bya
deoxyribophosphodiesterase (dRpase) activity. Thus, the initial reactionsteps
of the uracil-DNA BER pathway generatea one-nucleotide gap with 3'-OH
and 5'-PO4 termini in a process that is highly conserved from microorganisms
to man. In eukaryotes, recent studies have demonstrateda functional
redundancy at the DNA synthesis and DNA ligation steps (53, 77, 183). This
leads to one of two alternative pathways for DNA repair synthesis and
ligation. As a result, repair patchesare heterogeneous in size. The major
pathway in higher eukaryotesappears to be dependent on pol p and results in44
the synthesis of a one-nucleotide repair patch (123, 183, 247). The minor
pathway is PCNA-dependent, implying a role for pol 8 and/ore in the DNA
synthesis step, and results in the incorporation ofup to 7 nucleotides (77, 158,
183). Unlike short-patch repair, long-patch BER most likely dependson
strand displacement and/or exonuclease activity tocarry out additional DNA
synthesis. Five distinct DNA ligases (I, II, III, IV, and V) have been identified
in proliferating human cells (145, 224, 275, 299) but their definitive role in
BER remains to be elucidated (35, 215, 299).
The entire BER reaction has been detected by using cell extracts derived
from S. cerevisiae (294, 295), X. laevis (155, 156, 158), hamster (76), bovine (247),
and human cells (54, 183). Experimental approaches involving genetic
analysis, DNA polymerase inhibitors, neutralizing antibodies, and
reconstitution systems have provided valuable insights into delineating the
enzymatic components of short- and long-patch eukaryotic BER.
Short-patch BER appears to be dependenton the dRpase activity
associated with the 8-kDa N-terminal domain of Pol-13 (157). This observation
suggested that pol p conducts two consecutive steps (dRp removal and DNA
repair synthesis) of the BER pathway. Alternatively, anotherenzyme has also
been partially purified from human cells that catalyzes the release of 5'-
terminal deoxyribose phosphate residues from abasic sites when previously
incised with AP endonuclease (211). If this activitywere to function in short-
patch BER, it would requireaccess to the AP site prior to cleavage by the
dRpase activity of pol 13. Removal of the 51-terminal dRpgroup during long-
patch BER most likely dependson strand displacement synthesis by DNA
polymerases followed by a structure-specific endonuclease activity.In this
case, the release of the 5'-terminal dRp moiety could occur as part ofa short
oligonucleotide. Experimental evidence for all of these mechanismsis
described in more detail below.
The exclusive participation of pol p in eukaryotic BERwas initially
observed in studies utilizing DNA polymerase inhibitorsand neutralizing45
antibodies in order to inhibit DNA synthesis associated with BER.
Experiments with He La cell nuclear extracts supplemented with ddCTP
demonstrated that mismatch-specific thymine-DNA glycosylase and pol
exclusively mediated the repair of Oa mismatches by the short-patch BER
pathway (302). In a separate study, a pol 3 neutralizing polyclonal antibody
and ddCTP were shown to completely inhibit uracil-initiated BER ofa
synthetic 51-bp uracil-containing duplex DNA substrate (247). These
observations indicated that pol R was exclusively responsible for gap-filling
synthesis in He La cell and bovine testis nuclear extracts, respectively. No
significant effect on DNA repair synthesis in bovine testis nuclear extractswas
observed with aphidicolin, suggesting that pol a, 6, and cwere not involved
in the DNA synthesis step (247). By using a genetic approach, extracts derived
from an embryonic fibroblast cell line homozygous fora deletion mutation in
the gene encoding pol p were unable to perform BER ofa uracil-containing
synthetic oligonucleotide and the cells exhibited increased sensitivity to
monofunctional DNA-alkylating agents (253). Stable transfection witha
minigene encoding pol 3 restored the deficiency in BER and eliminated the
hypersensitivity to DNA-alkylating agents, demonstrating that pol p
specifically functions in BER in vivo (253). However, recent studies have
indicated that circular DNA substratesmay be required for the interaction of
pol 6 and c with auxiliary proteins involved in polymerase loading and DNA
synthesis (20, 205, 206). Linearization of circular substrates DNA substrates
was shown to abolish DNA synthesis by pol 8 and prevent the interaction of
pol e with the auxiliary proteins, replication factor C (RF-C) and proliferating
cell nuclear antigen (PCNA) (205). Thus, theuse of linear DNA in the
aforementioned studies (248, 253, 302)may have inadvertently biased the
results against recognizing the participation ofa PCNA-dependent DNA
polymerase(s) in uracil-initiated BER.46
These studies concluded that the DNA synthesis step was exclusively
conducted by pol $3 but have since been critically reevaluated. Experiments
utilizing human lymphoblastoid nuclear extracts demonstrated that -70-80 %
of the newly synthesized repair patches following uracil-DNA BER contained
only one nucleotide, providing strong evidence that short-patch BER is the
dominant repair pathway and suggesting that the associated DNA repair
synthesis was conducted by pol(54). However, the completed BER reaction
was found to be only partly inhibited (67 %) by 100 RM ddTTP, an inhibitor of
pol p, and limited inhibition (-23 %) of DNA repair synthesiswas observed
following inclusion of 50 1.1g/m1 aphidicolin (54). In a similar study, Nealon
and co-workers (183) were able to reduce uracil-initiated base excision repair
synthesis in He La crude extracts by -50 % and -20 % using ddNTPs and
aphidicolin, respectively. Neutralizing antibodies specific to poi 13 only
inhibited DNA repair synthesis by -70 % (183). These results suggested that
pol $3 was the major DNA polymerase associated with DNA repair synthesis
during uracil-initiated BER in mammalian cells due to the sensitivity of the
repair process to ddNTPs and neutralizing antibodies. However,an inability
to completely repress DNA synthesis following neutralization of pol 13
implicated a role for other DNA polymerases, particularly pol 8 and/ore, in
this repair mechanism.
Fractionation of crude cell extracts that supported repair of uracil
residues and AP sites provided another approach to identifying DNA
polymerase requirements for short- and long-patch BER (158, 183). The
addition of purified pol 13 to a pol 13-depleted He La cell extract completely
restored DNA repair synthesis while purified pol 8 and polE only supported
repair synthesis to a limited extent (183). It was estimated that pol 13 catalyzed
-75 % of base excision DNA repair synthesis in this system while other DNA
polymerase(s) (notably pol 8) contributed the remaining -25 % of the activity.47
In a separate study, a PCNA-dependent long-patch BER pathwaywas
reconstituted by using a fractionated X. laevis ovarian extract (158). Three of
these fractions were demonstrated to individually contain AP endonuclease,
pol 8, and PCNA and were able to repair natural AP sites and tetrahyrdofuran
residues in BER reactions involving the incorporation ofno more than four
nucleotides. This indicated that a distinct PCNA-dependent repair pathway
that excluded pol 0 was responsible for conducting long-patch DNA repair
synthesis (158). In a PCNA-independent BER reaction, pol 13was able to
replace pol 8 for the repair of the DNA substrate containing the natural AP
site but not the tetrahydrofuran residue (158). Since tetrahydrofuran residues
are resistant to cleavage by 13-elimination (6), the associated dRpase activity of
pol 13, which operates by a 13-elimination mechanism, most likely eliminated
the ability of pol 0 to repair synthetic tetrahydrofuran AP sites in thissystem
(157, 158, 203). This is another piece of evidence linking pol 13 to two
consecutive steps of the BER pathway (dRpase activity and DNA synthesis).
These observations using fractionated eukaryotic cell extracts demonstrated
that uracil residues and AP sitescan be repaired by two distinct pathways
separately involving pol 13 or pol 8.
Similar to that observed for BER conducted by pol 8 in X. laevis, studies
utilizing S. cerevisiae extracts have implicated pole in both the short- and long-
patch BER pathways (294, 295). DNA repair synthesis associated with BERwas
found to be conducted exclusively by pole in a PCNA-dependent fashion
(294). There seems to be no apparent role for pol 13 in yeast BER since this
enzyme is rarely expressed in vegetative cells and pol 0 deletion mutants are
not sensitive to DNA damaging agents (32, 210, 244). Approximately 50 % of
the DNA repair synthesis events during BER of uracil-containing DNA in
yeast resulted in a one-nucleotide repair patch whereas repair patches of 2, 3,48
and 5 nucleotides accounted for --25 `)/0, 13 %, and 5 `)/0 of the repairevents,
respectively (295).
Genetic studies have also demonstrated a role for pol 8 and/ora in both
short- and long-patch BER using the identical embryonic fibroblast cellline
homozygous for a deletion mutation in thegene encoding pol 13 previously
described (69, 253). The difference between this study and the previous study
was the use of a circular substrate versus a linear substrate. In vitro repair of
circular duplex plasmid DNA containinga uracil residue or a single abasic site
by the pol 13-deficient cell extracts showed that both short- and long-patchBER
could be performed by DNA polymerases other than pol (3 (69). Short-patch
BER was performed in the absence of PCNA, but the repair kineticswere
significantly slower than pol 13-proficient extracts (69). This result suggested
that pol 13 was the predominant DNA polymerase involvedin one-nucleotide
gap-filling but other DNA polymerases could actas back-up polymerases
when pol (3 was defective. The repair kinetics of long-patch BERwere
unaffected by the absence of pol 13. Furthermore, the BER reactionwas PCNA-
dependent, providing the additional evidence that pol 8 and/ora are
specifically involved in long-patch BER (69).
Reconstitution of the BER pathway with purified human proteins has
provided important information detailing the biochemistry ofshort- and
long-patch BER in mammalian cells and has demonstrated thatthe core BER
reaction may be modulated byaccessory factors. Short-patch BER was
reconstituted by using purified uracil-DNA glycosylase (UDG), AP
endonuclease (HAP1), pol [3, and either DNA ligase III (123)or DNA ligase I
(190). Pol 13 primarily produced one-nucleotide repairpatches but patches of
two or three nucleotides in lengthwere also observed, suggesting strand
displacement activity by pol 13 (123). These longerrepair patches were shown
to undergo ligation but only after the addition of purified humanDNase49
IV/FEN1, which specifically removes overhang structures at DNA strand
breaks (94, 225). Replacement of DNA ligase III with DNA ligase I also
facilitated ligation of repair patches, suggestinga potential role for DNA ligase
I in BER (123). Addition of XRCC1,a protein with no known catalytic
function, to the reconstituted BER reaction expedited repair synthesis with
little or no strand displacement, suggesting that XRCC1 might coordinate
repair events so as to prevent the accumulation of repair intermediates (123).
Uracil-initiated BER in cell extracts procured froman XRCC1 mutant CHO
cell line resulted in pronounced strand displacement activity and excessive
gap filling (123). These observations suggest that XRCC1 may support short-
patch DNA repair synthesis by suppressingunnecessary strand displacement
in vivo. Alternatively, DNase IV/FEN1may act in conjunction with pol 13 to
promote long-patch DNA repair synthesis during strand displacement DNA
synthesis. Together, these studies suggest that pol 13, in cooperationwith
specific accessory proteins,can participate in the short- and long-patch BER
pathways.
Reduced AP site- and natural AP site-containing DNA substrateswere
used to probe the complexities of long-patch BERas it involved pol 13 (118).
The pathway was reconstituted using purified AP endonuclease (HAP1),pol
13, and DNA ligase I (118). Theuse of the reduced AP site-containing DNA
substrate provided a strategy for selecting against the dRpaseactivity of pol 13,
since the dRpase activity operates bya (3-elimination mechanism. Reduced
AP sites are not subject to (3-elimination. This provideda means for
examining the ability of pol 13 to perform strand displacement associated with
long-patch BER. By using this system, natural AP siteswere found to be
efficiently repaired by a short-patch BER mechanism whereas reducedAP
sites were incompletely repaired (119). The incompleterepair products were
generated by unligated repair intermediates containing repairpatches of up to
six nucleotides, which presumably formedas a result of strand displacement50
DNA synthesis (118). Addition of purified DNase IV/FEN1 to the
reconstituted repair reaction released the 51-terminal deoxyribose phosphate
group as part of a small oligonucleotide and generated a repair intermediate
that was acted upon by DNA ligase I. Under these conditions, repair patches
of 2-6 nucleotides in length were produced (118). These results demonstrated
a coordination of activities between polDNase IV, and PCNA to complete
long-patch BER in vitro. DNA ligase IIIwas also able to substitute for DNA
ligase I in this reconstituted system, indicatingan apparent lack of specificity
for a defined ligase (118). The ability of PCNA to stimulate DNase IV in this
study and in others (140, 309) providedan alternative interpretation for the
PCNA-dependent long-patch BER pathway reportedly involving pol 8 and/or
C.
1.8Physical Interactions Detected Between BER Enzymes
Several studies have detected physical interactions between
mammalian BER proteins, suggesting that protein-protein contactsare
important for the coordinated regulation of individual reactions involved in
the multistep BER pathway. In thisway, the accumulation of DNA repair
intermediates during the reactionmay be reduced and the overall efficiency
of the pathway enhanced. Since both the nucleotide excision repair (230, 306)
and DNA mismatch repair (75) pathways act ina coordinated fashion, it has
been of great interest to probe for protein-protein interactions between BER
enzymes that might provide evidence for an orchestrated BER pathway.
Evidence for a direct physical interaction in vivo between pol 13 and
human AP endonuclease has been demonstrated using theyeast two-hybrid
assay system (13). Electrophoretic mobility-shift assays have provided
evidence for an in vitro interaction between pol 13, AP endonuclease, and
uncleaved double-stranded AP-site-containing oligonucleotides (in the
absence of Me), indicating that this complexcan be achieved in association51
with a BER substrate intermediate (13). In this complex, AP endonuclease
appears to act as a loading factor for pol 13 onto AP sites in DNA (303). After
addition of Mg' and incision by AP endonuclease, only pol 13was stably
associated with the nicked AP site (13). Additionally, the intrinsic dRpase
activity of pol 13 was observed to be stimulated up to 4.3-fold by AP
endonuclease (13). This interaction provides an efficient mechanism forone-
nucleotide gap-filling by pol 13 and implies coordination between AP site
incision, dRp removal, and DNA repair synthesis.
A physical interaction between pol 13 and XRCC1 was detected in vitro by
using an affinity precipitation assay and in vivo by using the yeast two-hybrid
system (123). Affinity precipitation experiments using full length XRCC1 and
internal/C-terminal deletion mutants of XRCC1 demonstrated that pol 13
binds to the N-terminal region of XRCC1, between amino acids 84 and 183
(123). Gel retardation assays also demonstrated that complex formation
occurred between pol 13 and XRCC1 at incised AP sites, indicating that pol
and XRCC1 can physically interact in association witha BER substrate
intermediate (123). XRCC1 was also shown to bind to DNA ligase III under
similar conditions (35, 299). Deletion mutant analysis demonstrated that
DNA ligase III binds to the C-terminal 96 amino acids of XRCC1 (182). The
physical interaction between XRCC1 and DNA ligase III, coupled with genetic
evidence for a role of XRCC1 in the BER pathway (271), providesan argument
for the participation of DNA ligase III in eukaryotic,BER. Together, these
studies suggest that poi (3 interacts with DNA ligase III via the XRCC1 protein.
A multiprotein complex (-180 kDa) from bovine testis nuclear extracts
that was capable of performing complete in vitro uracil-initiated BERwas
purified by affinity chromatography using pol 13or pol 13 antibody as the
immobilized ligand (209). By inference, this complex contained uracil-DNA
glycosylase and AP endonuclease activities and thepresence of pol 13 and52
DNA ligase I was definitively determined by usingmore direct biochemical
and immunological techniques (209). This is the only study that provides
evidence for the physical association of uracil-DNA glycosylase with other
enzyme components of the BER pathway. The -180-kDa complex appeared to
contain equal stoichiometric levels of pol (3 (39-kDa), UDG (32-kDa), and AP
endonuclease (34-kDa) in addition to DNA ligase I, which hasan estimated
molecular weight of -98-kDa, as previously determined by sedimentation
velocity and gel filtration (274). An antibody specific for pol 13was able to
supershift the complex to a larger molecular weight insucrose density
gradients, and the presence of pol 13 and DNA ligase I in the complexwere
confirmed by immunoblotting using antibodies specific for bothenzymes
(209). Co-immunoprecipitation of pol 13 and DNA ligase I from the testis
nuclear extract was also achieved using anti-pol 13 IgG (209). This interaction
has recently been characterized by affinity chromatography, analytical
ultracentrifugation, and domain mapping techniques (56). The physical
association was mediated by an interaction between the non-catalytic N-
terminal domain of DNA ligase I and the N-terminal 8-kDa domain of pol 13
and binding stoichiometry is influenced by temperature (56). Attemperatures
below 18°C, a 1:1 stoichiometrywas observed whereas above 18°C, a pol (3
:DNA ligase I protein ratio of 3:3was detected (57). Domain mapping results
imply that a temperature-mediated conformational change occurredin the
31-kDa domain of pol 13 (56). Sincea physical interaction between pol 13 and
DNA ligase I has been shown to exist in vitro, it is likely that theseenzymes
also associate within the naturally occurring BER complex in vivo.The
influence of a pol 13:DNA ligase I heterodimer (1:1)or heterohexamer (3:3) on
the BER pathway remains to be determined.53
1.9Fidelity of Repair DNA Synthesis
1.9.1Error Discrimination Steps During Polymerization
During DNA synthesis, base substitution fidelity is dictated by base
selectivity and exonucleolytic proofreading of DNA polymerases. Thesetwo
error discrimination steps occur upon incorporation of a nucleotide during a
single cycle of polymerization (223). These proofreading mechanisms begin
with the formation of the ternary complex formed between the DNA
polymerase, the template-primer DNA, and the incoming
deoxyribonucleoside triphosphate. Following complex formation,a
conformational change occurs to correctly position the incoming dNTP for
phosphodiester bond formation. Afterproper alignment is achieved, the
chemical reaction step to form the bond is executed,a second conformational
change releases the pyrophosphate (PP;) end-product, and the polymerase
translocates in the 5' -3' direction to the next nucleotide position for thenext
cycle of polymerization. If the 3'-terminal base of the primer DNA strandis
not properly base paired with the template strand,a 3' -5' exonuclease
activity, if intrinsic to the DNA polymerase, will perform exonucleolytic
proofreading. As DNA polymerases playan important role in most DNA
repair processes, it is important thatgaps in the DNA are filled accurately to
ensure the success of the DNA repair process.
Base selectivity begins with dNTP binding in the polymerase
triphosphate binding site of the DNA polymerase/template-primer DNA
complex in the "open" conformation. Dissociation ofan incorrect dNTP at
this stage is influenced by hydrogen bonding potentials betweenthe incoming
dNTP and the template base and localized base stacking interactions (64).
However, the free energy of binding fora base pair versus a mispair is not
sufficient to account for the high fidelity observed for the enzyme-catalyzed
polymerization step (114). Becausesome incorrect base pairs (for example,
GT versus AT) do not exhibit large structuralor energetic differences from54
those of a correct Watson-Crick base pair (198),a second level of
discrimination occurs when the DNA polymerase/dNTP/template-primer
DNA complex transforms to the "closed" conformation to perform catalysis
(64). This conformational change appears to be inhibited by mismatches
between the dNTP and the templateor in any of the three terminal base pairs
of the primer/template (114). The rate of misincorporation and
polymerization for incorrect nucleotide mispairs can be 2000- to 4000-fold
slower than that of a Watson-Crick base pair (114). Thus, the replication
fidelity associated with base selectivity ultimately dependson the level of
discrimination in the active site pocket of the DNA polymerase in question,
the composition of the mispair, and the surrounding DNAsequence context
(64).
Exonucleolytic proofreading is provided by DNA polymerases
containing an intrinsic 3'>5' exonuclease activity and is influenced by the
rate of nucleotide extension from each of the 12 possible mispairs and by
enzyme- and sequence-specific factors (30). The rate of primer extension from
a terminal mispair is much slower than onto a properly base paired terminus.
As a result, the selectivity of the DNA polymerase toward hydrolysis ofa 3'-
terminal mismatch is favored when theenzyme stalls and is unable to
achieve the critical catalytic configuration for catalyzing phosphodiester bond
formation (114). This requires movement of the 3' terminus from the
polymerase active site to the exonucleolytic site withor without enzyme
dissociation from the primer-template DNA (223). Of the six characterized
eukaryotic DNA polymerases, pol 8, c, andy contain intrinsic 3'-->5'
exonuclease activities while pol a, f3, anddo not. This is an important
concept when weighing the contribution of specific DNA polymerases
implicated in DNA repair synthesis during BER, namely pol 13, 8, andc.
Pol p is the least accurate of the eukaryotic DNA polymerases, inpart,
due to its lack of an intrinsic 3'-->5' exonuclease activity. Thefidelity of55
distributive long gap DNA synthesis by DNA pol 13 has been examinedon
M13mp2 partial duplex DNA with a 390-nucleotide single-strandedgap
containing a 250-base mutational target (127, 129, 133). Usingan in vitro
M13mp2 lacZa DNA-based forward mutation assay, Kunkel and co-workers
(127) (129) (132) demonstrated that purified pol 13 from rat Novikoff hepatoma
and chick embryos conductederror-prone DNA synthesis that resulted in a
high frequency of frameshift, base substitution, and deletionerrors at a
frequency of 4-6 % per single round of gap-filling DNA synthesis (127, 129).
The average base substitution error frequency of pol 13was calculated to be
approximately one error per 1500 bases polymerized and involved nucleotide
misincorporation events propagated by direct miscoding and transient
misalignment of the primer-template (129, 133). Distinct site preferenceswere
apparent for single-base substitution errors by pol f3 and averagederror
frequencies for individual mispairs ranged from 0.45x 10' (AcICMP) to 10 x
10' (AclAMP) (129). Transition mutations produced by CdAMP, AcICMP,
TcIGMP, and GdTMP mispair insertions accounted for -78 % of the base
substitution mutation spectra where dAMPwas the most frequently
misinserted nucleotide (127). Since the fidelity of pol (3 is not influenced by
exonucleolytic proofreading, these results can be interpretedon the basis of
base selectivity alone.
The fidelity of pol 13 on a M13mp2 DNA substrate containinga 5-
nucleotide gap was also examined (11). This type of substratemore likely
resembles that encountered by pol 13 during base excision repair. By usingan
in vitro M13mp2 lacZa DNA-based reversionassay, short gap-filling DNA
synthesis by human pol p resulted in frequent TclGTP and AclGTP
misincorporation events oppositean opal (TGA) codon and yielded a
reversion frequency of 27 x 104 (1 revertantper 370 filled gaps) (11). DNA
sequence analysis of these revertants often detected two consecutive56
misincorporations and suggested that a difference in fidelity might exist
between processive short-gap filling and distributive long-gap filling by pol 13
(11). Consecutive misincorporations were not previously observed using the
large-gapped M13mp2 DNA template (127, 133). Under pre-steady-state
kinetic assay conditions, the formation of TdCMP and TdGMP mispairs
were recently reported to be the most kinetically favorable misinsertions out
of all 12 possible mispairs for purified rat pol 13 (2). Transition mutations
were favored over transversion mutations as previously reported (129). In a
separate study, the nucleotide insertion fidelity of pol 13 was demonstrated to
be 10- to 100-fold higher on a 5'-phosphorylated single-nucleotide gapped
DNA substrate as compared to non-phosphorylated one nucleotide gaps, 5'-
phosphorylated and non-phosphorylated gaps of 6 nucleotides, and recessed
3'-termini (40).Specifically, misinsertion of dGTP, dTTP, and dATP opposite
a template G occurred at frequencies of 2 x 10', 1 x 10, and 6 x 10,
respectively (40). These results establish the fidelity of pol 13 DNA synthesis in
vitro on gapped DNA substrates of various size.
The base substitution fidelity of DNA pol 8 and e are considerably less
error prone than polymerases lacking exonuclease activity. By using an
M13mp2 lacZoc DNA-based forward mutation assay on a 390-base single-
stranded gap, the fidelities of gap-filling synthesis by purified pol 8 and e were
compared (270). Pol 8 was unable to fill gaps to completion unless its
accessory protein, PCNA, was included in the reaction. Base substitution
error rates for pol 8 were dependent on the type of mispair and were < 0.1 x
10-4 for 7 out of 12 types of base substitution errors. Theerror rates for the
remaining 5 types of base substitution errors ranged between 0.11 x 104
(CdTTP) and 0.29 x 104 (GdATP) (266). Several studies have shown that
misinsertion of dGTP opposite a template T is one of the most common
mistakes made by exonuclease-deficient eukaryotic DNA polymerases (error57
frequency > 1.0 x 104) but the error frequency for pol 8was measured at -0.04 x
10' for TcIGTP errors (2, 129, 270). The fidelity of polc in this study was even
greater than that of pol 8, did not require PCNA, and produced an error
frequency that was equal to the background mutation frequency of uncopied
DNA (5_ 0.0067 x 10') (270). In fact, base substitution errorswere detected only
when dGMP, a reported inhibitor of exonucleolytic proofreading,was
included in the reaction (270). This high level of misinsertion fidelity is
consistent with a 3'>5' exonucleolytic proofreading activityas suggested in a
previous study using pol e (131). By using an M13mp2 lacZa DNA-based
reversion assay, an average of less than 1 base substitutionerror per 106
nucleotides polymerized was detected for this polymerase (131). The fidelity
of pol e isolated from calf thymus was 500-foldmore accurate than pol p, in
part, due to its intrinsic proofreading exonuclease activity (131).
1.9.2Base Substitution Errors Involving Template-Primer
Misalignment
In addition to direct nucleotide misinsertion during replication,an
alternative means of producing base substitutionerrors occurs by transient
misalignment of the primer-template and has been termed dislocation
mutagenesis (129). These types of errors are sequence- and polymerase-
dependent. Misalignment of the primer-template followed by incorporation
of the next correct nucleotideas dictated by the template provides a DNA
intermediate containing a "looped out" nucleotide in the template strand.If
the "looped out" nucleotide resumes its normal position in the DNA before
continued nucleotide incorporation,a terminal mispair is created (128). Of
the DNA polymerases involved in BER, pol (3appears to frequently
misincorporate nucleotides by a dislocation event within specific DNA
sequence contexts.58
Previously, two base-substitution mutational hot spot locations for
T-->G transversions by pol 13 were detected by using an M13mp2 lacZa DNA-
based forward mutation assay (127). Both errors occurred within thesequence
contexts 5'-C-G-T-T-T-T-A-C-3' and 5'-C-G-T-T-A-C-3' where the mutation
occurred at the site of the underlined T nucleotide. As theerror specificity for
pol f3 appeared to be related to the DNAsequence, the dislocation
mutagenesis model was proposed for pol f3 errors at these two sites. These
same sites were not mutational hot spots for base substitution errors by
purified pol 8 and E and suggested a greatly decreased propensity for these
DNA polymerases to conduct dislocation mutagenesis within the
aforementioned sequence contexts (270). To test the premise that the next
nucleotide position in the template encoded these pol 13-catalyzed mutations,
the G preceding the T on the 5' sidewas changed to an A (133). This template
change resulted in the disappearance of T-4G transversion mutations at this
site and exclusively generated T>A transversion mutations by >300-fold
(133). In a kinetic study, the misinsertion rate by dislocation for pol 13was
calculated to be between 10- and 110-fold greater than by direct miscoding (25).
Thus, base-substitution errors by pol 13can be initiated by primer-template
misalignments and at least within thesesequence contexts, pol 8 and E do not
appear to introduce errors by this mechanism.
1.10Research Objectives
The bacteriophage PBS2 uracil-DNA glycosylase inhibitor (Ugi) protein
inactivates uracil-DNA glycosylase (Ung) by forminga stable protein-protein
complex in which Ugi mimics electronegative and structural features of DNA
(12, 167). Two primary features of Ugi suggest that the negatively charged
amino acid residues are involved in mediating the Ung/Ugi interaction.59
First, the overall electronegative potential of the inhibitor is engendered by its
unusually high (21 %) glutamic acid and aspartic acid content (15, 293).
Second, analysis of the tertiary NMR structure of the free inhibitor indicate
that these residues are distributed in a nonrandom fashion, primarily in the
loop and turn regions that terminate the 13-strands and in the both the al and
a2 helices (7, 12). As a first step in elucidating the functional role of these
negatively charged amino acids in the formation of the irreversible UngUgi
complex, experiments were conducted to selectively modify specific carboxylic
acid residues of the Ugi protein. Modification of important Glu and Asp
residues was expected to disrupt essential protein/protein interactions and
interfere with the preliminary "docking" step or destabilize the final "locked"
complex. This approach was anticipated to provide important insights that
relate biochemical, structural, and kinetic elements of Ugi in its association
with Ung.
Studies were also undertaken which utilized the Ugi protein to assess
the fidelity and error specificity of DNA repair synthesis associated with the
uracil-initiated base excision repair (BER) pathway. In this regard, the Ugi
protein was also used as a tool to probe the biological importance of Ugi-
insensitive uracil-DNA repair systems in human cell extracts. To investigate
the fidelity of DNA synthesis associated with uracil-initiated BER, to
determine the mutational spectrum, and to quantitate the distribution of
short-patch and long-patch BER, an M13mp2 lacZa DNA-based reversion
assay was designed, developed, and successfully implimented. The results
provided in this dissertation offer the first report of DNA synthesis fidelity
measurements associated with the complete BER process.60
2. MATERIALS AND EXPERIMENTAL PROCEDURES
2.1Materials
2.1.1Chemicals
Trizma (Tris-base), HEPES, EDTA, ampicillin, streptomycin sulfate,
bovine serum albumin, 2-mercaptoethanol, 1- ethyl -3 -(3- dimethylamino-
propyl(carbodiimide)) (EDC), glycine ethyl ester, transfer ribonucleic acid(type
X-SA), 13-nicotinamide adenine dinucleotide (NAD), phosphocreatine di-Tris
salt, phenylmethylsulfonyl fluoride (PMSF), leupeptin, pepstatinA,
aprotinin, and chymostatin were obtained from Sigma. Isopropyl-13-6-
thiogalactopyranoside (IPTG), dithiothreitol (DTT), 1-kb DNA ladder,L-
glutamine, penicillin-streptomycin, geneticin (G418), RPMI medium 1640, F-
12 nutrient mixture (Ham's), and ultra-pure cesium chloride,urea, sodium
dodecyl sulfate, glycine,sucrose, ammonium sulfate, and agarose were
purchased form Life Technologies.2'-deoxyribonucleoside triphosphates and
poly(U) were obtained from Pharmacia Biotech and 2'-deoxyribonucleosidea-
thiotriphosphates were from Amersham Life Science. 5-bromo-4-chloro-3-
indoly113-D-galactopyranoside (X-Gal)came from United States Biological and
dextrose, boric acid, sulfuric acid, monobasic and dibasicpotassium
phosphate, 1-butanol, iso-amyl alcohol, glycerol, dimethylformamide,and
dimethyl sulfoxide were obtained from J.T. Baker. Fisherwas the source of
methanol, toluene, acetic acid, hydrochloric acid, ammoniumhydroxide
(50%), trichloroacetic acid, and phenol. Chloroformwas obtained from
Mallinckrodt, and. Boehringer Mannheimwas the source for aphidicolin.
Acrylamide (>99% pure), bis N,N'-methylene-bis-acrylamide,ammonium
persulfate, TEMED, and proteinassay (Bradford reaction) dye reagent
concentrate was from Bio-Rad. Cyanogen bromidecame from Aldrich.61
Fluoroscein-5-isothiocyanate (Isomer I)was purchased from Molecular
Probes. Hy Clone Laboratories Inc.was the source of defined fetal bovine
serum.
2.1.2Radioisotopes
[35S]methionine,[a-32P]dATP, [y- 32P]ATP, and [31-I]dTTPwere purchased
from DuPont-New England Nuclear. [31-1]dUTPwas obtained from
Amersham Corp.
2.1.3Bacterial Media
M9 medium contained 1.28 `)/0 Na2HPO47H20, 0.3 % KH2PO4, 0.05%
NaC1, and 0.1 % NH4C1. Following sterilization, M9 mediumwas adjusted to
2 mM MgSO4, 0.1 mM CaC12, 0.4 % glucose, and 10µg /ml thiamine from
individual sterile stocks. TYN mediumwas composed of 1 % yeast extract
(Difco), 1 `)/0 tryptone (Difco), and 0.5 % NaCl. YT mediumwas composed of
0.5 % yeast extract, 0.8 `)/0 tryptone, and 0.5 `)/0 NaCl. LB mediumwas
composed of 0.5 % yeast extract, 1 % tryptone, and 1 % NaCl.VAT medium
contained 1 % tryptone, 0.4 % yeast extract, 1 ()/0 K2HPO4, and 0.1 %KH2PO4.
SOC medium contained 0.5 `)/0 yeast extract, 2 %tryptone, 0.05 % NaC1, 2.5 mM
KC1, 10 mM MgC12, and 20 mM glucose and the pHwas adjusted to pH 7.0
with 5 N NaOH. SM mediumwas composed of 50 mM Tris-HC1 (pH 7.5) 0.58
% NaCl, 0.2 % MgSO47H20, and 1 % gelatin. Solid plates andtopagar were
prepared by the addition of 1.5 % and 0.7 % (w/v) bacto-agar(Difco),
respectively, to the appropriate liquid media. Whereappropriate, liquid
media or media plateswere supplemented with 100 µg /ml ampicillin from a
sterilized stock (100 mg/ml)as needed to enforce maintenance of
recombinant plasmids. In order to detect a-complementation oflacZa, M9
topagar was adjusted to 0.4 mM IPTG and 1 mg/ml X-Gal.62
2.1.4Bacterial Strains
The strains of E. coli used for this research and their representative
genotypes are listed in Table 1. Strain JM105 was provided by W. Ream
(Oregon State University) and strains CJ236, MC1061, NR9162, and CSH50
were provided by T.A. Kunkel (NIEHS, Research Triangle Park, NC). Strain
RR1 was provided by W.H. Konigsberg (Yale University). JM109was obtained
from New England Biolabs.
2.1.5Plasmids and Bacteriophage
Plasmid pSB1051, an overexpression vector for Ung,was constructed by
S. Bennett (NIEHS, Research Triangle Park, NC)as described (17). The Ugi
overexpression plasmid, pZWtacl, was constructed by Z. Wang (University of
Kentucky) as described (293). Plasmid pTL43W,an overexpression vector for
producing 14 DNA polymerase,was provided by W.H. Konigsberg (Yale
University) and constructed as described (141). Bacteriophage M13mp2was
obtained from T.A. Kunkel (NIEHS, Research Triangle Park, NC) and
M13mp2op14 was constructed as described in this thesis. The eukaryotic
replication-defective MLV retroviral vector pvBiPNeo1001 containing the ugi
gene was provided by E.H. Radany (University of Michigan) and constructed
as described (219).
2.1.6Tissue Culture Media
For growth of human glioblastoma U251 cells, RPMI 1640 mediumwas
supplemented with 2 mg/m1 NaHCO3, 0.3 mg/m1 L-glutamine, 50 units/ml
penicillin, and 50 gg/m1 streptomycin. The mediumwas adjusted to pH 7.2
with 1 N HC1 and sterilized bypassage through a 0.2 µm membrane filter unit
(Nalgene). RPMI 1640 mediumwas supplemented with 10% (v/v) fetal
bovine serum. For the selection of U251 cells transfected with the
pvBiPNeo1001 construct, RPMI 1640 mediumwas adjusted to 400 p.g /ml G41863
Table 1
E. coli Strains and Genotypes
E. coli Strain Genotype Reference
CJ236 dut ung thi-1 relA spoT1 mcrA/ (105)
F'cat (pCj105; M13sCmr)
CSH50 ara- thi d(pro-lac)/ (126)
F' traD36 proAB lacriZAM15
(313) JM105 thi rpsl (Ste) endA sbcB15 sbcC hsdR4
(rk- mk+) d(lac-proAB)/F traD36 IacI
d(lacZ)M15 proA+13+
JM109 recA1 e14-(McrA") d(lac-proAB) thi gyrA96 (313)
(Nair) endA1 hsdR17 (rk- mk+) relA1 supE44/
F' traD36 lacP1 d(lacZ)M15 proA+13+
MC1061 hsdR- hsdivr araD d(ara,leu) d1ac1POZY (132)
galU galK strA
NR9162 hsdR- hsdA4+ araD d(ara,leu) dlac1POZY (222)
RR1 F hsdS20,m8-) ara-14 proA2 lacY1 galK2 (141)
rpsL20 (Smr) xy1-5 mtl -1 supE4464
from a sterile stock (100 mg/ml). For growth of human colon
adenocarcinoma LoVo cells, Ham's F-12 mediumwas supplemented with 1.2
mg/ml NaHCO3 and the pHwas adjusted to pH 7.2 with 1 N HC1. Ham's F-12
medium was supplemented with 20 % (v/v) fetal bovineserum. All
supplemented medium was sterilized bypassage through a second 0.2 gm
membrane filter unit prior to use.
2.1.7 Human Cell Lines
The human glioblastoma U251 cell line and daughter cell lines
transfected with and stably expressing the pvBiPNeo1001or pvBiPNeo1001-
mugi constructs were kindly provided by E.H. Radany (University of
Michigan). The human colon adenocarcinoma LoVo cell linewas procured
from the American Type Culture Collection. All cell cultureswere grown at
37 °C, 5 % CO2, and 90 % humidity.
2.1.8Chromatographic Resins
DE52 anion exchange resin and P-11 cation exchange resinwere
obtained from Whatman. Sephadex G-25, G-50, and G-75were purchased
from Pharmacia Biotech. Bio-Gel P-4 (130 ± 40 gm), hydroxyapatite Bio-Gel
HTP, and AG 501-X8(D) (20-50 mesh) and AG 1-X8 (100-200 mesh) ion
exchange resins were purchased from Bio-Rad.
2.1.9Oligonucleotides
Oligonucleotides used for this research are listed below. Oligonucleo-
tides A-41-mer, C-41-mer, and PMR PLUSwere synthesized on an Applied
Biosystems 380B DNA synthesizer by the Center for Gene Research and
Biotechnology (Oregon State University). Oligonucleotides U-34-mer,T-34-
mer, A-34-mer, and G-34-mer were synthesized by Midland Certified Reagent
Company. Oligonucleotides U-23-mer and A-23-merwere synthesized and65
gel purified by Oligos Etc. The nucleotidesequence and use of each synthetic
oligonucleotide are indicated below:
1. Oligonucleotides for site-directed mutagenesis of
M13mp2op14 and M13mp2R14G
A-41-mer: 5'-GGG TAA CGC CCG GGT TTT CCC AGT
CAC GTC ATT GTA AAA CG-3'
C-41-mer: 5'-GGG TAA CGC CCG GGT TTT CCC AGT
CAC GTC CTT GTA AAA CG-3'
2. Base excision DNA repair substrate oligonucleotides
U-23-mer: 5'-CCC AGT CAC GTC UTT GTA AAA CG-3'
A-23-mer: 5'-CCC AGT CAC GTC ATT GTA AAA CG-3'
Uracil- and thymine-DNA glycosylase substrate
oligonucleotides
U-34-mer: 5'-AGC TTG GCT GCA GGT UGA CGG ATC
CCC GGG AAT T-3'
T-34-mer: 5'-AGC TTG GCT GCA GGT TGA CGG ATC
CCC GGG AAT T-3'
A-34-mer: 5'-AAT TCC CGG GGA TCC GTC AAC CTG
CAG CCA AGC T-3'
G-34-mer: 5'-AAT TCC CGG GGA TCC GTC GAC CTG
CAG CCA AGC T-3'
4. DNA sequencing primer
PMR-PLUS: 5'-GCA CTC CAG CCA GCT TTC CGG-3'
2.1.10 Enzymes
Proteinase K and creatine phosphokinase (type I, rabbit)were from
Sigma. T4 DNA polymerase, T4 DNA ligase, T4 polynucleotidekinase, E. coil
exonuclease III, and restriction endonucleases EcoRI, Hinfl,and Smal were
obtained from New England Biolabs. WorthingtonBiochemicals was the66
source of ribonuclease A and endoproteinase Asp-N was from Boehringer
Mannheim. Trypsin-EDTA was supplied by Life Technologies. E. coli
endonuclease IV (fraction V) was kindly provided by B. Demple (Harvard
University).
2.2Experimental Procedures
2.2.1Preparation of Chromatographic Resins
2.2.1.1 Preparation of DE52, P-11, Sephadex G-25, G-50, and
G-75, Bio-Gel P-4, and Hydroxyapatite Bio-Gel HTP
Pre-swollen DE52 diethylaminoethyl cellulosewas used to prepare
DEAE-cellulose resin. The resinwas defined at a 1:5 ratio (w/v) and
equilibrated in TED buffer (50 mM Tris-HC1 (pH 8.0), 1 mM EDTA, 1 mM
DTT) for the purification of Ugi protein, buffer A (50 mM Tris-HCI (pH 7.0),1
mM EDTA, 1 mM DTT) containing 50 mM NaC1 for the purification of
EDC/GEE-modified Ugi, or DAB buffer (30 mM Tris-HC1 (pH 7.4), 1 mM
EDTA, 1 mM DTT, 5 % (w/v) glycerol) containing 50 mM NaCl for the
isolation of the UngUgi complex. Fibrous P-11 cellulose phosphateresin was
defined and equilibrated in buffer P (50 mM Tris-FIC1 (pH 7.5), 10 mM KC1,5
mM 2-mercaptoethanol, 0.1 mM EDTA, 25 % (w/v) glycerol). Bothresins
were stored at 4°C.
Bio-Gel P-4 and Sephadex G-25, G-50, and G-75 resinswere hydrated
under various buffer conditions atroom temperature and defined,
equilibrated, and stored as described above. Bio-Gel P-4was equilibrated in TE
buffer (10 mM Tris -HCI (pH 8.0), 1 mM EDTA)or 50 mM potassium
phosphate (pH 6.0) buffer dependingon the application and stored as a 50 °A)
slurry. Sephadex G-25 was equilibrated and stored in KEG buffer (50mM
potassium phosphate (pH 9.5), 1 mM EDTA, 5 % (w/v) glycerol). Sephadex
G-50 was equilibrated and stored in TEAB buffer (10 mM triethylamine-67
bicarbonate (pH 7.0)). Sephadex G-75was equilibrated and stored in Ugi
equilibration buffer (Ugi EB) (50 mM Tris-HC1 (pH 8.0),1 mM EDTA, 1 mM
DTT, 100 mM NaCl, 10 % (w/v) glycerol)or Ung equilibration buffer (Ung EB)
(10 mM Hepes-KOH (pH 7.4), 1 mM EDTA,10 mM 2-mercaptoethanol, 1 M
NaC1, 5 % (w/v) glycerol) for the purification ofUgi and Ung, respectively.
Hydroxyapatite Bio-Gel HTPwas defined and equilibrated in HA buffer
(10 mM potassium phosphate (pH 7.4),1 mM DTT, 200 mM KC1).
2.2.1.2 Preparation of Single-Stranded DNA-Agarose
Calf thymus DNA (Type I, Sigma)was solubilized at 15 mg /ml in 300
ml of 20 mM NaOH and slowly stirredovernight at room temperature. After
thorough mixing, the DNA solutionwas divided into 100-m1 aliquots and
incubated for 15 min at 95°C. An aliquot of thedenatured DNA mixture
equilibrated at 95°C was added toan equal volume of molten 4 % agarose
solution equilibrated at 70°C, mixed thoroughly,and poured into an ice cold
glass dish (Pyrex, 196mm x 100 mm) held on ice and allowed to solidify. The
solidified DNA-agarose mixturewas pressed twice through a stainless steel
sieve (60 mesh) and suspended in 300 ml ofresuspension buffer (10 mM Tris-
HC1 (pH 7.5), 1 mM EDTA, 100 mM NaC1)per 200 ml of the sieved DNA-
agarose. Each resuspended gel mixture was placed ina Buchner funnel (17
cm diameter) and washed with 9000 ml of resuspension bufferat room
temperature until the A260 of the wash dropped below 0.02.The single-
stranded DNA-agarosewas stored at 4 °C as a 50 % slurry in buffer containing
10 mM Tris-HC1 (pH 7.5), 1 mM EDTA, and1 M NaCl.
2.2.1.3 Preparation of Dowex 1-X8 Ion Exchange Resin
Dowex AG 1-X8 (100-200 mesh, chloride form)was converted to the
intermediate hydroxyl counterion formprior to conversion to the final
formate counterion form foruse in the uracil-DNA glycosylase and uracil-68
DNA glycosylase inhibitorassays. Dowex AG 1-X8 was added to 400 ml of 1 M
NaOH until the volumewas equal to 500 ml. After mixing, the resin was
allowed to settle for 20 min and the 1 M NaOHwas decanted by aspiration.
This step was repeated until 2000 ml of 1 M NaOH had beenused. The resin
was transferred to three 150-m1 glass filter funnels (60-C) and the remaining 1
M NaOH was filtered from the resin by gravity. Thecontents of each funnel
was washed with 100 ml of 1 M ammonium formate buffer (pH 4.2) followed
by three -333-m1 washes of 10 mM ammonium formate buffer (pH4.2). The
resin was allowed to fully drain between each addition. Dowex AG1-X8 was
stored at 4°C in 10 mM ammonium formate buffer (pH 4.2).
2.2.2Miscellaneous Methods
2.2.2.1 Preparation of Dialysis Tubing
Dialysis tubing (SpectraPor)was cut into lengths of 20 to 30 inches and
soaked in 1 °A acetic acid solution for 1 h. The soaking solutionwas decanted
and tubing was rinsed with distilled H2O priorto boiling in 1 L of 1
NaHCO3 and 0.1 `)/0 EDTA with intermittent stirring. TheNaHCO3 /EDTA
solution was exchanged after it became cloudy and/or yellow. Thisstep was
repeated three times. The tubingwas rinsed and boiled in distilled H2O,
rinsed again, and stored at 4°C in 10 mM EDTA (pH 8.0).
2.2.2.2 Protein Concentration Measurements
The protein concentrations of E. coli Ung and Ugiwere determined by
absorbance spectroscopy by using the molarextinction coefficientse280 nm = 4.2 x
104 liters/molcm (Ung) and£280= 1.2 x 104 liters/molcm (Ugi). The
concentration of E. coli Ung[35S]Ugi complexwas determined from [35S]Ugi
radioactivity since the complex exhibits 1:1 stoichiometry(15). The
concentration of human UDGwas determined by absorbance spectroscopy by69
using the molar extinction coefficiente280 nm = 5.04 x104 and the concentration
of the human UDGUgi complex by using themolar extinction coefficient E280
nm= 6.3 x 104 which was calculated from the sum of the extinction coefficients
from UDG and Ugi, respectively. The concentration ofhuman whole cell
extract protein was measured by the Bradford reaction using the Bio-Rad
protein assay and was capable of accurately determiningconcentrations of 5.0
15.0 pg /ml extract protein. Bovineserum albumin (Standard II) was used as
the protein standard for the microassay. Theconcentration of the protein
standard was determined by using the molar extinctioncoefficient E280nm =0.67
ml/mgcm. Standards were diluted from 0-20 pg/m1in 2.5-pg/m1
increments to generate a standardcurve.
2.2.2.3 Rapid Protein Staining of Nondenaturing
Polyacrylamide Gels
Proteins resolved by nondenaturing polyacrylamide gelelectrophoresis
were visualized by staining with Coomassie Brilliant Blue G-250 in 3.5 %
HC1O4 as described by Reisner (221). The rapidstain solution was prepared by
diluting 100 ml of 70 % HC1O4 into 1900 ml ofdistilled H2O followed by the
addition of 0.8 g of Coomassie Brilliant BlueG-250. The mixture was stirred
at room temperature for 1 h and filtered through WhatmanNo. 1 paper.
Nondenaturing polyacrylamide gelswere submerged in - 500 ml of rapid
stain solution and most protein bandswere typically visualized after 10 min
of incubation with gentle agitationat room temperature. In some cases, gels
were also stained overnight. The background color of the gel turneda light
amber color while protein bands staineda darker amber hue. After staining,
the gels were placed in 5 % (v/v) acetic acid(-500 ml) which helped increase
the sensitivity of detection by about three-fold.Under these conditions, the
background color of the gel turneda light blue while protein bands stained a
dark blue. Several changes of the 5 % acetic acidwash greatly reduced the
light blue background color.70
2.2.2.4 Isolation of M13mp2 Single-Stranded DNA
M13mp2 or M13mp2op14 bacteriophage stocks of unknown
concentration were titered against mid-log E. coli JM109or CJ236 cells to
determine the number of plaque forming unitsper ml of stock (pfu/ml). E.
coli JM109 or CJ236 cells were streakedon M9 plates and incubated at 37°C
until isolated colonies were visible. An isolated colonywas picked and placed
into 25 ml of YT medium and incubated overnight at 37°C with shaking. The
overnight culture was diluted 10-fold intoa fresh volume (25 ml) of YT
medium and incubated with vigorous shaking at 37°C for 1 h. The M13mp2
or M13mp2op14 bacteriophage stocks were serially diluted into SM medium
and 100 1.1,1 aliquots of each dilution pointwere placed into sterile 13 x 100 mm
glass test tubes. Bacteriophage dilutionswere supplemented with 500 pl of
mid-log bacterial culture and gently agitated to mix the bacterial cells and
bacteriophage. Prewarmed YT topagar containing 0.4 mM IPTG and 1 mg/ml
X-Gal equilibrated at -45°C (2.5 ml)was added.to each tube, mixed, and
quickly poured onto YT plates prewarmed at 37°C. Topagarwas allowed to
solidify for 5-10 min at room temperature and plateswere incubated
overnight at 37°C. The concentration of viable bacteriophagewas calculated
from the discernible number of plaques scoredat appropriate dilutions.
Single-stranded M13mp2 or M13mp2op14 DNAwas isolated from
bacteriophage grown in E. coli JM109 cells. Overnight cultures ofE. coli JM109
cells grown in YT mediumwere used to inoculate a 2.5-L culture in 2X YT
medium. Bacterial growthwas monitored by absorbance spectroscopy (1 OD595
nm= 8 x 108 cells/m1) until the cells reached early mid-log phase (-3.2 x 108
cells/m1). The total number of cells in the culture mediumwas calculated
and bacteriophage were added toan MOI (multiplicity of infectionratio of
infectious particles to host) of 0.5. The bacteriophage infectionmixture was
incubated for an additional 9 h with extremely vigorousshaking (250 rpm) at71
37°C. After placing the cultureon ice for 10 min, bacterial cells were pelleted
by centrifugation (GSA rotor, 7,000rpm, 15 min, 4°C) and the supernatant
containing the bacteriophage particleswas saved and the volume measured.
Approximately 5 ml of the supernatantwas stored at 4°C for future infections.
To the remaining supernatant, 5X PEG/NaC1 (15 % PEG8000,2.5 M NaC1) was
added to a final lx concentration (equalto 25 % of the supernatant volume)
and the mixture incubatedon ice for 1 h with gentle mixing. Precipitated
bacteriophage were isolated by centrifugation (GSArotor, 7,000 rpm, 15 min,
4°C) and pellets were thoroughly drained for 15 minat room temperature.
The pellet in each centrifuge bottlewas resuspended in 2.5 ml of buffer PEB
(100 mM Tris-HC1 (pH 8.0), 300 mM NaC1, and 1 mM EDTA)and incubated on
ice for 1 h with intermittent shaking. Resuspendedbacteriophage were
pooled, centrifuged (SA600 rotor, 6,000rpm, 15 min, 4°C), and the supernatant
was adjusted to 0.1% SDS using a 20 `1/0 SDS stock. The phage suspensions (5-
ml aliquots) were extracted twice withan equal volume of phenol
equilibrated in PEB buffer and twice withan equal volume of
chloroform:isoamyl alcohol (24:1). All extractions involvedrocking by hand
for 3 min and phaseswere separated in a clinical centrifuge (IEC, setting #6 for
2 min). The recoveredaqueous phase containing the single-stranded
M13mp2 or M13mp2op14 DNAwas concentrated in a Centriprep 30
concentrator (Amicon) by centrifugation (GSArotor, 4,500 rpm, 4°C) and
buffer exchanged against TE buffer. Theconcentration of DNA was measured
by absorbance spectroscopy (1 OD260.= 36 µg /m1) and the purity was
determined by the OD280 nm/OD260ratio (0.500).
Uracil-containing single-stranded M13mp2 DNAwas similarly isolated
from M13mp2 bacteriophage infections ofE. coli CJ236 except that YT medium
was supplemented with 34 µg /ml chloramphenicol and 0.25 1.1,g/m1 uridine
was added to the 1.5-L cell culture medium 10 min prior to infection.72
2.2.2.5 Preparation of Oligonucleotides
Preparations of synthetic oligonucleotides were deblocked and supplied
as a lyophilized powder by the Center for Gene Research and Biotechnology
(Oregon State University) and by the Midland Certified Reagent Company.
Synthetic oligonucleotides prepared by Oligos Etc.were deblocked, gel
purified, and supplied as a lyophilized powder.
Lyophilized oligonucleotides A-41-mer, C-41-mer, and PMR-PLUS
were resuspended in 1 ml of TEAB buffer (10 mM triethylamine-bicarbonate
(pH 7.0)). The pH of the TEAB bufferwas adjusted by "bubbling" CO2 gas
produced by sublimation of dry ice into the buffer solution. Each samplewas
applied to a separate Sephadex G-50 column (1.8 cm2x 3.1 cm) equilibrated in
TEAB buffer (pH 7.0) at room temperature and eluted with equilibration
buffer. Fractions (1 ml) were collected ata flow rate of -15 ml/h and
oligonucleotide-containing fractions were detected by absorbance spectroscopy
at 260 nm. Peak fractions (-4 ml) containing the oligonucleotideswere
evaporated to dryness in a Speed-Vac Concentrator (Savant) and each
oligonucleotide preparation was resuspended ina total of 300-500of
distilled H2O. The concentration of resuspended oligonucleotidewas
determined by absorbance spectroscopy (1 A260= 20 µg /m1) and the purity was
determined by the OD280 nm/OD260. ratio (0.500).
Oligonucleotides A-41-mer, C-41-mer, U-34-mer, T-34-mer, A-34-mer,
and G-34-mer were subjected to further purification by polyacrylamide gel
electrophoresis. Samples (300-500 ill containing -100-200 nmol
oligonucleotide) were combined with native sample buffer toa final
concentration of 50 mM Tris-HC1 (pH 6.8), 10 `)/0 (w/v) glycerol, and 0.1 ()/0
bromophenol blue and loaded onto separate nondenaturing 12 %
polyacrylamide gels (30 x 40 x 0.16 cm) buffered with 1X TBE (90 mM Tris, 90
mM boric acid, 2 mM EDTA). Electrophoresiswas conducted using TBE
buffer at 1000 V until the tracking dye had migrated -25cm. After
electrophoresis, the polyacrylamide gelwas placed on top of a sealed TLC plate73
(Polygram Cel 300 PEI/UV254) and the oligonucleotide bandswere visualized
by UV-shadowing. Oligonucleotide bandswere excised from the gel by using
a clean razor blade and the gel slice was placed into SpectraPor dialysis tubing
(6,000-8,000 MWCO; 25.5 mm diameter) containing -5 ml ofa 0.1X
concentration of TBE buffer. Oligonucleotideswere electroeluted in 0.1X TBE
buffer at 95 V for 2.5 h ina horizontal agarose gel chamber (35 x 21 cm). The
dialysis tubing was positioned parallel to the electrodes and heldin place by a
glass plate. Following electroelution, thecurrent was reversed for -30 sec and
the DNA solution was transferred into fresh dialysis tubing anddialyzed
overnight in distilled H2O at 4°C. The concentration of oligonucleotidewas
determined by absorbance spectroscopy (1 OD260,..= 20 gg/m1) and
oligonucleotides were aliquoted into 5-nmol quantities, evaporatedto
dryness, and stored at -80°C.
2.2.2.6 5'-End Phosphorylation of Oligonucleotides
Oligonucleotides (4 nmol) were 5'-end phosphorylated in reaction
mixtures (137.5 gl) containing 50 mM Tris-HC1 (pH 7.6), 10mM MgC12, 5 mM
DTT, 0.1 mM EDTA, 250 pCi [7-32P]ATP (6,000 Ci/mmol),and 50 units of T4
polynucleotide kinase. Sampleswere incubated for 15 min at 37°C and
adjusted to 200 p,M ATP by usinga 5 mM ATP stock. The reaction was
incubated an additional 45 min at 37°C and terminatedby adjustment to 10.7
mM EDTA and heated for 10 min at 70°C. The terminatedreaction volume
was adjusted to 250 gl with TE buffer and unreacted [7-32P]ATPwas removed
from the mixture bypassage through two consecutive P-4 (Bio-Rad) spun
columns containing 1.4 ml of resin and equilibratedin TE buffer. P-4 spun
columns were centrifuged ina clinical centrifuge (IEC, setting #4 for 2.5 min).
Oligonucleotides were also 5'-end phosphorylated under similar
reaction conditions except the 250 p,Ci [7-32P]ATP additionwas omitted.
Instead, these reaction mixtureswere initially adjusted to 0.3 gM ATP by74
using a 1.67 1.iln ATP stock in 10 mM tricine (pH 8.0). These conditionsare
identical to those of the reaction mixture containing [y- 32P]ATPsince the [7-
3213]ATP stock was supplied ata concentration of 1.67 µM in 10 mM tricine (pH
8.0).
2.2.2.7 Annealing Reaction of U/A-, U/G- and T/G-34-mer
Duplex DNA
Hybridization of 750 pmol of [3213]U-34-meror [32P]T -34 -mer to 1,500
pmol of A-34-mer or G-34-mer toconstruct duplex [3211U/A-, [3211U/G-, and
[32P]T/G-34 -mer DNA substrateswas conducted in annealing reaction
mixtures (186 gl) containing 20 mM Tris-HC1 (pH 7.4), 2 mM MgC12,and 50
mM NaCl. Reaction mixtureswere placed in a 500-m1 beaker containing 70°C
distilled H2O and allowed to cool toroom temperature (-4 h). Duplex DNA
was stored at -80°C.
2.2.2.8 Transfection of Competent E. coli Cells by
Electroporation
In order to prepare competent E. coli JM109, NR9162,or MC1061 cells
for electroporation of M13mp2 DNA, overnight cultures of bacterialcells
were used to inoculate 500 ml of LB medium at a 1:100 ratio and growth
continued with vigorous shaking at 37°C. The cell densitywas monitored by
absorbance spectroscopy (1 OD595,= 8 x 108 cells/m1). After the cells reached
the early mid-log phase (0D595= 0.300-0.400) of growth, the culture was
placed on ice for 10 min. Cellswere placed into 250-ml centrifuge bottles and
harvested by centrifugation (GSA rotor, 5,000rpm, 10 min, 4°C). Each cell
pellet was resuspended in 250 ml of cold, sterile distilled H2O.Centrifugation
was repeated as described above and each cell pellet was resuspended in 125
ml of cold, sterile distilled H2O. Centrifugationwas again conducted as
described above and each pelletwas resuspended in 5 ml of cold, sterile 10
(w/v) glycerol, transferred toa 30 ml Corex tube, and centrifugation (SS3475
rotor, 5,700 rpm, 10 min, 4°C) was again repeated. The final cell pellet was
resuspended in a volume of -3 ml of ice cold, sterile 10 % (w/v) glycerol toa
final cell density of -0.5-1.0 x 1011 cells/ml. The resuspended cell mixturewas
aliquoted (70 lip into. Eppendorf tubes, frozen in liquid nitrogen, and stored at
-80°C until ready for use.
Electroporation was conducted using a Gene Pulser electroporation
system (BioRad) and 0.2-cm gapped electroporation cuvettes. To a prechilled
1.5-ml Eppendorf tube, competent E. coli cells (40-50 ill)were mixed with 0.5-
2.5 IA of transfection DNA and held on ice for 1-2 min. The DNA/cell
mixture was transferred to a cold electroporation cuvette and placed into the
chamber with tapping to eliminate any air bubbles. A single pulse set at 25
pF capacitance, 2.5 kV, and 200-400 SI was applied. The time constant of the
pulse was -9.3 ms. Transfected cells were serially diluted into YT medium
(1/102 to 1/107) and a sample (100 ill) of each dilution pointwas placed into a
sterile 13 x 100 mm test tube and 500 pl of mid-log E. coli JM109or CSH50 cells
was added. Prewarmed YT topagar containing 1 mg/ml X-Gal and 2.5 mM
IPTG was equilibrated at -45°C and 2.5 mlwas added to each tube, mixed, and
the mixture quickly poured onto YT plates prewarmed at 37°C. Plateswere
incubated overnight at 37°C.
2.2.2.9 Detection of 35S-labeled Protein
[35S]Ugior Ung[35S]Ugi complex was resolved by nondenaturing
polyacrylamide tube gel electrophoresis or nondenaturing polyacrylamide
slab gel electrophoresis. Polyacrylamide tube gelswere removed from
cylindrical glass casting tubes (12.5 cm length x 0.5 cm internal diameter) by
injecting distilled H2O between the tube gel and the wall of the glass cylinder
with a 30-ml syringe and a 22G1 hypodermic needle and simultaneously
pushing the gel outward with a cotton swab applicator, wrapped ina strip of
cheese cloth to form a tight seal. The tube gelwas horizontally sliced into 3.176
mm discs using a tube gel slicing device (Hoeffer). Gel discs were placed into
separate scintillation vials (Wheaton, 7 ml) and dried overnight atroom
temperature. A 500-g1 volume of 30 % hydrogen peroxide was addedto each
vial, and vials were tightly capped and incubated at 55°C for 24-48hours to
solubilize the polyacrylamide gel. After cooling toroom temperature, each
vial was supplemented with 5 ml of scintillation fluor (Formula989, DuPont
NEN), mixed by inversion, and analyzed for 35S radioactivity ina Beckman LS
6800 liquid scintillation counter. Polyacrylamide slab gelswere dried under
vacuum, and autoradiography was performed with X-OMAT AR5 film
(Kodak). Bands containing 35S radioactivitywere excised from the dried gels
and processed as described above.
2.2.2.10Transfer of DNA to Nitrocellulose
[32P]DNAbands resolved by 0.8% agarose gel electrophoresiswere
transferred onto Gene Screen Plus (NEN) membranes usinga downward
alkaline blotting technique (119). Following electrophoresis,agarose gels were
incubated for 15 min in 0.25 N HC1 until the bromophenol bluetracking dye
turned yellow and then soaked in 0.4 M NaOH for -5 min. Thetransfer
apparatus was prepared by placing a stack ofpaper towels in a Pyrex baking
dish. On top of the paper towels, three gel-sized Whatman No.1 filters
(Whatman, Clifton, NJ) were positioned and thetop filter was soaked in the
0.4 M NaOH transfer solution. Next,a gel-sized sheet of Gene Screen Plus
soaked in 0.4 M NaOH was placed, followed by theagarose gel. On top of the
gel, two additional gel-sized Whatman No. 1 filters soaked in0.4 M NaOH
were placed followed by two long, wet blotting strips of Whatman No. 1 filter
paper used to wick the transfer solution from two 0.4 M NaOH reservoirs
positioned on either side of the transferapparatus. A glass plate (19 x 20 cm)
was positioned on top to secure the gel and promote even distribution of the
transfer solution. Air bubbleswere carefully removed from each layer of the
transfer apparatus during construction. Additionally,a strip of plastic wrap77
was tucked under both edges of the gel between thepaper towels and the wick
to prevent a short circuit of transfer solution directlyto the paper towels.
Transfer of DNA was allowed to proceedovernight and the filter was hung to
dry at room temperature prior toautoradiography.
2.2.3Purification of Uracil-DNA Glycosylase
E. coli JM105 cells transformed with pSB1051were grown at 37°C in 9
liters of TYN-ampicillin medium (1tryptone, 1 `)/0 yeast extract, 0.5 % NaC1,
0.01 % ampicillin) with vigorous shaking. Whenthe cells reached a density
of 6.4 x 108 cells/ml,ung gene expression was induced by adjusting the
medium to 1 mM IPTG and incubationwas continued for an additional 3 h.
Cells were harvested by centrifugation(GSA rotor, 6,000 rpm, 15 min, 4°C),
pellets were thoroughly drained, and frozenovernight at -80°C. All
subsequent purification stepswere conducted at 4°C. Cell pellets were
thawed, resuspended ina total of 360 ml of TED buffer (50 mM Tris-HC1 (pH
8.0), 1 mM EDTA, 0.1 mM DTT), Douncehomogenized to break up cell
aggregates, and lysed in 40-m1 aliquots ina French pressure cell at 15,000 psi.
The cell lysatewas collected, pooled, and centrifuged (SS34 rotor, 13,000rpm,
20 min) to remove the cellular debris.The volume of the supernatantwas
measured and an equal volume of 1.6% streptomycin sulfate in TED buffer
was slowly added by burette with stirringover a period of 30 min. After
equilibration for an additional 30 min,precipitated material was removed by
centrifugation (SS34 rotor, 13,000rpm, 20 min) and powdered ammonium
sulfate was slowly added to the recoveredsupernatant to 35 % saturation and
equilibrated for 10 min. The precipitatewas removed by centrifugation (SS34
rotor, 13,000 rpm, 15 min) and powdered ammoniumsulfate was slowly
added to the collected supernatantto 70 % saturation and equilibrated for 10
min. The precipitate was recovered bycentrifugation (SS34 rotor, 13,000rpm,
15 min) and resuspended in 20 ml ofUng EB (10 mM Hepes-KOH (pH 7.4), 178
mM EDTA, 10 mM 2-mercaptoethanol, 1.0 M NaC1, 5 % (w/v) glycerol)and
dialyzed overnight against Ung EB. The dialyzed samplewas loaded onto a
Sephadex G-75 column (6 cm2 x 88 cm) equilibrated in Ung EB andfractions
(5.0 ml) were eluted with equilibration buffer ata flow rate of -20 ml/h and
assayed for uracil-DNA glycosylase activity. Active fractionswere pooled
(-120 ml) and dialyzed against HA buffer (10 mM potassium phosphate(pH
7.4), 1 mM DTT, 200 mM KC1) overnight. The dialyzed samplewas loaded
onto a hydroxyapatite column (19.6 cm2 x 3.6 cm) equilibrated in HA buffer,
fractions (7.5 ml) were eluted with equilibration bufferat a flow rate of -30-40
ml/h and assayed for uracil-DNA glycosylase activity. Active fractionswere
detected in the flow through, pooled (-120 ml), and dialyzed againstDA
buffer (30 mM Tris-HC1 (pH 7.4), 1 mM EDTA, 1 mM DTT, 5 % (w/v)glycerol)
overnight. The dialyzed samplewas applied to a single-stranded DNA-
agarose column (19.6 cm2 x 44 cm) equilibrated in DA buffer, washed with
-1,720 ml of equilibration buffer, and step eluted with 1,600 ml ofDA buffer
containing 150 mM NaCl ata flow rate of 40 ml/h. Fractions containing
uracil-DNA glycosylase activitywere analyzed by 12.5% SDS-polyacrylamide
gel electrophoresis and fractions (-680 ml)were pooled and concentrated (6.8-
fold) under N2 gas (55 psi) ina 200-ml Amicon stirred cell (62 mm YM10
membrane) attached to a 4-liter Amicon reservoir. Following the
concentration step, diafiltration was performed using 700 ml of DA buffer
lacking NaCl and the resulting samplewas designated uracil-DNA glycosylase
(fraction V).
2.2.4Purification of Uracil-DNA Glycosylase Inhibitor Protein
2.2.4.1 Large Scale Purification of Ugi
E. coli JM105 cells transformed with pZWtac1were grown at 37°C in 9
liters of TYN-ampicillin medium (1 %tryptone, 1 % yeast extract, 0.5 % NaC1,
0.01 `)/0 ampicillin) supplemented with 10µg /ml thiamine. When the cells
reached a density of 6.4 x 108 cells/ml, ugigene expression was induced by79
adjusting the medium to 1 mM IPTG and incubationwas continued for an
additional 3 h. Cells were harvested by centrifugation (GSArotor, 6,000 rpm,
15 min, 4°C), pellets were thoroughly drained, and frozen overnightat -80°C.
Frozen cell pellets were thawed, resuspended in 360 ml of TEDbuffer (50 mM
Tris-HC1 (pH 8.0), 1 mM EDTA, 1 mM DTT), and Dounce homogenizedto
break up cell aggregates. The resuspended cellswere lysed in 40-m1 aliquots
using a French pressure cell at 15,000 psi. The cell lysatewas collected on ice
and centrifuged (SS34 rotor, 13,000rpm, 20 min, 4°C) to pellet the cellular
debris. The supernatantwas transferred into 30-ml Corex tubes, heated at 100°
for 10 min, and allowed to cool toroom temperature. The extract was
centrifuged (SS34 rotor, 13,000rpm, 15 min, 4°C) to remove precipitated
material and the supernatantwas dialyzed overnight against TED buffer. The
dialyzed sample was loaded ontoa DEAE-cellulose (Whatman DE52) column
(19.6 cm2 x 10.2 cm) equilibrated in buffer TED, washed with600 ml of
equilibration buffer, and Ugiwas eluted by using a 1,100-m1 linear gradient
from 0 to 650 mM NaC1 in TED buffer. Fractions (8 ml)were collected at a
flow rate of 40 ml/h and assayed for uracil-DNAglycosylase inhibitor activity.
Fractions containing peak inhibitor activity andan OD280run:OD260. ratio of
>0.5 were pooled (-230 ml) and concentrated (2.3-fold) underN2 gas (55 psi) in
a 200-ml Amicon stirred cell (62 mm YM10 membrane) attached toa 4.0-liter
Amicon reservoir. After the concentration step, diafiltrationwas performed
using 700 ml of Ugi EB (50 mM Tris-HC1 (pH 8.0), 1 mMEDTA, 1 mM DTT,
100 mM NaCI, 10 % (w/v) glycerol) until the volumewas -25 ml. The
diafiltered sample was applied toa Sephadex G-75 column (5.3 cm2 x 60 cm)
equilibrated in Ugi EB and proteinwas eluted with equilibration buffer at a
flow rate of 20 ml/h. Fractions (4.2 ml) containinginhibitor activity were
analyzed for purity by 20 % SDS-polyacrylamide gelelectrophoresis and
fractions (-65 ml) were pooled.80
2.2.4.2 Purification of [Methionine-35S]LIgi
E. coli JM105 transformed with pZWtac1 was grown in 2.5 liters ofM9
medium supplemented with 10 11g/m1 thiamine and 0.01 `)/0 ampicillinat
37°C. Upon reaching a cell density of 6.5 x 108 cells/ml, 9.4 nmol of
rSimethionine (specific activity, 1,175 Ci/mmol)was added, and 35 min later,
25 ml of 100 mM IPTG was added to induce ugigene expression. Cells were
grown for an additional 3 h, harvested by centrifugation (GSA rotor, 6,000
rpm, 15 min, 4°C), pellets were thoroughly drained, and stored frozen at
80°C. Cells were thawed and resuspended ina total volume of 50 ml TED
buffer. Resuspended cellswere aliquoted (5 ml) and sonicated on ice in 1-min
bursts separated by 1-mM breaks fora total of eight cycles. The remaining
steps of the purification were performed similarly to that of unlabeled Ugi
with the following modifications: (i) DEAE-cellulose chromatography
(fraction II) was performed usinga 4.9 cm2 x 10.2 cm column, and the
inhibitor was eluted witha 300 ml linear gradient from 0 to 650 mM NaC1 in
TED buffer; and (ii) following Sephadex G-75 chromatography, fractions
containing inhibitor activity (fraction IV) were pooled (-80 ml) and
concentrated (4-fold) in an Amicon stirred cellas described above. [35S]Ugi
was then extensively dialyzed into 50 mM potassium phosphate (pH 6.0)
buffer.
2.2.5Purification of T4 DNA Polymerase
E. coli RR1 cells transformed with pTL43Wwere grown in 1.5 liters of
VAT medium (1 %0 tryptone, 0.4 % yeast extract, 1 % K2HPO4, 0.1 % KH2PO4)
supplemented with 1 `)/0 glucose and 0.01 % ampicillin at 30°C. Bacterial
growth was monitored by absorbance spectroscopy until the cells reacheda
density of 6.4 x 108 cells /ml and gp43gene expression was induced by the
addition of 1.5 liters of supplemented VAT medium equilibratedat 50°C.81
Incubation was continued at 40°C for 2 h, cellswere harvested by
centrifugation (GSA rotor, 6,000rpm, 15 min, 4°C), pellets were thoroughly
drained, and stored overnight at -80°C. Cellpellets were weighed (16.7 g) and
resuspended at 70 g/L in TEDM buffer (50mM Tris-HC1 (pH 8.0), 2 mM EDTA,
0.1 mM DTT, 1 mM 2-mercaptoethanol)supplemented with 20 mg/L of
lysozyme. Following resuspension, the cellmixture was adjusted to 1 mM
PMSF and stirred vigorously for 30 minat room temperature. Sodium
deoxycholate was then added toa concentration of 0.05 % (w/v) and PMSF
was added to a final concentration of 1.5 mM. The cell suspensionwas then
transferred to ice and stirred foran additional 20 min. Cells were aliquoted
(20 ml) and sonicatedon ice in 1 min bursts separated by 1 min breaks fora
total of five cycles. Centrifugationwas performed (SA600 rotor, 8,500 rpm, 20
min, 4°C) to pellet cellular debris. Twelvealiquots (200 R1) of the recovered
supernatant were removed and polyethyleneimine (PEI)was added to each to
achieve final concentrations of PEIranging from 0.05 % to 0.60 % in 0.05
increments by using a 5 % (v/v) PEI stock.Mixtures were placed on ice for 30
mM with intermittent mixing, precipitatedmaterial was removed by
microcentrifugation (12,000x g, 5 min, 4°C), and aliquots of the supernatant
(10 gl) were analyzed by 10 % SDS-polyacrylamidegel electrophoresis for their
T4 DNA polymerase content andsilver stained. T4 DNA polymerasewas
detected and migratedas an 94 kDa polypeptide. Based on this analysis, the
most quantitative precipitation of T4 DNA polymeraseoccurred at a PEI
concentration of 0.20 %. Using the 5 % (v/v)PEI stock, the supernatant from
the cell lysate was adjustedto 0.20 % PEI over a 15-min period on ice with
gentle mixing. Afteran additional 20 min, the precipitated material was
collected by centrifugation (SA600rotor, 8,500 rpm, 20 min, 4°C) and pellets
were resuspended in buffer X (50 mM Tris-HC1 (pH 7.5), 2 mMEDTA, 10 mM
2-mercaptoethanol) supplemented with 50mM NaCl using a volume equal
to 1/20th of the volume of the cell lysatesupernatant prior to PEI82
precipitation. Pellets were Dounce homogenized (20 strokes) and the
suspension was diluted with an equal volume of buffer X lacking NaC1. After
mixing on ice for 30 min, centrifugation (SA600 rotor, 8,500 rpm, 20 min, 4°C)
was conducted and the supernatants were saved. The resultant pellets were
re-extracted with 10 ml of buffer X containing 50 mM NaCl, diluted, mixed,
and centrifuged as described above. Supernatant fractions from both
extractions were combined and powdered ammonium sulfate was added to 35
% (saturation) over a 15 min period followed by a 20 min equilibration
period. Centrifugation (SA600 rotor, 14,500 rpm, 20 min, 4°C) was performed,
the supernatant fraction was saved, and powdered ammonium sulfate was
added to 55 % (saturation) as described above. Precipitated material was
recovered by centrifugation (SA600 rotor, 14,500 rpm, 20 min, 4°C) and
resuspended in a volume of buffer X containing 200 mM NaCI equal to 1/5th
of the cell lysate supernatant volume prior to the ammonium sulfate
precipitation step. The resuspended pellet was dialyzed extensively against
buffer D (50 rnM Tris-HC1 (pH 7.5), 50 mM KC1, 5 mM 2-mercaptoethanol, 0.1
mM EDTA, 25 % (w/v) glycerol) and applied to a single-stranded DNA
agarose column (19.6 cm2 x 40 cm) equilibrated in buffer D at 20 ml/h and
fractions (8 ml) were collected at a flow rate of 40 ml/h. After washing the
column with equilibration buffer (1,800 ml), T4 DNA polymerasewas step
eluted with 1,600 ml of buffer D containing 200 mM KCl. Fractions
containing peak T4 DNA polymerase activity were analyzed by 10 % SDS-
polyacrylamide gel electrophoresis, fractions were pooled (-560 ml) and
concentrated (14-fold) under N2 gas (55 psi) in an Amicon stirred cell (62mm
YM10 membrane) attached to a 4-liter Amicon reservoir. The concentrated
sample was dialyzed extensively against buffer P (50 mM Tris-HC1 (pH 7.5), 10
mM KC1, 5 mM 2-mercaptoethanol, 0.1 mM EDTA,. 25 % (w/v) glycerol) and
loaded onto a P-11 phosphocellulose column (19.6 cm2 x 7 cm) equilibrated in
buffer P at 20 ml/h. After washing the column with equilibration buffer (-
600 ml), T4 DNA polymerase was eluted by using a 1,100-m1 linear gradient83
from 10 to 400 mM KC1 in buffer P. Fractions (5 ml) containingpolymerase
activity were analyzed by 10 % SDS-polyacrylarnide gel electrophoresis,
fractions were pooled, concentrated (-7.5-fold)as described above. The pooled
fractions were dialyzed extensively against buffer S (20 mMTris-HC1 (pH 8.1),
50 mM NaC1, 2 mM DTT) containing 10 % (w/v) glycerol followedby
extensive dialysis against buffer S containing 50 % (w/v) glycerol.T4 DNA
polymerase was stored at -80°C.
2.2.6Resolution of UngUgi Complexes by DEAE-Cellulose
Chromatography
UngrSlUgi complexeswere formed by mixing 26.4 nmol of E. coli
Ung with 5.3 nmol of either unmodifiedor EDC/GEE-modified [35S]Ugi forms
I-V and were incubated at 25°C for 10 min and thenat 4°C for 20 min.
Following complex formation, each UngrSlUgi samplewas loaded onto a
DEAE-cellulose (Whatman DE52) column (0.8 cm2x 1.9 cm) to resolve the
complex from its component proteins. The columnwas equilibrated in DAB
buffer containing 50 mM NaCl. After sampleapplication, the column was
shut off for 5 min and then washed with 30 ml of equilibrationbuffer at a
flow rate of 20 ml/h. Proteinswere eluted with a two-step gradient consisting
of 25 ml and 10 ml of DAB buffer containing 150 and250 mM NaC1,
respectively. Fractions were collected, and sampleswere analyzed for Ung
activity and 35S radioactivity. Fractions containing Ung[35S]Ugicomplex
were pooled and concentrated by using a Centriplus-10 (Amicon)
concentrator.
The UDGUgi complexwas formed by combining 0.5 1=01 of human
placental UDG with 1.0 limo' of Ugi and incubatedunder standard complex
formation conditions described above. UDGUgicomplex was purified from
excess Ugi by a DEAE-cellulose column (1.8 cm2x 5.7 cm) equilibrated in
buffer DAB containing 50 mM NaCl. The complexwas loaded at a flow rate84
of 20 ml/h, washed with equilibration buffer (-40 ml), and elutedby the
addition of 120 ml of equilibration buffer containing 125 mMNaCl. Fractions
(4 ml) were collected ata flow rate of 40 ml/h and aliquots (25 1,11) were
analyzed by both 18 % nondenaturing and 20 % SDS-polyacrylamidegel
electrophoresis to verify that complexwas resolved from free UDG and Ugi.
Peak fractions containing UDGUgi complexwere pooled, concentrated (32-
fold) to - 1 ml, and diafiltered into equilibration bufferwithout NaC1 by using
an Amicon stirred cell (25 mm YM10 membrane). Following the
concentration step, the UDGUgi complex (A280= 10.8) was determined to
contain 170 jiM protein by absorbance spectroscopy.
2.2.7Enzyme Assays
2.2.7.1 Uracil -DNA Glycosylase
Standard uracil-DNA glycosylaseassay mixtures (100 gl) contained 70
mM Hepes-KOH (pH 8.0), 1 mM EDTA, 1 mM DTT, and8.2 nmol of activated
calf-thymus [uracil-31-1]DNA (181-195 cpm/pmol of uracil).Exogenous E. coli
Ung, human UDG, or human whole cellextract protein were introduced as
samples (25 gl) andwere typically diluted in Ung dilution buffer (50 mM
Hepes-KOH (pH 7.4), 1 mM EDTA, 1 mM DTT, 100µg /ml bovine serum
albumin) as needed. Reaction mixtureswere incubated at 37°C for 30 min
and terminated on ice with 250 R1 of10 mM ammonium formate (pH 4.2).
Free [3H]uracil was resolved from unhydrolyzed[uracil- 3H]DNA by applying
300 ml of the terminated reaction mixtureto a Dowex 1-X8 ion exchange
column (0.2 cm2 x 2.0 cm) equilibrated in 10mM ammonium formate (pH
4.2). Columns were washed with 1.7 ml ofequilibration buffer and two 1-ml
fractions were collected. Fractionswere combined with 5 ml of Formula 989
Fluor, mixed by inversion, and 3H radioactivitywas measured. One unit of
uracil-DNA glycosylase is definedas the amount that releases 1 nmol of
uracil/h under standard conditions.85
Uracil-DNA glycosylase activity in human crude cellextracts was also
measured on single-stranded [32P]U-34-mer, and double-stranded[32I1U/A-34-
mer and [32P]U/G -34 -mer DNA substrates. Reaction mixtures (100 1.11)
contained 25 mM Hepes-KOH (pH 7.8), 0.5 mMEDTA, 0.5 mM DTT, 4 pmol of
uracil-containing [32P]34 -mer oligonucleotide andvarious amounts of crude
cell extract (0.16-160 pg) diluted with HE buffer(25 mM Hepes-KOH (pH 7.8), 1
mM EDTA, 1 mM DTT, 10 % (w/v) glycerol).Crude cell extract dilutions
were introduced as 20111 samples. Samples containing uracil-DNA
glycosylase inhibitor proteinwere prepared by mixing 1000 units of Ugi
(fraction IV) with the crude cellextract prior to the addition of DNA
substrates. Reaction mixtureswere incubated at 30°C for 30 min and
terminated with an equal volume ofa stop solution containing 2SDS and
50 mM EDTA. Sampleswere adjusted to a final concentration of 0.3 mg/ml
yeast tRNA and 2 M ammonium acetate, extracted twice withan equal
volume of phenol/chloroform (50:50),ethanol-precipitated, and resuspended
in 20 ill of distilled H2O. Apyrimidinicsites (AP-sites) generated by uracil
removal from DNA substrateswere hydrolyzed by the addition of 0.55 gl of 3
M K2HPO4 (pH 13.7) to 5 pi of resuspendedDNA and incubated for 3 h at 55°C.
Samples were then neutralized with 1.2 illof 1.5 M KH2PO4 and combined
with an equal volume of denaturingsample buffer (95 % deionized
formamide, 10 mM EDTA, 0.1 `)/0 bromophenolblue, 0.1 % xylene cyanol).
After heat treatment at 95°C for 3min, samples were analyzed by denaturing
12 % polyacrylamide/8.3 Murea gel electrophoresis. Electrophoresis was
performed using TBE buffer (90 mM Tris, 90mM boric acid, 2 mM EDTA) at
1,200 V until the bromophenol blue trackingdye migrated 20 cm. Gelswere
dried under vacuum and autoradiographywas performed by using X-OMAT
AR5 film (Kodak). Bands containing 32Pradioactivity were excised from the
dried gel, placed in scintillation vials (7 ml)containing 0.5 ml of 30 % H202,
and incubated at 55°C for 24 h. Once solubilized,5 ml of Formula 989 Fluor86
was added and 32P radioactivity was measured by using a Beckman LS6800
liquid scintillation counter.
Thymine-DNA glycosylase and double-stranded uracil-DNA
glycosylase activities in human crude cellextracts were assayed similarly to
that described above. Reaction mixtures (100 gl) contained25 mM Hepes-
KOH (pH 7.9), 50 mM KCI, 1 mM DTT, 0.5 mM EDTA,0.01 mM ZnC12, 0.1
mg/ml acetylated bovineserum albumin (BSA), 4 pmol of either [93]T/G-34-
mer, [32P]U /A- 34 -mer, or [3'I1U/G-34 -mer, and various amounts of crude cell
extract (0.16-160 pg) diluted with HE buffer. Samples containinguracil-DNA
glycosylase inhibitor proteinwere prepared by mixing 1000 units of Ugi
(fraction IV) with the crude cell extract priorto the addition of DNA
substrates. Enzymatic activitywas determined following incubation at 30°C
for 30 min. [32P]oligonucleotide reactionproducts were processed and
analyzed by denaturing polyacrylamide gelelectrophoresis as described above.
2.2.7.2 Uracil-DNA Glycosylase Inhibitor Protein
Uracil-DNA glycosylase inhibitor activitywas measured in reaction
mixtures containing 70 mM Hepes-KOH (pH 8.0), 1 mMEDTA, 1 mM DTT,
8.2 nmol of [uracil-41]DNA, 0.05-0.15 units ofE. coli uracil-DNA glycosylase
(fraction V) and various amounts of uracil-DNAglycosylase inhibitor protein
diluted in Ugi dilution buffer (50 mMTris-HC1 (pH 8.0), 1 mM EDTA, 1 mM
DTT, 100 mM NaC1) or heat-treated humancrude cell extract protein. Ugi
and heat-treated cell extractwere introduced as 25 IA samples. Reactions were
conducted for 30 min at 37°C. Theamount of [3H]uracil released was
measured by using a Dowex 1X-8 columnas described for uracil-DNA
glycosylase. One unit of uracil-DNA glycosylase inhibitoris defined as the
amount that inactivates 1 unit of uracil-DNA glycosylaseunder standard
reaction conditions.87
2.2.7.3 DNA Polymerase
T4 DNA polymerase activitywas measured in reaction mixtures (100
IA containing 67 mM Tris-HC1 (pH 8.8),6.7 mM MgC12, 16.7 mM (NH4)2SO4,
6.7 µM EDTA, 10 mM 2-mercaptoethanol,200 µg /ml acetylated BSA, 10 lig
activated calf thymus DNA, 33 µM each of dATP, dTTP,dCTP, and dGTP, and
[3H]dTTP (1700 cpm/pmol). ExogenousT4 DNA polymerase was introduced
as samples (25 1.11) and diluted in T4 DNA polymerase buffer S.Reaction
mixtures were incubated at 37°C for 30 min and terminatedon ice by the
addition of 200 IA of 1 mg/ml BSA in 0.1 M sodiumpyrophosphate. DNA
was precipitated with 1 ml of 10 % (saturated) trichloroacetic acid (0.30g /ml)
and held on ice for 5 min. Acid-insolubleDNA was collected on #30 glass
fiber filters (Schleicher and Schuell) pre-soakedin 0.1 M sodium
pyrophosphate, washed with 18 ml (sixx 3 ml applications) of 0.1 M sodium
pyrophosphate in 1 N HC1, and dried with 95 % ethanol.Glass filters were
dried under a heating lamp for 10 mM, placedinto glass vials containing 10
ml of 0.4 % 2, 5- bis- 2-( 5- tertbutylbenzoxazolyl)- thiophene (BBOT) in toluene,
and [3H]dTMP incorporation into DNAwas measured by using a Beckman
LS6800 liquid scintillationspectrometer. One unit of T4 DNA polymerase
activity catalyzes the incorporation of 10 nmolof total dNMP into activated
calf thymus DNA in 30 mM at 37°C.
DNA polymerase activity in human whole cellextracts was measured
in reaction mixtures (100 gl) containing100 mM Tris-HC1 (pH 7.5), 5 mM
MgC12, 1 mM DTT, 0.1 mM EDTA, .2 mMATP, 0.5 mM P-NAD, 20 µM each of
dATP, dTTP, dCTP, and dGTP, 5 mMphosphocreatine di-Tris salt, 40 units of
creatine phosphokinase, 10 gg activated calf thymusDNA, and [3H]dTTP (1700
cpm/pmol). Human whole cell extractprotein was introduced as samples (40
gl) diluted in whole cell extract dialysisbuffer (25 mM Hepes-KOH (pH 7.9),
100 mM KC1, 12 mM MgC12, 1 mM EDTA,2 mM DTT, 17 % (w/v) glycerol).
Samples supplemented with variousamounts of aphidicolin in DMSO88
(constituting 1 % of the total reaction volume) were mixed with the crude cell
extract protein prior to the addition of the DNA substrate. Reaction mixtures
containing human U251 cell extract protein were incubated for 60 mM and
reaction mixtures containing human LoVo cell extract protein were incubated
for 45 mM at 30°C. Samples were terminated and the amount of [3H]dTMP
incorporated into activated calf thymus DNA was determined as described
above.
2.2.8Electrophoresis
2.2.8.1 Sodium Dodecyl Sulfate Polyacrylamide Slab Gel
Electrophoresis
Sodium dodecyl sulfate polyacrylamide slab gel electrophoresis was
performed similarly to that described by Laemmli (134). Slab gels containeda
resolving gel (13 cm) composed of various concentrations of acrylamide and
N,N-methylenebis(acrylamide) (typically 20 %:0.53 %, 12.5 %:0.33 %, or 10
%:0.27 %) from a stock solution of 30 % acrylamide:0.8 % N,K-
methylenebis(acrylamide) (37:1 ratio), 0.1 % SDS, and 375 mM Tris-HC1 (pH
8.8). The resolving gel was polymerized by adjustment to 0.03 `)/0 (w/v)
ammonium persulfate and 0.075 % (v/v) TEMED. The stacking gel (1 cm)
contained 3 %0 acrylamide, 0.08 % N,N'-methylenebis(acrylamide), 0.1 % SDS,
and 125 mM Tris-HC1 (pH 6.8). The stacking gel was polymerized by
adjustment to 0.10 % (w/v) ammonium persulfate and 0.10 % (v/v) TEMED.
Protein samples were mixed with an equal volume of cracking dye buffer (50
mM Tris -HCI (pH 6.8), 1 % SDS, 143 mM 2-mercaptoethanol, 10 % (w/v)
glycerol, 0.04 % bromophenol blue) and heated at 100°C for 10 min before
being loaded onto the gel. Electrophoresiswas conducted at room
temperature at 100 V until the tracking dye reached the resolving gel and
then the voltage was increased to 200 V until the tracking dyewas 2 cm from
the bottom of the gel. The running buffer contained 25 mM Trizma base, 192
mM glycine, and 0.1 % SDS. Gelswere fixed in a solution containing 10 %89
acetic acid and 50 % methanol and protein bandswere visualized by staining
in a solution of 10 % acetic acid, 50 % methanol, and0.05 % Coomassie
brilliant blue G-250. Gelswere destained in 7 % acetic acid and 5 % methanol.
2.2.8.2 Nondenaturing Polyacrylamide Slab Gel
Electrophoresis
Nondenaturing polyacrylamide slab gel electrophoresiswas performed
by a modification of that described by Laemmili (134).Slab gels contained a
resolving gel (13 cm) composed of 18 % acrylamide, 0.36% N,N'-
methylenebis(acrylamide), and 375 mM Tris-HC1 (pH 8.8) anda stacking gel (1
cm) containing 3 % acrylamide, 0.08 % N,N'-methylenebis(acrylamide), and
125 mM Tris-HC1 (pH 6.8). Both the resolving andstacking gels were
polymerized as described above. Protein samples (30-60 111)were adjusted to
final concentrations of 50 mM Tris-HC1 (pH 6.8),10 % (w/v) glycerol, and 0.01
bromophenol blue prior to being loadedon the gel. Electrophoresis was
performed at 4°C and 100 V until the tracking dye migratedthrough the
stacking gel, at which point the electrical potentialwas increased to 200 V.
Electrophoresis continued until the tracking dye migrated within-2 cm from
the bottom of the gel. The native running buffercontained 25 mM Trizma
base and 192 mM glycine. Protein bandswere detected by a rapid protein
staining method originally described by Reisner (221) withmodifications as
described above.
2.2.8.3 Nondenaturing Polyacrylamide Tube Gel
Electrophoresis
Nondenaturing polyacrylamide tube gel electrophoresiswas performed
as described by Davis (50) with some modifications. Tube gels (0.6cm
diameter) contained a resolving gel (9 cm) composedof 18 % acrylamide, 0.36
N,N'-methylenebis(acrylamide), and 375 mM Tris-HC1 (pH 8.8) anda
stacking gel (1 cm) containing 3 `)/0 acrylamide, 0.08% N,N'-
methylenebis(acrylamide), and 125 mM Tris -HCI (pH 6.8). Boththe resolving90
and stacking gels were polymerizedas described above but at 4°C. Protein
samples were adjusted to final concentrations of 50 mM Tris-HC1(pH 6.8), 10
% (w/v) glycerol, and 0.01 % bromophenol blue and electrophoresiswas
performed at 4°C as described above. After electrophoresis,gels were either
stained by rapid protein staining (221)or solubilized for radioactivity as
described previously.
2.2.8.4 Urea-Polyacrylamide Sequencing Gel Electrophoresis
Analysis of uracil-DNA glycosylaseor whole cell extract base excision
repair reaction products was performed using denaturingpolyacrylamide gels
(30 x 40 x 0.08 cm) composed of 12 % acrylamide, 0.40 %N,N'-
methylenebis(acrylamide), 8.3 Murea, and TBE buffer (90 mM Tris, 90 mM
boric acid, 2 mM EDTA). Polymerizationwas catalyzed by adjustment to 0.067
% (w/v) ammonium persulfate and 0.012 % (v/v)TEMED. Samples were
mixed with an equal volume of denaturing formamidedye buffer (95 %
deionized formamide, 10 mM EDTA, 0.1 % bromophenolblue, 0.1 % xylene
cyanol) and heated at 95°C for 3 mM. Samples (5-15 111)were loaded and
electrophoresis was performed at 1000-1200 V in TBEbuffer until the
bromophenol blue tracking dye had migrated -20-25cm. The gels were
soaked in tepid water for -2-3 mMto diffuse urea out of the gel and gels were
dried under vacuum and autoradiographywas performed with X-OMAT AR5
film (Kodak). Bands containing 32P radioactivitywere either excised from the
gel for solubilization and measurement of 32Pradioactivity by liquid
scintillation or the intact gelwas quantitated by using a Phosphor Imager.
Nondenaturing 5 % polyacrylamide sequencinggels were similarly
prepared but withouturea. Samples (-5-10 )11) were adjusted to 50 mM Tris-
HC1 (pH 6.8), 10 % (w/v) glycerol, and0.01 % bromophenol blue and
electrophoresis was performed at 750 Vas described above. Gels were dried
under vacuum, autoradiographywas performed, and 32P radioactivity was
quantitated by using a Phosphor Imager.91
2.2.8.5 Agarose Gel Electrophoresis
Agarose slab gels (0.8 %)were prepared by heating electrophoresis grade
agarose powder in a volume of TAE buffer (40 mM Tris-acetate and 1 mM
EDTA (pH 8.0)) in a microwaveoven for -1-2 min. After cooling to -50-60°C,
ethidium bromide (500 fig/m1)was added to 0.1 µg /ml, the mixture was
poured into 12 x 13 cmor 7 x 8 cm casting trays (Owl Scientific) containing a
20-well or 10-well teflon comb, respectively, andallowed to polymerize for -1
h. To physically separate Form I fromForm II DNA or to measure M13mp2
DNA recoveries or primer extensionreaction products, samples were
combined with agarose dye bufferto a final concentration of 10 mM EDTA
(pH 8.0), 0.1% SDS, 5% (w/v) glycerol, and0.01% bromophenol blue, loaded
onto 0.8% agarose gels, and electrophoresiswas performed at 100 V (12 x 13
cm gel) or 70 V (7 x 8 cm gel) in TAE buffer containing 0.1µg /ml ethidium
bromide until the tracking dye had migrated-75% of the distance of the gel.
DNA was visualized by UV-lighttransillumination (-302 nm).
2.2.9 EDC/GEE Modification of [35S]Ugi
An EDC/GEE modification reaction mixture (16.9ml) containing 1,050
nmol of [35S]Ugi (fraction IV), 228 Rrnolof glycine ethyl ester (GEE), and 45.6
limo' of 1- ethyl- 3- (3- dimethylaminopropyl)carbodiimide (EDC) in 50 mM
potassium phosphate buffer (pH 6.0)was incubated at 25°C for 30 min. GEE
was introduced into the reaction mixture with [35S]Ugi priorto the addition of
EDC. The reactionwas terminated by addition of 16.9 ml of 2 M sodium
acetate (pH 4.75). Excess EDC and GEEwere removed from the EDC/GEE-
modified [35S]Ugi by processing 250-41aliquots through spun columns
containing 1.4 ml of Bio-Gel P-4 resin (Bio-Rad)equilibrated in 50 mM
potassium phosphate buffer (pH 6.0). P-4spun columns were centrifuged in a
clinical centrifuge (IEC, setting #4 for 2.5min). After processing, all aliquots92
were pooled and extensively dialyzed against buffer A (50 mM Tris-HC1 (pH
7.0), 1 mM EDTA, 1 mM DTT) containing 50 mM NaCl.
2.2.10Purification of EDC/GEE-Modified [35S]Ugi Forms I-V
In order to isolate individual forms of EDC/GEE-modified [35S]Ugi
protein, a sample containing 486 nmol of the EDC/GEE-modified [35S]Ugi
mixture was applied to a DEAE-cellulose (Whatman DE52) column (0.6 cm2 x
7.9 cm) equilibrated at 4°C in buffer A containing 50 mM NaCl. The column
was washed with 15 ml of equilibration buffer , and [35S]Ugi was eluted with a
100 ml linear gradient of 50-300 mM NaCl in buffer A at a flow rate of 10
ml/h. Fractions (1 ml) were collected in Eppendorf tubes, samples (10 IA)
were mixed with 5 ml of Formula 989 Fluor, and 35S radioactivity was
measured in a Beckman. LS 6800 liquid scintillation counter. Fractions
containing EDC/GEE-modified [35S]Ugi forms I-V were analyzed by 18 %
nondenaturing polyacrylamide gel electrophoresis. Each form was separately
pooled and evaporated to dryness in a Speed-Vac Concentrator (Savant),
resuspended with 1 ml of buffer A, and then dialyzed extensively against Ugi
EB.
2.2.11Fluorescein 5-Isothiocyanate Labeling of Ung
Four preparations of Ung (fraction V) were extensively dialyzed against
buffer KEG containing 50 mM potassium phosphate (pH 8.5, 9.0, 9.5, or 10.0), 1
mM EDTA, and 5 % (w/v) glycerol at 4°C. Fluorescein 5-isothiocyanate stock
(810 pM) was freshly prepared in dimethylformamide, and 1.5 ml was added
to 14 ml of Ung (2.9 mg) with thorough mixing. After 2.5 h in the dark, the
mixture was placed on ice and then loaded onto four separate Sephadex G-25
columns (4.9 cm2 x 13.5 cm) equilibrated in buffer KEG (pH 8.5, 9.0, 9.5, or
10.0). The columns were washed with equilibration buffer at a flow rate of 20
ml/h and fractions (2 ml) were monitored at 260, 280, and 496 nm for93
absorbance. After the FITC-Ung (F-Ung) containing fractionswere pooled, the
concentration of F-Ung was determined based on absorbance at 280 and 496
nm. The concentration of FITC in the dye-protein conjugate was determined
by the absorbance, where e496= 7.8 x 104 liter /rnolcm. It was experimentally
determined that 1 p,M FITC contributed 0.025 A280. Thus, the concentration of
F-Ung was determined by subtracting the A280 contributed by FITC from the
overall A280 of the dye-protein conjugate and dividing by the molar extinction
coefficient of Ung.
2.2.12Steady-State Fluorescence Measurements
Steady-state fluorescence measurements were conducted at 25°C using
an LS50 luminescence spectrometer (Perkin-Elmer) equipped with a xenon
flash tube and a thermostatted minicell (4 mm). Excitation and emission
wavelengths were 496 and 520 nm, respectively; both slit widthswere set at 5
mm.
2.2.13Isolation of Cyanogen Bromide-Generated Peptide
Fragments from EDC/GEE-Modified ['S]Ugi Forms I-V
Cyanogen bromide cleavage reaction mixtures (200-650 1.11) contained 20
mM CNBr, 0.1 N HC1, and 25 µM of [35S]Ugior EDC/GEE-modified rSlUgi
forms I-V. After incubation at 25°C for 24 h, sampleswere evaporated to
dryness, resuspended in 65 .t1 of distilled H2O, and analyzed by using MALDI
mass spectrometric methods. Samples utilized for peptide C3 purification
were resuspended in 600 p.1 of buffer A and applied to individual DEAE-
cellulose (Whatman DE52) columns (0.79 cm'x 1.3 cm) equilibrated in buffer
A at 4°C. After sample loading, the flowwas stopped for 5 min, and then the
column was washed with 2.5 ml of buffer A. Peptide fragmentswere eluted at
a flow rate of 10 ml/h with a 50-ml linear gradient of 0-250 mM NaCI in
buffer A. Fractions (500 p.1) were collected in Eppendorf tubes, and samples
were analyzed for CNBr-cleaved peptide fragments by MALDI mass94
spectrometry. Fractions containing peptide C3 were pooled and concentrated
to -300 Ill by using a Centricon-3 (Amicon) concentrator, buffer was
exchanged with distilled H2O, and fractions were submitted for amino acid
sequence analysis.
2.2.14Asp-N Endoproteinase Digestion of Ugi Protein
Proteolysis reaction mixtures contained Asp-N (0.04 mg/ml in 10 mM
Tris-HC1 (pH 7.5)) and unmodified [35S]Ugi or EDC/GEE modified {'SlUgi
forms II-III (10 mM Tris-HC1 (pH 7.5)) in a 1:100 (w/w) ratio. Incubation was
carried out for 3 h at 25°C, and the extent of proteolysis was monitored by
MALDI mass spectrometry.
2.2.15Amino Acid Sequence Analysis
Samples (30 1.1,1 in distilled H2O) containing purified peptide C3 from
unmodified [35SJUgi or EDC/GEE-modified [35S]Ugi forms I-IV were applied to
a cartridge filter precycled with Biobrene (Applied Biosystems). Amino acid
sequencing was conducted using an Applied Biosystems model 475A gas
protein sequencer by the Center for Gene Research and Biotechnology
(Oregon State University).
2.2.16MALDI Mass Spectrometric Analysis
MALDI mass spectrometry was performed by the Mass Spectrometry
Facilities and Service Core Unit (Environmental Health Science Center,
Oregon State University) using a custom-built time of flight instrument (112).
Two different matrices were used in the sample preparation: (i)10 mg/ml of
sinapinic acid dissolved in 33 % acetonitrile and 67 % trifluoroacetic acid (0.1
% solution) was mixed (3:1) with samples (0.5 IA) containing 10 µM EDC/GEE-
modified or unmodified Ugi protein; and (ii)a saturated solution of a-cyano-
4-hydroxycinnamic acid in 33 % acetonitrile and 67 % trifluoroacetic acid (0.195
solution) was mixed (10:1) with samples (0.5 111)containing CNBr-treated
Ugi, purified peptide C3, and Asp-N-digested Ugiprotein. Each matrix
solution was applied to amass spectrometric probe and allowed to dry on the
probe by slow evaporation. Amass spectrum was generated from 30
individual laser pulses (+24 kV), and the summed signalswere calibrated by
using standard ion signals from the matrix.
2.2.17Site-Directed Mutagenesis of the M13mp2 lacZa Gene
M13mp2 DNA was isolated from E. coli CJ236 cells and purifiedas
described by Kunkel (130). Site-specific mutations in thelacZa gene were
introduced by annealing 5'-end phosphorylatedA-41-mer to M13mp2 DNA.
Oligonucleotide A-41-mer (192 pmol)was hybridized to uracil-containing
M13mp2 DNA (64 pmol) ina reaction mixture (440 R1) containing 150 mM
NaCl and 15 mM sodium citrate (pH 7.0). Hybridizationwas facilitated by
heating to 70°C and cooling slowlyto room temperature (-4 h).
Oligonucleotide A-41-mer sharedsequence complementarity with lacZa from
nucleotide positions 68-108 except for discrepanciesat positions 78-80 and 98.
These two sites introducedan opal codon (TGA) in place of an arginine codon
(CGT) coding for amino acid residue 14 of the lacZagene product and a silent
mutation generating a unique Smal restriction site,respectively. Primer
extension reaction mixtures (300 p.1) contained 20 mMHepes-KOH (pH 7.4), 2
mM DTT, 13 mM MgC12, 1 mM ATP, 500RM each of dATP, dTTP, dGTP, and
dCTP, 50 µg/m1 acetylated bovineserum albumin, 27 units of T4 DNA
polymerase, 1,200 units of T4 DNA ligase, and8.8 pmol of heteroduplex A-41-
mer/M13mp2 DNA. After incubation for 5 mMon ice, 5 mM at 25°C, and 4 h
at 37°C, the reaction was terminated with the addition of53 gl of 0.1 M EDTA.
Competent E. coli JM109 cells (-1.4x 1011 cells/m1) in 10 % (w/v) glycerol (40
1.1.1) were mixed with the primer-extendedDNA (0.5 p.1) and electroporation
was carried out using a Gene Pulser system (Bio-Rad) witha single pulse set at96
2.5 kV, 25 µF capacitance, and 200 O. Transfected cells were diluted into SOC
medium, serially diluted, and aliquots (100 p.1) were mixed with prewarmed
M9 topagar (2.5 ml) containing 0.4 mM IPTG and 1 mg/ml X-Gal andgrown
on M9 plates. An isolated clear plaque was placed into sterile 0.9 % NaC1
solution (200 1.1,1) in an Eppendorf, heated to 60°C for 5 mM, vortexed
vigorously for 30 sec, centrifuged (12,000 x g, 3 min, 25°C), and retitered using
mid-log E. coil JM109 cells on M9 plates with M9 topagar containing IPTG and
X-Gal. An isolated clear plaque from the secondary screening was placed into
sterile 0.9 % NaCl (1 ml) and phage were propagated in E. coil JM109 and
M13mp2op14 DNA was purified as described previously. DNA sequence
analysis was conducted using an Applied Biosystems 373 DNA sequencer by
the Center for Gene Research and Biotechnology (Oregon State University)
and verified that M13mp2op14 DNA contained the desired lacZa opal codon
and a unique SmaI restriction site.
2.2.18Preparation of Base Excision DNA Substrates
M13mp2op14 DNA was isolated from E. coli JM109 cells as described by
Kunkel (130). Oligonucleotides U-23-mer and A-23-merwere 5'-end
phosphorylated as described previously and annealed to M13mp2op14 DNA
in separate hybridization reaction mixtures (1515 p.1) containing 1,500 pmol of
U-23-mer or A-23-mer, 500 pmol of M13mp2op14 DNA, 20 mM Tris-HC1 (pH
7.4), 2 mM MgC12, and 50 mM NaCl. The mixtureswere placed in a 500-m1
beaker filled with 70°C distilled H2O and slowly cooled toroom temperature
(-4 h). The heteroduplex U-23-mer/M13mp2op14 substrate formeda UT
mispair at nucleotide position 78 of the lacZa gene whereas the homoduplex
A-23-mer/M13mp2op14 substrate formedan AT basepair. Heteroduplex
[3211U-23-mer/M13mp2op14 substratewas also prepared by 5'-end97
oligonucleotide U-23-mer followed byhybridization to Ml3mp2op14 DNAas
described above. The duplex DNAwas stored at -80°C.
Pilot primer extension reactionmixtures (50 111) were prepared and
contained 3.3 pmol of heteroduplexU-23-mer/M13mp2op14 or homoduplex
A-23-mer/M13mp2op14 DNA substrate, 20 mMHepes-KOH (pH 7.8), 2 mM
DTT, 10 mM MgC12, 1 mM ATP, 500p.M each of dATP, dTTP, dCTP, and
dGTP, and various amounts of T4DNA polymerase and T4 DNA ligaseas
indicated in the figure legends. T4DNA ligase was introduced into the
primer extension reaction mixturesas a 100-fold unit excess over T4 DNA
polymerase. Enzyme stockswere diluted in T4 DNA polymerase dilution
buffer (20 mM Tris-HC1 (pH 8.1),50 mM NaCl, 2 mM DTT, 50 % (w/v)
glycerol) or T4 DNA ligase dilution buffer(10 mM Tris-HC1 (pH 7.4), 50 mM
KC1, 1 mM DTT, 0.1 mM EDTA,200 lig/ml acetylated bovineserum albumin,
50 % (w/v) glycerol). Individualcomponents of the reaction mixture
contributed to a specific percentage ofthe overall reaction volume andwere
strictly enforced. The DNA additionconstituted 20 % of the reaction mixture
volume while the T4 DNA polymeraseand T4 DNA ligase additions
contributed 8.6 % and 13.2 `)/0, respectively.T4 DNA polymerase and T4 DNA
ligase were the second to last andfinal additions, respectively. After
incubation for 5 mMon ice, 5 min at 25°C, and 4 h at 37°C, the reactionwas
terminated with 8.8 RI of 0.1 M EDTA.Aliquots (2 1.1.1) of the primer extension
reaction mixtureswere adjusted to a final concentration of 10 mM EDTA (pH
8.0), 0.1% SDS, 5% (w/v) glycerol, and0.01% bromophenol blue and analyzed
by 0.8 % agarose gel electrophoresis.This process was repeated for each
annealing reaction mixture preparation.Pilot primer extension reaction
mixtures containing 6.6 units of T4DNA polymerase and 660 units of T4
DNA ligase per 3.3 pmol of primedtemplate consistently yielded the best
results as was determined by theamount of Form I DNA detected by 0.8
agarose gel electrophoresis.98
Preparative primer extension reaction mixtures (3030 111)were prepared
that contained 200 pmol of U-23-mer/M13mp2op14or A-23-mer/
M13mp2op14 substrate DNA, 20 mM Hepes-KOH (pH 7.8), 2 mM DTT, 10mM
MgC12, 1 mM ATP, 500 j.tM each of dATP, dTTP, dCTP, and dGTP, 400units of
T4 DNA polymerase, and 40,000 units of T4 DNA ligase. The specific
percentage of individual components of the reaction mixture and order of
addition are described above. After incubation for 5 mMon ice, 5 mM at 25°C,
and 4 h at 37°C, the reactionwas terminated with the addition of 535 tl of 0.1
M EDTA. An aliquot (2 ill) was saved for analysis by 0.8 %agarose gel
electrophoresis.
Covalent ly closed circular duplex DNA reaction products (Form I
DNA) from the preparative primer extension reactions described abovewere
isolated by ethidium bromide-cesium chloride gradient centrifugationas
described by Sambrook et al. (228). The terminated primer extensionreaction
was mixed with 18.12 g of optical grade CsC1 (Gibco BRL) and -10-15 ml of TE
buffer at 30°C. After the CsC1 had dissolved, the mixturewas adjusted to a
volume of 23.12 ml with TE buffer followed by the addition of 1.88 ml of
ethidium bromide from a 10 mg/ml stock dissolved in distilled H2Oto
achieve a final volume of 25 ml. The final concentrations of CsC1 and
ethidium bromide were 0.725 g/ml and 0.752 mg/ml, respectively. The
sample was divided and loaded into two 12.5-m1 polyallomer centrifugetubes
(Beckman) fitted for an SW41 ultracentrifuge rotor (Beckman).
Centrifugation was performed at 39,000rpm for 60 h at 20°C and the
deceleration step occurred without braking. Form I DNAwas collected from
the centrifuge tubes by usinga 22G11 gauge hypodermic needle, by inserting
the needle beveled side up through the wall of the tube and underneaththe
Form I DNA band. The Form I DNA band (-500-600 pi)was removed,
extracted four times with an equal volume of 1-butanol saturated with 5 M
NaC1, concentrated by usinga Centricon-30 (Amicon) concentrator, and buffer
exchanged into TE buffer (10 mM Tris-HC1 (pH 8.0), 1 mMEDTA).99
2.2.19Preparation of Human Whole Cell Extracts
Human glioblastoma U251or colon adenocarcinoma LoVo cells were
grown to -85 % confluency in 75 cm2 tissue culture flasks andwere harvested
by scraping into 8 ml of PBS buffer (8.1mM Na2HPO4, 1.5 mM KH21304, 2.7
mM KC1, 137 mM NaCl (pH 7.2)). Theapproximate cell yield of a 75 cm2
tissue culture flask at confluencywas 2 x 10' cells (73). By extrapolation,
standard whole cell extract preparations (40 flasks)at 85 °A) confluency yielded
an approximated 6.8 x 108 cells. Cells were pelleted ina Dynac centrifuge
(Becton Dickinson) (3 min, speed setting 65)and cell pellets were combined,
washed once with ice cold PBS buffer (-10 ml),and pelleted again. The
supernatant fraction was carefully removed and the packedcell volume
(PCV) was estimated. Cellswere resuspended in 4 PCV of hypotonic lysis
buffer (10 mM Tris-HC1 (pH 8.0), 1 mMEDTA, 5 mM DTT). For each 1 ml
PCV measured, the cell suspensionwas supplemented with 5 pl of 87 mg/ml
PMSF in methanol, 2 pl of 5 mg/mlleupeptin in distilled H2O, 2 pi of 5
mg/ml pepstatin in DMSO, 2 pl of 5 mg/mlchymostatin in DMSO, and 50 pl
aprotinin. The suspensionwas mixed, placed on ice for 20 mM, transferred to
a 30-m1 glass homogenizer (Jencons), and cellswere homogenized on ice by
using a Teflon pestle (-20-30 strokes)to break the cells. The homogenate was
then transferred toa glass beaker on ice and 4 PCV of sucrose-glycerol buffer
(50 mM Tris-HCI (pH 8.0), 10 mM MgC12,2 mM DTT, 25 % sucrose, 50 % (w/v)
glycerol) were slowly added. Aftermixing was complete, 1 PCV of saturated
ammonium sulfate (pH 7.0)was slowly added with stirring at a rate of- 1
revolution per second to avoid shearing theDNA. The homogenate was
stirred on ice for an additional 30 mM, pouredinto 5-ml polyallomer
centrifuge tubes (Beckman) fitted foran SW50.1 ultracentrifuge rotor
(Beckman). Centrifugationwas performed at 32,000 rpm for 3 h at 4°C. The
supernatant fraction was carefully removed (leaving thelast 1 ml above the
pellet in the tube), volume measured,and transferred to a glass beakeron ice.100
While mixing, 0.33 g of powdered ammonium sulfateper ml of supernatant
was slowly added followed by a 10 IA addition of 1 M NaOH per gram of
ammonium sulfate to neutralize the mixture. Mixingwas continued for 30
min and the precipitate was recovered by centrifugation (SS34rotor, 13,000
rpm, 20 min, 4°C). The pellets were resuspended in -200-300 gl of whole cell
extract dialysis buffer (25 mM Hepes-KOH (pH 7.9), 100 mM KC1, 12 mM
MgC12, 1 mM EDTA, 2 mM DTT, 17 % (w/v) glycerol), transferredinto
SpectraPor dialysis tubing (6-8,000 MWCO, 6.4mm diameter), and dialyzed for
1-2 h against -500 ml of whole cell extract dialysis buffer. The bufferwas
exchanged once and dialysis was continued foran additional 8-12 h. The
dialysate was transferred to an Eppendorf tube (1.5 ml) and centrifugation
conducted (12,000 rpm, 10 min, 4°C) toremove precipitated material. The
supernatant was frozen in small aliquots (100 Ill) and stored at -80°C. Each
aliquot was used onlyonce, without refreezing.
2.2.20Preparation of Human Crude Cell Extracts
Human glioblastoma U251 cellswere grown to -85confluency in
tissue culture flasks (75 cm2) and harvested by scraping in thepresence of 8 ml
of PBS buffer. Following centrifugation, the cell pelletwas washed with PBS
and resuspended in HE buffer (25 mM Hepes-NaOH (pH7.8), 1 mM EDTA, 1
mM DTT, 10 % (w iv) glycerol) equal to the volume of the packedcell pellet.
Resuspended cells were placedon ice and disrupted by using an Ultrasonic
Processor (Model W-380, Heat Systems-Ultrasonic, Inc.) equippedwith a
microtip probe. After five 15-second pulses (35 % output control,45 % duty
cycle), the sample was centrifuged at 15,000x g for 10 min at 4°C to pellet cell
debris and the supernatant fractionwas stored in 100 [El aliquots at -80°C. The
crude cell extract was assayed for uracil-DNA glycosylaseor Ugi activity.
Uracil-DNA glycosylaseassays were performed using standard assay
conditions with activated calf-thymus [uraci/-3H]DNAor in some cases with101
the single-stranded [32P]U-34-mer and double-stranded[3211U/A-34-mer or
[32P]U/G-34 -mer DNA substrates as described previously. Ugiassays were
performed similarly to the standard uracil-DNA glycosylaseinhibitor assay
except crude cell extract was heated to 95°C for 10 min and centrifugedat
13,000 x g for 10 min toremove the precipitate. The supernatant fraction
containing the heat-stable Ugi proteinwas then measured for Ugi activity.
2.2.21Base Excision DNA Repair Reactions
Standard base excision repair (BER) reaction mixturescontained 100
mM Tris-HC1 (pH 7.5), 5 mM MgC12, 1 mM DTT, 0.1 mMEDTA, 2 mM ATP,
0.5 mM I3-NAD, 20 p,M each of dATP, dTTP, dCTP, anddGTP, 5 mM
phosphocreatine di-Tris salt, 200 units/ml phosphocreatinekinase, 10 µg /ml
of M13mp2op14 (UT) heteroduplex DNA (Form I)or M13mp2op14 (AT)
homoduplex DNA (Form I), and 2 mg/ml human wholecell extract protein.
In some cases, 200 p,Ci/m1 of [a-32P]dATP (6,000 Ci/mmol)was also included
in the reaction. Standard BER reactionmixtures used to measure repair patch
sizes contained 2'-deoxyribonucleoside a-thiotriphosphatesin place of the
standard 2'-deoxyribonucleoside triphosphatesat identical concentrations. In
all cases, DNA and whole cellextract protein additions constituted 20 ()/0 and
40 % of the reaction mixture volume, respectively.Incubation occurred at
30°C for various amounts of time. Reactionswere terminated by the addition
of 2000 units of Ugi and adjustmentto 20 mM EDTA. RNase A was then
added to 80 pg/m1 and incubatedat 37°C for 10 min. Following addition of
SDS to 0.5 %, proteinase Kwas added to 190 µg /ml and the mixture was
incubated an additional 30 min at 37°C. The sampleswere extracted with an
equal volume of phenol:chloroform:isoamyl alcohol(25:24:1), ethanol
precipitated for 1 h at -80°C, washed with 75 % ethanol,and resuspended in 30
1.1,1 of TE buffer.102
2.2.22Isolation of Repaired DNA
Samples of repaired M13mp2op14 (UT) DNA, isolatedas described
above, were treated with 400 units of Ungper gg of DNA for 30 min at 37°C.
After terminating the reaction witha 10-fold unit excess of Ugi, 4 units of E.
coli endonuclease IV (Endo IV)was added per lag of DNA and incubation
continued at 37°C for 30 min. This reactionwas then terminated by heating
for 3 mM. Form I DNA thatwas insensitive to the Ung/Endo IV cleavage
was isolated by 0.8 % agarose gel electrophoresis. DNA sampleswere
combined with agarose dye buffer toa final concentration of 0.1 % SDS, 10
mM EDTA, 5 % (w/v) glycerol, and 0.01 % bromophenol blue.After loading
the sample (-15 111 per well) ontoan agarose gel (12 x 13 cm) containing TAE
buffer (40 mM Tris-acetate, 1 mM EDTA (pH 8.0)) and0.1 pg/ml ethidium
bromide, electrophoresiswas performed at 100 V until the tracking dye had
migrated -75 % of the distance through the gel. By restricting95 % of the gel
from UV-light transilluminescence with aluminum foil,Form I DNA was
localized using an external Form I standardon the outer-most lane and
excised from the gel with a cleanrazor blade. Form I DNA was recovered
from the agarose gel slice by electroelution into TAE bufferusing an Elutrap
(Schleicher and Schuell) apparatus placed ina 35 x 21 cm agarose gel
electrophoresis chamber filled with TAE buffer. Electroelutionwas conducted
at 150 V (50-60 mA) for 3 h atroom temperature. Following electroelution,
the current was reversed for -15sec and the DNA solution (-1 ml) was
transferred into a Centricon-30 (Amicon)concentration device, concentrated,
and buffer exchanged with distilled H20.103
2.2.23 Analysis of Base Excision Repair Reaction Products
2.2.23.1Quantitation of Form I and II DNA
Standard BER reactions were performed except that 200 mCi/m1 [a-
3211cIATP(6,000 cpm/mmol) was included in the reaction mixture. DNA
reaction products were isolated, treated in thepresence or absence of E. coli
Ung/Endo IV, and Form I and II DNAwere resolved by 0.8 % agarose gel
electrophoresis as described above. Ethidium bromide-stained DNA bands
were visualized by transillumination (302 nm) and the percentage of Form I
and II DNA was quantitated against Form I and II standards from thesame gel
by using a Gel Documentation System (Model GDS7500; Ultra-Violet Products
Ltd.) and Image Quant (Molecular Dynamics) software. Theamount of Form
I and II DNA recovered after incubation with whole cell extract protein
decreased in a time dependentmanner. The percentage of Form I DNA
measured was calculated from the total amount of Form I and II detected in
any given time point. To detect [32P]DNA, the gel was blotted onto a Gene
Screen Plus (NEN) membrane by usinga downward alkaline transfer
technique described by Koetsier et al. (119). Autoradiographywas conducted
using X-OMAT AR5 film (Kodak) and quantitation of Form I and II [32P]DNA
bands was performed usinga Phosphorlmager (Molecular Dynamics) and
Image Quant software.
2.2.23.2Hinfl Restriction Analysis
In order to detect uracil-initiated base excision repair-specific DNA
synthesis, standard BER reactions supplemented with 200 I.LCi/m1 [a-32P]dATP
(6,000 cpm/mmol) were performed. DNA reaction productswere isolated as
described above and subjection to restriction analysis using Hinff restriction
endonuclease. Samples (2.5-50 ng) were digested with 5 units of Hinff for
1 h at 37°C and restriction fragmentswere resolved by 5 % nondenaturing104
polyacrylamide gel electrophoresis. After drying the gel under vacuum,
autoradiography was performed and the amount of each [32P]DNA fragment
was quantitated by using a Phosphor Imager. The relative intensity of various
bands was determined and the amount of [32P]DNA fragments (253-, 261-, 486-,
529-bp) was compared after subtracting background values obtained froma
blank lane.
2.2.23.3EcoRI and Smal Restriction Analysis
In order to analyze the strand specificity of DNA repair synthesis,
standard BER reactions were performed in the presence of 200 liCi/m1 of [a-
32P]dATPas described above. DNA reaction products were isolated and
simultaneously digested with EcoRI and Smal (10 units /µg of DNA) for 1 h at
25°C. The restriction endonuclease reactions (10 gl) were terminated by
adjustment to 12.2 mM EDTA. A modification of this procedure involved
the digestion of DNA reaction products with EcoRI for 1 h at 25°C followed by
digestion with SmaI for 1 h at 25°C. Both individual restriction digestion
reactions were terminated by heat for 20 min at 70°C. Samples were treated
with or without E. coli Ung and Endo IVas indicated, combined with an equal
volume of denaturing formamide dye buffer (95 % deionized formamide, 10
mM EDTA, 0.1 % bromophenol blue, 0.1 % xylene cyanol), heated for 3 min at
95°C, and DNA fragments were resolved by 12 `)/0 polyacrylamide/8.3 Murea
gel electrophoresis as previously described.
2.2.23.4Determination of Repair Patch Size
Standard BER reaction mixtures were preparedas described above
except that 2'-deoxyribonucleoside a-thiotriphosphates were used in place of
the standard 2'-deoxyribonucleoside triphosphates and [32P]M13mp2op14
(UT) Form I DNA was used as the BER substrate. The 32P labelwas105
introduced at the 5'-end of oligonucleotideU-23-mer prior to the primer
extension reaction and isolation of Form IDNA. In the Form I DNA
molecule, the radiolabelwas located between the uracil target and the Smal
restriction site at nucleotide position 90on the transcribed strand of the lacZa
gene sequence. Reaction mixtureswere incubated at 30°C for 45 mM (LoVo)
or 60 min (U251) and DNA reaction productswere isolated. Samples (8.0 IA,
-500 ng) were removed for digestion with25 units of EcoRI for 1 h at 25°C.
Following termination at 70°C for20 mM, samples were incubated in the
absence or thepresence of various amounts of E. coli exonuclease III (Exo III)
for 30 mM at 37°Cas indicated. Following Exo III digestion, sampleswere
heated at 70°C for 20 mM andreaction products were then restricted with 25
units of Smal for 1 h at 25°C. Sampleswere then combined with an equal
volume of denaturing formamidedye buffer and DNA reaction products
were resolved by 12% polyacrylamide/8.3 Murea gel electrophoresis. After
drying the gel undervacuum, autoradiography was performed and the
amount of each [32P]DNA bandwas quantitated by using a Phosphor Imager.
2.2.24Transfection of E. coli and Determination ofReversion
Frequencies and Mutational Spectrum
E. coil. MC1061 or NR9162 cellswere transfected with repaired and
purified Form I DNA recoveredfrom human whole cell extract BER
reactions. Form I DNA samples(0.5-2.5 111) were mixed with competent E. coli
MC1061 or NR9162 cells (-1-2x 1011 cells/m1) in 10 % (w/v) glycerol (50 11,1)
and incubatedon ice for 1-2 mM. Transfection was conducted usinga Gene
Pulser electroporationsystem with a single pulse set at 2.0 kV, 25 !IF
capacitance, and 400 O. Transfected cellswere serially diluted into SOC media
(1 /102 to 1/107) and 100 R1 of eachdiluted sample was placed intoa sterile 13 x
100 mm test tube, mixed with500 !al of mid-log E. coli CSH50 cells and
prewarmed M9 topagar (2.5 ml)containing 0.4 mM IPTG and 1 mg/ml X-Gal106
was added. The cells were plated on M9 plates and incubated overnightat
37°C. One diluted sample from each transfectionexperiment was increased in
volume (-3.0 ml) to allow for themass plating of -25 individual M9 plates. A
separate titration series was prepared for each transfectionexperiment in
order to quantitate the number of plaques detectedfor each mass plating.
Typical dilutions formass platings yielded a concentration of 1,000 to 3,000
plaque forming unitsper plate. After scoring plaques as either colorless or
blue, the reversion frequencywas calculated from the ratio of the number of
blue plaques to total (colorless plus blue) plaquesdetected. Blue plaques were
picked, placed into 200 pi of sterile 0.9 % NaC1solution, and extracted phage
were diluted into SM media and titered against mid-log E. coli CSH50 cellson
M9 plates with IPTG and X-Galas described above. An individual blue plaque
from each secondary screeningwas placed into 1 ml of sterile 0.9 % NaC1
solution and used to isolate M13mp2op14 derivedsingle-stranded DNA for
nucleotide sequence analysisas previously described but with one
modification. Aliquots (100 gl) of the extracted phagewere placed into 100 ml
of 2X YT medium inoculated with 5 ml ofan E. coli CSH50 overnight culture
and infection was allowed to proceed for9 h. DNA sequence analysis was
performed using the dideoxynucleotide chaintermination method. The
nucleotide sequence of the lacZagene was determined by using an
oligonucleotide DNA primer (PMR PLUS)complementary to the (+) strand at
nucleotide positions 249 to 269.107
3.IDENTIFICATION OF SPECIFIC CARBOXYL GROUPS ON URACIL-
DNA GLYCOSYLASE INHIBITOR PROTEIN REQUIRED FOR ACTIVITY
This chapter presents the results and interpretations generated from
studies involving the chemical modification of carboxylic acid residues of Ugi
to determine their role in the formation of the UngUgi complex. The
approach involved the use of the water-soluble carbodiimide, 1-ethy1-3-(3-
dimethylaminopropyl)carbodiimide (EDC), and the nucleophile, glycine ethyl
ester (GEE), to chemically modify specific glutamic acid and aspartic acid
residues. It was hoped that charge neutralization of highly reactive residues
brought about by EDC /GEE- modification would interfere with the function of
Ugi. Five differentially modified forms of Ugiwere purified and each form
was characterized with regards to the effect of modification on Ugi specific
activity, stability of the UngUgi complex, and reversibility of the UngUgi
complex in the presence of unmodified Ugi and nucleic acid competitors.
Identification of specific sites of adductionwere determined utilizing matrix-
assisted laser desorption ionization (MALDI)mass spectrometry and amino
acid sequencing techniques. This study established the importance oftwo
glutamic acid residues (Glu-28 and Glu-31) involved in achieving stable
UngUgi complex formation.
3.1Results
3.1.1Modification of Carboxylic Acid Residues in Uracil-DNA
Glycosylase Inhibitor Protein
To assess the importance of Glu and Asp residues in mediating the
Ung/Ugi interaction, chemical modification of Ugiwas conducted, and the
effect on inhibitor activity was investigated. Glu and Asp residues ofUgi that
are potential candidates for modification are indicated in Figure 1. The water-108
Figure 1. Tertiary structure of bacteriophage PBS2 uracil-DNA glycosylase
inhibitor protein. The tertiary structure of Ugi has been determined by
solution state multidimensional nuclear magneticresonance (12). Secondary
structural elements include the a1-helix (Ser-5 to Lys-14), 01-strand (Glu-20to
Met-24), a2-helix (Glu-27 to Asn-35), 02-strand (Ile-41 to Asp-48), I33-strand
(Glu-53 to Ser-60), I34-strand (Ala-69 to Asp-74), and I35-strand (Asn-79to Leu-
84). In the tertiary structure, the 12 Glu residuesare shown in red and the 6
Asp residues are in yellow.1 1 0
soluble carbodiimide, EDC,was used in a two-stage modification reaction
with the nucleophile, GEE, to selectively modify carboxylgroups (39). Under
mild reaction conditions, this carbodiimide preferentiallyforms an 0-
acylisourea-activated carboxylgroup that subsequently undergoes
nucleophilic attack by GEE to forma terminal acyl-glycine ethyl ester reaction
product (39) as depicted in Figure 2. Theextent of carboxyl group
modification was optimized by varying the molar ratio ofcarbodiimide to
carboxyl groups and the effect of modificationon uracil-DNA glycosylase
inhibitor activity was analyzed at different time points(Figure 3). Pilot
reaction mixtures containing 1, 4, and 20 ginol of EDCover 1.75 [tmol of
potentially reactive carboxylgroups were prepared and the specific activity of
Ugi was determined following each reaction. The ability ofEDC/GEE-
modified Ugi to inhibit uracil-DNA glycosylaseactivity decreased as a
function of increasing EDC concentration. Within30 minutes, the specific
activity of Ugi was reduced by 63, 80, and 98 % followingincubation with 1, 4,
and 20 priol of EDC when comparedto that of an unmodified Ugi control.
By using an EDC to carboxylgroup molar ratio of 2.3:1, a limited modification
reaction was conducted, and modified forms of [35S]Ugiwere resolved by
DEAE-cellulose chromatography (Figure 4). Five distinctforms (I-V) were
identified and eluted at approximately 180, 165,150, 140, and 100 mM NaC1,
respectively. The order of elution of [35S]Ugi forms I-V fromthe DEAE-
cellulose column commenced with form V, elutingat 100 mM NaC1, and
terminated with form I which eluted at 180 mM NaCl. [35S]Ugiforms I
(fractions 118-131), II (fractions 101-106), III(fraction 89-93), IV (fractions 79-84),
and V (fractions 68-74)were separately pooled after analysis by nondenaturing
polyacrylamide gel electrophoresis (Figure 5). Theamount of [35S]Ugi forms I-
V recovered was determined to be approximately267, 493, 589, 502, and 305
Ix& respectively.1 1 1
Figure 2. Scheme for acyl-glycine ethyl ester adduction of Ugi by EDC/GEE
modification. Uracil-DNA glycosylase inhibitor (Ugi) is an acidic protein
containing 19 carboxyl groups (12 glutamic acid, 6 aspartic acid, carboxyl-
terminus) which are available for activation by the water-soluble
carbodiimide, 1- ethyl -3- dimethylaminopropylcarbodiimide (EDC). A
protonated carboxylic acid group is activated by EDC to forman EDC-carboxyl
adduct which is subsequently attacked by the nucleophile, glycine ethyl ester
(GEE), to form the acyl-glycine ethyl ester adduct. Standard modification
reaction conditions involved a 1:2.3:11.5 molar ratio of COOH:EDC:GEE in 50
mM potassium phosphate buffer (pH 6). Following incubation at 25°C for 30
min, the reaction was terminated by adjustment to 1 M sodium acetate (pH
4.75). The acyl-glycine ethyl ester adduct is electrically neutral in charge and
adds 85 daltons to the overall molecular weight of the Ugi protein.113
Figure 3. Effect of EDC:COOH ratio and EDC/GEEmodification time on
Ugi activity. Three EDC/GEE modification reactionmixtures (1000 [a)
containing 92 nmol of Ugi (-1.75 gmol COOH groups)were supplemented
with 1 (closed squares), 4 (open circles),or 20 (closed circles) gmols of EDC and a
five-fold molar excess of GEEover EDC. Samples (100 1.t1) were removed after
various amounts of time at 25°C and the modificationreaction was
terminated with an equal volume of 2 M sodiumacetate (pH 4.75). Excess
EDC and GEE were removed from the terminatedreactions by P-4 spun
columns equilibrated in 50 mM potassium phosphate(pH 6.0) and standard
uracil-DNA glycosylase inhibitorassays were conducted for each sample as
described under "Experimental Procedures". Theactivity of Ugi at each time
point was determined and expressedas a percentage relative to the activity of
mock modified Ugi.100
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Figure 4. Isolation of EDC/GEE-modified I'SlUgiforms I-V by DEAE-
cellulose chromatography. Chemical modificationof [35S]Ugi (1,050 gl) was
performed using EDC and GEEas described under "Experimental Procedures".
After terminating the reaction andremoving the excess EDC and GEE, the
modified [35S]Ugi was dialyzed against bufferA (50 mM Tris-HC1 (pH 7.0), 1
mM EDTA, 1 mM DTT) containing 50 mM NaCl.A sample (32 ml)
containing 486 nmol of [35S]Ugiwas then applied to a DE-52 cellulose column
(0.6 cm2 x 7.9 cm) equilibrated in thesame buffer. The column was washed
and eluted with a linear gradient of50-300 mM NaC1 in buffer A, fractions (1
ml) were collected, and sampleswere monitored for conductivity (closed
squares) and 35S radioactivity (closed circles)as described under "Experimental
Procedures". Fractions were pooled correspondingto the various forms (I-V),
as indicated by brackets, and evaporated to dryness; each poolwas
resuspended in buffer A (1 ml) and dialyzedagainst Ugi EB (50 mM Tris-HC1
(pH 8.0), 1 mM EDTA, 1 mM DTT, 100mM NaC1, 10 % (w/v) glycerol).40
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Figure 5. Nondenaturing polyacrylamide gel electrophoresis ofDEAE-
cellulose column fractions containing EDC/GEE-modified [35S]Ugiforms I-
V. Samples (15 RD of fractions containing [35S]Ugi forms I-V separatedby
DEAE-cellulose chromatography (Figure 4)were combined with an equal
volume of native dye buffer, loaded onto 18% polyacrylamide gels(panel A,
fractions 58-94; panel B, fractions 96-132), and electrophoresiswas conducted
at 4°C using 200V as described under "Experimental Procedures." A sample
(-300 pmol) of the unfractionated EDC/GEE-modified [35S]Ugireaction
mixture was included as a reference standard (lane C). Protein bandswere
detected by rapid protein staining with Coomassie Brilliant BlueG-250. The
location of EDC/GEE-modified [35S]Ugi forms I-Vare located by arrows.
Fractions of EDC/GEE-modified [35S]Ugi forms I-Vwere separately pooled
according to their purityas designated above each panel.1 1 9
3.1.2Identification and Purity of Ugi Forms I-V
After separately pooling and concentrating the five [35S]Ugi peaks, each
Ugi form was again analyzed by nondenaturing polyacrylamide gel
electrophoresis to assess the purity of each form (Figure 6, lanes 4-8). Samples
of unmodified [35S]Ugi (lane 1), [35S]Ugi from the unfractionated modification
reaction mixture (lane 2), and mock-modified [35S1Ugi (lane 3)were analyzed
for comparative purposes. The unfractionated [35S]Ugi sample contained five
protein bands; three were very discrete (bands and two appeared to be
more diffuse (bands IV and V). Band I corresponded to unmodified Ugi (lane
1) which comigrated with the single protein band of [35S]Ugi form I (lane 4).
The other protein bands (II-V) observed in the reaction mixture (lane 2)were
individually represented by [35SJUgi forms II-V, respectively (lanes 5-8).
Forms II-V showed progressively reduced electrophoretic mobility that
inversely correlated with their order of elution from the DEAE-cellulose
column (Figure 4). Taken together, these results indicate that EDC/GEE-
mediated modification of Ugi (forms II-V) caused negative charge
neutralization of carboxyl groups.
The purity of [35S]Ugi forms I-Vwas assessed based on the relative
Coomassie Brilliant Blue staining intensities of individual fractions from
across the DEAE-cellulose column (Figure 5). These results indicated that
forms I-III are .190 % pure, whereas forms IV and Vappear to contain 65 `)/0 of
the corresponding form. From the 35S radioactivity detected in gel slices of
forms I-V (Figure 6, lane 2), itwas determined that forms I-V constituted
approximately 14, 23, 26, 18, and 10 % of the total unfractionated [35S]Ugi
sample, respectively.
To determine the extent of EDC/GEE-mediated modification, each Ugi
form along with unmodified Ugiwas analyzed by MALDI mass spectrometry
(Figure 7 and Table 2). As previously observed (15), twomass peaks were
obtained for the unmodified Ugi protein; peak I (9,475 daltons) closely agreed
with the predicted mass of the complete amino acidsequence of Ugi, and peak120
Figure 6. Purity and activity of EDC/GEE-modified 135SlUgiforms I-V.
Eight samples (30 p1) containing 106 pmol of unmodified [35S]Ugi (lane1), 318
pmol of EDC/GEE-modified [35SJUgi reaction mixture (lane2), 106 pmol of
mock-modified [35S]Ugi (lane 3),or 106 pmol of purified [35S]Ugi forms I-V
(lanes 4-8, respectively)were loaded onto an 18% nondenaturing
polyacrylamide gel. Following electrophoresis, the gelwas stained with
Coomassie Brilliant Blue G-250. The direction of migrationwas from top to
bottom, and the locations of unmodified Ugi and the trackingdye (TD) are
indicated by arrows. Prior to electrophoresis, standard uracil-DNAglycosylase
inhibitor assays were conductedon each sample as described under
"Experimental Procedures". The specific activity of each Ugi formwas
determined and expressed relevant to that of unmodified {35S]Ugicontrol.
Gel slices of the EDC/GEE-modified rSlUgi reactionmixture sample (lane 2)
were analyzed for 35S radioactivity in order to quantitate the distribution of
[35S]Ugi forms I-V.(-)
Ugi -
TD-+
(+)
Sp. Act.
(x 106 U/mg)
% Control
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Figure 7. Molecular weight determination of EDC/GEE-modified [35S]Ugi
forms I-V by MALDI mass spectrometry. Samples of unmodified [35S]Ugi
and [35S]Ugi forms I-V were analyzed by MALDI mass spectrometryas
described under "Experimental Procedures". The mass spectra of unmodified
[35S]Ugiand [35S]Ugi form I showed two singly charged ion species (Peaks I and
II). The mass spectra of EDC/GEE-modified [35S]Ugi forms II-V also showed
two primary mass peaks with relative mass increases due to EDC/GEE-
modification over that of unmodified [35S]Ugi,as indicated in Table 2.
Samples containing [35S]Ugi forms III-V included an internal standard (S).4
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Table 2
Acyl-glycine Ethyl Ester Adducts Detected on EDC/GEE-modified Ugi Using
MALDI Mass Spectrometry
Ugi Predicted
Mass"(A)
Experimental
Mass' (B)
Mass Increase
(B-A)
Acyl-GEE
Adducts/Ugic
Unmodified
Peak r 9,477 9,475 ± 10.5
Peak II' 9,346 9,341 ± 3.0
Form I
Peak I 9,477 9,478 ± 8.1 1 0
Peak II 9,346 9,346 ± 6.1 0 0
Form II
Peak I 9,477 9,569 ± 4.7 92 1.1
Peak II 9,346 9,437 ± 0.6 91 1.1
Form III
Peak I 9,477 9,646 ± 8.4 169 2.0
Peak II 9,346 9,507 ± 0.1 161 1.9
Form IV
Peak I 9,477 9,727 ± 0.8 250 2.9
Peak II 9,346 9,594 ± 0.7 248 2.9
Form V
Peak I 9,477 9,794 ± 0.5 317 3.7
Peak II 9,346 9,665 ± 5.7 319 3.8
aPredicted mass values were determined by the computer program MacProMass, version 1.05,
by Lee and Vermuri (137).
bAverage molecular weights and standard errors are determined from two independent
measurements.
One acyl-glycine ethyl ester adduct per Ugi protein would be expected to result inan 85-
dalton mass increase.
dPeak I corresponds to the intact Ugi protein.
Peak II corresponds to the Ugi protein minus 131 daltons, which correlates to the loss of the
amino-terminal methionine residue (15).125
II (9,341 daltons) corresponded with Ugi protein minus the N-terminal
methionine. Ugi form I also contained two species withmasses nearly
identical to those of the unmodified Ugi control and apparently escaped
modification during the EDC/GEE reaction. Ugi form II appearedto contain a
single acyl-glycine ethyl ester modification, since this adduct would be
expected to add 85 daltons per modified carboxylgroup. By dividing the mass
increase observed for each modified Ugi form by 85 daltons, itwas deduced
that forms II-V contained approximately 1.1, 2.0, 2.9, and 3.8adducts,
respectively per Ugi protein.
3.1.3Effect of EDC/GEE Modificationon the Specific Activity
of Ugi Forms I-V
The effect of chemical modificationon the inhibitor activity of purified
Ugi forms I-V was determined by using E. coli uracil-DNAglycosylase (Figure
6). The specific activity of unmodified Ugiwas essentially the same as either
mock EDC/GEE-modified Ugior Ugi form I. The slight increase in specific
activity observed for the modified protein samplemay have resulted from
the removal of inactivated Ugi contained in the originalpreparation during
DEAE-cellulose chromatography. In contrast, the specificactivity of Ugi
forms II-V displayed progressively decreased levels (58-17 %)of inhibitor
activity coinciding with the increased extent of Ugi modification.
3.1.4Ability of Ugi Forms I-V to Forma Complex with Ung
Ugi forms I-V were incubated witha 3-fold molar excess of Ung under
conditions that typically promote UngUgi complex formation.The complex
was then resolved from its individual components by nondenaturing
polyacrylamide gel electrophoresis. As controls, unmodified [35S]Ugi,
EDC/GEE-modified [35S]Ugi reaction mixture, andUng were individually
separated by electrophoresis (Figure 8, lanes 1-3,respectively). The addition of
unmodified Ugi or EDC/GEE-modified Ugi reactionmixture to excess Ung
resulted in Ung rSlUgi complex formation of99 and 75 % of [35S]Ugi,126
Figure 8. Ability of [35S]Ugi forms I-V to complex with E. coli uracil-DNA
glycosylase. Ten samples (60 pl) containing 106 pmol of unmodified [35S]Ugi
(lane 1), 318 pmol of EDC/GEE-modified [35S]Ugi reaction mixture (lane 2), 318
pmol of Ung (lane 3), 106 pmol of unmodified [35S]Ugi plus 318 pmol of Ung
(lane 4), 318 pmol of EDC/GEE-modified [35S]Ugi reaction mixture plus 951
pmol of Ung (lane 5), or 106 pmol each of f'SJUgi forms I-V plus 318 pmol of
Ung (lanes 6-10, respectively) were incubated under standard UngUgi
complexing conditions as described under "Experimental Procedures". Each
sample was loaded onto an 18% nondenaturing polyacrylamide gel,
electrophoresis was performed, and the gel was stained with Coomassie
Brilliant Blue G-250 to visualize protein. The arrows indicate the location of
Ung, Ung.[35S]Ugi, [35S]Ugi, and tracking dye (TD). Proteins migrated from
top (-) to bottom (+).Ung --
Ung.[35S]Ugi --
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respectively (Figure 8, lanes 4 and 5). Interestingly, theUngUgi complex
formed by Ugi from the EDC/GEE reaction mixture resultedin a series of
bands with decreased mobility (lane 5). When individualUgi forms I-V were
analyzed, the uncomplexed [35S]Ugi bands disappeared coincidentwith the
appearance of 97, 90, 77, 67, and 61 % of the [35S]Ugi in complex with Ung
(lanes 6-10). The reduced electrophoretic mobility of eachcomplex was
explained by the decreased electronegativity of individualEDC/GEE-modified
Ugi forms. These findings demonstrate that modifiedUgi forms remain
capable of forming a UngUgi complex.
3.1.5Competitive Interaction Between Ugi and EDC/GEE-modified
Ugi Forms I-V for Ung Binding
Experiments were conducted to determine the competitive abilityof
unmodified Ugi and EDC/GEE-modified [35S]Ugi formsI-V to form a stable
complex with Ung. In the first set of experiments, unlabeledunmodified Ugi
was separately mixed with each of the modified [35S]Ugi forms in various
molar ratios (100:0, 80:20, 60:40, 40:60, and 20:80;modified:unmodified Ugi).
Each Ugi mixturewas combined with Ung in a 2-fold molar excess of
inhibitor over enzyme to form complex, andthe proteins were resolved by
nondenaturing polyacrylamide gel electrophoresis and analyzedfor 35S
radioactivity. Samples containing variousratios of unmodified Ugi
competitor were mixed with unmodified rSlUgi,as controls, and analyzed by
electrophoresis (Figure 9A). Two peaks of [35S]Ugi radioactivitywere observed
in each sample, one corresponding to unbound [35S]Ugiand the other to the
Ung[35S]Ugi complex. As expected, thepercentage of [35S]Ugi forming a
complex almost exactly reflected the ratio of [35S]Ugito competitor Ugi in the
unmodified reaction mixture (Figure 10, inset). Similarresults were obtained
when [35S]Ugi form I competed with unmodifiedUgi for complex formation,
indicating that both preparations sharedan equal ability to stably and
irreversibly associate with Ung (Figure 9B andFigure 10). In contrast, [35S]Ugi
forms II-V showeda sequential decrease in their ability to compete with129
Figure 9. Ability of unmodified Ugi to compete with modified [35SlUgi
forms I-V for complex formation with Ung. (A) Competitionreaction
mixtures (70 p1) contained 158 pmol of Ung and 316 pmol combinationsof
unmodified [35S]Ugi and non-radioactive competitor Ugi at [35S]Ugi:Ugiratios
of 100:0 (closed circles), 80:20 (open circles), 60:40 (closed squares),40:60 (open
squares), and 20:80 (closed triangles). Following the Ung addition, thereaction
mixtures were incubated under standard complexing conditions andthen
loaded onto 18% nondenaturing polyacrylamide tube gelsas described under
"Experimental Procedures". After electrophoresis, each gelwas horizontally
sliced (3.1 mm), dried overnight, solubilized in 30% H202 (500gl), and
analyzed for 35S radioactivity. The direction of migrationwas from left to
right. Competition reaction mixtures containing [35S]Ugi formI (B), form II
(C), form III (D), form IV (E), and form V (F)were mixed with non-radioactive
competitor Ugi at [35S]Ugi:Ugi ratios described above and similarly analyzed.10 15 20 0 5 10
SLICE NUMBER
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Figure 10. Quantitation of modified [35S]Ugiforms I-V in the UngP'SlUgi
complex after competition with unmodified Ugi.The competition reactions
mixtures described in Figure 9 that containedunmodified [35S]Ugi (I) and
EDC /GEE-modified [35S]Ugi form I ( ®),form II (L), form III ( Z ), form IV
(), and form V ( 0 )were analyzed and the amount of [35S]Ugi (pmol) in
complex was plotted. The amount of [35S]Ugi (pmol)forming complex in the
absence of competitor (100:0) is givenin parenthesis in the inset. The relative
percentage of unmodified or modified (forms I-V) [35S]Ugi thatformed a
complex during the competition reactionsrelative to the 100:0 controlwas
determined for each ratio of [35S]Ugito unmodified Ugi. Each reaction was
conducted in duplicate, and thepercentages of [35S]Ugi complexed represent
averaged values.150
0
0.
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unmodified Ugi, since the amount of [35S]Ugi detected in complexwas
significantly less than that reflected by the modified [35S]Ugi:unmodifiedUgi
ratios (Figure 9C-F and Figure 10). The decreased competitive performanceby
the modified forms II-V of Ugi directly correlated with the extent ofEDC/GEE
adduction.
As a second approach in examining the ability of EDC/GEE-modified
Ugi forms I-V to compete with unmodified Ugi for complex formation with
Ung, each of the modified [35S]Ugi forms (360 pmol)was separately mixed
with increasing molar amounts of unlabeled Ugi such that the [35S]Ugi
component constituted 100, 95, 90, 85, 80, 75, 50, 25, or >1 % of the total
[35S]Ugi /Ugi mixture. Each Ugi mixturewas then combined with Ung (160
pmol), and the proteins were resolved by nondenaturing polyacrylamide gel
electrophoresis and analyzed for 35S radioactivity. If the ability ofany
modified [35S]Ugi form to forma complex with Ung was equal to that of the
unmodified Ugi competitor, then the percentage of [35S]Ugi in complexwould
reflect the component percentage of [35S]Ugi in the [35S]Ugi /Ugimixture. As a
verification, unmodified [35S]Ugiwas combined with increasing amounts of
unmodified Ugi and analyzed by electrophoresis (Figure 11). Thepercentage
of unmodified [35S]Ugi in complexwas 100, 94, 92, 86, 81, 76, 50, 25, and <1 %
and almost exactly matched the expected valuesas exhibited by the percentage
of [35S]Ugi in the [35S]Ugi /Ugi mixture. [35S]Ugi form I also yielded similar
results, indicating an equal ability tocompete with unmodified Ugi in
binding and stabilizing a complex with Ung. However, [35S]Ugi formsII-V
showed a reduced ability to effectively compete with unmodifiedUgi as
indicated by the reduced amounts of [35S]Ugi detected incomplex at each
titration point (Figure 11). These results substantiate theprevious
observation that the decreased competitive performance by EDC/GEE-
modified Ugi forms II-V is directly correlatedto an increased level of
EDC/GEE modification.134
Figure 11. Ability of modified [35S]Ugi forms I-Vto compete with
unmodified Ugi in forminga complex with Ung. Competition reaction
mixtures (175 p1) contained 158 pmol of Ung and combinationsof 318 pmol of
unmodified [35S }Ugi (closed circles) plus 0, 16, 32, 80, 107,320, and 960 pmols of
unlabeled competitor Ugi to generate [3SS]Ugi:[35S]Ugi plusUgi ratios of 1.0,
0.95, 0.9, 0.8, 0.75, 0.5, and 0.25. Following Ung addition, thereaction mixtures
were incubated under standard complexing conditions and then loaded onto
18% nondenaturing polyacrylamide tube gelsas described under
"Experimental Procedures". After electrophoresis, each gelwas horizontally
sliced (3.1 mm), dried overnight, solubilizedin 30% H202 (500 Ill), and
analyzed for 35S radioactivity. The relativepercentage of unmodified [35S]Ugi
that forms a complex during the competitionreactions relative to the control
([35S]UgieS]Ugiplus Ugi ratio of 1.0) was determined for each sample.
Competition reaction mixtures containing [35S}Ugi formI (open circles), form II
(closed squares), form III (open squares), form IV (closedtriangles), and form V
(open triangles) were mixed with unlabeledcompetitor Ugi at [35S]Ugi:[35S]Ugi
plus Ugiratios described above andwere similarly analyzed. Each reaction
was conducted in duplicate, and the percentages of rSIUgi complexed
represent averaged values.1.0 0.8 0.6 0.4
[35S]Ugi
[35S]Ugi + Ugi
Figure 11
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3.1.6Stability of the UngUgi Complex Containing
EDC/GEE-modified Ugi Forms I-V
To examine the complex stability of modified Ugi forms I-V, 5.3 nmol
of [35S]Ugi (unmodified or modified forms (I-V)) was incubated witha -5-fold
molar excess of Ung, and the Ung [35S]Ugi complex was purified from its
constituent components by DEAE-cellulose chromatography (Figure 12). In
each case, almost all of the rSlUgi eluted as UngrSlUgi complex following
the 150 mM NaC1 step as determined by 35S radioactivity. No significant
amount of free inhibitor protein was detected after the 250 mM NaC1 elution
step, and excess Ung eluted in the wash fractions. After pooling Ung [35S]Ugi-
containing fractions, each Ung [35S]Ugi complex preparation was then
analyzed by nondenaturing polyacrylamide gel electrophoresis toassess
complex formation and stability (Figure 13). Purified Ung[35S]Ugi complexes
containing unmodified and modified [35S]Ugi forms I and II each contained
>95 % of the total inhibitor protein in complex (Figure 14A). In contrast, free
[35S]Ugiwas observed for Ugi forms III-V in complex with Ung, as
demonstrated by 17, 34, and 30 % of the total [35S]Ugi migratingas
uncomplexed inhibitor protein, respectively. A diffuse band of free Ung also
appeared in these samples. These results were consistent withan
interpretation that more extensive levels of EDC/GEE modification of Ugi
cause less stable complexes to dissociate during electrophoresis.
To determine if modified forms I-V of [35S]Ugi in complex could
exchange with free Ugi, each complex preparation was incubated witha 3- and
30-fold molar excess of unmodified Ugi, and gel electrophoresiswas
performed, as before, to resolve the constitutive components and analyzed for
35Sradioactivity. The analysis of unmodified and modified forms I-V of
[35S]Ugi in complex incubated witha 3-fold molar excess of unmodified Ugi is
represented in Figure 15. As anticipated for the control Ung[35S]Ugi,no
significant release of unmodified [35S]Ugi (<2.5 %)was detected, indicating the
irreversibility of complex formation. A nearly identical resultwas obtained
for the Ung[35S]Ugi form I complex. In contrast, thepresence of a 3-fold137
Figure 12. Purification of Ung[35S]Ugi complexes containing unmodified
and EDC/GEE-modified Ugi forms I-V by DEAE-cellulose chromatography.
(A) A reaction mixture (1.5 ml) containing 26.4 nmol of Ung and5.3 nmol of
unmodified [35S]Ugi was incubated under standard UngUgi complexing
conditions and then applied toa DE-52 cellulose column (0.8 cm2 x 1.9 cm).
The column was washed and step-eluted with DAB buffer (30mM Tris-HC1
(pH 7.4), 1 mM EDTA, 1 mM DTT, 5 % (w/v) glycerol) containing150 mM and
250 mM NaCl (arrows) as described under "Experimental Procedures".
Fractions (1 ml) were collected and analyzed for 'S-radioactivity (closed circles)
and uracil-DNA glycosylase activity (open circles). Fractions (numbers33-44)
containing the Ung[35S]Ugi complexwere pooled and concentrated -42-fold
using a Centriplus-10 (Amicon) concentrator. Five similar reactionmixtures
containing Ung and [35S]Ugi form I (B), form II (C), form III (D), form IV (E),
and form V (F) were prepared and purification of each corresponding
UngrSiUgi complexwas carried out as described above.6
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Figure 13. Purity and stability of the various UngrSlUgi complexes. Six
samples (50 gl) containing 85 pmol of purified complex formed with
unmodified [35S]Ugi (lane 1) and EDC/GEE-modified [35S]Ugi forms I-V (lanes
2-6, respectively) were analyzed by 18% nondenaturing polyacrylamide gel
electrophoresis. Protein was visualized after staining with Coomassie
Brilliant Blue G-250. The arrows indicated the location of Ung and the bracket
denotes the location of the Ung[35S]Ugi complex. Prior to electrophoresis,
standard uracil-DNA glycosylase assays were conductedon each sample as
described under "Experimental Procedures". The percentage of Ung activity
detected for each complex was determined by dividing the specific activity of
Ung measured in each Ung[35S]Ugi complex (U/mg) by the specific activity of
an equal amount of uncomplexed Ung (2 x 106 U/mg).Specific Activity
(x 106 U/mg)
Control
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Figure 14. Quantitation of various [35S]Ugi forms releasedfrom the
UngrSlUgi complex by unmodified Ugi.Competition reaction mixtures
(140 41) each containing 228 pmol of preformed UngrSlUgicomplex
constituted with unmodified [35S]Ugi (), form I ( ®), form II (), form III
), form IV ( a ), and form V ( )were incubated with buffer A (50 mM
Tris-HC1 (pH 7.0), 1 mM EDTA, 1 mM DTT), 684 pmolof Ugi (B), or 6,840
pmol of Ugi (C) under standard complexformation conditions. Sampleswere
loaded onto 18% nondenaturing polyacrylamidetube gels and electrophoresis
was performed. After electrophoresis, each gelwas horizontally sliced (3.1
mm), dried overnight, solubilized in 30%H202 (500 p.1), and analyzed for 35S
radioactivity. The percentage of [35S]Ugi released fromcomplex was
determined as the amount of free [35S]Ugi dividedby the sum of free plus
complexed [35S]Ugi multiplied by 100.100 A
80
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Figure 15. Ability of unmodified Ugito exchange with various [35S]Ugi
forms in the UngrSlUgi complex.Competition reaction mixtures (140 1.11)
containing 228 pmol of preformed UngrSlUgi constitutedwith unmodified [35S]Ugi(closed circles), form I (open circles), form II (closed squares),form III (open
squares), form IV (closed triangles), and form V (opentriangles) were incubated
with 684 pmol of unmodified and non-radioactiveUgi under standard
complex formation conditions and then loadedonto 18% nondenaturing
polyacrylamide tube gels as described under "ExperimentalProcedures".
After electrophoresis, each gelwas horizontally sliced (3.1 mm), dried
overnight, solubilized in 30% H202 (500 pi), and analyzedfor 35S radioactivity.
The direction of migrationwas from left to right.5
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molar excess of Ugi promoted the release of 27, 50, 63,and 54 `)/0 of total
modified Ugi forms II-V from the complex, respectively(Figure 14B). Similar
increases in the amount of [35S]Ugi releasedwere observed for the exchange
reactions containing the 30-fold molarexcess of Ugi (Figure 14C). These
results further suggest that charge neutralizationdue to modification leads to
the destabilization of the UngUgi complex.
If modification of Ugi facilitated UngUgi dissociationin the presence
of exogenous Ugi, then perhaps these complexesundergo dissociation in the
presence of a competing uracil-containing DNA substrate. The Ung activity
profiles of the DEAE-cellulose chromatographyfractions containing
Ung [35S]Ugi complexes II-V suggest thatsome free Ung was present and may
have appeared asa result of a dissociated complex (Figure 12C-F). Thus, the
enzymatic activity of Ung in each complex containing unmodifiedor
modified Ugi forms I-Vwas determined under standard assay conditions
(Figure 13). The preformed complexcontaining unmodified Ugi showed <0.1
`)/0 of the total uracil-DNA glycosylase activityin complex displayed catalytic
activity. In contrast, Ung complexed withUgi forms 1-V, respectively,
possessed 2, 18, 46, 37, and 28 % of the uracil-DNA glycosylaseactivity
expected for completely uncomplexed and uninhibitedUng. Taken together,
these results confirm that EDC/GEE- modifiedforms of Ugi are less capable of
maintaining an irreversible and catalytically inactiveUngUgi complex.
3.1.7Fluorescein 5-Isothiocyanate Labeling and Propertiesof F-Ung
To further investigate the properties of EDC/GEE-modifiedUgi
interactions with Ung, theenzyme was labeled with FITC to produce F-Ung.
As previously reported (17), F-Ungfluorophores, when quenched, functionas
reporter groups for both Ugi and nucleic acid binding.The standard
modification reactionwas conducted at pH 9.5 with a 10.7-fold molar excess of
FITC over Ung as described under"Experimental Procedures", and resulted in
the adduction of --2.3 FITC moleculesper enzyme molecule (Table 3). Under
these conditions,no significant change in the specific activity of uracil-DNA146
Table 3
Effect of Various pH Conditionson Fluorescein 5-Isothiocyanate Conjugation of
Llracil -DNA Glycosylase
pHOverall OD280nmFITC OD496.rn [FITC]a Ung OD,, nmb[Ung] [FITC]/[Ung]`
pM IM mol /mol
8.5 0.376 0.577 7.40 0.191 4.53 1.63
9.0 0.395 0.683 8.76 0.176 4.17 2.10
9.5 0.440 0.793 10.17 0.186 4.41 2.31
10.0 0.439 0.811 10.40 0.179 4.24 2.45
aThe concentration of FITC in the dye-protein conjugatewas determined by spectrophotometric
absorbance using the extinction coefficient£496 nm = 7.8 x 104 liters/mol*cm (99).
bThe spectrophotometric absorbance of Ung at OD280tim wasdetermined by subtracting the
OD280. contributed by FITC from the overall OD280, of the dye-protein conjugate. Itwas
experimentally determined that 1 41%4 FITC contributed 0.025 OD280nm.
The extent of fluorescein conjugationwas measured by the molar ratio of FITC bound to Ung.147
glycosylase or the ability of Ugi to inhibit theFITC-conjugated enzyme was
observed. The excitation and emissionspectra of F-Ung were determined
(Figure 16) and showed two maximumexcitation peaks at 472 and 496 nm
and single maximum emission peakat 524 nm that are characteristic of the
conjugated FITC molecule (99). Upon addition ofexcess Ugi and after
correcting for the necessary dilution factor, theintensity of the emission
spectra decreased by 10.9 % at 520nm.
3.1.8Steady-state Fluorescence Measurements of Fluorescein
5-Isothiocyanate-labeled Ung Binding to Ugi Forms I-V
To determine whether fluorescence quenchingwas quantitative
between differentially modified formsof Ugi, F-Ung was titrated with Ugi,
and the relative fluorescencewas monitored under steady-state conditions
(Figure 17). Prior to the Ugi addition,F-Ung emitted a steady fluorescent
signal which subsequently decreasedproportionally to the amount of Ugi
added. In the control, the addition ofunmodified Ugi caused a proportional
decrease in fluorescent signal andelicited a 9.4 % maximal quench achieved
at a Ugi:Ung molar ratio of 0.8:1 (Figure 17A).Titration of F-Ung with
modified. Ugi Forms I-V also displayeda linear decrease in fluorescence
intensity with maximum fluorescencequench occurring at 9.2, 7.7, 5.4, 4.9,
and 5.4 %, respectively (Figure17B-F). When the change in relative
fluorescence was plotted against themolar ratio of Ugi:Ung, saturation of F-
Ung occurred between Ugi:Ung ratios of0.8:1 and 1.3:1 for each modified Ugi
form I-V (Figure 18). These resultsare consistent with an inhibitor:enzyme
stoichiometry of 1:1. We interpret the reducedlevels of relative fluorescent
quench for Ugi forms II-V to indicatethat EDC/GEE modification either alters
amino acid residues that directlyinteract with F-Ung fluorophoresor perturbs
the local structure and environmentaround the fluorophores in the final F-
UngUgi complex.148
Figure 16. Excitation and emission spectra of fluoroscein 5-isothiocyanate
conjugated Ung (F-Ung) and the F- Ung.Ugi complex. The excitation and
emission spectra of F-Ung (open circles) in a volume (440 gl) containing 100
nM F-Ung in buffer DAB (30 mM Tris-HC1 (pH 7.4), 1 mM EDTA, 1 mM DTT,
5 % (w/v) glycerol) supplemented with 50 mM NaC1 was measured at 25°C
with a LS50 luminescence spectrometer (Perkin-Elmer)as described under
"Experimental Procedures". The spectrum of the F-UngUgi complex (closed
circles) in a volume (440 ill) containing 100 nM F-Ung and 1µM Ugiwas also
determined.25
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Figure 17. Effect of EDC/GEE-modified Ugi bindingto fluorescein-
conjugated Ung on fluorescence intensity. Samples(400 p,1) containing 110
nM F-Ung were equilibrated at 25°C for 5 min andplaced into a thermostatted
quartz minicell cuvette, and fluorescencewas measured (496 nm excitation
and 520 nm emission wavelengths) for1 min to establish the F-Ung signal
corresponding to 100% relative fluorescenceas described under
"Experimental Procedures". Following this equilibrationperiod, additions (40
p,1) containing either 0 (- ), 138 (-0- ), 275 (--), 413 (-0- ), 550 ), 688 ( -fr-), 825
( -o- ), 963 (-0- ), 1,100 ( -a- ), 1,238 (-to- ), 1,375 ( -w), 5,500 (-13-), or 11,000 ( -s- ) nM of
unmodified [35S]Ugi (A), form I (B), form II (C), formIII (D), form IV (E), and
form V (F) were added to F-Ung, and thefluorescence intensity was
monitored for an additional 5.5 min. Fluorescencemeasurements were
recorded at 5 sec intervals; however, onlythose taken every 15 sec have been
plotted for clarity. All net decreasesare plotted as a percentage relative to the
F-Ung fluorescence control after correcting for dilutioneffects..
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Figure 18. Summary of EDC/GEE-modified Ugi forms I-V binding to
fluorescein-conjugated Ung on fluorescence intensity. Samples (400 p1)
containing 110 nM F-Ung and additions (40 ill) of 0, 138, 275, 413, 550, 688, 825,
963, 1,100, 1,238, 1,375, 5,500, and 11,000 nM each of unmodified [35S]Ugi (closed
circles), form I (open circles), form II (closed squares), form III (open squares), form
IV (closed triangles), and form V (open triangles)were prepared and the
fluorescence intensity was monitoredas described in Figure 17.
Measurements taken at 15-sec intervals were used to determine theaverage
relative fluorescence for each Ugi concentration. After correcting for dilution
effects, the percentage decrease in relative fluorescence intensitywas
calculated as the average relative fluorescence following the Ugi addition
subtracted from the 100% relative fluorescence of F-Ung alone. Each analysis
was carried out in duplicate, and the average values were plotted.0
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3.1.9Effect of Ugi Forms I-V on F-Ung Binding to Poly(U)
The linearity of the titrationcurves for Ugi forms I-V binding to F-Ung
(Figure 18) indicate that Ugi remains in complex withuracil-DNA glycosylase
after complex formation and does not freely dissociate.This observation
would appear to contradict findings showing thatfree Ugi will exchange with
modified forms II-V in the preformed complex andthat Ung demonstrates
catalytic activity in thesesame complexes. However, an explanation for both
results could be that complexesare maintained in solution but that the
addition of competitor Ugior nucleic acid present in the standard reaction
mixture promotes dissociation of modified complexes.Thus, the influence of
Ugi on F-Ung binding to poly(U)was investigated. When F-Ung (42 pmol)
was combined with a saturating amount of poly(U), theaverage fluorescent
intensity was quenched by 7.9 ± 0.8 % (Figure 19A,ARF1). The addition of
unmodified [35S]Ugi (63 pmol) resulted ina further fluorescent intensity
decrease of 4.5 % (Figure 19A, ARF2), indicatingthat Ugi preferentially binds
to F-Ung in the presence of poly(U) and effectivelycompetes poly(U) out of
the complex. Similar experimentswere conducted using modified Ugi forms
I-V in place of the unmodified Ugi. Afterthe initial fluorescence quench
(ARF1 -8 %) due to poly(U), the addition ofUgi forms I-V resulted in ARF2
values of 4.3, 3.1, 1.4, 1.2, and 2.1 `)/0, respectively(Figure 19B). Each of the
EDC/GEE-modified Ugi forms, except Ugi form I, showeda significantly
reduced ARF2 value compared with theunmodified Ugi control (LRF2= 4.5
%)
As a second approach,an analogous experiment was conducted where
F-Ung (42 pmol) was combined with eitherunmodified or modified Ugi
forms I-V (63 pmol) prior to the poly(U)addition, and the relative
fluorescence intensitywas monitored after each addition to determine ARF1
and ARF2 (Figure 20). The initial additionof unmodified Ugi causedan 8.5 %
reduction of fluorescence intensity, andno significant quenching of the156
Figure 19. Effect of Ugi forms I-V on F-Ung binding to poly(U). Six
samples (400 pl) containing 105 nM F-Ung were placed intoa thermostatted
quartz minicell cuvette and equilibrated at 25°C, and fluorescent intensity
measurements were recorded as described in the legend to Figure 17. (A) To
one sample, an addition (30 pl) containing 4.4 mg/ml of poly(U) was made
after 1 min (arrow), and a second addition (30 11,1) containing 2,100 nM [35S]Ugi
(form I) was added after 6 min (arrow). Fluorescence measurementswere
recorded at 5 sec intervals; however, only those takenevery 15 sec have been
plotted for clarity. a RE, represents the net decrease in fluorescent intensity
caused by the first addition, andRF2 is the decrease due to the second
addition. All net decreasesare plotted as a percentage relative to the F-Ung
fluorescence control after correcting for dilution effects. (B) Poly(U)was
added to each of the six F-Ung samples (first addition), and then either 2,100
nM of unmodified [35S]Ugi or 2,100 nM [35S]Ugi forms I-Vwas added (second
addition) as indicated above. Quenching of F-Ung fluorescencewas
measured, and ORF1 was determined for the poly(U) addition (black bars) and
RF2 for the Ugi addition (striped bars).a)100
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Figure 20. Effect of poly(U) on F-Ung binding to Ugi forms I-V. Aset of
six samples (400 p1) containing 105 nM F-Ung were placed intoa
thermostatted quartz minicell cuvette and equilibrated at 25°C, and
fluorescent intensity measurementswere recorded as described in the legend
to Figure 17. (A) To one sample, an addition (30 Ill) containing 2,100 nM
[35SJUgi(form I) was made after 1 min (arrow), anda second addition (30 p1)
containing 4.4 mg/ml of poly(U) was added after 6 min (arrow). Fluorescent
measurements were recorded at 5 sec intervals; however, only those taken
every 15 sec have been plotted for clarity.RF1 represents the net decrease in
fluorescent intensity caused by the first addition, andRF2 is the decrease due
to the second addition. All net decreases are plottedas a percentage relative to
the F-Ung fluorescence control after correcting for dilution effects.(B) Either
2,100 nM of unmodified [35SlUgior 2,100 nM f'SJUgi forms I-V was added to
each of the six F-Ung samples (first addition), and then poly(U)was added
(second addition) as indicated above. Quenching of F-Ung fluorescencewas
measured, and t1 RF1 was determined for the Ugi addition (black bars) and
RF2 for the poly(U) addition (striped bars).100
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fluorescent signal was observed following the poly(U) addition(ARF2 <0.17
%) (Figure 20A). This observationwas consistent with an interpretation that
the UngUgi complex was refractory to binding nucleic acid(17). Conversely,
the addition of poly(U) to each of the EDC/GEE-modifiedUgi forms I-V in
complex with F-Ung elicited additional fluorescence quenchingof 1.5, 1.5, 2.1,
2.1, and 2.6 %, respectively (Figure 20B). Collectively, theseresults
demonstrate the reversibility of modified Ugi forms in complexwith Ung
when nucleic acidwas present, a property not exhibited by the unmodified
UngUgi complex.
3.1.10Identification of EDC/GEE-modified Amino Acid Residuesin
Ugi
In order to locate EDC/GEE-modified residues of Ugiforms I-V, the
inhibitor protein was chemically cleaved withcyanogen bromide, and the
peptide fragments were analyzed by MALDImass spectrometry (Figure 21 and
Figure 22). Ugi contains four methionine residues capableof producing five
peptide fragments following complete CNBr-inducedcleavage (Figure 21).
Following CNBr cleavage, four peptide fragmentswere identified for
unmodified Ugi; mass valueswere in excellent agreement with the predicted
mass of peptides C1/2, C2, C3, and C4 (Table 4). A similar analysiswas
performed on EDC/GEE-modified Ugi forms I-V (Figure22 and Table 4). As
anticipated, Ugi form I generateda set of four peptides with nearly the same
mass values as the unmodified control. In contrast, five peptidefragments
were identified for CNBr-treated Ugi form II; four correspondedto
unmodified peptides C1/2, C2, C3, and C4. The fifthpeptide (C3M1),
comprising 82 `)/0 of C3-derived peptide fragments, hada mass of 3,643 daltons,
which was 89 daltons larger than that predictedfor peptide C3. These findings
indicated that the major site of adductionis located on the C3 peptide.
Similarly, the vast majority (92 `)/0) ofUgi form III adducts were localizedon
the C3 peptide (Table 4). A secondmodified peptide (C3M2)was identified161
Figure 21. Primary amino acidsequence of bacteriophage PBS2 uracil-DNA
glycosylase inhibitor protein. The four possible CNBr cleavagesites and the
six potential endoproteinase Asp-N sitesare indicated by arrows with the
corresponding peptide fragments (C1-05 and A1-A7, respectively)numbered
according to amino acidsequence alignment. Negatively charged amino acid
residues are denoted bya minus sign. Amino acid sequence analysis of peptide
C3 isolated from Ugi forms II and III (*) and form IV (**)revealed unique
PTH-derivatives. A third site of adductionwas localized to peptide A6/7; the
three potential amino acid targetsare indicated (open circles).10 20 30
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Figure 22. Molecularmass determination of CNBr-generated peptides from
Ugi forms I-V by MALDImass spectrometry. [35S]Ugi forms I-V were
treated with CNBr, and peptide fragmentswere produced and analyzed by
mass spectrometry as described under "Experimental Procedures". (A)Mass
spectra of Ugi form I peptide fragments showed the relativeintensity of singly
charged ions corresponding tomass peaks of peptides C1/2, C2, C3, and C4
(Figure 21). Peptide C1/2represents the C2 fragment containing an uncleaved
amino-terminal methionine residue, and individualfragments C1 and C5
were not detected. Mass spectra on CNBr-generated peptides from [35S]Ugi
form II (B), form III (C), form IV (D),and form V (E) are shown, focusingon
the mass peaks between 3,500 and 4,000daltons. This region contained
unmodified peptide C3 and four modifiedpeptides, M1 to M4. The othermass
peaks corresponding to peptides C1/2,C2, and C4 remained essentially
unchanged for forms I-V.3
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164Table 4
Molecular Mass of Ugi Peptides Produced by CNBr Cleavage
Peptide Predicted
Massa
ExperimentalMassb
Unmodified Form I Form II Form III Form IV Form V
daltons
C1/2' 2,674 2,700 2,696 2,701 2,703 2,706 2,707
C2 2,554 2,555 2,551 2,556 2,552 2,553 2,552
C3 3,554 3,556 3,549 3,558 3,552 3,553 3,551
C3M, 3,643 (89)d 3,638 (84) 3,641(87) 3,640(86)
C3M2 3,710 (156) 3,712(158) 3,710(156)
C3M3 3,795(241) 3,792(238)
C3M4 3,846(310)
C4 3,012 3,015 3,008 3,018 3,011 3,013 3,011
Relative Amounts of C3 Peptides'
0/0
C3 >95 >95 18 8 5 7
C3M, 82 22 17 12
C3M2 70 34 29
C3M3 28 25
C3M4 16 27
aPredicted mass values of CNBr-generated peptides were determined by the computer program MacProMass, version 1.05, by Lee and Vermuri
(137).
bAverage molecular masses were determined from four independent measurements and standard errors range from 0.3 to 4.5 daltons.
Peptide C1/2 contains the amino-terminal methionine residue that was neither post-translationally removed in vivo (284)nor cleaved by
CNBr to generate peptide C2 in vitro, possibly due to oxidation of the methionine to the sulfone.
dNumbers in parentheses correspond to mass values obtained by subtracting the experimentally determined mass from the predictedmass and
reflect mass increases.
Relative amounts of modified or unmodified peptide C3 were determined as percentages of total peak area (3,500-4,000 daltons) for
unmodified Ugi and Ugi forms I-V in Figure 7.166
with a mass of 3,710 daltons, indicative of two adducts, each of -85 daltons.
Ugi form III also produced a C3M1 peptide fragment (3,638 daltons), connoting
a single acyl-glycine ethyl ester adduction (Table 4). Mass determination of
CNBr-treated Ugi forms IV and V both included peptide fragments C3M1 and
C3M2 and possessed additional peptides C3M3 and C3M4. The relative
percentage of peptides C3M14 detected for each Ugi form is indicated in Table
4. in all cases, the primary modification site(s) were specifically localized to
peptide C3, which contained 10 Glu and Asp residues.
The location of the adducted site(s)on peptide C3 was further
investigated by using the same approach but following endoproteinase Asp-N
digestion of Ugi. A comparison of the molecular weights of unmodified and
form II Ugi peptides revealed two modified fragments derived from peptides
A2 and A6/7 (Figure 23 and Table 5). The major A2M1 (-82 `)/0) and minor
A6/7M1 (-23 %) modified peptide species each showeda mass increase of -85
daltons, denoting the presence of a single acyl-glycine ethyl ester adduct.
Peptide A2M1 was detected in equal abundance with C3M1 and overlapping
amino acid sequence from Leu-25 to Ser-39 (Figure 21). Thus, itwas deduced
that modification by EDC/GEE likely involved Glu-27, Glu-28, Glu-30, Glu-31,
and/or Glu-38. The appearance of peptide A6/7M1 suggested that another site
of adduction occurred with reduced frequency at Glu-64, Asp-74, Glu-78,
and/or the carboxyl terminus of the Ugi protein. Unfortunately, the latter
observation was not confirmed by detectinga modified peptide corresponding
to peptide C4 (Table 4). We assume that the low abundance of this modified
species and interference by minor mass peaks in the C4 region obscured
detection following CNBr cleavage of Ugi form II. Ugi form III digested with
endoproteinase Asp-N also produced peptides A2M1 and A6/7M1; however,
an additional modified fragment (A2M2) was detected with a mass increase of
162 daltons (Table 5). As observed for peptide C3M2, the A2M2 peptidemost
likely contained two acyl-glycine ethyl ester adductsamong the five glutamic
acid residues located between Leu-25 and Ser-39.167
Figure 23. Molecular mass determination of Asp-Ngenerated peptides
from unmodified Ugi and EDC/GEE-modified Ugi formsII and III by
MALDI mass spectrometry. Unmodified [35S]Ugi and forms IIand III were
treated with endoproteinase Asp-N, and peptide fragmentswere produced
and analyzed by mass spectrometryas described under "Experimental
Procedures". (A) Mass spectra of unmodified Ugi peptidefragments showed
the relative intensity of singly charged ions correspondingto mass peaks of
peptides A2, A3, A6, A6/7, and A7 (Figure 21). Peptide A6/7represents the
uncleaved dipeptide of A6 plus A7, and individual fragmentsAl, A4, and A5
were not detected. Mass spectra of Asp-N generated peptides from [35S]Ugi
form II (B) and form III (C)are shown, focusing on the mass peaks between
1,000 and 5,000 daltons. This region contained bothunmodified peptides A2
and A6/7 and modified peptides A2M1,A2M2, andA6/7M1. The other mass
peaks corresponding to peptides A3, A6, and A7 remainedessentially
unchanged between samples.20
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Table 5
Molecular Mass of Ugi Peptides Produced by Endoproteinase Asp-N
Peptide Predicted
Massa
Experimental Mass'
Unmodified Form H Form III
daltons
Alc 565
A2 3,837 3,837 3,838 3,837
A2M, 3,920(83)d 3,923 (86)
A2M2 3,999 (162)
A3 932 931 932 932
A4` 451
A5' 1,021
A6 1,530 1,530 1,529 1,529
A6/7 2,759 2,760 2,762 2,759
A6/7M2 2,846(87) 2,844 (85)
A7 1,249 1,248 1,249 1,248
Relative Amounts of Peptidesf
A2 18 10
A2M, 82 25
A2M2 65
A6/7 77 63
A6 /7M, 23 37
aPredicted mass values of peptides produced by Asp-Nendoproteinase were determined by
the computer program MacProMass, version 1.05,by Lee and Vermuri (137).
bAverage molecular masses were determined fromtwo to three independent measurements,
and standard errors range from 0.0 to 4.5 daltons.
Peptides Al, A4, and A5 were not detected, presumably dueto their small size or unusual
protein properties.
dNumbers in parentheses correspond tomass values obtained by substracting the
experimentally determined mass from the predictedmass and reflect mass increases.
ePeptide A6/7 corresponds to the uncleaved dipeptide A6 plusA7.
fRelative amounts of modified or unmodified peptidesA2 and A6/7 were determined by a
method similar to that described in Table 4.170
In order to identify the precise sites of adduction, modified and
unmodified peptide C3 were purified to apparent homogeneity by DEAE-
cellulose chromatography (data not shown). Amino acidsequence analysis
unambiguously identified peptide C3 from CNBr-treated Ugi formsI-IV
(Figure 24 and Table 6). Examination of the amino acidPTH-derivatives
detected in sequencing cycles for the C3 peptide of Ugi form II revealedpeaks
of a unique PTH-derivitized amino acid (PTH-1) appearingat cycles 4 and 7
(Figure 25 and Figure 26A), thus identifying Glu-28 and Glu-31as sites of
modification. The unique amino acid derivative peaks concordantly
appeared, corresponding to decreases in Glu-28 and Glu-31, and similarpeaks
were not detected at other cycles containing Glu or Asp residues. Almost
equal amounts of the novel amino acid derivativewere detected at cycles 4
and 7 for forms II, III, and IV (Figure 26A-C). Interestingly,an additional
unique PTH-derivatized amino acid (PTH-2)was detected for Glu-28 and Glu-
31 in Ugi form IV (Figure 26D), suggesting twotypes of adducts (Figure 21).
Taken together, these results identify Glu-28 and Glu-31as two major sites of
EDC/GEE modification.
3.2Discussion
It was determined that EDC/GEE modification of Ugi proteinresulted
in the selective adduction of specific glutamic acid residues thatinactivated
Ugi activity. Ugi form I represented unmodified inhibitorprotein, since it did
not exhibit any neutralization of charge, increase inmass, or reduction in
inhibitor activity. Ugi form II containeda single EDC/GEE-induced adduct
per protein, defining the location of the most highly reactive amino acids.
The results demonstrated that 82 `)/0 of Ugi Form II adductswere located
within the peptide sequence Leu-Pro-Glu-Glu-Val-Glu-Glu-Val-Ile-Gly-Asn-
Lys-Pro-Glu-Ser (residues 25-39) containing the a2-helix andadjoining loop
region. Of the five glutamic acid residues that reside in thissequence, only
Glu-28 and Glu-31 were significantly modified andin roughly equal171
Figure 24. Amino acidsequence analysis of the Ugi form II peptide C3.
Amino acid sequencing was conducted usingan Applied Biosystems model
475A gas phase proteinsequencer as described under "Experimental
Procedures". The amount (pmol) of PTH-derivatives detected foreach amino
acid and the unique PTH-derivative (PTH1)are plotted by amino acid residue
for the first 28 cycles.5
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174Table 6
Quantitation of Gas-Phase Sequencing of the DEAF- Cellulose PurifiedUgi Form II C3 Peptide
Cycle
Amino
Acid' 1 2 3 4 5 6 7 8 9 10 11
Ala 4.0 2.1 2.8 2.7 2.5 3.4 4.2 2.8 3.1 2.9 2.5
Arg 2.7 1.4 0.8 15.6 4.0 0.1 14.5 5.6 <0.1 <0.1 0.5
Asn 687.4 480.9 204.7 86.8 48.9 24.1 10.7 6.0 4.0 2.4 33.8b
Asp 1.6 4.7 3.5 3.7 43.2 38.5 11.3 7.3 4.9 3.6 4.3
Glu <0.1 <0.1 63.8b 71.9b 30.9 69.4b 56Ab 45.0 36.3 33.3 20.7
Gln <0.1 <0.1 <0.1 <0.1 1.2 0.7 0.6 <0.1 0.6 1.1 0.7
Gly <0.1 <0.1 <0.1 <0.1 <0.1 25.0 13.3 6.7 7.2 38.4b 15.9 His <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 0.1 0.5 0.2 <0.1 0.1 Ile 2.1 1.9 2.6 2.5 2.5 35.6 56.6 32.5 58.9b 26.4 10.9
Leu 182.41' 13.8 94.9 54.2 10.0 6.9 6.5 5.6 6.8 6.8 5.3
Lys 2.7 1.5 0.8 1.6 1.7 1.7 2.2 2.0 32.6 30.3 11.4
Met 58.2 1.0 0.3 0.2 <0.1 <0.1 0.1 0.1 0.3 <0.1 0.2
Phe 0.2 <0.1 0.5 <0.1 <0.1 <0.1 0.2 <0.1 0.2 <0.1 <0.1
Pro 1.7 70.7b 30.9 14.5 6.4 5.3 4.2 3.6 3.4 2.9 2.6
Ser 3.7 3.0 2.3 26.7 16.7 3.8 2.1 0.8 1.1 1.6 1.2
Thr <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 0.8 <0.1 1.1 1.7 11.3
Trp 3.7 4.6 10.5 5.4 11.6 10.6 12.1 12.5 11.3 12.5 12.8
Tyr 1.2 0.6 0.7 1.4 1.0 1.2 1.2 1.6 2.4 3.3 2.2
V a 1 1.6 0.4 1.6 2.0 59.6b 28.2 12.0 51.11' 24.4 11.4 5.0
PTH1` <0.1 240.0 2354.0 597.0 422.0 2181.0 840.0 357.0 132.0 79.0 <0.1
Pep tidedLeu Pro Glu Glu V a 1 : Glu Glu V a 1 Ile Gly AsnTable 6 (continued)
Quantitation of Gas-Phase Sequencing of the DEAE-Cellulose Purified Ugi Form II C3 Peptide
Cycle
Amino
Acid' 12 13 14 15 16 17 18 19 20 21 22
Ala 2.8 2.8 3.0 3.1 3.0 2.4 2.5 2.7 2.7 2.4 8.1b
Arg 0.2 <0.1 0.3 <0.1 <0.1 <0.1 <0.1 0.1 0.7 <0.1 <0.1
Asn 18.6 8.8 6.1 3.3 3.4 2.1 2.4 2.2 2.3 1.8 2.3
Asp 4.6 3.0 5.0 3.4 12.0b 9.9 8.2 6.3 5.1 3.2 1.0
Glu 12.6 7.5 20.0b 16.2 11.8 7.8 5.8 8.3 8.1 5.4 3.8
Gln 0.9 0.7 9.6 11.6 6.8 3.4 7.4 10.8 6.5 3.4 1.5
Gly 19.6 16.8 8.6 4.1 3.2 2.8 2.1 2.8 2.4 2.2 1.2
His 0.2 <0.1 0.6 <0.1 <0.1 0.3 0.5 <0.1 3.9" 3.7 3.0
He 7.8 5.1 4.4 3.7 3.2 19.6b 18.8 12.6 7.6 8.0 8.1
Leu 5.9 4.9 5.4 15.8 18.3 11.3 17.9" 16.7 12.5 8.9 10.9
Lys 48.5" 33.3 25.8 13.4 7.4 5.0 3.6 3.5 3.2 2.8 2.7
Met 0.3 <0.1 0.1 0.1 <0.1 0.2 <0.1 0.2 0.2 0.1 <0.1
Phe 0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Pro 3.6 23.8b 20.4 12.4 7.8 5.0 3.4 3.3 2.8 2.7 2.4
Ser 1.4 1.2 0.7 5.6" 6.3 4.2 2.4 2.5 4.1 3.9 2.1
Thr 11.3 4.8 1.8 1.0 1.1 0.9 0.6 1.4 1.2 5.4" 4.2
Trp 12.5 9.0 8.1 9.5 10.0 9.2 7.7 10.9 8.7 8.9 9.2
Tyr 2.2 1.7 1.6 1.6 1.8 1.6 1.3 1.6 1.7 1.8 1.6
Val 4.1 2.6 2.1 2.1 9.6 11.2 5.5 11.0 10.6 7.1 4.5
PTH1` <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 <0.1 103.0 <0.1 <0.1
PeptidesLys Pro Glu Ser Asp Ile Leu Val His Thr AlaTable 6 (continued)
Quantitation of Gas-Phase Sequencing of the DEAE-Cellulose Purified Ugi Form II C3Peptide
Amino
Cycle
Acid' 23 24 25 26 27 28
Ala 8.2 6.8 4.6 3.7 3.8 3.0
Arg 0.1 <0.1 <0.1 <0.1 0.6 <0.1
Asn 1.9 2.6 1.8 1.6 2.8 1.7
Asp 3.2 8.9" 7.7 6.3 6.9 5.4b
Glu 3.9 3.3 6.6b 8.0 8.4 7.6
Gin 1.7 1.3 1.4 1.5 1.0 1.4
Gly 1.9 1.4 1.9 2.0 1.3 2.2
His 1.9 1.4 0.5 0.5 0.8 0.4
Ile 5.9 4.8 3.3 3.1 3.4 2.9
Leu 11.4 12.5 9.5 8.4 7.7 5.8
Lys 2.4 2.6 1.7 2.2 2.4 2.1
Met 2.5 3.4 1.7 1.1 0.8 0.3
Phe <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Pro 2.8 2.6 3.9 5.3 5.7 4.2
Ser 1.7 1.5 1.4 2.8" 3.1 2.8
Thr 3.7 2.3 2.1 1.7 2.7" 3.3
Trp 10.3 9.2 7.3 10 9.6 8.4
Tyr 7.7" 8.0 5.3 4.0 3.4 2.2
V al 3.9 3.2 2.0 1.9 2.4 2.7
PTH1` <0.1 <0.1 <0.1 <0.1 88.0 <0.1
PeptidesTyr Asp Glu Ser Thr Asp
aThe yield of PTH-derivatized amino acids detected in each cycle are indicated in picomols. Cytosine residuesare not detected.
"Denotes the amino acid residue in each cycle expected to correspond to the deduced amino acid sequence of Ugi peptide C3.
The yield of PTH1 detected in each cycle is indicated in arbitrary absorbance units (AAU) and not picomols becausean internal amino acid standard for PTH1 is unavailable for quantitative purposes.
°The amino acid sequence for the C3 peptide is elucidated from the deduced amino acid sequence of the published ugigene nucleotide sequence (292).178
Figure 25. Amino acid sequence determination of the Ugi form II C3
peptide. A histogram shows the relative amount ofa unique PTH-
derivative detected during each cycle of Edman degredation of Ugi form II C3
peptide. This novel derivative appeared witha retention time of 15.54 ± 0.05
min between standards identified as Arg (-15.17 min) and Tyr (16.13 min).
The amino acid sequence determined for the C3 peptide that overlaps with
the A2 peptide is indicated.3000
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Figure 26. Quantitation of unique PTH-derivatives detected by aminoacid
sequenceing of peptide C3 from Ugi forms II-IV. Amino acid sequencing
was conducted using an Applied Biosystems model 475A gas phase sequencer
as described under "Experimental Procedures".The relative amount of
unique PTH-derivatives (PTH1 and PTH2) detected for peptide C3 from Ugi
forms II-IV are plotted for the first 23 cycles. PTH1 appeared witha retention
time of 15.54 ± 0.05 min between standards identifiedas Arg (15.17 min) and
Tyr (-16.13 min). PTH2 appeared witha retention time of 19.02 ± 0.02 min
between standards identifiedas Tyr (16.13 min) and Pro (20.08 min).3000
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proportions. The preferential modification of 2 out of 19 carboxylgroups in
Ugi may be facilitated by the closely spaced pairing of Glu residues (Glu-27,
Glu-28 and Glu-30, Glu-31), the repeating Glu-Glu-Valsequence, and the
solvent-accessible a2-helix of Ugi (12). Selective carbodiimide-mediated
modification has been previously observed when acidic amino acidsare
clustered within a polypeptide sequence, creatinga negatively charged local
environment (33, 83, 160). A secondary site of modificationwas detected on
peptide A6/7M1 (residues 61-84) but represented only -18 `)/0 of the total Ugi
form. II adducts. Ugi form IIIwas shown to contain two acyl-glycine ethyl
ester adducts, and 65-70 % of these protein molecules had adductson both
Glu-28 and Glu-31 sites. The remaining molecules of Ugi form III apparently
possessed a single adduct on both peptide A2 and A6/7, since theamount of
peptide A2M1 (25 %) nearly equaled that of A6/7M1 (37 `)/0). Thetype, location,
and distribution of each adducton Ugi forms IV and V became more difficult
to define due to the heterogeneity of modification. The second PTH-
derivative associated with form IV peptide C3was suspected to represent an
N-acylurea adduct formed byan internal rearrangement of acylisourea (272).
This alternative EDC-dependent modification is representedin Figure 27.
Previous studies have shown that if the concentration of nucleophileis
sufficiently high, the kinetics of this internal rearrangementcan be reduced
relative to nucleophilic attack of the 0-acylisourea-activatedcarboxyl group
(104).. These results indicated that the predominant modificationresulted in
the formation of the terminal acyl-glycine ethylester reaction product.
The results presented in this investigation provide evidencethat Glu-
28 and Glu-31, located in the a2-helix of Ugi, playan important role in
promoting stable UngUgi complex formation. Involvement ofthese two
residues was implied, since 82 and 90 `)/0 of Ugi forms II andIII contained at
least one adduction in the a2-helixsequence. Thus, little room is left to
explain the 42 and 67 `)/0 reduction in Ugi activity by anothermodified site.
However, the possible involvement of minor adductsin influencing the183
Figure 27. Scheme for 0-acylisourea adduction of Ugi by EDC/GEE
modification. Activation ofa protonated carboxylic acid group by EDC forms
an 0-acylisourea adduct which is subject to nucleophilic attack by glycine
ethyl ester (GEE) to form the primary acyl-glycine ethylester adduct described
in Figure 2. A secondary modificationoccurs by an internal rearrangement of
the 0-acylisourea adduct to forman N-acylurea adduct. Kinetic studies on
carbodiimide-carboxyl-nucleophile systems have shown that formation of the
N-acylurea adduct is slow as compared to nucleophilic attack if the
nucleophile (GEE) concentration is sufficiently high (104). TheN-acylurea
adduct is positively charged and adds 156 daltonsto the overall molecular
weight of the Ugi protein.185
stability of some complexes cannot be discounted. Itwas postulated that both
Glu-28 and Glu-31 contribute to the formation ofa stable UngUgi complex.
This proposal is reinforced by recentx-ray crystallographic studies of the
human and herpes simplex virus type-1 uracil-DNA glycosylaseUgi
complexes (167, 237). Both structures reveal that residues of the Ugia2-helix
and adjoining 131 strand dominate the interface with theenzyme and provide
sites of interaction between the two proteins. The hydrophobic faceof the a2-
helix in conjunction with the 13-sheet formsa hydrophobic pocket that
surrounds the conserved Leu-272 active site loop of human uracil-DNA
glycosylase (167). This pocketappears to be stabilized by Ugi Glu-28 and Glu-
31 contacts with conserved residues thatare shared between human and E.
coli Ung (167, 196). These interactions have beenproposed to involve the Ugi
Glu-28 carboxylate forminga pair of hydrogen bonds with the Ser-247 (Ser-166
of E. coli Ung) backbone amide and side chain 0-y(167). In addition, Glu-28 0-
E1 also forms water-mediated hydrogen bonds withthe human His-268
backbone amide and Ser-273 0-y, correspondingto E. coli Ung His-187 and Ser-
192, respectively (167). By thesame token, Ugi Glu-31 appears to be capable of
forming a salt bridge with Arg-276 of human uracil-DNAglycosylase (Arg-195
of E. coli Ung). Thus, EDC/GEE modification of eitherGlu-28 or Glu-31 might
be expected to disrupt important protein/proteininteractions and destabilize
the complex as observed in this investigation.
Several lines of evidence suggest that the interactionsbetween Ugi
Glu-28 and Glu-31 influence the formation ofa tight UngUgi complex
without dramatically impeding the association of theinitial pre-complex.
Steady-state kinetic experiments that monitored thebinding of Ugi forms I-V
to F-Ung demonstrated that neither modifiednor unmodified Ugi freely
dissociated from Ungonce the final complex was achieved. However, the
structures of these complexes differed since binding of Ugiforms II-V resulted186
in reduced levels of maximal fluorescence quench. Theseobservations
suggest that the conjugated acyl-glycine ethylester adducts of Glu-28 and/or
Glu-31 interact directly with F-Ung fluorophoresor perturb the local structure
and environment of the final F-UngUgi complex.It was observed from
competition binding experiments that unmodified Ugi preferablyformed a
complex over the modified protein species.Furthermore, unmodified Ugi
was observed to replace modified Ugi (forms II-V) froma preformed complex.
These properties of Ugi forms II-Vwere revealing, since unmodified Ugi
maintains an irreversible UngUgi complex (17). Thus,Ugi forms II-V
appeared to be defective in achievingan irreversible association with Ung.
Observations indicating that poly(U) promoteddissociation of modified Ugi
from complex and that preformedUngUgi (form II-V) complexes displayed
uracil-DNA glycosylase activity also supported thisinterpretation.
The results providenew insight concerning the structural and
functional relationship of the Ugi a2-helixin complex formation.
Previously, stopped-flow kinetic experimentsindicated that the Ung/Ugi
association involved a two-step mechanism composedof a docking and
locking reaction. The docking reactionwas shown to involve a rapid pre-
equilibrium in which Ung and Ugi associatedto form a reversible complex
(17). It is likely that the transitionbetween the docking and locking steps
involves an isomerization reaction. Thiscould be achieved by a
conformational change in Ung, Ugi,or both proteins. A comparison of the
crystal structures of free human and herpes-simplexvirus type-1 uracil-DNA
glycosylase with each respectiveenzyme in complex with Ugi indicates that
only minor changesoccur within the enzyme tertiary structure upon complex
formation (168, 235). A similarcomparison between the NMR tertiary
structure of unbound Ugi with the crystalstructure of Ugi complexed with
either human or herpes simplex virustype-1 enzyme reveals that significant
structural changes occur in Ugi (12, 167, 237).Direct evidence that Ugi
undergoes a conformationalupon binding to Ung was provided by NMR187
results (12). The heteronuclear multiple quantum correlation spectroscopy
spectrum of free [151\l]Ugi compared with that of the Ung[151\1]Ugi complex
clearly indicates that many Ugi residues undergo a chemical shiftas a
consequence of forming the "locked" complex. One of the most dramatic
rearrangements appears to involve the location of the Ugi a2-helix. It is
speculated that movement of the a2-helix, at least in part, transforms the
reversible UngUgi complex to an essentially irreversible locked state. This
interpretation is consistent with the observation that Ugi forms II-Vwere
capable of successfully conducting the docking but not the locking interaction.
Conformational change in the Ugi a2-helix providesan attractive
explanation that unifies the biochemical, kinetic, and structural data.
However, several issues remain to be elucidated regarding the role of Glu-28,
Glu-31, and other residues in the Ung/Ugi interaction. First, what is the
relative involvement of GIu -28 and Glu-31 in facilitating the locking
reaction? Second, does charge neutralization of these carboxylgroups alone
bring about inactivation of Ugi,or does EDC/GEE modification sterically
hinder a2-helix positioning? Third, what other amino acids playa role in the
docking and locking interaction? Ina related study, site directed mutagenesis
of Glu-28 and Glu-31 in Ugiwas performed to assess the individual
contribution of these and other negatively charged amino acids in mediating
the docking and locking interactions with E. coil Ung (152). Thespecific
activity of Ugi mutants E28L and E31Lwere 88 `)/0 and 53 % relative to that of
wild-type Ugi and were capable of associating with Ung and formingan
apparently stable UngUgi complex (152). However, Ugi located withina
preformed UngUgi complex composed of Ugi mutant E28Lwas reversible
when challenged with wild-type [35S]Ugi (- 50 % exchange) whereas Ung
complexed with Ugi E31L, for the most part, maintainedan irreversible
complex (- 3.4 % exchange) (152). When taken together, these observations
argue that Glu-28 was predominantly responsible for stabilizingan188
irreversible UngUgi complex while Glu-31 contributedonly a minor role in
the locking reaction. Thus, charge neutralization ofGlu-28 apparently played
a significant role in destabilizing the UngUgi complex although potential
steric hindrance by EDC/GEE-modified Glu-28 and/or Glu-31cannot be ruled
out. Three other mutant Ugi proteins (E20I, E3OL, and D61G) also variedin
their individual ability to inhibit Ungactivity but were unaltered in their
ability to form an irreversible complex (152).Together, these studies suggest
that multiple Ugi amino acidsare involved in mediating the Ung/Ugi
docking and locking interaction but that Glu-28plays an essential role in
facilitating the "locking" reaction.189
4. FIDELITY, MUTATIONAL SPECIFICITY, AND REPAIR PATCH SIZE
OF URACIL-INITIATED BASE EXCISION REPAIR SYNTHESIS IN
HUMAN GLIOBLASTOMA AND COLON ADENOCARCINOMA CELL
EXTRACTS
Although the molecular mechanism of human uracil-initiated BER is
understood in some detail, the fidelity and error specificity of DNA repair
synthesis has not been adequately addressed. Thus,an M13mp2 lacZa DNA-
based reversion assay was developed for detecting base substitutionerrors
produced at a site-specific uracil residue during BER in human U251 and
LoVo whole cell extracts. Experimentswere conducted to establish that
uracil-DNA repair occurred via the BER pathway. The location of DNA
repair synthesis was examined to determine if dNMP incorporationwas
localized to the uracil target and to determine if synthesis occurredon the ( -)-
strand, (+)-strand, or both DNA strands. Additional experiments utilized the
Ugi protein to inhibit uracil-DNA repair initiated by Ugi-sensitive uracil-
DNA glycosylase(s) and to study the Ugi-insensitive uracil-DNA repair
pathway. To determine if mismatch repair in human whole cell extracts
might influence uracil-DNA repair, an identical set of experimentswas
conducted with LoVo whole cell extracts thatare defective in the hMSH2
mismatch repair protein. Experiments in this chapter also evaluated the size
of the repair patch produced during DNA repair synthesis associated with the
Ugi-sensitive and -insensitive BER. In addition, the specific involvement of
aphidicolin-sensitive and -insensitive DNA polymerases that participated in
DNA repair synthesis was investigated.
The fidelity of BER synthesis ata defined uracil residue located in the
E. coli lacZa gene of heteroduplex M13mp2 DNAwas measured, and the
mutation spectrum was elucidated for uracil-initiated BER in human U251
and LoVo whole cell extracts. Comparative analysis between thesetwo cell
types identified nearly identical mutation frequencies and mutation
spectrums. These results are indicative of nucleotide misincorporation190
events associated with uracil-initiated BER in human whole cellextracts and
provide a measurement of DNA repair synthesis fidelity.
4.1Results
4.1.1Uracil-Initiated Base Excision DNA Repair Assay
An M13mp2 lacZa DNA-based reversionassay was developed to
investigate the fidelity of DNA synthesis associated with uracil-initiatedDNA
repair in human whole cell extractsas illustrated in Figure 28. Site-directed
mutagenesis was used to construct the base excision repair DNAsubstrate
(M13mp2op14 DNA) as described under "Experimental Procedures".
Substrate modifications included incorporation ofa transcriptional stop
codon in the E. coli lacZagene of M13mp2 DNA and a downstream silent
mutation that generated a unique Smal restriction endonucleasesite. By
introducing an opal codon (TGA) in place ofan arginine codon (CGT) for
amino acid 14 of the lacZagene product, lacZa was rendered inactive and
incapable of a-complementation. DNAsequence analysis of isolated
M13mp2op14 DNA verified the introduction of the opal codon(Asp14 CGT
> TGA opal 14) at nucleotide positions 78-80 of the lacZagene and also
confirmed the presence of the silent point-mutation (Pro20CCT --> CCG
Pro20) at nucleotide position 98 tocreate the novel Smal restriction site
(Figure 29). Circular heteroduplex M13mp2op14DNA with a site-specific
uracil at nucleotide position 78 of the (-) strandwas then constructed using T4
DNA polymerase and T4 DNA ligase ina primer extension reaction and
Form I DNA was purified. This DNA substratecontained a UT base mispair
at the first nucleotide of the opal codon and servedas the uracil-target for
repair. The uracil residuewas strategically located so that faithful and
unfaithful uracil-initiated DNA repairsynthesis in human whole cell extracts191
Figure 28. Scheme for measuring base excision DNA repair synthesis
fidelity in human cell extracts. (A) M13mp2op14 DNA containinga site-
specific UT mispair at position 78 of the lacZagene was constructed as
described under "Experimental Procedures". Nucleotide positions 48-108 of
the lacZa gene are depicted with position 1 correspondingto the first lacZa
transcribed base. The uracil target for human uracil-DNA glycosylase (UDG,
vertical arrow) and direction of DNA synthesis (horizontal arrow) duringbase
excision repair are indicated. EcoRI and Smal endonuclease recognition
sequences are underlined and incision sites are indicated by vertical arrows. (B)
Standard base excision repair reaction mixtures containing 10 Kg/m1 of
M13mp2op14 DNA, 2 mg/nil of human whole cell extract protein, 20 [tM
each of dATP, dTTP, dGTP, and dCTP and other componentswere prepared as
described under "Experimental Procedures". DNA reaction productswere
isolated at various times after incubation at 30°C and analyzed by0.8% agarose
gel electrophoresis. Conversion of uracil-containing Form I DNAto Form II
DNA and then to Form I DNA thatwas resistant to cleavage by the combined
treatment of E. coli Ung and Endo IV was indicative of DNA repair.
Ung/Endo IV resistant Form I DNAwas purified from the agarose gel and
used for mutational analysis. E. coli NR9162 cellswere then transfected with
the recovered DNA usinga Gene Pulser electroporation system. Transfected
cells were diluted into SOC medium, mixed with E. coli CSH50 (indicator
strain) and plated on M9 plates containing 0.4 mM IPTG and 1 mg/mlX-Gal
as described under "Experimental Procedures". Colorless and blue (dark and
light blue) plaques were counted. (C) Possible nucleotideincorporations at
the uracil target site during BER. Faithful incorporation of dAMPto replace
the uracil residue at position 78 in the (-) strand results in theproduction of
an opal codon. Whereas, incorporation of dCMP, dGMP or dTMP restoresa
wild-type phenotype and allows a-complementation.A.
B.
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Figure 29. DNA sequence of Ml3mp2op14 DNA. An isolated clearplaque
was used to procure single-stranded M13mp2op14 DNA and the DNA
sequence was determined using an Applied Biosystems Model 373A DNA
sequencer as described under "Experimental Procedures". Mutations were
introduced into the nucleotidesequence of the lacZa gene and resulted in the
replacement of an opal codon (TGA) foran arginine codon (CGT) at codon
position 14 (opal, brackets) and the introduction ofa silent mutation to create a
unique Smal restriction endonuclease site (Smal, brackets). The opal codon
and the Smal restriction siteare labeled accordingly. The sequence depicted is
that of the (-) DNA strand determined in the 5'to 3' direction. Unidentified
bases are denoted by an 'N' in the DNAsequence.195
could be distinguished basedon reversion of the opal codon. If faithful DNA
synthesis occurred with dAMP incorporationopposite thymine at nucleotide
position 78, the opal codonsequence would be restored to the (-) strand
(Figure 28C). Alternatively, if unfaithfulDNA synthesis incorporated dGMP
or dTMP, a wild type arginine codon would be generated; whereas, dCMP
incorporation would introducea glycine codon into the (-) strand. In order to
preserve mispairs introduced into repaired M13mp2op14 DNA by inaccurate
DNA synthesis, the substratewas transfected into E. coli NR9162 (mutS),
which is methyl-directed mismatchrepair defective. Transfection of E. coli
NR9162 (mutS) cells with faithfully repairedM13mp2op14 DNA was expected
to produce a colorless plaqueon host indicator plates due to the inability of
the lacZa gene product to performa-complementation (Figure 30). In
contrast, unfaithful incorporation ofa noncomplementary nucleotide in
place of the uracil residue restoreda-complementation and produced mixed
burst blue plaques (colorless plus blue).These phenotypes were
independently verified by transfecting E. coliJM109 with M13mp2 DNA
containing each of the four possible nucleotidesubstitutions at positions 78
and plating on host indicator plates(Figure 31). As expected, M13mp2 DNA
containing a lacZa opal (TGA) and arginine(CGA, AGA) codon 14 produced
colorless and dark blue plaques, respectively(Figure 31A-C); however, a
glycine (GGA) codonwas found to produce a light blue plaque (Figure 31D).
These results validated theassay for detecting misincorporation events
introduced at the target site duringuracil-initiated DNA repair synthesis.
4.1.2Preparation and Characterization of Uracil-Excision
Repair DNA Substrates
In order to optimize primer extensionreaction conditions for
producing the Form T DNA uracil-excisionrepair substrates, 3.3 pmol of
M13mp2op14 DNA was annealedto a three-fold molar excess of 5'-end
phosphorylated U-23-mer and incubated withT4 DNA polymerase at ratios of196
Figure 30. Detection of base excision DNA repair synthesis fidelityby
lacZa complementation. A standard BER reaction mixturecontaining 10
gg/m1 M13rrip2op14 (UT) DNA and 2 mg/ml human. U251 wholecell
extract protein was prepared, DNA was isolated, and repaired Form I DNA
was purified as described under "Experimental Procedures". Competent E.
coli NR9162 cells transfected with repaired Form I DNAwere diluted into SOC
media, mixed with mid-log E. coli CSH50 cells and platedon M9 plates
containing 0.4 mM IPTG and 1 mg/ml X-Gal. Typical plating conditionswere
adjusted to yield approximately 1,000 to 3,000 plaque formingunits (pfu) per
plate and plaques were scoredas either colorless or blue.197
Figure 30198
Figure 31. Plaque phenotype color produced byM13mp2op14 DNA and
revertants. The four possible nucleotide incorporations at the uraciltarget
site during BER in U251 whole cell extractswere analyzed for plaque
phenotype color upon transfection and plating ofE. coli NR9162 cells as
described under "Experimental Procedures".M13mp2op14 DNA containing
an opal codon (TGA) (plate A) produced colorless plaques while reversion of
the opal codon toan arginine codon (CGA and AGA) (plates B and C,
respectively) or a glycine codon (GGA) (plate D)produced dark blue or light
blue plaques, respectively, andare represented accordingly. The single-base
substitution generated by the original misincorporatednucleotide has been
underlined for M13mp2op14 revertants...*. 10.1 se
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8:1, 2:1. 0.5:1, and 0.125:1 (polymerase unit to pmol primed template).
Following DNA synthesis reactions, the reaction productswere analyzed by
agarose gel electrophoresis (Figure 32, lanes 3-6, respectively). As a control, 3.3
pmol of heteroduplex U-23-rner/M13rnp2op14 DNAwas included to indicate
the position of the unextended primer/template DNA (lane 2). Theaddition
of T4 DNA polymerase and T4 DNA ligase resulted in the extension of the
primer to yield various ratios of covalently closed circular DNA (Form I),
nicked circular DNA (Form II), and linearized DNA (Form III) products(lanes
3-6). Undefined reaction products accumulated at ratios of 0.5:1 and 0.125:1
(lanes 5 and 6) and may have resulted from incomplete primerextension
DNA synthesis around the template. However, optimal production ofForm I
DNA consistently occurred ata ratio of 2:1 (lane 4) as determined by ethidium
bromide staining intensity and this ratiowas applied to preparative primer
extension reaction mixtures in order to generate consummateamounts of
Form I DNA. Similar resultswere also obtained with M13mp2op14 DNA
annealed to 5'-end phosphorylated A-23-mer (datanot shown).
To separate Form I DNA from the Form II and III DNA by-products,
the terminated reaction mixturewas subjected to ethidium bromide-cesium
chloride gradient centrifugation. Form I DNAwas purified as described
under "Experimental Procedures". The purity of isolated Form IDNA was
assessed by agarose gel electrophoresis (Figure 33, lane 4) andwas found to
contain almost exclusively Form I DNA95 %). Samples of the
heteroduplex U-23-mer/M13mp2op14 DNA primer extensionreaction
substrate (lane 2) and DNA reaction products from the primerextension
reaction (lane 3) were analyzed for comparativepurposes. Experiments were
then conducted to determine the susceptibility of theuracil-containing DNA
substrate to treatment with E. coli uracil-DNA glycosylase andendonuclease
IV (Ung/Endo IV) and to treatment with the restrictionendonucleases, EcoRI
and Smal (Figure 34).Isolated Form I DNA (200 ng)was treated with excess
E. coli Ung and Endo IV (lane 3), 10 units of EcoRI (lane4), or 10 units of SmaI201
Figure 32. Effect of T4 DNA polymerase concentrationon the efficiency of
the primer extension reaction. Pilot primer extension reaction mixtures(50
RD containing 3.3 pmol of M13mp2op14 DNA annealed to 5'-end
phosphorylated U-23-mer, 500 1.tM each of dATP, dTTP, dCTP, and dGTP, and
various amounts of T4 DNA polymerasewere prepared as described under
"Experimental Procedures". A 100-fold unitexcess of T4 DNA ligase over T4
DNA polymerase was included in each reaction. After incubation for 4 hat
37°C and termination by adjustment to 15 mM EDTA, samples (2 ttl, -275ng
DNA) from reactions containing 26.4, 6.6, 1.7, and 0.4 units of T4 DNA
polymerase (lanes 3-6, respectively)were analyzed by 0.8% agarose gel
electrophoresis. As controls, untreated M13mp2op14 DNA annealed to U-23-
mer (-150 ng) and a sample containing 2.5 jig of a 1-kb ladder (Gibco BRL)
were included as reference standards (lanes 2 and 1, respectively). The
location of ethidium bromide stained Form I, II, and III DNA bands and the
primed template are indicated byarrows.LANE
1 2 3 4 5 6
%Rd
' Form II
Form Ill
Form I
Primed Template203
Figure 33. Analysis of Form I DNA isolated by ethidium bromide/cesium
chloride gradient centrifugation. A primer extension reaction(3030 ill)
containing 200 pmol of M13mp2op14 DNA annealed to 5'-end
phosphorylated U-23-mer, 500 µM of each dNTP, 400units of T4 DNA
polymerase and 40,000 units of T4 DNA ligasewas performed and Form I
DNA was isolated by ethidium bromide-cesium chloridegradient
centrifugation as described under "Experimental Procedures". Samplesof the
terminated primer extension reaction mixture (-275 ng) and ethidium
bromide-cesium chloride purified Form I DNA (-100 ng)were analyzed by
0.8% agarose gel electrophoresis (lanes 3 and 4, respectively).As controls,
untreated M13mp2op14 DNA annealed to U-23-mer (-150 ng)and a sample
containing 2.5 gg of a 1-kb ladder (Gibco BRL)were included as reference
standards (lanes 2 and 1, respectively). The location of ethidiumbromide-
stained Form I and II DNA bands and the primed templateare indicated by
arrows.LANE
1 2 3 4
-4- Form II
-44-Form I
-4- Primed Template205
Figure 34. EcoRI and Smell restriction site analysisof Form I Ml3mp2op14
DNA. Samples (10 1.11) containing 200ng of M13mp2op14 (UT) Form I DNA
were digested with 10 units of EcoRI (lane 4) or 10 units of Smal (lane 5)for 1
h at 37°C and aliquots (2.550 ng) were analyzed by 0.8%agarose gel
electrophoresis. As controls, samples (50 ng) ofuntreated Form I DNA and
Form I DNA treated with E. coli Ung and EndoIV (lanes 2 and 3, respectively)
and 2.5 i.tg of a 1-kb ladder (NEB) (lane 1)were included as reference
standards. The location of ethidium bromide-stainedForm I, II, and III DNA
bands are indicated byarrows.I
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(lane 5) and reaction products were separated byagarose gel electrophoresis.
Mock-treated Form I DNA (lane 2) was analyzed to indicate the positionof
the unreacted DNA substrate. As expected, removal of the site-specificuracil
residue by Ung followed by apyrimidinic site incision by Endo IVconverted
the Form I DNA substrate into Form II DNA. No detectable Form I DNAwas
observed which verified that the substratewas completely susceptible to the
Ung/Endo IV treatment. Individual restriction digestion reactions of FormI
DNA with EcoRI and Smal generateda single linearized DNA reaction
product (Form III DNA) withan electrophoretic mobility that was roughly
equidistant between the 8 kb and 6 kb bands of the DNA ladder (lane 1). This
was consistent with the expected location of a linearized Ml3mp2op14 DNA
of 7,196 bp. No other linear DNA fragmentswere detected. These results
indicated that both restriction siteswere unique and provided corroborating
evidence for the introduction of thenew Smal restriction site by site-directed
mutagenesis.
4.1.3Detection of Uracil-DNA Repair in Human Glioblastoma U251
Whole Cell Extracts
Initial experiments were conducted using M13mp2op14 DNAto detect
uracil-DNA repair in human U251 whole cell extracts. Form I DNAwas
mixed with whole cell extract protein, incubated for varioustimes (0, 15, 60
min), DNA isolated, and reaction products analyzed byagarose gel
electrophoresis (Figure 35). Whereas the unreacted controlDNA substrate
was found to contain almost exclusively (?.95 %) Form I DNA, the amount of
Form I DNA was significantly reduced after incubation for15 min with
human whole cell extract. The majority of the DNA migratedas Form II
DNA molecules. While some Form II DNA remained after further
incubation (60 min), the amount of Form I DNA dramaticallyincreased,
suggesting that DNA repair had occurred. To establish whether the uracil
residue was removed during thisprocess, the DNA reaction products were
treated with excess E. coli Ung and Endo IV in orderto cleave uracil-208
Figure 35. Agarose gel electrophoresis ofM13mp2op14 DNA following
base excision DNA repair in humanU251 cell extracts. A standard BER
reaction mixture (600 IA containing 6µg ofM13mp2op14 (UT) DNA (Form
I) and 1.2 mg of human U251 whole cellextract protein was incubated at 30°C
and aliquots (150 pi)were removed at various times (0, 15 and 60 min). DNA
reaction products were then isolated, treated with(+) or without (-) E. coli Ung
and Endo IV, and analyzed by 0.8%agarose gel electrophoresis as described
under "Experimental Procedures". Theposition of Form I and Form II DNA
is indicated by horizontalarrows. Form I DNA that was resistant to Ung/Endo
IV treatment was isolated from the gelslice (bracket) by electroelution into 1
ml of TAE buffer and concentrated(-5-fold) using a Centricon-30
concentrator.ILUJOJ
(uRu) auqi 090991.0
Ai opu3/Bun +210
containing Form I DNA. Following this treatment, most of the Form I DNA
was shown to be resistant to Ung/Endo IV-mediated cleavage after the 60 min
repair reaction. Thus, the uracil residuewas apparently removed from a
significant fraction of the M13mp2op14 DNA substrate.
4.1.4Evidence for Uracil-Initiated Base Excision DNA Repair in
Human U251 Whole Cell Extracts
To establish the maximal extent of uracil-DNA repair, the
M13mp2op14 DNA substrate was incubated for various times with human
U251 whole cell extract (Figure 36A-B, lanes 9-14). Following the repair
reaction, the recovered DNA was treated in the absence (panel A)or presence
(panel B) of excess Ung and Endo IV prior to resolving the reaction products
on separate 0.8 % agarose gels. As a control, the DNA substrate was also
incubated with whole cell extract dialysis buffer in order toassess the stability
of Form I DNA to components of the base excision repair reaction and during
the DNA isolation procedure (Figure 36A, lane 8). Treatment with Ung/Endo
IV demonstrated that the substratewas completely susceptible to cleavage
(Figure 36B, lane 8). Untreated Form I DNAwas included as a reference
standard (Figure 36A-B, lane 7). Examination of DNA reaction products from
time points treated without Ung/Endo IV (Figure 36A, lanes 9-14) showa
direct correlation between theappearance of Form I DNA and the
disappearance of Form II DNA between 15 min and 90 min of incubation.
Again, this suggests that the U251 whole cell extractsare uracil-DNA repair
proficient. Inspection of DNA reaction products from time points after
treatment with Ung/Endo IV (Figure 36B, lanes 9-14) showa time-dependent
accumulation of Form I DNA thatwas resistant to cleavage and indicated that
removal of the uracil residue had occurred. In order to quantitate the
amount of DNA reaction products, internal standards containing
predetermined quantities of Form I and II M13mp2op14 DNAwere prepared
and separately analyzedon each agarose gel (panels A and B, lanes 1-5). Since
the ethidium bromide staining intensity of Form I and II DNA varied from211
Figure 36. Susceptibility of M13mp2op14 DNArepaired in human U251 cell
extracts to E. coli Ung and Endo IV treatment. A standardBER reaction
mixture (1050 pi) containing 10.5pg of M13mp2op14 (U.T) DNA, 2.1 mg of
U251 whole cell extract protein, and 210 i.tCi of [32P]dATPwas prepared.
Samples (150 pi) were removed after incubation for0, 15, 30, 45, 60, and 90
mM at 30°C (panels A and B, lanes 9-14, respectively) and eachreaction was
terminated by addition of 2000 units of Ugi followedby adjustment to 20 mM
EDTA. DNA was isolated, samples (5 pl)were mock treated (panel A) or
treated with E. coli Ung and Endo IV (panel B), andprepared for 0.8% agarose
gel electrophoresis as described under"Experimental Procedures". As a
control, M13mp2op14 (UT) DNA (1.5 pg)was incubated in the absence of
whole cell extract protein and treated withor without E. coli Ung and Endo IV
as described above (panel A and B, lane 8). Untreated M13mp2op14 (UT)
DNA (25 ng) and a sample containing 2.5µg of a 1-kb DNA ladder (Gibco
BRL) were also includedas reference standards (panels A and B, lanes 7 and 6,
respectively). The amount of Form I and II DNAdetected in lanes 7-14 was
measured relative to standards containing 100, 50, 25,12.5, and 6.25 ng each of
Form I and II DNA (panel A and B, lanes 1-5,respectively). The location of
ethidium bromide-stained Form I and II DNAare indicated by arrows.in ..... up OM
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gel to gel, it was necessary to includea complete set of internal standards with
each analysis. By using the ethidium bromide staining intensity of the
internal standards, individual standardcurves for Form I and II DNA were
generated to correlate the staining intensity of experimental samples with
defined quantities of DNA, as illustrated in Figure 37.
In order to associate the involvement of DNA repair synthesis with the
removal of the uracil target, the M13mp2op14 DNA substratewas similarly
incubated for various times with human U251 whole cellextract but in the
presence of [a-3213]c1ATP. The recovered DNA was treated with excess Ung
and Endo IV prior to resolving the reaction productson a 0.8 % agarose gel
(Figure 38A, lanes 2-7). As before, analysis of the ethidium bromide-stained
gel revealed the time-dependentappearance of an Ung/Endo IV-resistant
Form I DNA band. The percentage of Form I DNA detected in each lanewas
determined and is represented in Figure 38B. Asa control, the extent of
Ung/Endo IV cleavage of the M13mp2op14 DNA substratewas examined
(Figure 38A, lanes C and 1). Before Ung/Endo IV treatment, --95 % of the
DNA migrated as Form I whereas after treatment,no detectable Form I DNA
was observed (Figure 38B, columns C, (-) and (+)). This indicated the extent of
the substrate susceptibility to the Ung/Endo IVtreatment. Upon examination
of the products from the reaction timecourse, a linear rate (-3.61 fmol/min)
for the appearance of Ung/Endo IV-resistant Form I DNAwas observed
during the initial 30 min period. Thereafter, the rate appearedto plateau with
-50 % of the DNA being repaired. Autoradiography of theagarose gel
demonstrated that the Ung/Endo IV-resistant Form I DNA appeared with
concomitant incorporation of [3211dAMP (Figure 38C). Interestingly,
significantly less [3211c1AMP incorporationwas observed in the Form I DNA as
compared to Form II DNA though both represented -50 % of the total DNA
molecules after a 60 -min BER reaction (Figure 38C, lane 6). This resultwas
expected if Form I DNA was generated by BER involving DNA synthesis of
only one or a few nucleotides. While these results implythat uracil-DNA214
Figure 37. Standardcurves used for quantitation of Form I and II DNA.
The ethidium bromide staining intensity ofForm I and II DNA standards in
Figure 36B (lanes 1-5) were quantitated usinga Gel Documentation System.
The relative intensity of DNA bandscontaining 100, 50, 25, 12.5, and 6.25 ng of
Form I (open circles) and II (closed circles) DNAwere used to generate individual
standard curves for quantitating theamount (ng) of Form I and II DNA in the
experimental samples. Theaverage ethidium bromide staining intensity of
Form II DNA was -2.72-fold greater thanthat of an equal amount (ng) of
Form I DNA.20 40 60 80
DNA (ng)
Figure 37
100
215216
Figure 38. Analysis of reaction productsgenerated by uracil-DNA base
excision repair in human U251 cellextracts. (A) A standard BER reaction
mixture (1050 p.1) containing 10.5[t,g of M13mp2op14 (UT) DNA, 2.1 mg of
U251 whole cell extract protein, and 210 pCi of [32P]dATPwas prepared.
Samples (150 gl) were removed after incubation for0, 15, 30, 45, 60, and 90
min at 30°C (lanes 2-7, respectively) and eachreaction terminated by addition
of 2000 units of Ugi followed by adjustmentto 20 mM EDTA. DNA was
isolated, treated with E. coli Ung and EndoIV, and prepared for 0.8% agarose
gel electrophoresisas described under "Experimental Procedures". As a
control, M13mp2op14 (UT) DNA (1.5 tig)was mock treated without cell
extract and incubated with Ung and Endo IV (lane 1). Untreated
M13mp2op14 (UT) DNA (25 ng) anda sample containing 2.5 jig of a 1-kb
DNA ladder (Gibco BRL)were analyzed as reference standards (lanes C and M,
respectively). The location of ethidium bromide stainedForm I and II DNA
bands are indicated byarrows. (B) DNA bands detected by ethidium bromide
staining (A) were quantitatively measured usinga Gel Documentation
System and the percentage of Form I DNA ineach sample was determined.
Amounts of Form I and II DNAwere measured relative to standards (6.25-100
ng) analyzed on thesame gel. The percentage of Form I DNA observed before
(-) or after (+) E. coli Ung/Endo IVtreatment was determined after correcting
for the 2.72-fold greater ethidium bromidestaining intensity of Form II
compared to Form I DNA. Thepercentage of Form I DNA detected was
calculated by dividing the amount of Form IDNA (ng) by that of Form I plus
II DNA. (C) Autoradiographywas conducted after blotting [32P]DNA from the
0.8% agarose gel ontoa Gene Screen Plus Membrane. (D) A standard reaction
mixture (600 Al) was preparedas described under "Experimental Procedures"
except that 1000 units of Ugi was added before addition ofsubstrate. Samples
(150 111) were removed at 0, 60 and90 min, treated with (+) or without (-) E.
coli Ung/Endo IV as indicated, processed forgel electrophoresis, and data
analyzed as described above.A.
100
80
60
40
20
MC1 2 34 5 6 7 MC 1234 5 6 7
MIW.. .... - -
C.
Form II
Form I
B. D.
I
Ung/Endo IV ++++ +++
C C 0 15 30 45 60 90
Time (min)
-+-+-+
0 60 90
-,1218
repair involved limited DNA synthesis, these observations fell short of
establishing that repair was uracil-initiated through the base excisionrepair
pathway.
To determine if base excision repair was involved, Ugi proteinwas
added to the whole cell extract in order to specifically inactivate human
uracil-DNA glycosylase. In the absence of Ugi, U251 whole cell extracts
contained -8.6 units of Ung per mg of extract protein. However, the addition
of a 45-fold unit excess of Ugiover Ung reduced the level of Ung activity to
the limit of detection in the in vitroassay (data not shown). When the base
excision repair assay was repeated in thepresence of excess Ugi, the vast
majority of recovered Form I DNAwas sensitive to Ung/Endo IV cleavage
(Figure 38D). This indicated thata Ugi-sensitive uracil-DNA glycosylase was
initiating most of the repair and strongly suggested the involvement of the
BER pathway. However,a small amount of Form I DNA corresponding to 3.7
and 9.4 % of the substrate was insensitive to Ung/Endo IV cleavage after60
and 90 min of BER reaction, respectively. Upon examination of theproducts
from the reaction timecourse, an initial rate (-0.58 fmol/min) for the
appearance of Ung/Endo IV-resistant Form I DNA was observed between 60
and 90 min. This implies thatsome repair may have occurred without the
involvement of a Ugi-sensitive uracil-DNA glycosylase.
4.1.5Analysis of Uracil-Initiated DNA Repair Synthesis in Human
U251 Whole Cell Extracts
In order to localize the repair synthesison M13mp2op14 DNA, [a-
32P]dATPwas added to human U251 whole cell extracts and standard BER
reactions were performed. At various times, reaction productswere isolated
and digested with the restriction endonuclease Hinfl, whichwas expected to
generate a 529-bp DNA fragment that contained the uracil target (Figure 39A).
Following the Hinfl digest, DNA fragmentswere resolved by nondenaturing
polyacrylamide gel electrophoresis and autoradiographywas performed to
detect [32P]dAMP incorporation (Figure 39B). While [32P]dAMPincorporation219
Figure 39. Analysis of uracil-initiated base excisionrepair-specific DNA
synthesis in human U251 cell extracts. (A) Map of M13mp2DNA
indicating the location of the uracil residue (U)at position 78 in the (-) strand
of the lacZa gene. The hash marksrepresent Hinfl restriction endonuclease
recognition sites, and the size in base pairs (bp) of eachcorresponding DNA
fragment is indicated. (B) After carryingout the base excision repair reactions
described in Figure 38A, DNAwas isolated and samples (2.5-50 ng) were
removed for digestion with 5 units of Hinfl for 60 minat 37°C. DNA
restriction fragments were resolved by 5% nondenaturingpolyacrylamide gel
electrophoresis from BER reactions conductedat 0, 15, 30, 45, 60 and 90 min
(lanes 1-6, respectively) and 32P- labeled DNAwas detected by autoradiography.
The location of the uracil-containing DNA fragment(U-529 bp) and other
fragments are indicated byarrows. (C) Two BER reaction mixtures (150 IA)
were prepared as described under "Experimental Procedures"except that one
reaction mixture contained Ml3mp2op14 DNA withan AT basepair at
position 78 (lane 1) and the other contained M13mp2op14DNA substrate
with a UT mispair (lane 2). After incubation for60 min at 30°C, and
isolation of reaction products, Hinfl endonucleasereactions were conducted.
Polyacrylamide gel electrophoresis and autoradiographywere performed as
described above. (D) The amount of [32P]dAMPincorporation into DNA
fragments of 253 (striped bars), U-529 (black bars),261 (white bars), and 486
(stippled bars) base pairs in lengthwas determined using a Phosphor Imager.
The relative intensity of each designated fragment( and U-529 was
measured at the time points depicted in (B, lanes 2-6)and plotted after
subtracting background values.12 0
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was detected in many of the fragments, the 529-bp fragment showed
preferential incorporation that accumulated ina time-dependent manner.
Control reactions were conducted with both M13mp2op14DNA containing
an AT base pair or a UT mispair at position 78 of the lacZagene to
determine if incorporation into other fragments resulted fromnonspecific
DNA synthesis (Figure 39C). As before, preferentialincorporation was
observed specifically into the 529-bp fragment but only whencontaining the
uracil residue. Corresponding non-uracil-containing fragmentsbetween both
substrates appeared to accumulate similar levels of [32P]dAMPincorporation.
The level of specificitywas evaluated after quantitating the amount of
rIlciAMP incorporation into individualDNA fragments (Figure 39D).
During the reaction timecourse, the relative amount of incorporation was
compared for four DNA fragments (253-, U-529-, 261-, and 486-bp).A 5.2- to
7.6-fold greater [32P]dAMP incorporationwas observed in the U-529 by
fragment than in a similar sized 486-bp fragment locatedon the opposite side
of the M13mp2op14 DNA molecule. Similarly, only lowlevels of
incorporation were detected for the 253- and 261-bp fragments thatflanked
either side of the uracil-containing 529-bp fragment.When taken together,
these results indicate that the vast majority ofDNA synthesis on the 529-bp
fragment was most likely uracil initiated andwas limited to this fragment.
Thus, most of the DNA synthesis observedwas consistent with the
occurrence of a uracil-initiated base excision repair mechanism.
DNA repair synthesis was further characterized to determinewhether
rildAMP incorporation occurredon the (-) strand, (+) strand, or both DNA
strands. Standard BER reactionswere conducted in the presence, of [a-
32P]dATPand DNA reaction productswere then digested with restriction
endonucleases EcoRI and Smal. As illustrated in Figure28, the resulting
restriction fragment containeda 44- and 40-nucleotide sequence
corresponding to the (+) and (-) strands, respectively.This allowed the uracil-
containing (-) strand to be distinguished from the (+)strand based on the size222
of the single-stranded DNA fragments.When restriction endonuclease
digested DNA productswere analyzed by denaturing polyacrylamide gel
electrophoresis, incorporation of [32P]dAMPwas observed to accumulate
during the time course in association with the40-mer fragment (Figure 40A,
lanes 1-6 left). No incorporationwas observed into the 44-mer fragment. To
determine whether the uracil residuewas removed from the 40-mer during
DNA repair synthesis, a duplicateset of [32P]DNA samples was treated with E.
coli Ung and Endo IV following restriction endonucleasedigestions. As
before, rIldAMP incorporationwas observed in the 40-mer at nearly the
same level and no smaller 32P- labeled fragmentswere detected as a result of
cleavage at the uracil site (Figure 40A, lanes1-6 right). As a control, the
activity of both Ung and Endo IVwas verified using a duplex uracil-
containing 34-mer substrate (Figure 40B). Collectively, theseresults indicate
that DNA repair synthesiswas directed exclusively to the (-) strand containing
the uracil target.
4.1.6Evidence for Uracil-Initiated Base Excision DNA Repairin
Human LoVo Whole Cell Extracts
To determine if mismatch repair in human whole cellextracts
influenced the rate of uracil-DNA repair, theexperiments described above
were repeated using whole cell extracts generated from human LoVo cells
that are defective in the mismatchrepair protein, hMSH2 (27, 282). The
M13mp2op14 DNA substratewas incubated for various times with human
LoVo whole cell extract supplemented with [a- 32P]dATPin the presence or
absence of Ugi, treated withexcess Ung and Endo IV, and DNA reaction
products were analyzed by 0.8agarose gel electrophoresis (Figure 41).
Analysis of the ethidium bromide-stainedgel shows a time-dependent
increase in Ung/Endo IV-resistant Form I DNAincubated in the absence of
Ugi (Figure 41, lanes 4-9). A similarpattern was also observed for LoVo
whole cell extract incubated in thepresence of Ugi (Figure 41, lanes 10-15)
albeit at a much reduced level. Thepercentage of Form I DNA at each time223
Figure 40. Strand specificity of uracil-DNA repair synthesis by human
U251 cell extracts. (A) A standard BER reaction mixture (700 ill) containing
7 lig of M13mp2op14 (UT) DNA, 1.4 mg of U251 whole cell extract protein,
and 140 .tCi of [32P]dATP was prepared. Samples (100 fil)were removed after
incubation for 0, 15, 30, 45, 60 and 90 min at 30°C (lanes 1-6, respectively), the
reaction terminated by addition of 2000 units of Ugi followed by adjustment
to 20 mM EDTA, and DNA was isolated as described under "Experimental
Procedures". DNA samples (8-400 ng) were then simultaneously digested
with 4 units each of EcoRI and SmaI for 60 min at 25°C. After terminating the
restriction endonuclease reaction, equal volumes were removed, treated with
(+) or without (-) E. coli Ung/Endo IV, and the [32P]DNA productswere
analyzed by denaturing 12% polyacrylamide/8.3 Murea gel electrophoresis as
described under "Experimental Procedures". The location of the 40-mer
corresponding to the (-) strand EcoRI/SmaI restriction fragment is indicated
on the autoradiogram by an arrow. (B) The 5'-end 32P-labeled U-34-mer was
annealed to a complimentary oligonucleotide (A-34-mer) forminga [32P]U /A-
34 -mer duplex, as previously described (16, 150). Three samples of [32IV/A-
34-mer (6 gl, -20 ng) were either mock treated (lane 1), treated with E. coli Ung
(lane 2), or treated with Ung and Endo IV (lane 3)as described under
"Experimental Procedures". Following these reactions, [32P]DNA products
were analyzed on the identical denaturing 12% polyacrylamide/8.3 M urea gel
described above. The location of the DNA substrate (34-mer) and product (15-
mer) are located by arrows on the autoradiogram.225
Figure 41. Analysis of reaction products generated by uracil-DNAbase
excision repair in human Lo Vo cell extracts. Two standard BERreaction
mixtures (600 gl) containing 6gg of M13mp2op14 (UT) DNA, 1.2 mg of
LoVo whole cell extract protein and 120 !Xi [32P]dATPwere prepared as
described under "Experimental Procedures"except that one reaction mixture
was supplemented with 1000 units of Ugi (+) and the other containedno Ugi
(-) prior to the addition of substrateas indicated. Samples (100 gl) were
removed after 0, 15, 30, 45, 60 and 90 min at 30 °C from BERreaction mixtures
incubated in the absence of Ugi (lanes 4-9, respectively) and thepresence of
Ugi (lanes 10-15, respectively). Reactionswere terminated, DNA was isolated,
treated with E. coli Ung and Endo IV, and prepared for0.8% agarose gel
electrophoresis as described under "Experimental Procedures".As a control,
M13mp2op14 (UT) DNA (1 gg)was mock treated without cell extract and
incubated with Ung and Endo IV (lane 3). UntreatedM13mp2op14 (UT)
DNA (100 ng) and a sample containing 2.5gg of a 1-kb DNA ladder (Gibco
BRL) were analyzed as reference standards (lanes2 and 1, respectively). The
location of ethidium bromide-stained Form I and II DNAbands are indicated
by arrows.-Ugi +Ugi
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point was determined and was represented in Figure 42. The results donot
appear to differ significantly from those observed for uracil-DNA repair in
U251 whole cell extracts (Figure 38B and D). These results stronglysuggest
that uracil-DNA repair in LoVo whole cell extracts is predominantly
mediated through the base excision repair pathway by uracil-DNA glycosylase.
Under this condition where mismatch DNA repairwas presumably defective,
repair was again sensitive to the addition of Ugi. Thus, as previously detected
in U251 whole cell extracts, some repairwas initiated by a Ugi-insensitive
repair pathway that was neither dependenton uracil-DNA glycosylase or the
hMSH2 mismatch repair protein. On the assumption that the mechanism of
Ugi insensitive uracil-DNA repair was identical between U251 and LoVo
cells, the results suggest that the mismatch repair pathwaywas likely not
involved and does not significantly contribute to uracil-DNA repair in
human whole cell extracts. Upon examination of the reaction products after
incubation for various times in the absence of Ugi,an initial linear rate of 1.64
fmol/min for the appearance of Ung/Endo IV resistant Form I DNAwas
observed after a lag time of 15 minutes. The maximal extent of repairwas
determined to be -44 %. On the other hand, examination of Ung/Endo IV
resistant products from the LoVo reactions incubated in thepresence of Ugi
showed an initial linear rate of 0.30 fmol/min for theappearance of Form I
DNA. Again, a short lag periodwas observed and -15 % of the DNA was
repaired after 90 min. The observed rate of repair for the Ugi-insensitive
uracil-DNA repair reaction was -3-fold lower than that observed for uracil-
DNA BER in LoVo whole cell extracts.
To assess the involvement and the extent of DNA repair synthesis
between the Ugi sensitive and insensitive uracil-DNA repair pathways,
autoradiography of the agarose gelwas performed. The results illustrated that
in either case, Ung/Endo IV-resistant Form I DNA appeared withconcurrent
incorporation of [32P]dAMP (Figure 43). The extent of [32PIdAMP
incorporation per fig of repaired Form I DNA in the BER reaction lacking Ugi
reached a maximum after 30 min whereas [32P]dAMPincorporation in the228
Figure 42. Quantitation of reaction products generated by uracil-DNAbase
excision repair in human LoVo cell extracts. DNA bands detected by
ethidium bromide staining in Figure 41were quantitated by using a Gel
Documentation System and the percentage of Form I DNA fromreactions
supplemented with (striped bars)or without (black bars) Ugi was determined for
each time point. The amount of Form I and II DNAwas measured relative to
standards (6.3-100 ng) analyzedon the same gel. The percentage of Form I
DNA observed after E. coli Ung/Endo IVtreatment was determined after
correcting for the -2.72-fold greater ethidium bromide stainingintensity of
Form II compared to Form I DNA. Thepercentage of Form I DNA detected
was calculated by dividing the amount of Form I DNA (ng) by that of Form I
plus II DNA.100
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Figure 43. Analysis of [32P]dAMP incorporation into reactionproducts
generated by uracil-DNA base excision repair in human LoVo cellextracts.
Autoradiography was performed after blotting [32P]DNA from the0.8%
agarose gel described in Figure 41 onto a Gene Screen Plus nitrocellulose
membrane. The location of Form I and II [32P]DNAreaction products isolated
after 0, 15, 30, 45, 60 and 90 min from standard LoVo BERreaction mixtures
incubated in the absence of Ugi (lanes 1-6)or the presence of Ugi (lanes 7-12)
are indicated by arrows.232
BER reaction containing Ugi appeared to plateau after 45 min (Figure 44).The
maximal amount of [32P1dAMP incorporation observed in Form I DNA
generated by the Ugi insensitive repair reactionwas approximately two-fold
greater than that of the Ugi sensitive uracil-DNA glycosylase initiated BER
pathway. This result suggested that the Ugi-insensitive uracil-DNA repair
pathway involved more extensive DNA repair synthesis than that initiated
by uracil-DNA glycosylase.
4.1.7Analysis of Uracil-Initiated DNA Repair Synthesis in Human
LoVo Whole Cell Extracts
In order to localize the repair synthesison M13mp2op14 DNA, [oc-
'IldATP was added to human LoVo whole cellextracts in the presence and
absence of Ugi and standard BER reactionswere performed. Reaction
products were isolated at various times, digested with the restriction
endonuclease Hinfl, and DNA fragmentswere resolved by nondenaturing
polyacrylamide gel electrophoresis and subjected to autoradiographyto detect
[32P]dAMPincorporation (Figure 45). Preferential [32P]dAMP incorporation
was observed in a time-dependent manner into the 529-bp DNA fragment
that contained the uracil residue both in the absence (lanes 1-6) andpresence
(lane 7-12) of Ugi. The amount of [32P]dAMP incorporationwas significantly
reduced in all other DNA fragments for both reactions and appearedto
accumulate similar low levels of incorporation. The level of specificitywas
evaluated after quantitating the amount of [32P]dAMP incorporation into
individual DNA fragments (253-, U-529-, 261-, and 486-bp) and is represented
for Ugi-sensitive and -insensitive DNA repair products (Figure 46Aand B,
respectively). An 8.7- to 19.0-fold greater level of [32P]dAMP incorporation
was observed into the U-529-bp fragment than into the 486-bp fragment
located on the opposite side of the M13mp2op14 DNA substrate forreaction
products generated in the absence of Ugi. A similar comparison ofreaction
products generated in thepresence of Ugi showed a 3.1- to 12.1-fold greater
level of [32P]dAMP incorporation. Bothsets of reaction products revealed233
Figure 44. Quantitation of InlidAMP incorporationinto Form I DNA
generated by uracil-DNA base excision repair in humanLoVo cell extracts.
The amount of [3213]dAMP incorporated into FormI DNA for the BER
reactions described in Figure 41was determined by using a Phosphorlmager.
The relative intensity of Form. I DNAwas measured from BER reactions
conducted for 0, 15, 30, 45, 60 and 90 min in the absence ofUgi (open circles) or
the presence of Ugi (closed circles) and background valueswere subtracted. The
relative intensity of Form I [32P]DNAwas divided by the amount of Form I
DNA (ng) as determined by ethidium bromide stainingintensity and the ratio
of relative intensity/jig Form I DNAwas plotted versus time.F
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Figure 45. Analysis of base excision repair DNA synthesisassociated with
the uracil-containing DNA target using humanLoVo cell extracts. After
conducting the BER reactions described in Figure 41,Ml3mp2op14 DNA was
isolated and samples (2.5 p.1, -50 ng)were removed for digestion with 5 units
of Hinfl for 1 h at 37°C. DNA restriction fragmentswere resolved by 5%
nondenaturing polyacrylamide gel electrophoresis from BERreactions
conducted for 0, 15, 30, 45, 60, and 90 min in the absence ofUgi (lanes 1-6,
respectively) or the presence of Ugi (lanes 7-12, respectively) and 32P-labeled
DNA was detected by autoradiography. The location of theuracil-containing
fragment (U-529 bp) and other Hinfl DNA fragmentsare indicated by arrows.
The uracil-containing fragment (U-529) and designated fragments(*) were
quantitated.237
Figure 46. Quantitation of base excision repair DNA synthesis associated
with the uracil-containing DNA target using human LoVo cell extracts.
After conducting the BER reactions described in Figure 41 and resolving Hinfl
DNA restriction fragments by 5% nondenaturing polyacrylamide gel
electrophoresis, the amount of [32P]dAMP incorporation into DNA fragments
of 253 (striped bars), 529 (black bars), 261 (white bars), and 486 (stippled bars) base
pairs (bp) in length were determined by using a Phosphor Imager. The
relative intensity of each fragment was measured at the time points depicted
for BER reactions containing LoVo cell extracts conducted in the absence of
Ugi (A) or the presence of Ugi (B) and plotted after subtracting background
values.5
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only low levels of incorporation into the 253-bp and 261-bpfragments
flanking the uracil-containing 529-bp DNAfragment and indicated that the
vast majority of DNA synthesis was uracil-initiated and limitedto this
fragment. As was determined for U251 whole cellextracts, most of the DNA
synthesis observed was consistent witha uracil-initiated base excision repair
mechanism.
DNA repair synthesis was further characterizedto determine whether
[32P]dAMP incorporation occurredon the (-) strand, (+) strand or both DNA
strands. Therefore two standard BER reaction mixturescontaining [a-
32P]dATP were supplemented withUgi as indicated, isolated DNA reaction
products were digested with the restriction endonucleasesEcoRI and Smal,
and products were analyzed by denaturingpolyacrylamide gel electrophoresis
(Figure 47). Autoradiography of the gel revealeda time-dependent
accumulation of [3213]cIAMP into the 40-n-ter fragment forthe BER reaction
lacking Ugi (Figure 47, lanes 1-6). Some variationsin sample loading and
complete digestion with EcoRI and SmaI do apply.However, a reduced
amount of [32P]dAMP incorporationwas observed into the 40-mer fragment
for the BER reaction supplemented withUgi (Figure 47, lanes 7-12). Under
both reaction conditions,no incorporation was observed into the 44-mer
fragment. Together, these results indicatedthat uracil-DNA repair synthesis
was directed exclusively to the uracil-containing (-) strand for Ugi-sensitive
and -insensitive repair pathways.
4.1.8Comparison of Uracil-Initiated Base Excision Repair Between
Human U251 and LoVo Whole Cell Extracts
To compare the amount of nonspecific DNA synthesisintroduced by
human U251 or LoVo whole cellextracts into the M13mp2op14 DNA
substrates, [a-32P]cIATPwas added to two sets of standard BER reactions
containing either M13mp2op14 DNA withan MT base pair or a UT mispair
at position 78 of the lacZa gene. Reactionswere terminated after 45 and 60240
Figure 47. Strand specificity of uracil-DNA repair synthesis by human
LoVo cell extracts. After conducting the BER reactions described in Figure
41, DNA was isolated and samples (4 111, -200 ng)were removed for
restriction analysis with Smal and EcoRI. Samples. from BER reactions
containing LoVo cell extracts were conducted for 0, 15, 30, 45, 60, and 90 min
in the absence of Ugi (lanes 1-6, respectively) or thepresence of Ugi (lanes 7-
12, respectively). After digestion with 10 units of Smal for 1 h at 25°C and 10
units of EcoRI for 1 h at 25°C, the [32P]DNA products were analyzed by
denaturing 12% polyacrylamide/8.3 Murea gel electrophoresis as described
under "Experimental Procedures." The location of the 40-mer corresponding
to the (-) strand EcoRI/Smal restriction fragment is indicated on the
autoradiogram by an arrow.-41- 40-mer
-Ugi +Ugi
. - 411 IMM ame .......MEV .1=1041IND
as. am Mb WM
123456 789101112
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min for reactions containing LoVo and U251 whole cellextract protein,
respectively. Following the BER reaction, the productswere digested with the
restriction endonuclease Hinfl, DNA fragmentswere resolved by
nondenaturing polyacrylamide gel electrophoresis, and autoradiographywas
performed to detect rIldAMP incorporation (Figure 48). As expected,
preferential incorporation was observed specifically into the 529-bpfragment
and was dependentupon the presence of the uracil residue for reactions
containing both U251 and LoVo whole cell extracts (Figure 48, lanes2 and 4,
respectively). This was consistent with theoccurrence of a uracil-initiated
base excision repair mechanism. Correspondingnon-uracil-containing
fragments between both substrates appearedto accumulate similar levels of
[32P]dAMPincorporation when incubated with either U251or LoVo whole
cell extract. However, the amount of [32P]dAMPincorporation into non-
uracil-containing fragments by U251 extracts into either substratewas
apparently greater than that observed for LoVoextracts. Therefore, the level
of nonspecific DNA synthesis between U251 andLoVo was compared after
quantitating the amount of [32P]dAMP incorporation into designatedDNA
restriction fragments from the M13mp2op14 (AT) and(UT) DNA substrates
(Figure 49). Incubation of M13mp2op14 (AT)DNA with U251 whole cell
extracts resulted in a 3.7- to 5.2-fold greater level of [32P]dAMPincorporation
into the 253-, 529-, 261-, and 486-bp DNA fragmentsas compared to LoVo
extracts. In a similar comparison,a 3.4- to 9.9-fold greater level of [32P]dAMP
incorporation by U251 was observed into DNA fragments of253-, 261-, and
486-bp in length generated from the M13mp2op14(UT) DNA substrate.
However, the level of incorporation into the 529-bpfragment containing the
uracil target was observed to be similar (-1.4-foldgreater [32P]dAMP
incorporation by U251) between U251 and LoVoextracts. Non-uracil
containing Hinfl DNA fragments exhibiteda 4.8- to 6.6-fold reduced level of
[32PJdAMPfollowing incorporation and repair by U251extracts. For LoVo
extracts, this value exhibited a 16.2- to 42.6-fold reduction. Theseresults243
Figure 48. Comparison of specific and nonspecific DNA synthesis
associated with uracil-initiated base excision repair in human U251 and
Lo Vo cell extracts. Standard BER reaction mixtures (200 111) containing 0.4
mg of human U251 (lanes 1 and 2) or LoVo (lanes 3 and 4) whole cell extract
protein, 2 jig of M13mp2op14 (AT) DNA (lanes 1 and 3) or M13mp2op14
(UT) DNA (lane 2 and 4), and 40 jxCi of [32P]dATP were prepared. Samples
containing U251 or LoVo whole cell extract protein were incubated at 30 °C
for 60 min or 45 min, respectively. Each reaction was terminated with 2000
units of Ugi protein followed by adjustment to 20 mM EDTA, DNA was
isolated, and samples (2.5-50 ng) were removed for digestion with 5 units
of Hinfl for 1 h at 37°C. DNA restriction fragments were resolved by 5%
nondenaturing polyacrylamide gel electrophoresis and 32P- labeled DNAwas
detected by autoradiography. The location of the uracil-containing fragment
(U-529 bp) and other Hinfl DNA fragments are indicated by arrows. The uracil-
containing fragment (U-529) and designated fragments (*) were quantitated.245
Figure 49. Quantitation of specific and nonspecific DNA synthesis
associated with uracil-initiated base excision repair in human U251 and
LoVo cell extracts. The amount of rliclAMP incorporation into DNA
fragments of 253 (striped bars), 529 (black bars), 261 (white bars), and 486 (stippled
bars) base pairs (bp) in length from the autoradiogram depicted in Figure48
were determined by using a Phosphor Imager. The relative intensities of each
designated fragment from U251 and LoVo BER reaction mixturescontaining
the M13mp2op14 (AT) DNAor M13mp2op14 (UT) DNA substrates were
plotted after subtracting background values.r7=1r-d-ir-r-F71,
U251+A/TU251+urr LoVo +AITLoVo+U/T
Figure 49
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indicate a decreased level of nonspecific DNA synthesis by LoVo whole cell
extract preparations. As previously observed, FII1dAMP incorporation
profiles for both extract preparationsare consistent with a uracil-initiated base
excision repair mechanism.
To determine if the amount of nonspecific [3211dAMP incorporation
into designated Hinfl restriction fragmentswas influenced by the presence of
Form II DNA repair intermediates,a standard BER reaction containing
Ml3mp2op14 (UT) DNA and Lo Vo whole cell extract proteinwas performed
and the recovered DNAwas divided into two aliquots. One sample was
designated the Form I/II DNA mixture. The second samplewas treated with
Ung/Endo IV and Ung/Endo IV-resistant Form I DNAwas purified by
agarose gel electrophoresis. Both samples were subsequently digested with
Hinfl and analyzed for rIldAMP incorporation,as described above. For
comparative purposes, the relative intensity of the 529-bp fragment from the
Form I/II DNA mixture (38,000 arbitrary units)was normalized to that of the
529-bp fragment from the isolated. Form I DNA (156,000 arbitrary units).
Hence, the relative intensities of designated fragments (253-, 261-,and 486-bp)
from the Form I/II DNA mixturewere multiplied by the normalization
constant (4.1) and plotted (Figure 50). A 3.0- to 3.7-fold increase in nonspecific
r2PRIAMP incorporation into DNA fragmentsof 253-, 261-, and 486-bp in
length was observed for the. Form I/II DNA mixtureas compared to the
isolated Form I DNA. These resultssuggest that the extent of DNA synthesis
associated with uracil-initiated repair into the 529-bp fragmentwas previously
underestimated due to thepresence of unrepaired or repair intermediate
DNA molecules that remainedas Form II DNA.248
Figure 50. Quantitation of nonspecific DNA synthesis associated with
Form II DNA present in Form I/II DNA mixtures. Two standard BER
reaction mixtures (500 pl) containing 5 lig of Ml3mp2op14 (UT) DNA, 1mg
of LoVo whole cell extract protein, 100 tiCi rPlclATP, and 1000 units of Ugi
were prepared and incubated for 1 h at 30°C. Reactions were terminated by
addition of 2000 units of Ugi followed by adjustment to 20 mM EDTA. DNA
was isolated and treated with or without E.coli Ung and Endo IV. Untreated
M13mp2op14 (UT) DNA was designated Form I/II DNA mixture. Repaired
Form I DNA from the sample treated with Ung and Endo IVwas isolated by
0.8% agarose gel elctrophoresis as described under "Experimental Procedures"
and designated Form I DNA. Samples of Form I/II DNA mixture and Form I
DNA (2.5 p1, -50 ng) were removed for digestion with 5 units of Hinf I for 1 h
at 37°C. DNA restriction fragments were resolved by 5% nondenaturing
polyacrylamide gel electrophoresis and 3213-labeled DNAwas detected by
autoradiography. The amount of [32P]clAMP incorporated into DNA
fragments of 253 (striped bars), 529 (black bars), 261 (white bars), and 486 (stippled
bars) base pairs (bp) in lengthwere determined by using a Phosphor Imager.
The relative intensities of the 529 by fragment from each samplewere
normalized and normalization constantswere generated for each sample set.
The relative intensity of DNA fragments of 253, 486, and 261 base pairs in
length were adjusted by multiplying the relative intensity of each with the
derived normalization constant and valueswere plotted.1
0
15
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Figure 50
Form I
249250
4.1.9Mutational Frequency of Base Excision DNA Repair Synthesis in
Human U251 Whole Cell Extracts
Using the M13mp2op14 lacZa DNA-based reversion assay, the fidelity
of BER synthesis was examined in U251 whole cell extracts. Standard BER
reactions containing either M13mp2op14 DNA with a UT mispair or an AT
base pair at position 78 were conducted and Ung/Endo IV resistant Form I
DNA was purified from the reaction products. DNA was subsequently
transfected into either E. coli NR9162 (mutS-) or the isogenic strain MC1061
(mutS+) for comparative purposes. The reversion frequency of opal codon 14
was determined by the analysis of M13 plaque phenotype color as a result of
proficient or deficient a-complementation detected on host indicator plates.
The appearance of light or dark blue plaqueswas indicative of putative
mismatches at the opal codon introduced during inaccurate DNA repair
synthesis. Background reversion frequencies for M13mp2op14 (T) DNA
substrate incubated in the absence of whole cell extract proteinwere
determined to be 0.079 x 10-4 and 0.78 x 104 when transfected into E. coli
MC1061 and NR9162 cells, respectively (Table 7). The observed -10-fold
difference in reversion frequencywas attributed to the correction of
endogenous errors by E. coli MC1061 cells capable of conducting methyl-
directed mismatch repair. The background reversion frequency for
M13mp2op14 (UT) incubated in the absence of whole cell extract proteinwas
also determined and yielded significantly higher reversion frequencies of 4.6x
10' and 2.1 x 104, respectively, when transfected into MC1061 and NR9162
cells. The -2-fold difference in reversion frequency observed between
MC1061 and NR9162 cells was also attributed to methyl-directed mismatch
repair by E. coli MC1061. However, it must be noted that these reversion
frequencies do not directly reflect the true a-complementation status of the
substrate since the (-) strand DNA correctly encodesa wild-type lacZa gene.
Additionally, the presence of uracil in transformed DNA would elicit in vivoTable 7
Frequency of Mutations Produced by Uracil-Initiated Base Excision Repair in Human U251 Whole Cell Extracts
Standard base excision DNA repair reaction mixtures (500 Al) were prepared containing 1 mg of human U251 whole cell extract protein and
either 5 jig of Ml3mp2op14 (UT) or (AT) DNA. After incubation at 30°C for 1 h, reactions were terminated, DNA products recovered, and
Form I DNA that was resistant to E. coli Ung/Endo IV treatment was isolated by 0.8% agarose gel electrophoresis as described under
"Experimental Procedures". Form I DNA was then transfected into E. coli NR9162 and MC1061 cells as indicated below and the M13mp2 lacZa
DNA-based reversion assay was performed as described by Kunkel (130).
DNA
(_/ 4.)b
NR9162 (mutS") MC1061mutS+)
Plaques Scored Plaques Scored
Reversion Reversion
Total Blue Frequency' Total Blue Frequency
(x10') (x104)
Control'
A/T 216,840 17 0.78 251,680 2 0.079
U/T 176,540 81
U251 WCE
A/T 532,480
U/T 150,705
U251 WCE + Ugid
U/T 350,428 993 28.3 59,748
eversionequencies were caate. .y mg t e num er olue p agues scorey the tota number oue p us color ess p agues. Revertants inc udear
blue and light blue phenotypes.
bDenotes the (-) and (+) strand nudeotide at the target site.
Control reaction mixtures (500 a contained 5 lig of Ml3mp2op14 (UT) or (AT) DNA and substituted whole cell extract (WCE) dialysis buffer (25 mM Hepes-
KOH, 100 mM KC1, 2 mM DTT, 12 mM MgCl 1 mM EDTA, and 17% (w/v) glycerol adjusted to pH 7.9) instead of human wholecell extract protein in standard
BER reaction mixtures.
A standard reaction mixture (500 ul) was prepared as described under "Experimental Procedures" except that 1000 units of Ugi (-100-fold unit excess over
whole cell extract UDG) was added before the substrate addition.
13
78
4.6 211,770 44 2.1
0.24
5.2
309,218
150,355
8
19
162
0.26
1.3
27.1252
BER by the transfected host cells. Thus, the observed increase in reversion
frequency relative to the M13mp2op14 (AT) substrate is nota direct or
accurate measurement of the background reversion frequency of the
M13mp2op14 (UT) substrate but a measurement of a-complementation
influenced by unrepaired uracil residues in the (-) strand and the fidelity of in
vivo uracil-initiated BER in the transfected host.
Experiments were subsequently conducted to measure the fidelity of
uracil-initiated DNA repair synthesis using U251 whole cell extracts in the
presence or absence of Ugi. When M13mp2op14 (UT) DNA was incubated
with U251 whole cell extract in the absence of Ugi and processed,a reversion
frequency of 5.2 x 104 was observed after transfection of repaired Form I DNA
into E. coli NR9162 (mutS) cells. This valuewas -22-fold greater than that of
M13mp2op14 (T) DNA incubated with U251 whole cell extract. As
expected, this value was reduced (-4-fold) when thesame repaired Form I
DNA was transfected into E. coli MC1061 cells capable of removing mispairs
from the unmethylated (-) strand. These resultsare indicative of nucleotide
misincorporation events associated with uracil-initiated base excision repair
in human whole cell extracts and providea measurement of DNA repair
synthesis fidelity. When M13mp2op14 (UT) DNAwas incubated with U251
whole cell extract protein in thepresence of Ugi, a reversion frequency of 28.3
x 10-4 was observed following transfection of repaired Form I DNA into E. coli
NR9162 (mutS). This value was -5-fold higher than that of M13mp2op14
(UT) DNA repaired by U251 whole cell extract in the absence of Ugi and-36-
fold greater than that of the U251 whole cell extract treated M13mp2op14
(AT) DNA control. Interestingly, transfection of thesame repaired Form I
DNA into E. coli MC1061 yieldeda nearly identical reversion frequency of 27.1
x 10-4 and implied that endogenous errors introduced by human whole cell
extracts were not repaired by the methyl-directed mismatch repair in the
transfected host. These results indicated that the Ugi-insensitiverepair253
pathway in U251 cells is more errorprone than that of the uracil-DNA
glycosylase-initiated uracil-base excision repair pathway.
4.1.10Mutational Spectrum of Human U251 Cells
Mutational analysis was performedon individual revertant M13 phage
DNA to define the type of misincorporation that occurred during uracil-
initiated base excision DNA repair synthesis in U251 whole cellextracts.
Single-stranded DNA was isolated and sequenced from the 78 blue plaques
obtained from repaired DNA produced in human U251 whole cellextracts
incubated in the absence Ugi. The DNAsequence analysis of three revertants
representing each of the three possible nucleotide misincorporation eventsat
the site of the uracil are shown in Figure 51A-C. The distribution and
specificity of single-base substitutions located within the opal codonare
shown in Figure 52 and Table 8, respectively. Seventy-four (95 %) of the
mutations occurred at the first nucleotide of the opal codon whileone
mutation (1 %) was detected at the second nucleotide position and three (4 %)
were observed at the third nucleotide position. Thus, almost all of the base
substitutions occurred at the location of the uraciltarget. Interestingly, the
major class of these base substitutionswere transversion mutations (--94 %)
and were nearly equally divided between T to G and Tto A changes in the (+)
strand template. Only four mutationswere scored as T to C transitions at this
site. These results define the uracil-initiated repair-mediated mutation
spectrum at this target site.
4.1.11Mutational Frequency of Base Excision DNA Repair
Synthesis in Human LoVo Whole Cell Extracts
To determine if mismatch repair in human whole cellextracts might
influence the determination of reversion frequency, the fidelity ofBER
synthesis was examined in LoVo whole cell extracts using theM13mp2op14
lacZa DNA-based reversionassay, as described above. Upon transfection of254
Figure 51. DNA sequence analysis of M13mp2op14DNA lacZa gene
revertants. Isolated dark blue and light blue plaqueswere used to procure
single-stranded M13mp2op14 DNA and the DNAsequences were determined
using an Applied Biosystems Model 373A DNAsequencer as described under
"Experimental Procedures". The DNAsequence analysis of M13mp2op14
DNA containing an arginine codon (CGA, AGA) (pp.255 and 256,
respectively) or a glycine codon (GGA) (pp. 257)are indicative of (A) T--->G, (B)
T-4A, and (C) TIC mutations at the site of the uracil,respectively. The
codon containing the single-base substitution generated bythe original
mispair is indicated by brackets for each revertant. Thesequences depicted are
those of the (-) DNA strand determined in the 5'to 3' direction. Unidentified
bases are denoted by an 'N' in the DNAsequence.ABI A
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Figure 52. Mutation spectrum of uracil-initiated base excision DNA repair
synthesis in human U251 cell extracts. A standard BER reactionwas
performed using M13mp2op14 (UoT) DNA and human U251 whole cell
extract as described in Table 7. Following transfection of Ung/Endo IV
resistant Form I DNA into E. coli NR9162 cells, 78 blue plaqueswere isolated,
single-stranded DNA purified and DNA sequencedover the lacZa gene target
as described under "Experimental Procedures". The nucleotide sequence
(TGA) for the opal codon opposite the transcribed (-) strandserves as the
template strand for uracil-initiated base excision DNA repair synthesis andis
indicated. Above each template nucleotide, the four possible
deoxyribonucleotide triphosphates used for nucleotide incorporationare
indicated with the coded amino acid (parenthesis). The number of individual
base-substitution mutations observed from DNAsequence analysis are
plotted.-
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Table 8
Specificity of Mutations Produced by Uracil-Initiated Base ExcisionRepair in Human
U251 Whole Cell Extracts
Revertant Mispair (+/)a Codon Changeb Phenotype'
1 T/G CGA (Arg)d Dark
2 T/C SIGA (Gly) Light
3 T/T AGA (Arg) Dark
4 A/G TGC (Cys) Dark
5 T/C C,GA (Gly) Light
6 T/C GGA (Gly) Light
7 T/T AGA (Arg) Dark
8 T/T AGA (Arg) Dark
9 T/T AGA (Arg) Dark
10 T/T AGA (Arg) Dark
11 T/T AGA (Arg) Dark
12 T/T AGA (Arg) Dark
13 T/C C,GA (Gly) Light
14 T/T AGA (Arg) Dark
15 T/C caGA (Gly) Light
16 TIT AGA (Arg) Dark
17 G/A TTA (Leu) Light
18 T/T AGA (Arg) Dark
19 T/C C,GA (Gly) Light
20 T/C CiGA (Gly) Light
21 T/C C,GA (Gly) Light
22 T/T AGA (Arg) Dark
23 T/C CIGA (Gly) Light
24 T/G CGA (Arg) Dark
25 T/C C,GA (Gly) Light
26 T/C caGA (Gly) Light
27 T/T AGA (Arg) Dark
28 T/C caGA (Gly) Light
29 T/C C,GA (Gly) Light
30 T/C C,GA (Gly) Light
31 T/C caGA (Gly) Light
32 T/T AGA (Arg) Dark
33 T/T AGA (Arg) Dark
34 T/T AGA (Arg) Dark
35 T/C C.,GA (Gly) Light
36 T/C LiGA (Gly) Light
37 T/T AGA (Arg) Dark
38 T/G CGA (Arg) Dark
39 T/T AGA (Arg) Dark
40 T/C caGA (Gly) Light
41 T/T AGA (Arg) Dark
42 T/C C,GA (Gly) Light261
Table 8 (continued)
Specificity of Mutations Produced by Uracil-Initiated Base Excision Repair in Human
L1251 Whole Cell Extracts
Revertant Mispair (+/-)a Codon Change" Phenotype'
43 T/T AGA (Arg)d Dark
44 T/C caGA (Gly) Light
45 T/T AGA (Arg) Dark
46 T/G QGA (Arg) Dark
47 T/T AGA (Arg) Dark
48 T/T AGA (Arg) Dark
49 T/T AGA (Arg) Dark
50 TIC CJGA (Gly) Light
51 T/C C,GA (Gly) Light
52 T/C caGA (Gly) Light
53 T/T AGA (Arg) Dark
54 T/C C2GA (Gly) Light
55 A/G TGC (Cys) Dark
56 T/C gaGA (Gly) Light
57 T/C C,GA (Gly) Light
58 T/C C.,GA (Gly) Light
59 T/T AGA (Arg) Dark
60 T/C GGA (Gly) Light
61 T/C c2GA (Gly) Light
62 A/C TGG (Trp) Dark
63 T/C GGA (Gly) Light
64 T/T AGA (Arg) Dark
65 T/C caGA (Gly) Light
66 T/C C.CA (Gly) Light
67 TIC C.,GA (Gly) Light
68 T/T AGA (Arg) Dark
69 T/C C,GA (Gly) Light
70 T/T AGA (Arg) Dark
71 T/C CiGA (Gly) Light
72 T/C c2GA (Gly) Light
73 T/T AGA (Arg) Dark
74 T/T AGA (Arg) Dark
75 T/T AGA (Arg) Dark
76 T/C C,GA (Gly) Light
77 T/T AGA (Arg) Dark
78 T/C caGA (Gly) Light
aDenotes the mispair produced by uracil-initiated base excision DNA repair synthesisas extrapolated from
the DNA sequence analysis of individual revertants. The template (+) strand nucleotide and the
misincorporated opposite (-) strand nucleotide within opal (TGA) codon 14are indicated.
bThe nucleotide sequence of the opal codon for individual revertantswas determined by DNA sequence
analysis as described under "Experimental Procedures" and the single-base substitution generated bythe
original mispair is underlined.
`Revertants included dark blue and light blue phenotypes.
dThe amino acid for each codon change is indicated in parenthesis.262
repaired M13mp2op14 (UT) DNA into E. coli NR9162,a reversion frequency
of 5.4 x 10' was observed which closely matched that obtained from human
U251 whole cell extracts (Table 7 and 9). Interestingly, similar reversion
frequencies were also measured for control M13mp2op14 (AT) DNAafter
incubation with U251 or Lo Vo whole cell extracts and transfectioninto either
E. coli MC1061 or NR9162 cells. Thus, incubation of this substrate with either
extract apparently created a background level of mutation that does not differ
between U251 and LoVo cells. Together, these resultssuggest that mismatch
repair in both human whole cell extracts doesnot appear to influence the
detection of misincorporations that occurred during the BERreaction.
Experiments were also conducted tomeasure the fidelity of Ugi-
insensitive uracil-DNA repair using LoVo whole cellextracts supplemented
with Ugi (Table 9). When Ung/Endo IV resistantForm I DNA was
transfected into E. coli NR9162,a reversion frequency of 11.7 x 10' was
observed which was -2-fold greater than that observed forM13mp2op14
(UT) DNA repaired by LoVo whole cell extract in the absenceof Ugi. This
value was also -2.4-fold less than that of M13mp2op14 (UT)DNA repaired
by U251 whole cell extract in thepresence of Ugi. Interestingly, transfection of
the repaired Form I DNA into MC1061 cells yieldeda reversion frequency of
2.4 x 104 and exhibited the 4- to 5-fold reduction previouslyobserved
following transfection of repaired Form I DNA substratesinto cells capable of
removing mispairs from the unmethylated (-) strand. Comparison ofthis
result to those obtained for U251 whole cellextracts suggests that the repaired
Form I DNA from U251 extracts didnot contain endogenous mispairs for the
MC1061 methyl-directed mismatch repair machineryto correct, perhaps due
to the fixation of potential mispairs during incubation with the whole cell
extract protein. Overall, these results suggest that the Ugi-insensitive uracil-
DNA repair pathway in LoVo cells is alsomore error prone than that of the
predominantly uracil-DNA glycosylase initiated uracil BERpathway.Table 9
Frequency of Mutations Produced by Uracil-Initiated Base Excision Repair in Human LoVo WholeCell Extracts
Standard base excision DNA repair reaction mixtures (500 pl) were prepared containing 1mg of human LoVo whole cell extract protein and
either 5 lig of Ml3mp2op14 (UT) or (AT) DNA. After incubation at 30°C for 45 minutes, reactionswere terminated, DNA products recovered,
and Form I DNA that was resistant to E. coli Ung/Endo IV treatment was isolated by 0.8% agarose gel electrophoresisas described under
"Experimental Procedures". Form I DNA was then transfected into E. coli NR9162 and MC1061 cellsas indicated below and the M13mp2 lacZa
DNA-based reversion assay was performed as described by Kunkel (130).
DNA
NR9162 (mutS") MC1061 (mutS+)
Plaques Scored Plaques Scored
Reversion Reversion
Total Blue Frequency' Total Blue Frequency
.0b (x104) (x101
Control'
A/T 216,840 17 0.78 251,680 2 0.079
U/T 176,540 81 4.6 211,770 44 2.1
LoVo WCE
A/T 222,820 7 0.31 48,490 2 0.41
U/T 121,290 66 5.4 162,240 28 1.7
LoVo WCE + Ugid
U/T 163,670 191 11.7 141,960 34 2.4
Reversionequencies were caate.y ivi. mg t e num r oue p agues scorey t e tota num er ofue p us co or ess plaques. Revertants include . - ar
blue and light blue phenotypes.
bDenotes the (-) and (+) strand nucleotide at the target site.
Control reaction mixtures (500 Al) contained 5 lag of Ml3mp2op14 (UT) or (AT) DNA and substituted whole cell extract (WCE) dialysis buffer (25 mMHepes-
KOH, 100 mM KC1, 2 mM DTT, 12 mM MgCl 1 mM EDTA, and 17% (w/v) glycerol adjusted to pH 7.9) instead of human wholecell extract protein in standard
BER reaction mixtures.
d A standard reaction mixture (500 ul) was prepared as described under "Experimental Procedures" except that 1000 units of Ugi (-100-foldunit excess over
whole cell extract UDG) was added before the substrate addition.
0)
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4.1.12Mutational Spectrum of Human LoVo Cells
A preliminary mutational analysis of individual revertant M13phage
DNA was performed to define the types of misincorporationevents that
occurred during uracil-initiated base excision DNArepair synthesis in LoVo
whole cell extracts. Single-stranded DNAwas isolated and sequenced from 59
of the 66 blue plaques obtained from repaired DNAproduced in LoVo whole
cell extracts in the absence of Ugi. The distribution and specificityof single-
base substitutions located within the opal codonare shown in Figure 53A and
Table 10, respectively. Fifty four (90 %) mutations occurredat the first
nucleotide of the opal codon while six (10 %) mutationswere detected at the
third nucleotide position. One doublemutant containing base substitutions
at both the first and third nucleotide positions of the opal codonwas detected.
As observed for repaired DNA in U251 whole cellextracts, almost all of the
base substitutions were detectedat the location of the uracil target. Similarly,
-91 `)./. of the base substitution at this site promotedtransversion mutations
and were represented by T to G (-61 %) and Tto A (-39 %) changes in the (+)
strand template. Five mutations (-9 %)were scored as T to C transitions.
These results defined the uracil-initiated base excisionrepair-mediated
mutation spectrum at this site and did notappear to differ significantly
between U251 and LoVo cells.
A limited investigation of mutations introduced duringthe Ugi-
insensitive uracil-DNA repair pathway in LoVo whole cellextracts was also
conducted. Single-stranded DNAwas isolated from 24 of the 191 blue plaques
obtained from repaired Form I DNA transfectedinto E. coli NR9162 cells and
DNA sequence analysiswas performed. The distribution and specificity of
single-base substitutions located within the opal codonare shown in Figure
53B and Table 11, respectively. All of themutations were detected at the first
nucleotide position of the opal codon. All base substitutionswere scored as
transversion mutations and were representedas T to G (71 %) and T to A (29
`)/0) changes in the (+) strand template. Theseresults define the mutation265
Figure 53. Mutation spectrum of uracil-initiated base excision DNA repair
synthesis in human LoVo cell extracts. Standard BER reactionswere
performed using Ml3mp2op14 (UT) DNA and human LoVo whole cell
extract as described in Table 9. Following transfection of Ung/Endo IV
resistant Form I DNA into E. coli NR9162 cells, blue plaques were isolated,
single-stranded DNA purified and DNA sequenced over the lacZagene target
as described under "Experimental Procedures". The nucleotide sequence
(TGA) for the opal codon opposite the transcribed (-) strandserves as the
template strand for uracil-initiated base excision DNA repair synthesis and is
indicated. Above each template nucleotide, the four possible
deoxyribonucleoside triphosphates used for nucleotide incorporationare
indicated with the coded amino acid (parenthesis). The number of individual
base-substitution mutations observed from DNAsequence analysis from
standard BER reaction mixtures incubated in the absence of Ugi (A) and the
presence of Ugi (B) are plotted. The DNA sequences of 59 and 24 revertants
from standard BER reaction mixtures containing LoVo whole cell extract and
LoVo whole cell extract supplemented with Ugi, respectively,were analyzed.d
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Table 10
Specificity of Mutations Produced by Uracil-Initiated Base Excision Repair in Human
LoVo Whole Cell Extracts
Revertant Mispair (+/)a Codon Change' Phenotype'
1 T/C GGA (Gly)d Light
2 A/G TGC (Cys) Dark
3 T/C GGA (Gly) Light
4 T/T AGA (Arg) Dark
5 T/C GGA (Gly) Light
6 T/T AGA (Arg) Dark
7 T/C GGA (Gly) Light
8 T/T, A/A AGT (Ser) Dark
9 T/C GGA (Gly) Light
10 T/G CGA (Arg) Dark
11 T/C caGA (Gly) Light
12 T/C ,C,GA (Gly) Light
13 T/C GGA (Gly) Light
14 T/C C.,GA (Gly) Light
15 T/C GGA (Gly) Light
16 A/G TGC (Cys) Dark
17 T/C GGA (Gly) Light
18 T/G CGA (Arg) Dark
19 T/C GGA (Gly) Light
20 T/C caGA (Gly) Light
21 T/C GGA (Gly) Light
22 T/T AGA (Arg) Dark
23 T/T AGA (Arg) Dark
24 T/C GGA (Gly) Light
25 T/C GGA (Gly) Light
26 T/C C.,GA (Gly) Light
27 T/T AGA (Arg) Dark
28 T/G CGA (Arg) Dark
29 T/T AGA (Arg) Dark
30 T/C caGA (Gly) Light
31 T/G CGA (Arg) Dark
32 T/T AGA (Arg) Dark
33 T/C C,GA (Gly) Light
34 T/C caGA (Gly) Light
35 T/T AGA (Arg) Dark
36 T/C CTGA (Gly) Light
37 T/C GGA (Gly) Light
38 T/T AGA (Arg) Dark
39 T/C GGA (Gly) Light
40 T/C GGA (Gly) Light
41 T/C czGA (Gly) Light
42 T/G CGA (Arg) Dark269
Table 10 (continued)
Specificity of Mutations Produced by Uracil-Initiated Base Excision Repair in Human
LoVo Whole Cell Extracts
Revertant Mispair (+/-)a Codon Changeb Phenotype`
43 A/C lUci (Trp) Dark
44 T/T AGA (Arg) Dark
45 T/T AGA (Arg) Dark
46 T/C QGA (Gly) Light
47 T/T AGA (Arg) Dark
48 T/T AGA (Arg) Dark
49 A/G TUC (Cys) Dark
51 T/T AGA (Arg) Dark
52 T/C C,GA (Gly) Light
53 T/T AGA (Arg) Dark
54 T/C GGA (Gly) Light
59 T/T AGA (Arg) Dark
60 T/T AGA (Arg) Dark
62 T/C C,GA (Gly) Light
63 T/T AGA (Arg) Dark
64 A/C TGQ (Trp) Dark
65 T/C CiGA (Gly) Light
aDenotes the mispair produced by uracil-initiated base excision DNA repair synthesis as
extrapolated from the DNA sequence analysis of individual revertants. The template (+)
strand nucleotide and the misincorporated opposite (-) strand nucleotide within opal (TGA)
codon 14 are indicated.
bThe nucleotide sequence of the opal codon for individual revertants was determined by DNA
sequence analysis as described under "Experimental Procedures" and the single-base substitution
generated by the original mispair is underlined.
`Revertants included dark blue and light blue phenotypes.
dThe amino acid for each codon change is indicated in parenthesis.270
Table 11
Specificity of Mutations Produced by Uracil-Initiated Base Excision Repairin Human
LoVo Whole Cell Extracts in the Presence of Ugi
Revertant Mispair (+/-)a Codon Changeb Phenotype'
1 T/C GGA (Gly) Light
2 T/C c_GA (Gly) Light
3 T/C CiGA (Gly) Light
4 TIC C,GA (Gly) Light
5 T/C C,GA (Gly) Light
6 TIC C.,GA (Gly) Light
7 T/T AGA (Arg) Dark
8 T/C GGA (Gly) Light
89 T/C czGA (Gly) Light
90 T/C GGA (Gly) Light
91 T/C GGA (Gly) Light
92 T/T AGA (Arg) Dark
93 T/T AGA (Arg) Dark
94 T/C C.,GA (Gly) Light
95 TIT AGA (Arg) Dark
96 T/C C,GA (Gly) Light
149 T/C caGA (Gly) Light
150 TIT AGA (Arg) Dark
151 T/T AGA (Arg) Dark
152 T/C GGA (Gly) Light
153 T/C GGA (Gly) Light
154 T/C GGA (Gly) Light
155 T/T AGA (Arg) Dark
156 T/C E3GA (Gly) Light
aDenotes the mispair produced by uracil-initiated base excision DNA repair synthesisas
extrapolated from the DNA sequence analysis of individualrevertants. The template (+)
strand nucleotide and the misincorporated opposite (-) strand nucleotidewithin opal (TGA)
codon 14 are indicated.
bThe nucleotide sequence of the opal codon for individualrevertants was determined by DNA
sequence analysis as described under "Experimental Procedures" and the single-base substitution
generated by the original mispair is underlined.
Revertants included dark blue and light blue phenotypes.
dThe amino acid for each codon change is indicated in parenthesis.271
spectrum of the Ugi-insensitive uracil-DNA repair pathway at this site. The
overall distribution of mutations across the opal codon does not significantly
differ from distributions observed for Ugi-sensitive uracil-initiated base
excision DNA repair synthesis in U251 and LoVo cells. The frequency of each
individual type of transition and transversion mutation introduced during
Ugi sensitive and insensitive uracil-initiated DNA repair in human whole
cell extracts was represented in Table 12.
4.1.13Sensitivity of Uracil-DNA Repair Synthesis in Human
Whole Cell Extracts to Aphidicolin
To determine the effect of aphidicolin on the activity of a-like DNA
polymerases present in U251 or LoVo whole cell extracts, DNA synthesis
reactions containing activated calf thymus DNA and [3H]dTTPwere
supplemented with increasing concentrations of aphidicolin and standard
DNA polymerase assays were conducted as described under "Experimental
Procedures". Polymerase activity in both U251 and LoVo whole cell extracts
exhibited similar levels of sensitivity to aphidicolin and incorporation of
[31-1]dTMP decreasedas a function of increasing aphidicolin concentration
(Figure 54). The inhibitory effect of aphidicolin appeared to reach saturation
at concentrations of 25 and 50 .iM as exhibited by the reduction of DNA
polymerase activity by -80 % and -83 %, respectively, relative to the control
reactions lacking aphidicolin. These results confirm thepresence of a-like
DNA polymerase activity in. U251 and LoVo whole cell extracts under
standard BER reaction conditions and their susceptibility to the inhibitory
effects of aphidicolin.
To determine if a-like DNA polymerase(s) participated in the DNA
repair synthesis step associated with uracil-initiated base excision repair in
U251 or LoVo whole cell extracts, standard BER reactions containing
increasing concentrations of aphidicolinwere incubated with Ml3mp2op14
(UT) DNA. As before, the recovered DNAwas treated with excess Ung andTable 12
Frequency of Transition and Transversion Mutations Introduced by Uracil-Initiated Base ExcisionRepair in Human Whole Cell
Extracts
U251 LoVo LoVo + Ugi
Mutations'
Reversion
Frequencyb Mutations
Reversion
Frequency'
Reversion
Mutations Frequency'
(x104) (x104) (x104)
Transition Mispairs
T --> C 4 0.27 5(,...,5)d 0.41
G > A
A > G 1 0.07 2 (-2) 0.16
Transversion Mispairs
T -->G 38 2.5 30 (-34) 2.8 17 (-135) 8.2
T --> A 32 2.1 19 (-21) 1.7 7 (-56) 3.4
G -->C
G >T 1 0.07
A > C 2 0.13 3 (-3) 0.25
A --> T - 1 (-1) 0.08
The number of specific transition and transversion mutation typesare derived from the mutation spectrum generated by the transfection of
repaired Ml3mp2op14 (UT) Form I DNA into E. coli NR9162 cells.
bReversion frequencies for each category of mutation were calculated by dividing the number of specificmutations by the total number of blue
plus colorless plaques indicated on Table 7.
Reversion frequencies for each category of mutation were calculated by dividing the estimated number ofspecific mutations by the total
number of blue plus colorless plaques indicated on Table 9.
Numbers in parenthesis correspond to the predicted number of specific mutations for each category sinceall revertants have not been
sequenced. This value was obtained by dividing the number of mutations for each type of mutation by the totalnumber of revertants sequenced
and then multiplying by the total number of revertants scored.273
Figure 54. In vitro inhibition of DNA polymerase activity by aphidicolin in
U251 and LoVo cell extracts. DNA polymerase activity was assayed under
standard BER reaction conditions in reaction mixtures (100 pi) containing 20
pg of U251 or Lo Vo whole cell extract protein, 10 lig of activated calf thymus
DNA and [3FI]dTTP (1700 cpm/pmol). Reaction mixtures were supplemented
with 0, 1, 5, 10, 25, and 50 µM aphidicolin in DMSO prior to the addition of
substrate and incubated for 60 min (U251) or 45 min (LoVo) at 30°C.
Reactions were terminated on ice by the addition of 1 mg/ml BSA in 0.1 M
sodium pyrophosphate (200 ill), DNA precipitated with 10% (saturated)
trichloroacetic acid, and acid-insoluble DNAwas collected on #30 glass fiber
filters and analyzed for [31-T]dTMP incorporation. The percentage of
polymerase activity detected in U251 (closed circles) and LoVo (open circles)
whole cell extracts for each aphidicolin concentrationwas determined as the
amount of [31-T]dUMP incorporated in the presence of aphidicolin divided by
the amount of [3H]dTMP incorporated in the absence of aphidicolin and
multiplied by 100. The amount of [3FI]dTMP (1,700 cpm/pmol) incorporated
into activated calf thymus DNA that represents 100 % DNA polymerase
activity for U251 and LoVo cell extracts was 19.9 and 9.8 pmol of [3H]dTMP,
respectively.10
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Endo IV prior to resolving the reaction products by agarose gel electrophoresis
(Figure 55A and B). Analysis of the ethidium bromide stained gels revealed
similar ratios of ling/ Endo IV resistant Form I DNA to Form II DNA in each
BER reaction containing U251 (Figure 55A, lanes 6-10) or LoVo (Figure 55B,
lanes 6-10) whole cell extract proteins. As controls, standard BER reactions
lacking aphidicolin (Figure 55A and B, lane 5) or the aphidicolin
solubilization reagent, DMSO (Figure 55A and B, lane 4),were similarly
analyzed. The percentage of Form I DNA detected in lanes 5-10was
determined and was represented for U251 and LoVo whole cell extracts
(Figure 56A and B, respectively). The percentage of repaired Form I DNA
between aphidicolin concentrations of 1 and 50 [1,14 did not significantly differ
for U251 (50 `)/0 and 40 `)/0, respectively) and LoVo (55 % and 48 %, respectively)
cell extracts. Together, these results suggest that the a-like DNA
polymerase(s) present in U251 and LoVo whole cell extracts contribute onlya
minor percentage (20 % and 13 %, respectively) of the DNA repair synthesis
activity associated with uracil-initiated base excision repair under these
reaction conditions.
4.1.14Determination of the Repair Patch Size Generated During
Uracil-Initiated DNA Repair in Human U251 and LoVo
Whole Cell Extracts
A radioactively labeled [32P]M13mp2op14 (UT) DNA substratewas
constructed by introducing a site-specific [32P]dCMP residue at nucleotide
position 90 (corresponding the 5-terminal nucleotide of the [32P]U-23-mer
primer) during the primer extension reactionas described under
"Experimental Procedures". Thus, the location of the [32P]c1CMP residue in
the (-) strand between the uracil-target and the Smal restriction site enabled
autoradiographic detection of DNA bands following restriction with
endonucleases EcoRI and Smal. Standard BER reactions containing
[3211M13mp2op14 (UT) DNA and all four dNTP[aS1precursors were prepared
in order to detect the 3' boundary of the repair patch introduced during uracil-276
Figure 55. Effect of aphidicolinon uracil-DNA base excision repair in
human U251 and LoVo cell extracts. (A) Standard BERreaction mixtures
(100 gl) containing 1 gg of M13mp2op14 (UT) DNA, 200lig of U251 whole
cell extract protein, and 20 gCi of [32P]dATPwere supplemented with 0, 1, 5,
10, 25, and 50 gM aphidicolin in DMSO (lanes 5-10, respectively). Samples
were incubated for 60 min at 30°C and terminated by addition of 2000 units of
Ugi followed by adjustment to 20 mM EDTA. As controls, M13mp2op14
(UT) DNA (1 gg) was supplemented with whole cellextract dialysis buffer
(lane 3) or with 200 gg of U251 whole cellextract protein (lane 4) in reaction
mixtures lacking DMSO. DNAwas isolated, treated with E. coli Ung and Endo
IV, and analyzed by 0.8%agarose gel electrophoresis as described under
"Experimental Procedures", Untreated M13mp2op14 (UT) DNA(100 ng) and
a sample containing 2.5 gg of a 1-kb DNA ladder (Gibco BRL)were analyzed as
reference standards (lanes 2 and 1, respectively). (B) Standard BERreaction
mixtures containing LoVo whole cell extract proteinwere analyzed as
described above except sampleswere incubated for 45 mM at 30°C. The
locations of ethidium bromide-stained Form I and II DNAare indicated by
arrows.III-se
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Figure 56. Quantitation of uracil-DNA base excision repair reaction
products following aphidicolin treatment in human U251 and LoVo cell
extracts. DNA bands detected by ethidium bromide staining in Figure 55 (A
and B) were quantitated using a Gel Documentation System and the
percentage of Form I DNA in the U251 /aphidicolin titration series (A) and
the LoVo/aphidicolin titration series (B) were determined. Amounts of
Form I and II DNA were measured relative to standards (6.3-100 ng) analyzed
on the same gel. After correcting for the -0.38-fold reduction in ethidium
bromide staining intensity of Form I DNA relative to Form II DNA, the
percentage of Form I DNA was determined by dividing the amount of Form I
DNA (ng) by that of Form I plus II DNA.100
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initiated base excision DNA repair synthesis in human whole cell extracts.
Recovered DNA reaction products were restricted with EcoRI, which cuts after
nucleotide position 57 in the (-) strand of the lacZa gene, to generate linear
DNA with a recessed 3' terminus located twenty nucleotides downstream
from the uracil target. Linearized DNA reaction productswere subsequently
digested with E. coil exonuclease III (Exo III). This 3' to 5' exonuclease
reportedly does not hydrolyze phosphorothioate DNA linkages (107, 218) and
as a consequence, was expected to stop at the 3' border of the repair patch.
Digested reaction products were subsequently restricted with SmaI, which cuts
after nucleotide position 97 in the (-) strand, to generate small DNA
fragments with 5' DNA termini located nineteen nucleotides upstream from
the uracil target. DNA fragmentswere subsequently analyzed by denaturing
12 % polyacrylamide/8.3 M urea gel electrophoresis and autoradiography.
Repair patches of one nucleotide in length were expected to producea 20-bp
DNA band following the EcoRI/Exo III/SmaI treatment since the
incorporation of a single dNTP[aS] at the site of the uracil target blocked
further digestion by Exo III. Thus, repair patches of twoor more nucleotides
in length were expected to produce corresponding DNA fragments of 21or
greater nucleotides in length due to the inability of Exo III to hydrolyze
dNTP[aSJ nucleotides incorporated during associated uracil-initiated DNA
repair synthesis.
To optimize the amount of Exo III required tomeasure the 3' base
excision repair patch boundary, samples (-200 ng) of LoVo BER reaction
products (Form I and II DNA) recovered froma standard BER reaction
mixture containing rP1M13mp2op14 (UT) DNA and dNTP[ctS]precursors
were linearized with EcoRI and digested with various amounts of Exo III (0.16
1.6 x 10' units). After incubation with SmaI, [32P]DNA fragmentswere
resolved by denaturing 12 % polyacrylamide/8.3 Murea gel electrophoresis
and the gel was subjected to autoradiography. Analysis of [32P]DNA products
digested with 0.16 and 0.016 units of Exo III resulted in the production of eight281
predominant DNA bands that extended sequentially from 20to 27 nucleotides
in length (Figure 57, lanes 1 and 2). This result indicated that base excision
repair patches of one to eight nucleotides in lengthwere generated. The
distribution of DNA fragments did not differ significantly between thesetwo
treatments and indicated that complete digestion of the substrate had
occurred using an Exo III:DNA ratio of greater than 0.08:1 (units:gg DNA).
However, incubation with smaller unit amounts of Exo III resulted in the
production of incomplete Exo III digestion products (Figure 57, lanes 3-8). The
40-bp [32P]DNA fragment was the expected result fora completely undigested
EcoRI/SmaI restriction fragment corresponding to the (-) DNA strand. The
19-bp [32P]DNA fragment was the expected product froman unsynthesized
Form II DNA base excision repair intermediate containingan incised
apyrimidinic site at the location of the uracil target. This DNA fragment
appeared to represent 50 % of the DNA repair products. Furthermore, this
19-bp DNA fragment was expected to be susceptible to Exo III digestion since
dNMP[ocS] incorporation had not occurred.. Supporting this interpretation,
the 19-bp DNA fragmentwas observed to be degraded by Exo III (Figure 57,
lanes 1-3). Interestingly, base excision repair intermediatesexhibiting limited
DNA repair synthesis were not, observed.
Experiments were conducted to determine the size and distribution of
the DNA repair patches introduced during uracil-initiated DNArepair
synthesis in U251 whole cell extracts. The influence of aphidicolinon the size
and distribution of the repair patchwas also investigated. Standard BER
reactions containing all four dNTP[aS]precursors and [32IIM13mp2op14
(UT) DNA were prepared and samples (500 ng) of DNAreaction products
isolated from standard BER reactions supplemented withno addition, 2000
units of Ugi, 50 1.ilA aphidicolin,or 2000 units of Ugi and 50 1.tM aphidicolin
were incubated with EcoRI (Figure 58). Linearized DNA was mock-digestedor
digested with 20, 2, or 0.2 units of Exo IIIas indicated in the figure legend,
incubated with SmaI, and reaction productswere analyzed by denaturing 12 `)/0282
Figure 57. Effect of exonuclease III concentration on determining the size
of the uracil-initiated base excision repair patch. A standard BER reaction
mixture (500 ill) containing 5µg of [32P]M13mp2op14 (UT) DNA, 1 mg of
human LoVo whole cell extract protein, and 20 µM each of dATPaS, dTTPaS,
dCTPaS and dGTPaS was incubated at 30°C for 45 min and DNA reaction
products were isolated and resuspended in TE buffer (80 [1.1). Samples (3.2
200 ng) were removed for digestion with 10 units of EcoRI for 1 h at 25°C and
then incubated with 0.16, 1.6 x 10', 1.6 x 10-3, 1.6 x 10"4,1.6 x 10, 1.6 x 10-6, 1.6 x
10-7, and 1.6 x 108 units of E. coli exonuclease III (lanes 1-8, respectively) for 30
min at 37°C. Following Exo III digestion, reaction products were restricted
with 10 units of SmaI for 1 h at 25°C. DNA reaction products were resolved by
12% polyacrylamide/8.3 M urea gel electrophoresis as described under
"Experimental Procedures". The location of the 40-mer corresponding to the
(-) strand EcoRI/ SmaI restriction fragment and the 19-mer through 27-mer
BER reaction products are located by arrows on the autoradiogram.284
Figure 58. Effect of Ugi and aphidicolinon the 3' boundary of the repair
patch introduced by uracil-initiated base excision repairin U251 cell
extracts. Standard BER reaction mixtures (500 IA) containing 5lig of
[32P]M13mp2op14 (UT) DNA, 1mg of human U251 whole cell extract
protein, and 20 I.LM each of dATPaS, dTTPaS, dCTPaS and dGTPaSwere
supplemented with either no addition (lanes 3-6), 2000 units of Ugi (lanes7-
10), 50 pM aphidicolin (lanes 11-14),or 2000 units of Ugi and 50 1.1M
aphidicolin (lanes 15-18). Reactionswere incubated at 30°C for 60 min and
DNA reaction productswere isolated. Samples (8-500 ng) were removed
for digestion with 25 units of EcoRI for 1 hat 25°C. The linearized DNA was
then incubated with no addition (lanes 3/7/11/15)or the addition of 20 units
(lanes 4/8/12/16), 2 units (lanes 5/9/13/17),or 0.2 units (lanes 6/10/14/18) of
E. coli Exo III for 30 min at 37°C. FollowingExo III digestion, reaction products
were treated with 25 units of SmaI for 1 h at 25°C. As controls, unreacted
[32P]M13mp2op14 (UT) DNA (-500 ng)was incubated with EcoRI and SmaI
(lane 1) or EcoRT, Exo III (0.2 units), and SmaI (lane 2).Following these
reactions, DNA reaction productswere resolved by 12% polyacrylamide/8.3 M
urea gel electrophoresis as described under "Experimental Procedures". The
location of the 40-mer correspondingto the (-) strand EcoRI/SmaI restriction
fragment and the 19-mer through 27-mer BERreaction products are located by
arrows on the autoradiogram.286
polyacrylamide/8.3 M urea gel electrophoresis and autoradiographywas
performed. As controls, unreacted [32P]M13mp2op14 (UT) DNAwas
incubated with EcoRI and SmaI (Figure 58, lane 1) or EcoRI, Exo III, and SmaI
(Figure 58, lane 2). Incubation of the unreacted control with Exo III resulted
in the complete digestion of the 40-mer [32P]DNA fragment (lane 2). Thus, the
incorporation of dNTP[ocS] at and after the site of the uracil-target during
uracil-DNA repair synthesis in whole cell extractswas required for resistance
to Exo III digestion (Figure 58, lanes 4-6, 8-10, 12-14, 16-18). The relative
intensity of DNA fragments of 20 to 27 nucleotides in length, which
corresponded to DNA repair patches of one to eight nucleotides, respectively,
were quantitated and plotted (Figure 59) for each reaction condition. The
percentage of short patch BER (one nucleotide) and long patch BER (two to
eight nucleotides) associated with uracil-DNA repair synthesiswas also
determined under these conditions (Table 13). Several observationscan be
derived from these results.First, the Ugi-sensitive uracil-DNA repair
pathway initiated by uracil-DNA glycosylase produced repair patches
consistent with a base excision repair mechanism since 36-38 % of the repair
DNA synthesis involved short patch BER and 62-64 % involved long patch
BER (Figure 58, lanes 4-6 and 12-14, Figure 59A and C, and Table 13). These
results are similar for Ugi-insensitive uracil-DNA BER (Figure 58, lanes 8-10
and 16-18, Figure 59A and C, and Table 13). Second, standard BER reaction
mixtures containing Ugi (Figure 59B and D) exhibiteda 3.2- to 3.8-fold
reduction in the relative intensity of Exo III resistant DNA reaction products
as compared to equivalent BER reactions lacking Ugi (Figure 59A and C).
Reduced levels of uracil-DNA repairwere previously observed for the Ugi-
insensitive BER pathway and are consistent with these results (Figure 38D).
Third, the presence of a 19-mer in samples treated with EcoRI and SmaI but
not Exo III (Figure 58, lanes 7 and 15) suggested that the Ugi-insensitive uracil-
DNA BER reaction is initiated bya DNA glycosylase activity. The 19-mer
E32P]DNAproduct is the expected reaction intermediate following uracil base287
Figure 59. Quantitation of repair patch sizes introduced by uracil-initiated
base excision repair in U251 cell extracts under various conditions.
Relative amounts of DNA reaction products detected by autoradiographyin
Figure 58 were determined usinga Phosphor Imager. The relative intensity of
DNA bands of 20 to 27 nucleotides in length corresponded to BER repair
patches of 1 to 8 nucleotides in length, respectively, andwere measured for
U251 whole cell extract reaction products digested with 20 units (black bars), 2
units (white bars) and 0.2 units (grey bars) of E. coli exonuclease IIIas described
under "Experimental Procedures". Relative intensity values of individual
DNA bands were plotted after subtracting background values for standard
BER reactions containing no addition (A), 2000 units of Ugi (B), 50 tiM
aphidicolin (C), and 2000 units of Ugi and 50 jiM aphidicolin (D).6
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Table 13
Effect of Various Conditions on the Size of the Repair Patch Introduced by Uracil-
Initiated Base Excision Repair in Human Whole Cell Extracts'
Repair Patch
(nucleotides)
-Ugi
-Aphidicolin
+Ugi
-Aphidicolin
-Ugi
+Aphidicolin
+Ugi
+Aphidicolin
U251
% % % %
1 35.7 40.4 37.5 39.4
2 14.7 15.0 16.0 15.8
3 6.4 9.9 6.7 9.0
4 6.6 5.5 7.3 7.8
5 7.2 5.1 7.6 6.1
6 8.7 6.9 7.4 6.3
7 12.0 9.6 11.0 9.1
8 8.7 7.6 6.4 6.5
Short Patch 35.7 40.4 37.5 39.4
Long Patch 64.3 59.6 62.5 60.6
LoVo
1 31.8 46.3 29.0 26.6
2 19.0 19.0 17.8 15.7
3 9.2 12.5 9.8 11.9
4 7.6 4.5 12.6 14.7
5 8.2 4.3 8.9 8.9
6 7.6 3.7 6.8 7.2
7 10.4 6.7 9.5 8.0
8 6.2 3.0 5.6 7.0
Short Patch 31.8 46.3 29.0 26.6
Long Patch 68.2 53.7 71.0 73.4
aRepresented repair patch sizes correlate to data collected from human whole cell extract
reaction products digested with 2 units of E. coli exonuclease IIIas described under
"Experimental Procedures".290
removal and AP-site incision. Fourth, the addition of aphidicolin did not
significantly influence the size or distribution of the DNA repair patches
produced by either BER pathway. This implies that the a-like DNA
polymerase(s) are not specifically required for long patch BER (Figure 58 and
Figure 59C and D, and Table 13).Thus, the majority of DNA synthesis did
not appear to involve an aphidicolin-sensitive DNA polymerase that was
capable of supporting both short- and long-patch BER. Fifth, base excision
repair intermediates exhibiting limited DNA repair synthesiswere observed
for standard BER reactions supplemented with aphidicolin (Figure 58, lanes
11 and 15). Taken together, these results imply that all uracil-DNA repair
detected in U251 whole cell extracts involvesa base excision repair
mechanism that predominantly involves one-nucleotide DNA repair
synthesis mediated by an aphidicolin-insensitive DNA polymerase.
To determine the size and distribution of repair patches introduced
during uracil-initiated BER in a mismatch repair-deficient cell line,an
identical set of experiments was conducted using LoVo whole cell extract
protein. As before, reactions were conducted both in thepresence and absence
of aphidicolin. Standard BER reactions supplemented withno addition, 2000
units of Ugi, 50 1.iM aphidicolin, or 2000 units of Ugi and 50 [tM aphidicolin
were incubated for 45 min, reaction products isolated, and treated with EcoRI,
various amounts of Exo III, and SmaI. DNA productswere resolved by
denaturing 12 % polyacrylamide/8.3 Murea gel electrophoresis and
autoradiography was performed (Figure 60). The relative intensity of DNA
fragments of 20 to 27 nucleotides in lengthwere quantitated and plotted
(Figure 61) and expressedas a percentage in Table 13. Results detected for
Lo Vo cells were similar to those observed for U251 cells and suggest that the
presence or absence of mismatch repair does not influence the size or
distribution of uracil-initiated DNA repair synthesis. Uracil-DNA BER
initiated by uracil-DNA glycosylase resulted in short- and long-patch DNA
synthesis constituting 29-32 % and 68-71 % of the total repair synthesis and291
Figure 60. Effect of Ugi and aphidicolinon the 3' boundary of the repair
patch introduced by uracil-initiated base excision repair in LoVocell
extracts. Standard BER reaction mixtures (500 ul) containing 5Rg of
[3213]\413mp2op14 (UT) DNA, 1mg of human LoVo whole cell extract
protein, and 20 11,M each of dATPaS, dTTPaS, dCTPaS and dGTPaSwere
supplemented with no addition (lanes 3-6), 2000 units of Ugi (lanes 7-10),50
11,M aphidicolin (lanes 11-14),or 2000 units of Ugi and 50 1.04 aphidicolin
(lanes 15-18). Reactions were incubated at 30°C for 45 min and DNAreaction
products were isolated. Samples (8-500 ng) were removed for digestion
with 25 units of EcoRI for 1 h at 25°C. The linearized DNAwas then
supplemented with no addition (lanes 3/7/11/15)or the addition of 20 units
(lanes 4/8/12/16), 2 units (lanes 5/9/13/17),or 0.2 units (lanes 6/10/14/18) of
E. coli Exo III for 30 min at 37°C. Following Exo III digestion,reaction products
were restricted with 25 units of SmaI for 1 h at 25°C. As controls, unreacted
[32I1M13mp2op14 (UT) DNA (-500 ng)was incubated with EcoRI and SmaI
(lane 1) or EcoRI, Exo III (0.2 units), and SmaI (lane 2). Followingthese
reactions, DNA reaction productswere resolved by 12% polyacrylamide/8.3 M
urea gel electrophoresis as described under "Experimental Procedures". The
location of the 40-mer corresponding to the (-) strand EcoRU SmaIrestriction
fragment and the 19-mer through 27-mer BER reactionproducts are located by
arrows on the autoradiogram.293
Figure 61. Quantitation of repair patch sizes introduced by uracil-initiated
base excision repair in LoVo cell extracts under various conditions.
Relative amounts of DNA reaction products detected by autoradiography in
Figure 64 were determined using a Phosphor Imager. The relative intensity of
DNA bands of 20 to 27 nucleotides in length corresponded to repair patches of
1 to 8 nucleotides in length, respectively, and were measured for LoVo whole
cell extract reaction products following digestion with 20 units (black bars), 2
units (white bars) and 0.2 units (grey bars) of E. coli exonuclease III as described
under "Experimental Procedures". Relative intensity values of individual
DNA bands were plotted after subtracting background values for standard
BER reactions containing no addition (A), 2000 units of Ugi (B), 50 11M
aphidicolin (C), and 2000 units of Ugi and 50 jiM aphidicolin (D).O
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was not significantly influenced by aphidicolin. These results were also
similar to those observed for U251 cells.As expected, standard BER reaction
mixtures containing Ugi (Figure 61B and D) exhibiteda 4.3- to 8.2-fold
reduction in the relative intensity of Exo III-resistant DNA reaction products
as compared to BER reactions lacking Ugi (Figure 61A and C). These results
imply that an aphidicolin-insensitive DNA polymerase promotes both short-
and long-patch DNA repair synthesis in uracil-initiated base excision repair in
LoVo whole cell extracts.
4.2Discussion
The ability of human glioblastoma U251 and human colon
adenocarcinoma. LoVo whole cell extracts to conduct uracil-DNA repair using
an M13mp2 lacZcx DNA-derived substrate containing a site-specific uracil
residue was examined. Unlike several recent investigations that have
utilized uracil-containing oligonucleotides to characterize BER reactions in
eukaryotic cell extracts (54, 247, 253, 295),a covalently closed circular duplex
DNA substrate with a defined uracil targetwas used in this study to facilitate
DNA synthesis fidelity measurements and to mimic the natural DNA
substrate (20). Since a PCNA-dependent base excision repair pathway has
previously been observed in eukaryotic in vitro repair systems (77, 158) and
reports indicate that PCNA and PCNA-dependent DNA polymerases 5 and£
are loaded more stably on circular DNA than on linear DNA in vitro (205, 206),
a linear DNA substrate was considered inappropriate for this study.
Under the conditions examined in this system, most of the uracil-DNA
repair in U251 and LoVo whole cell extracts occurred via the uracil-initiated
BER pathway. Several observations support this conclusion: i) DNA
synthesis was preferentially localized to the Hinf I DNA fragment (529-bp) that
contained the uracil target; ii) repair DNA synthesis within the 529-bp
fragment was almost exclusively dependenton the presence of the uracil
residue; iii) DNA synthesiswas specifically confined to the (-) strand DNA296
that initially contained the uracil target; iv) addition of Ugi to the whole cell
extract significantly inhibited repair DNA synthesis; and v) Ugi-sensitive and
-insensitive uracil-DNA repair synthesis produced repair patches that
predominantly involved the incorporation of a single nucleotide. In contrast,
these results were not consistent with a mismatch DNA repair pathway since
DNA synthesis was confined to a region significantly <1000 nucleotides,
occurred preferentially on only one of the two DNA strands containing the
mispair, and efficient repair was observed in LoVo whole cell extracts that are
defective in the mismatch repair protein, hMSH2 (27, 282).
An examination of the BER reaction kinetics in human U251 whole
cell extracts revealed that -50 `)/0 of the uracil-DNA substratewas repaired and
repair had reached equilibrium after 60 min of incubation whereas -37 % of
the substrate was repaired by human LoVo whole cell extracts after thesame
amount of time. The ability to achieve this relatively high efficiency of
completed repair suggested that a coordinated set of repair reactions occurred
without significant accumulation of side products or repair intermediates.
This would be consistent with the notion that a concerted BER reaction
occurred (209). Inclusion of Ugi protein in the standard BER reaction
containing U251 whole cell extract protein reduced the amount of repaired
Form I DNA from 50 % to 3.7 % after 60 min. Thus, approximately 93 % of
the observed BER appeared to be initiated by a Ugi-sensitive uracil-DNA
glycosylase. The small but detectable amount (-7 %) of repair thatwas
insensitive to Ugi inhibition suggests that a back-up enzymeor repair
pathway exists. By an alternative comparison, the initial rates of repair for
the Ugi-sensitive (3.61 fmol/min) versus the Ugi-insensitive (0.58 fmol/min)
reactions suggests that the back-up enzyme or repair pathway could contribute
as much as 16 % of the uracil-DNA repair. However, this is most likely an
overestimate since the accumulation of repaired Form I DNAas initiated by
uracil-DNA glycosylase was essentially completed after 60 min. The BER
reaction in LoVo whole cell extracts supplemented with Ugi also yieldeda
reduction in the amount of repaired Form I DNA from 37 % to 6.5 % after 60297
min. This result indicated that approximately 82 `)/0 of the observed repair
activity appeared to be initiated by a Ugi-sensitive uracil-DNA glycosylase. By
this measurement, -18 % of the uracil-DNA repair in LoVo whole cell
extracts involved a Ugi-insensitive system. When the initial rates of repair by
the Ugi-sensitive (1.64 fmollmin) and the Ugi-insensitive (0.30 fmol/min)
reactions were compared, -18 % of the repair could have been initiated byan
activity other than that of uracil-DNA glycosylase. Again, this might be
expected to represent an overestimate since a significant accumulation of
repaired Form I DNA initiated by the Ugi-insensitive repair reaction is not
observed until 60 min. A potential candidate for this alternate activity might
be the human TDG protein, which is insensitive to Ugi and capable of
excising uracil from GU mispairs (80, 186). Recently, the ability of hTDG to
recognize and excise uracil from a TU mispair has been established (298).
Hence, it seems conceivable that hTDGmay be capable of removing uracil
from a TU mispair. Another formal possibility would be that GAPDH
functions as a back-up enzyme. However, the inability of several laboratories
to confirm that purified human GAPDH possesses significant uracil-DNA
glycosylase activity casts doubton this possibility (36, 190, 249). The biological
significance of two uracil-DNA repair systems within human cells remains to
be elucidated.
In experiments designed to measure the distribution of repair patch
sizes affiliated with uracil-initiated BER, the rate-limiting step appeared to
occur subsequent to uracil removal and AP-site hydrolysis and prior to DNA
synthesis for both the Ugi-sensitive and Ugi-insensitive repair activities. This
observation was deduced from an examination of the DNA repair products
treated with EcoRI and Smal but not with Exo III. DNA fragments of 19
nucleotides in length indicated that uracil-DNA glycosylase and AP
endonuclease had removed the uracil residue and incised the AP site but
DNA synthesis had not occurred. The absence of repair intermediates20
nucleotide in length and the presence of full length 40-mer EcoRI/ Smal298
restriction DNA fragments indicated that ligation was achieved in repair
events where DNA repair synthesis had occurred. This implies that the rate-
limiting step is not associated with DNA ligation but with the interaction of
the DNA polymerase with the nicked AP-site as it involves release of the 5'-
terminal deoxyribose phosphate moiety and DNA synthesis. Fortini andco-
workers (69) witnessed a similar accumulation of UDG/HAP1 reaction
intermediates (incised DNA molecules) and suggested that the release of the
5'-terminal deoxyribose phosphate moiety as free dRp or as part of a short
oligonucleotide preceded the DNA synthesis step. An additional observation
that supports this conclusion emerges from the results of Srivastava et al.
(256) that reported the rate-determining step of a reconstituted BER reaction
involving AP-endonuclease, pol 13, and DNA ligase I was the dRp lyase
activity associated with pol 13 (256). Interestingly, the presence of the 5'-
terminal dRp moiety of the nicked AP site did not disrupt DNA synthesis and
DNA ligase I activity was inhibited by the dRp flap intermediate presumably
created during strand displacement (256). Contrary to our observations and
those of Fortini et al. (69), the model proposed for AP site BER involved the
sequential enzymatic activities of AP endonuclease, DNA polymerase, dRp
lyase activity, and DNA ligase (256). These differences could be attributed to
the use of a whole cell extract versus a reconstituted system and DNA repair of
a uracil-containing circular DNA substrate versus an AP site-containing linear
DNA substrate.
Several independent studies have reported that the short-patch BER
provides the dominant pathway for mammalian cells (69, 118). Analysis of
short- and long-patch DNA repair synthesis in human U251 and LoVo whole
cell extracts revealed that 32 % to 46 % of the repaired uracil-containing DNA
substrate involved incorporation of a single nucleotide. Thus, longer DNA
repair patches (2 to 8 nucleotides) appeared to be the predominant route for
uracil-initiated BER under our assay conditions. Approximately 70-80 % of
the newly synthesized DNA repair patches in human lymphoblastoid cell299
extracts after uracil excision contained one nucleotide. This difference might
reflect the fact that the uracil-containing linear duplex oligonucleotide used
by Dianov et al. (54) was a poor substrate for the assembly of the RF-C-PCNA
sliding clamp which might be expected to influence theamount of long-patch
DNA repair synthesis. Previously, Podust et a/.(205, 206) havedemonstrated
that RF-C-PCNA associates with the stable assembly of pol 8 and/orpol e onto
the linear substrate. Thus, theuse of a covalently closed circular duplex DNA
substrate in this study might facilitate the stable assembly of BERenzymes
that influence the balance between short- and long-patch DNA repair
synthesis.
An examination of the DNA polymerase(s) involved in uracil-initiated
BER in human cell extracts was conducted using the a-like DNA polymerase
inhibitor, aphidicolin. Inclusion of aphidicolin into standardBER reactions
containing U251 and LoVo whole cell extracts reduced the amount of BER by
20 % and 13 °/0, respectively. Similar levels (-20 `)/0) of uracil-initiatedBER
inhibition by aphidicolinwere also observed in He La cell extracts (183).
Together, these observations suggest that pol p playsa predominant role in
BER in human cells. However, these results donot rule out the possibility
that other DNA polymerases, particularly pol 8 and/or pole, potentially
contribute to DNA repair synthesis. In particular, pol 8 ande may function in
synthesis involving long-patch BER. Several other studies havepreviously
implicated a role for pol 8 and/or pole in BER using eukaryotic whole cell
extracts (54, 77, 123, 158, 294). Examination of the repair patch size distribution
during DNA repair synthesis in U251 and LoVo cellextracts illustrated that
aphidicolin did not interfere with the repair kinetics of short-or long-patch
BER. This provided evidence that pol 13can participate in DNA repair
synthesis of both short and long DNA patches underour assay conditions.
Klungland and Lindahl (118) have describeda BER pathway that repairs
reduced AP sites. This pathwaygenerates repair patches of 2-6 nucleotides by300
pol 13 or pol 6. Experiments using cell extracts from mouse fibroblasts derived
from embryos harboring a homozygous pol I3-deletion mutation suggested
that the rate of short-patch BER initiated at AP-sites was dramatically reduced
but not completely eliminated in the absence of pol 13 activity (69). In contrast,
the rate of long-patch BER was apparently unaffected in these pol [3-deficient
extracts (69). These observations infer that short-patch BER is largely pol [3-
dependent and constitutes the major pathway for repair whereas DNA
polymerase(s) other than pol 13 are specifically involved in long-patch BER.
Interestingly, the kinetic rate of long-patch repair observed by Fortini et al. (69)
was significantly slower than that of short-patch repair and was attributed to a
strand displacement reaction mechanism. Thus, the faster rate of short-patch
DNA synthesis by pol [3 coupled with its processivity on short gaps and ability
to conduct strand displacement DNA synthesis could presumably influence
its role in the synthesis of longer DNA tracts (118, 248). In a separate study,
the addition of pol 13 antibodies to human lymphoblastoid cell-free extracts
inhibited long-patch BER, suggesting that poi 6 and pole were inefficient in
substituting for pol 13 during long-patch BER (118). Altogether, these results
imply that pol 13 is definitively involved in short- and long-patch DNA repair
synthesis but the contributing role of other DNA polymerases in long-patch
DNA repair synthesis remains to be clearly determined.
Using the lacZa reversion assay, we observed that uracil-initiated BER
in human U251 whole cell extracts occurred witha reversion frequency of 5.2
x 104 (-1 misincorporation per 1900 repaired uracil residues). Uracil-initiated
BER in human LoVo whole cell extracts yieldeda reversion frequency of 5.4 x
10' (-1 misincorporationper 1850 repaired uracil residues). Although the
presence of a functional mismatch DNA repair pathway in U251 whole cell
extracts has not been determined under our assay conditions, the similarity of
the reversion frequencies between U251 and LoVo cells implies that the301
fidelity of the BER reaction in U251 cellswas not influenced by the mismatch
DNA repair pathway. Inclusion of Ugi into standard BER reactions with U251
and LoVo whole cell extracts resulted in considerably greater reversion
frequencies of 28.3 x 104 (-1 misincorporationper 350 repaired uracil residues)
and 11.7 x 10 4 (-1 misincorporationper 850 repaired uracil residues),
respectively. The Ugi-insensitive BER pathwaywas 2 to 5 times more error
prone than uracil-BER initiated by the uracil DNA glycosylases. Elucidation
of the pathway involving this Ugi-resistant uracil-DNA glycosylase activity
must await further characterization.
In all cases, the uracil-DNA BER reactionwas considerably more error-
prone than DNA synthesis associated with leading or lagging strand
replication in human cell extracts (111). For example, the reportedaverage
replication error rates for GdGTP, TclGTP, and AcIGTP mispairs occurred
between 0.25 x 10' and 0.03 x 104errors per detectable nucleotide incorporated
(111). The error-prone nature of the BER reactionmay necessitate that the
repair patch size be kept to a minimum to avoid mutations from being
introduced during DNA repair synthesis. Thus, it isnot surprising that the
repair patch size associated with BER (1-8 nucleotides) is considerably smaller
than that associated with nucleotide excision repair (27-29 nucleotides)or
mismatch repair (>1000 nucleotides) in human cells (269). The lattertwo
repair pathways do not appear to utilize pol (3 for the DNA repair synthesis
step (229, 269).
The studies reported here present the first fidelitymeasurements
associated with BER DNA synthesis in mammalian whole cellextracts. The
analysis utilized a lacZa reversionassay capable of detecting 8 out of 9 possible
base substitutions within the opal (TGA) codon, including all 3misinsertions
at the uracil target site. Only a misincorporation of dTMP opposite G at
position 79 in the (+) strand templatewas undetectable since this created a
TAA stop codon that would not be scoredas a revertant with a blue plaque
phenotype. As expected, most (-95 %) of the 78revertants sequenced302
following the BER reaction in U251 whole cell extracts contained a base
substitution at the first position of the opal codon (nucleotide 78)
corresponding to the site of the uracil residue. In BER reactions containing
LoVo whole cell extract protein, -92 % of the 24 revertants sequenced
similarly contained a base substitution at the site of the uracil residue. Of the
24 revertants sequenced following uracil-DNA repair in standard BER
reactions containing LoVo whole cell extract and Ugi, all of the base
substitutions were found to occur at the site of the uracil. In all cases, these
results are consistent with DNA repair synthesis being initiated at the uracil
target site on the (-) strand and proceeding in the 5' to 3' direction away from
the opal codon. However, the results do not distinguish between BER
involving a short- or long-patch mechanism since the fidelity assay was
specifically designed to detect misincorporations only at the uracil target and
not downstream (5' to 3') along the (-) strand. Consequently, the error
frequencies represent those of short-patch BER and the first nucleotide
incorporated during long-patch BER.
A considerable amount of evidence implicates pol 13 as playing a major
role in uracil-initiated BER in mammalian cells (171) (13, 69, 157, 158, 174, 200,
209, 247). Recently, the fidelity of in vitro gap filling DNA synthesis by purified
pol (3 was evaluated (11). Beard et al. (11), using a lacZa opal codon reversion
assay to assess the DNA synthesis fidelity on a substrate containing a five-
nucleotide gap, demonstrated that purified human pol 13 producedone
revertant per 370 filled gaps (reversion frequency of 27 x 10'). This value
reflects a somewhat lower fidelity (-5-fold) than that observed for the
completed uracil-DNA glycosylase-initiated BER reaction in either U251 or
LoVo whole cell extracts. However, this value was similar to the reversion
frequencies observed for the Ugi-insensitive BER reaction in U251 (28.3 x 10-k)
and LoVo (11.7 x 10') whole cell extracts. Thus, the decreased DNA repair
synthesis fidelity associated with the Ugi-insensitive DNA glycosylase could
have resulted from the formation ofa gapped DNA substrate. Supporting the303
concept of lowered fidelity on gapped DNA substrates, Chagovetz et al. (40)
observed that the nucleotide insertion fidelity of purified rat pol 13was
considerably higher (>10-fold) ona DNA substrate containing a 5'-
phosphorylated single-nucleotidegap as compared to a gap of six nucleotides.
Additionally, the catalytic efficiency of pol 13on a 5'-phosphorylated gap was
.500 times greater than on a six-nucleotide gapped DNA substrate (40).
Clearly, other factors such as DNAsequence context and accessory proteins
associated with the BER reaction potentially contribute to the observed
fidelity of DNA repair synthesis and mutation fixation. In particular, the
ability of DNA ligase to acton nicks containing specific 3'-mismatched
nucleotides juxtaposed to a 5'-end could significantly influence themutation
spectrum derived from BER. In this regard, recent evidence indicates that
bovine DNA ligase III sealsa nick containing a 3'-CT mispair with nearly the
same efficiency as one containing base-paired termini, whereas a 3'-GT
mispair was recognized with ~5-fold less efficiency (109). A similar preference
for 3'-terminal mispairs (3I-CT> 3'-GT) was also observed for bovine DNA
ligase I; however, the overall efficiency of DNA joiningwas reduced 5-10-fold
for each individual mispaired termini compared with DNA ligaseIII (109).
These results may providea partial explanation for the high frequency of CT
versus GT mispairs detected following the BER assay.
The results observed by Husain et al. (109) potentially reflect the
fidelity of ligation associated with one-nucleotiderepair patches but not
ligation of DNA repair patches involvingtwo or more nucleotides. Thus, in
long-patch BER, the initial misinsertion event at the site of the uraciltarget
must be followed by primer extension from the 3'-terminal mispair.
Approximately 54 % to 68 `)/0 of the uracil-initiated BER in U251 andLoVo
whole cell extracts involved repair patches oftwo or more nucleotides.
Interestingly, the ability of pol 13 to efficiently utilize template-primers
containing up to three nucleotide mispaired termini has been reported(25,304
120). Specifically, the ability of pol 13 to conduct primer extension froma 3'-
CT and 3t-TT terminal mispairs was observed (25). This could also provide
a partial explanation for the 'fixation' of these types of mispairs in light of the
extensive long-patch DNA repair synthesis observed in this study. Currently,
it is unclear whether the error frequencies measured for U251 and LoVo
uracil-initiated BER represent errors associated with short- or long-patch
DNA repair synthesis.
DNA polymerase-mediated base substitutions occur as a consequence
of either direct nucleotide misincorporationor template-directed dislocation
events (25, 223). The mutational spectrum observed for BER in human U251
whole cell extracts included 73 transversion mutations (-94 %) and only five
transition mutations (-6 %). The transversion mutations were almost
equally distributed between T to G (38/73) and T to A (32/73) changes
resulting from dCMP and dTMP incorporation opposite thymine at position
78 in the DNA (+)-strand, respectively. In human LoVo whole cell extracts,
similar proportions of transversion mutations were observed for repair
reactions conducted in the absence (-88 %) and presence (-86 °/0) of Ugi.
Again, transversion mutations were distributed between T to G (30/53) and T
to A (19/53) changes for repair initiated by uracil-DNA glycosylase in the
absence of Ugi. Similarly, T to G (17/24) and T to A (7/24) changes in the
DNA (+)-strand constituted the transversion mutation spectrum for the Ugi-
insensitive BER reaction. In all cases, T to G changes were the dominant type
of transversion mutation. Transition mutations involvinga T to C change
for BER reactions containing U251 (4/5)or LoVo (5/7) whole cell extracts
occurred as a consequence of dGMP being inserted opposite the template
thymine residue. Misincorporation of dCMP and dGMP oppositea template
thymine were recently reported to be the most kinetically favorable
misinsertions for purified rat polwhile misincorporation of dTMP ranked
among the least favorable events (2). Inspection of the DNA template
sequence around the target site suggested that dTMP incorporation could305
have occurred via a dislocation mechanism. This couldoccur during the
DNA synthesis process as depicted in Figure 62. If the thymine at position 78
in the template strand was looped out prior to nucleotide incorporation, this
would allow the adenine at position 77 to base pair with the incoming dTTP.
Under this condition, primer extension wouldoccur due to the next
nucleotide effect, and incorporation of two dTMPs might be expectedto
follow because of the adenine dinucleotidesequence of the template strand.
Upon realignment of the primer-template,a TT mispair would be created at
position 78, and the 3' terminal nucleotide of the primer would forman AT
base pair at position 77. While this interpretation providesa plausible
explanation, further experimentation would be requiredto elucidate the
mutagenic mechanism. Additional studies will be required to determine the
fidelity and mutational specificity of uracil-initiated BER within other
sequence contexts.306
Figure 62. Model for base substitution errors introduced by dislocation of
the M13mp2op14 primer-template. A theoretical mechanism for introducing
single-base substitutions during DNA repair synthesis is diagrammed and
based upon the dislocation mutagenesis theory. After excision of the uracil
and incision at the 5'-end of the resultant apyrimidinic site, slippage of the
template or primer strand can result in the looping out of a single nucleotide
to generate a 3' terminal mispair. If nucleotide incorporation and
realignment of the template strand occur, the incorporated T will align with a
template T to create a T:T mispair. The incorporated base leading to the
mispair after realignment is outlined. In this model, mispairs are introduced,
not by direct misinsertion, but by transient misalignment of the template
strand. For clarity, the DNA sequence located to the 3' side of the uracil
residue of the uracil-containing DNA strand has been omitted.5'-C-A-A-T-G-A-C-G-3'
3'-G-T-T-U-C-T-G-C-5'
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5.INACTIVATION OF URACIL-DNA GLYCOSYLASE ACTIVITY IN
HUMAN CELLS EXPRESSING THE UGI PROTEIN
The use of the Ugi protein to create a uracil-DNA glycosylase defective
cell was initially explored in E. coli and resulted in the inactivation of Ung
activity and production of bacteria with phenotypic properties equivalent to
ung mutants (62, 291). Since ung mutants have not yet been isolated from
mammalian cells, a similar approach was applied to human U251
glioblastoma cells by Dr. E. Radany (University of Michigan) and human cell
lines stably expressing the ugi gene were characterized in this laboratory. This
dissertation specifically characterizes the effect of ugi expression on the
human uracil-DNA glycosylase activity of transduced cells in vitro. The
approach utilizes synthetic oligonucleotide substrates containing site-specific
uracil residues and the extent of uracil removal by crude cell extract protein
was assessed. The findings establish that U251 cells stably transfected with the
ugi gene express Ugi protein at a high level and have undetectable levels of
uracil-DNA glycosylase activity in crude cellular extracts. In the process, the
results indicated that a novel secondary uracil-DNA glycosylase activity exists
that is insensitive to Ugi.
5.1Results
5.1.1Expression of the ugi Gene in Human U251 Glioblastoma Cells
Expression of the ugi gene in intact human cells was explored as a
method to create a uracil-DNA glycosylase defective cell line. The ugigene
contained in pZWtac was modified and subcloned into a eukaryotic
expression vector to facilitate the protein synthesis of Ugi in human cells.
Construction of the mammalian expression vector and transduction of
human U251 cells were conducted by Eric Radany (University of Michigan).
The essential components of the mammalian expression vector,309
pvBiPNeo1001-mugi, are summarized in Figure 63 and consist of the
retroviral long terminal repeat (LTR) elements and extended packaging signal
(w+) (163), strong CMV early promoter (26), ugigene (219), and internal
ribosome entry signal (IRES) of the human BiP/GRP70gene (153) linked to
the wild type prokaryotic Tn5 neomycin phosphotransferasegene (315).
Transcription of the transgene (ugi) and drug resistancegene (Neo) were both
under the control of the same CMV early promoter. Asa result, a single
bicistronic mammalian mRNAwas expected to be transcribed with an
internal ribosome entry signal (IRES)sequence from the BiP/GRP70 locus
located between the individualgene sequences. This vector obligatorily links
expression of ugi to Neo (153). Following transient transfection of pvBiPNeo-
ugi into packaging cells, infectious retroviralvector containing supernatant
samples were produced for infection of human U251 cells. Infectionswere
conducted and G418 selection resulted in 51 independent drug-resistant
colonies of different sizes. Subsequently, 25 cloneswere expanded to stably
transduced cell lines.
Crude cell extracts were prepared fromone of the G418-resistant
transductants, U251ugi17, and unmodified parental U251 cells to specifically
characterize the effect of ugi gene expressionon the human uracil-DNA
glycosylase (UDG) activity of transduced cells in vitro. Cell extracts from
parental cells contained 11.7 units of UDGper mg of extract protein and no
detectable Ugi activity (Figure 63). In contrast, crude cellextracts derived from
U251ugi17 cells showed significantly reduced UDG activity (<0.08 units/mg)
and also expressed Ugi activity (0.7 units/mg). Thus, essentially complete
inhibition of endogenous UDG occurred in U251ugi17 cellextracts as
determined by the uracil-DNA glycosylaseassay.310
Figure 63. Construction of Ugi-expressing human glioma cell lines. The
plasmid map (top) depicts the structure of the ugi-containing retroviral vector
used for transient infection of BOSC packaging cells to generate infectious
amphitropic supernatants. Components include the retroviral long terminal
repeat (5'LTR and 3'LTR) elements and extended packaging signal (Nt), the
strong CMV early promoter (pCMV), ugi, and the internal ribosome entry
signal (IRES) of the human BiP/GRP70 gene linked to the wild type
prokaryotic Tn5 neomycin phosphotransferase gene (Neo). Below is a flow
diagram showing the steps used for selection and cloning of human glioma
cell lines carrying the pvBiPNeo-ugi provirus. Standard uracil-DNA
glycosylase and uracil-DNA glycosylase inhibitor assays were conductedon
U251 and U251ugi17 crude extract protein as described under "Experimental
Procedures" to determine levels of Ung and Ugi activity in control and
transformed cells.BiP
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5.1.2Detection of UDG Activity in Human U251ugi17 Cell
Extracts Using Various Uracil-Containing DNA Substrates
A more detailed investigation of the substrate specificity of UDG
activity was conducted since recent evidence has indicated that He La cells
contain a mismatch-specific thymine-DNA glycosylase (TDG) capable of
removing thymine and uracil from T:G and U:G mispairs, respectively (80,
186). Parental U251 and U251ugi17 crude cell extracts were examined for
uracil-DNA glycosylase activity using three 5'-end 32P-labeled uracil-
containing oligonucleotide substrates as indicated (Figure 64A). Increasing
amounts of crude cell extract from either the control (U251) or ugi-expressing
(U251ugi17) cells were incubated with each DNA substrate (U-34-mer, U/A-34-
mer, and U/G-34-mer). Following these reactions, DNA reaction products
were treated with alkali to hydrolyze the phosphodiester backbone on the 3'-
side of the resultant apyrimidinic sites. A product ([32I115*-mer) containing a
3'-terminal deoxyribose-phosphate residue was anticipated as a result of this
treatment. The products and substrate were resolved by denaturing
polyacrylamide gel electrophoresis to assess the extent of uracil removal
(Figure 64B-D, lanes 3-8). Control reactions were supplemented with no
addition or exogenous E. coli uracil-DNA glycosylase to determine the
efficiency of alkali-mediated AP-site cleavage (Figure 64B-D, lanes 1 and 2). In
each case, >98 `)/0 of the 34-mer (U, U/A, U/G) was shown to be susceptible to
cleavage by the combination of E. coli uracil-DNA glycosylase and alkali
treatments.
As expected, the reaction mixtures containing the single-stranded U-34-
mer and U251 cell extract produced a single reaction product ([32I115*-mer)
corresponding to uracil removal by uracil-DNA glycosylase (Figure 64B). In
an analogous experiment using the U251ugi17 cell extract, no UDG activity
was detected due to the expression of the ugi gene product. Similar results
were also observed in reaction mixtures containing either the double-
stranded U/A- or U/G-34-mer substrate (Figure 64C and D). In both cases, no
detectable UDG activity was observed with the U251ugi17 cell extract whereas313
Figure 64. Substrate specificity of uracil-DNA glycosylase activity of
human U251 and U251ugi17 cell extracts. (A) Three 5'-end 32P- labeled
oligonucleotides each containing a site-specific uracil residue located at
position 16 were prepared as single-stranded [32P]U -34 -mer, double-stranded
[32P]U/A-34-mer, and [32P]U/G-34-meras described under "Experimental
Procedures". The arrows flanking the uracil designate the 5'- and 3'-cleavage
sites produced by AP-endonuclease and AP-lyase activities, respectively. The
asterisk denotes the position of the .5' -end 32P-label. (B) Two sets of uracil-
DNA glycosylase reaction mixtures (100 IA) each containing 0.16, 0.63, 2.5, 10,
40, and 160 lig of U251 or U251-ugi17 crude extract protein (lanes 3-8,
respectively) were incubated with 4 pmol of [32P]U-34-mer at 30°C for 30 min.
Control reactions were similarly prepared but lacked cellular extract protein
(lane 1) or contained 400 units of E. coli uracil-DNA glycosylase (lane 2). The
order of these two controls was inverted in panel C for the U251 cell extract.
After incubation, the reactionswere terminated, DNA was isolated, and AP-
sites were hydrolyzed. Reaction productswere analyzed by electrophoresis
using a denaturing 12% polyacrylamide gel containing 8.3 Murea and
autoradiography was performedas described under "Experimental
Procedures". Identical sets of reactionswere prepared using 4 pmol of duplex
[32P]U/A-34-mer (C)or [32P]U/G-34-mer (D) as substrate. The location of the
DNA substrate (U-, U/A-, and U/G-34-mer) and reaction products (15*-mer
and 16-mer) are indicated by arrows. The 15*-mer correspondsto the location
of a 15-mer containing a 3'-terminal deoxyribose phosphate residue.315
significant cleavage of both duplex substrates occurred in extracts from
parental U251 cell lines. The appearance of the [321116-mer exclusively
detected in reactions containing the duplex substrate was consistent with
DNA synthesis that extended the 15-mer by one nucleotide. This product
could be explained as a predicted intermediate in the uracil-initiated base
excision DNA repair pathway (247). Taken together, these results imply that
Ugi production in U251ugi17 cells effectively eliminated uracil-DNA
glycosylase activity. After quantitating the amount of 15*-mer and 16-mer
detected for each of the three uracil-containing 34-mer substrates, the
percentage of product formed in each reaction was plotted as a function of
U251 crude cell extract protein (Figure 65A-C). The relationship between the
extent of uracil excision and the amount of cell extract protein was
determined for the initial 10 % of the reaction. Under these conditions, the
activity of crude cell extract protein from parental U251 cells for the removal
of uracil from each substrate was determined to be 317, 72, and 147 fmol of
uracil removed per gg of extract protein for U-, U/A-, and U/G-34-mer
substrates, respectively. Thus, the DNA substrate containing U/G was
preferred 2.0-fold over U/A whereas single-stranded U-34-mer was preferred
4.4- and 2.2-fold over both U/A and U/G substrates, respectively.
The observation that uracil-DNA glycosylase activity was not detected
under these assay conditions using the U/G-34-mer substrate inferred that
U251 and U251ugi17 cell extracts contained little, if any, TDG activity. Since
TDG has previously been detected in some human cell extracts, the
experiment was repeated using a T/G-34-mer DNA substrate under reaction
conditions specifically described for detecting TDG activity (246). U251 or
U251ugi17 cell extract protein (160 p,g) was incubated with 5'-end 32P-labeled
oligonucleotides (U-, U/A-, U/G-, T/G-34-mer), treated with alkali, and
analyzed by denaturing polyacrylamide gel electrophoresis. Reactions were
conducted both in the presence (Figure 66A-D, lanes 5 and 7) and absence
(Figure 66A-D, lanes 4 and 6) of exogenous Ugi and the results obtained are
shown following polyacrylamide/urea gel electrophoresis and316
Figure 65. Quantitation of the substrate specificity of uracil-DNA
glycosylase activity of human U251 and mugi cell extracts. [32P]DNA bands
detected by autoradiography in Figure 64 (lanes 3-8)were excised from the
dried gel and the amount of 32P radioactivitywas measured for reaction
mixtures containing U251 (closed circles) and U251ugi17 crude extract protein
(open circles). The percentage of product formed was calculated by dividing the
amount of product ([321115*-mer and [32P]16 -mer) by the amount of product
plus substrate ([32P }34 -mer) detected for single-stranded [32P]U -34-mer (A),
[32P]U/A-34 -mer (B), and [32P]U/G -34 -mer (C).100
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Figure 66. Analysis of thymine-DNA glycosylase activity in human U251
cell extracts. Four sets of uracil- or thymine-DNA glycosylase reaction
mixtures (100 ul) each containing 160 pg of crude extract protein from either
U251 (lanes 4 and 5) or U251ugi17 (lanes 6 and 7) cells were incubated with 4
pmol of [32P]U -34 -mer (A), [32P]U/A -34-mer (B), [32P]U/G -34 -mer (C), or
[32P]T/G-34 -mer (D), as indicated above in the presence (lanes 5 and 7) and the
absence (lanes 4 and 6) of 1000 units of Ugi protein. In addition, each reaction
mixture contained 25 mM Hepes-KOH (pH 7.9), 50 mM KC1, 1 mM DTT, 0.5
mM EDTA, 0.01 mM ZnCl2, and 100 pl/m1 acetylated BSA. Control reaction
mixtures either lacked crude extract protein (lane 1), contained 400 units of E.
coli Ung (lane 2), or 400 units of E. coli Ung plus 1000 units of Ugi protein (lane
3). Each reaction was terminated after 30 mM at 30°C and the mixtures
processed as described in Figure 64. Unreacted substrate (34-mer) and reaction
products (15*- and 16-mer) were resolved by denaturing 12 %
polyacrylamide/8.3 M urea gel electrophoresis, detected by autoradiography,
and are located by the arrows.320
autoradiography. Control reactions for each DNA substrate containing the
appropriate [32P]34 -mer supplemented with no addition, E. coli uracil-DNA
glycosylase, or uracil-DNA glycosylase plus Ugi are shown for comparison
(Figure 66A-D, lanes 1-3, respectively). The results indicate that TDG activity
was not detectable in either the U251 or U251ugi17 cell extracts (Figure 66D).
However, a novel activity was detected under these conditions that i)
preferentially recognized the U/G-34-mer over the U/A-34-mer by a factor of
-3.5-fold; ii) did not appear to recognize the single-stranded U-34-mer
substrate; iii) was insensitive to inhibition by Ugi; and iv) was expressed in
both U251 and U251ugi17 cell lines. Virtually identical results were obtained
for parental U251 and U251ugi17 cell extracts examined in the presence of
exogenous Ugi. This, in conjunction with the observations that Ugi
efficiently inhibited E. coli uracil-DNA glycosylase under identical reaction
conditions, essentially negates the trivial explanation that the activity arose
due to an inefficiency to inhibit UDG activity under these conditions.
Together, these results suggest that TDG activity was not detectable but that a
Ugi-insensitive double-strand specific uracil-DNA glycosylase (ds-UDG)
existed in the extract.
Since ds-UDG activity was detected in human cell extracts using TDG
but not UDG buffering conditions, an experiment was conducted to
determine the buffer component(s) required to detect the Ugi-insensitive
uracil-DNA glycosylase. Both buffers contained 25 mM Hepes-KOH (pH 7.8 or
7.9), 0.5 mM EDTA, and 0.5 mM or 1.0 mM DTT but buffer conditions
described for detecting TDG activity also included 50 mM KC1, 10 RM ZnC12,
and 100 pg/m1 acetylated bovine serum albumin (BSA) protein. Therefore,
U251 whole cell extract protein (160 gg) supplemented with and without
exogenous Ugi was incubated with 5'-end 3213-labeled oligonucleotides (U-,
U/A-, U/G-, T/G-34-mer) under UDG buffering conditions containing
various combinations of 50 mM KC1, 10 11M ZnC12, and/or 100 µg /ml
acetylated BSA, treated with alkali, and analyzed by denaturing
polyacrylamide gel electrophoresis (Figure 67A-D). Control reactions for each321
Figure 67. Effect of various buffer conditions on uracil-DNA glycosylase
activities in human U251 cell extracts. Four sets of uracil-DNA glycosylase
reaction mixtures (100 til) each containing 160 gg of U251 crude extract
protein were incubated with 4 pmol of [32P]U-34-mer (A), [32P]U/A -34 -mer (B),
[32P]U/G-34 -mer (C), or [32P]T/G -34 -mer (D) under various buffer conditions
(KC1, ZnC12, BSA) and in the presence or absence of 1000 units of Ugi protein
as indicated. Control reaction mixtures either lacked crude cell extract protein
(lane 1), contained 400 units of E. coil Ung (lane 2), or 400 units of E. coli Ung
plus 1000 units of Ugi protein (lane 3). Each reaction was terminated after 30
min at 30°C, DNA was isolated, and AP-sites were hydrolyzed. Unreacted
substrate (34-mer) and reaction products (15*- and 16-mer) were resolved by
denaturing 12% polyacrylamide/8.3 M urea gel electrophoresis followed by
autoradiography. The location of the substrate and reaction products are
located by arrows.324
DNA substrate containing the appropriate [32P]34 -mer supplemented with no
addition, E. con uracil-DNA glycosylase, or uracil-DNA glycosylase plus Ugi
were analyzed for comparative purposes using UDG buffer (Figure 67A-D,
lanes 1-3, respectively). As previously demonstrated, ds-UDG activity was not
detected on single-stranded [32P]U -34 -mer or duplex [32P]T/G -34 -mer using any
combination of buffer components (Figure 67A and D). However, ds-UDG
activity was detected using buffer conditions that included 50 mM KC1 and
duplex ['IV/A- or [32P]U/G -34 -mer (Figure 67B and C, lanes 7, 13, 15, and 19).
Importantly, UDG buffer supplemented with acetylated bovine serum
albumin (BSA) did not yield a positive result and eliminated BSA as a
potential source for this novel activity (Figure 67B and C, lane 11). These
results suggest that monovalent ions are influential in stimulating ds-UDG
activity.
To compare the amount of ds-UDG and uracil-DNA glycosylase activity
present in U251 and U251ugi17 cell extracts, various amounts of cell extract
were incubated with oligonucleotides [93]U/A- and [32P]U/G -34 -mer under
reaction conditions previously used to detect TDG activity, treated with alkali,
and analyzed by denaturing polyacrylamide gel electrophoresis. In addition,
duplex oligonucleotides [32I1A/U- and [32P]G/U -34 -mer, which contained the
32P-label on the non-uracil-containing strand, were incubated with cell extract
(160 lig) and similarly processed. Reactions were conducted both in the
presence and absence of exogenous Ugi and results obtained with U251 and
U251ugi17 cell extracts are represented in Figures 68 and 69 and Figures 70 and
71, respectively. As controls, each [32P]34 -mer substrate was incubated with no
addition, uracil-DNA glycosylase, or uracil-DNA glycosylase plus Ugi under
identical reaction conditions for comparative purposes (Figure 68 and Figure
70, A-D, lanes 1-3, respectively). As before, addition of Ugi to parental U251
cell extracts inhibited uracil-DNA glycosylase activity but did not inhibit the
Ugi-insensitive double-strand specific uracil-DNA glycosylase activity which
exhibited preferential activity toward U:G mispairs (Figure 68C) over U:A base
pairs (Figure 68A). This novel activity was also shown to be specific for the325
Figure 68. Effect of Ugi on uracil-DNA glycosylase activities detected in
human U251 cell extracts. (A) Two sets of uracil-DNA glycosylase reaction
mixtures (100 ill) each containing 160, 40, 10, 2.5, 0.63, and 0.16 jig of U251
crude extract protein were incubated in the absence (lanes 4-9, respectively)or
the presence (lanes 10-15, respectively) of 1000 units of Ugi protein with 4
pmol of [32PIU/A-34-mer at 30°C for 30 mM. Each reaction mixture contained
25 mM Hepes-KOH (pH 7.9), 50 mM KCI, 1 mM DTT, 0.5 mM EDTA, 0.01 mM
ZnC12, and 100 1.tg/m1 acetylated BSA.Control reaction mixtures either
lacked crude extract protein (lane 1), contained 400 units of E. coil Ung (lane 2),
or 400 units of E. coil Ung plus 1000 units of Ugi protein (lane 3). Reactions
were terminated, DNA isolated, AP-sites hydrolyzed, and reaction products
analyzed by denaturing 12% polyacrylamide/8.3 M urea gel electrophoresis
and autoradiography. The locations of unreacted substrate (34-mer) and
reaction products (15*- and 16-mer) are located by arrows. (B) Two uracil-
DNA glycosylase reaction mixtures (100 lip containing 160 pg of U251 crude
extract protein supplemented with (lane 5) or without (lane 4) 1000 units of
Ugi were incubated with 4 pmol of [32P]A/U -34 -mer at 30°C for 30 mM and
buffered as described above. Control reaction mixtures either lacked crude
extract protein (lane 1), contained 400 units of E. coil Ung (lane 2), or 400 units
of E. coil Ung plus 1000 units of Ugi protein (lane 3). Sampleswere processed
and analyzed as described above. (C) The effect of Ugion uracil-DNA
glycosylase activities in human U251 cell extractswas examined under
identical reaction conditions with [32P]U/G -34-mer substrate as described
above. (D) The effect of Ugi on uracil-DNA glycosylase activities in human
U251 cell extracts was examined under identical reaction conditions with the
[32P]G/U-34-mer substrate as described above.327
Figure 69. Quantitation of reaction products generated by U251 cell
extracts in the presence and absence of Ugi. [321311)NA bands detected by
autoradiography in Figure 67 (A and C, lanes 4-15) were excised from the
dried gel and the amount of 32P radioactivity was measured for reactions
containing U251 crude extract protein incubated with [32P1U/A-34-mer in the
absence (closed circles) or presence (open circles) of Ugi and with [3211U/G-34-mer
in the absence (closed squares) or presence (open squares) of Ugi. The percentage
of product formed was calculated by dividing the amount of product ([321115*-
mer and [32P]16 -mer) by the amount of product plus substrate ([32P]34-mer) and
multiplying by 100.100
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Figure 70. Effect of Ugi on uracil-DNA glycosylase activities detected in
U251ugi17 cell extracts. (A) Two sets of uracil-DNA glycosylase reaction
mixtures (100 Ill) each containing 160, 40, 10, 2.5, 0.63, and 0.16 lig of U251ugi17
crude extract protein were incubated in the absence (lanes 4-9, respectively) or
the presence (lanes 10-15, respectively) of 1000 units of Ugi protein with 4
pmol of [3211U/A-34-mer at 30°C for 30 mM. Each reaction mixture contained
25 mM Hepes-KOH (pH 7.9), 50 mM KC1, 1 mM DTT, 0.5 mM EDTA, 0.01 mM
ZnC12, and 100 gg/m1 acetylated BSA.Control reaction mixtures either
lacked crude extract protein (lane 1), contained 400 units of E. coli Ung (lane 2),
or 400 units of E. coli Ung plus 1000 units of Ugi protein (lane 3). Reactions
were terminated, DNA isolated, AP-sites hydrolyzed, and reaction products
analyzed by denaturing 12% polyacrylamide/8.3 M urea gel electrophoresis
and autoradiography. The location of unreacted substrate (34-mer) and
reaction products (15*- and 16-mer) are located by arrows. (B) Two uracil-
DNA glycosylase reaction mixtures (100 IA) containing 160 pg each of
U251ugi17 crude extract protein supplemented with (lane 5) or without (lane
4) 1000 units of Ugi were incubated with 4 pmol of [3213]A/U-34-mer at 30°C for
30 mM and buffered as described above. Control reaction mixtures either
lacked crude extract protein (lane 1), contained 400 units of E. coli Ung (lane 2),
or 400 units of E. coli Ung plus 1000 units of Ugi protein (lane 3). Samples
were processed and analyzed as described above. (C) The effect of Ugi on
uracil-DNA glycosylase activities in human U251ugi17 cell extracts was
examined under identical reaction conditions with [3211U/G-34-mer substrate
as described above. (D) The effect of Ugi on uracil-DNA glycosylase activities
in human U251ugi17 cell extracts was examined under identical reaction
conditions with the r131G/U-34-mer substrate as described above.331
Figure 71. Quantitation of reaction products generated by U251ugi17 cell
extracts in the presence and absence of Ugi. [3213]DNA bands detected by
autoradiography in Figure 69 (A and C, lanes 4-15) were excised from the
dried gel and the amount of 32P radioactivity was measured for reactions
containing U251ugi17 crude extract protein incubated with [3211U/A-34-mer in
the absence (closed circles) or presence (open circles) of Ugi and with [32M/G-34-
mer in the absence (closed squares) or presence (open squares) of Ugi. The
percentage of product formed was calculated by dividing the amount of
product ([321115*-mer and [321116-mer) by the amount of product plus substrate
([32P]34-mer) and multiplying by 100.100
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uracil-containing strand of both the U:A and U:G substrates as verified by the
presence of intact [32P]A- and [32I1G-34-mer DNA bands incubated under
identical conditions (Figure 68B and D, respectively, lane 5). Virtually
identical results were obtained for U251ugi17 cell extracts (Figure 70A-D)
although the presence or absence of Ugi did not affect the amount of uracil
removal since Ugi production in U251ugi17 cells effectively eliminated
endogenous uracil-DNA glycosylase activity.
After quantitating the amount of 15*-mer and 16-mer detected for the
[32P]U /A- and [32I1U/G-34-mer substrates, the percentage of product formed in
each reaction was plotted as a function of crude cell extract protein for U251
and U251ugi17 cells (Figure 69 and Figure 71, respectively). Again, the extent
of uracil excision was determined for the initial 10 % of the product formed.
For parental U251 cells, the activity of crude cell extract protein in the absence
of exogenous Ugi for the removal of uracil from the U/A and U/G substrates
was determined to be 433 and 1324 fmol of uracil removed per jag of extract
protein, respectively. In the presence of Ugi, these values decreased to 1.5 and
9.7 fmol of uracil removed per lig of extract protein for U/A and U/G
substrates, respectively. Thus, the double-strand-specific uracil-DNA
glycosylase activity appears to contribute only a minor percentage of the
overall uracil excision activity present in parental U251 cells under the
conditions tested. For U251 mugi-17 cells, the activity of crude cell extract
protein in the absence of exogenous Ugi for the removal of uracil from the
U/A and U/G substrates was determined to be 2.1 and 6.0 fmol of uracil
removed per gg of extract, respectively, whereas these values were calculated
to be 4.5 and 6.2 in the presence of exogenous Ugi. Thus, double-strand
specific uracil-DNA glycosylase activity is present at similar levels in both
U251 and U251ugi17 cell extracts but appears to contribute a relatively minor
role in uracil-initiated BER as compared to the Ugi-sensitive UDGs.334
5.2Discussion
Ugi has been previously demonstrated to inhibit various forms of
uracil-DNA glycosylase isolated from human cells, including the nuclear
(UNG2 or UDG1A), mitochondrial (UNG1 or UDG1), and cyclin-like (UDG2)
enzymes (36, 46, 167, 178, 292). Since in vitro observations have indicated that
the UDGUgi complex is essentially irreversible under physiological
conditions (15, 17, 231), it seemed feasible that expression of the ugi gene in
human cells might lead to a uracil-DNA glycosylase defective phenotype. A
similar strategy utilizing the in vivo expression of the ugi gene in E. coli
previously resulted in bacteria with phenotypic properties that were reflective
of ung mutants (291). Thus, a eukaryotic expression vector containing the ugi
gene designed by Dr. E. Radany (University of Michigan) was developed to
simultaneously knock out the three human UDG activities. This strategy
circumvented the need to individually disrupt the expression of at least two
UDG genes by a more complicated genetic approach. The results presented
here demonstrated that U251 glioma cells transformed with the
pvBiPNeo1001-mugi vector produced active Ugi in vivo which in turn
inactivated the uracil-DNA glycosylase. This observation was supported by
the apparent absence of uracil-DNA glycosylase activity (>775-fold reduction)
in U251ugi17 cell extracts when assayed on either activated calf-thymus DNA
containing UA base pairs or on U-34-mer, U/A-34-mer, and U/G-34-mer
synthetic DNA substrates.
A detailed investigation of UDG activity in U251 and U251ugi17 cell
extracts was conducted using defined uracil-containing oligonucleotide (U-,
U/A-, and U/G-34-mer) substrates. UDG activity was not detected in
U251ugi17 cell extracts, which was consistent with previous reports indicating
that the three major UDG activities in human cells are inhibited by Ugi (36,
167, 292). This observation was confirmed by the detection of excess Ugi in
extracts that lacked a detectable amount of uracil-DNA glycosylase activity.
Contrary to our expectations, the U251ugi17 cell extract did not exhibit activity335
toward the U/G-34-mer substrate. Recently, a human mismatch-specific
thymine-DNA glycosylase (TDG) activity was reported to excise uracil from
UG mispairs more efficiently than it excises thymine from TG mispairs
(186). Unlike UDGs, TDG has been shown to be Ugi-resistant and does not
recognize uracil residues in either single-stranded DNA or double-stranded
DNA containing UA base pairs (80, 186). Thus, it was anticipated that this
activity might appear in both the human U251ugi17 cell extracts and the U251
cell extracts treated with Ugi in vitro. The inability to detect TDG could not be
attributed to DNA substrate differences since the identical oligonucleotide
substrate previously reported for detecting TDG activity (186) was used in this
study. However, it was recognized that the standard reaction conditions used
for detecting uracil-DNA glycosylase differed somewhat from those reported
for optimal TDG activity. In an attempt to examine this difference, U251 and
U251ugi17 cell extracts were assayed under conditions specifically defined for
detecting TDG activity in vitro (246). Under these conditions, a Ugi-resistant
uracil-DNA glycosylase activity was detected that catalyzed the removal of
uracil from the U/A- and U/G-34-mer substrates but not thymine from the
T/G-34-mer substrate. In contrast to the UDG enzyme, a 50 mM KC1 buffer
component was required in order to detect this Ugi-resistant activity.
Additional experiments demonstrated that the removal of the uracil base was
indicative of glycosylase action and the activity was specific for the uracil-
containing strand. The inability of this Ugi-insensitive activity to remove
uracil from the single-stranded DNA substrate clearly distinguished this
activity from the conventional UDG activities. This observation eliminated
the trivial possibility that the observed activitywas derived from a sub-
population of UDG that had escaped inhibition by Ugi. On the basis of these
results, it seemed most likely that U251 and U251ugi17 cell extracts contained
little, if any, TDG activity. However, this is not to indicate that the TDGgene
product was excluded as a potential candidate for the activity detected in the
presence of Ugi. For example, deletion mutant analysis of the N-terminal336
and C-terminal regions of human TDG resulted in a mutant TDG enzyme
that could effectively remove uracil but not thymine from UG and TG
mispairs, respectively (80).Thus, it remains a formal possibility that post-
translational proteolysis of TDG in U251 and U251ugi17 cell extracts or
expression of a mutated form of TDG by these cell types could yield defective
TDG polypeptides capable of processing UG but not TG mispairs. These
results must be interpreted with considerable caution since the findings are
based on a complex mixture of cell extract protein. Nevertheless, the
observed substrate specificity clearly points to the existence of an alternative
Ugi-resistant UDG enzyme(s).
Subsequent to this study, a detailed report of the kinetics of substrate
recognition and excision by recombinant human TDG was published (298).
The results indicated that the initial rate of uracil removal from a UG
mispair (Iccat=11 min-1) was over 10-fold greater than that for the removal of
thymine from a TG mispair (kcat=0.91 min-1) (298). Coincidentally, the buffer
conditions used in the study by Waters and Swann (298) were nearly identical
to those of the present study and the 34-mer oligonucleotide substrates were
identical. Thus, if TDG activity were present in the human U251 cell extracts,
its detection should have been possible. When considering the limit of
detection of the assay, a 10-fold reduction in product formation with the T/G-
34-mer substrate should have been detectable.
In addition to the removal of uracil from UG mispairs, the Ugi-
resistant UDG activity in U251 cell extracts removed uracil from UA base
pairs at an approximately 3-fold reduced rate. The initial rate for uracil
removal from a UA base pair by purified human TDG was observed
(kcat=0.047 min-1) that was -234-fold lower than the initial rate observed for
removal of uracil from a UG mispair (298). Comparatively, the observed
activity toward UA base pairs of purified human TDG suggests that in U251
cells, an alternative enzyme other than TDG exists. Again, a comparison of337
the substrate specificities and catalytic rates observed for purified TDG to those
present in a cell extract are complicated due to the complex mixture of
proteins present in these cell extracts.
Further elucidation of this Ugi-resistant double-strand specific uracil-
DNA glycosylase activity must await the purification and characterization of
this enzyme(s). The significance of an alternative uracil-DNA glycosylase
activity requires further investigation. Experiments conducted to determine
the initial rate of uracil removal indicated that U251 cell extracts removed 433
and 1324 fmol of uracil per [tg of extract protein from U/A and U/G
substrates, respectively. This was in sharp contrast to the -2 and 6 fmol of
uracil removed when incubated with U251ugi17 cell extracts. A comparison
between U251 and U251ugi17 cell extracts for each of these respective
substrates indicated an approximate 216- and 220-fold reduction in both
activities for the Ugi-resistant double-strand specific UDG activity. Thus, the
in vitro assays presented here suggests that the Ugi-insensitive activity most
likely plays a relatively minor role in uracil-initiated BERas compared to the
Ugi-sensitive UDGs. As a consequence, pvBiPNeo1001-mugi transduction
resulting in ugi expression and inactivation of UDGs providea valuable
model system for further understanding the physiological importance of
uracil-DNA repair.338
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APPENDIX
Inhibition of Human UDG by PBS2 Ugi
The crystal structure of Ugi complexed with human uracil-DNA
glycosylase (UDG) was recently determined to understand how Ugi might act
as a DNA mimic. In order to biochemicallycharacterize this interaction, Ugi
inhibition studies of human UDG and E. coli uracil-DNA glycosylase (Ung)
were conducted to compare and contrast theefficiency of the
enzymeinhibitor interaction between these enzymes in the presence of a
uracil-containing DNA substrate. The effect of Ugi on human UDG and E.
coli Ung activity was determined by measuring the amount of uracil released
from calf thymus [uracil- 3H]DNA with various amounts of inhibitor protein
present in the reaction mixture. The substrate contained primarily UAbase
pairs since [3H]- uracil residues were introduced into the DNA by
incorporation of [3H]dUMP by E. coli DNA polymerase I. Ugi was observed to
effectively inactivate UDG activity toward uracil-containing double-stranded
DNA (Figure 72A). The human enzyme was inactivated -3 times more
efficiently than an equimolar amount of E. coli uracil-DNA glycosylase (Ung),
since 50 % inhibition was achieved at Ugi concentrations of 1.2 x 10' M and
3.6 x 10-11 M, respectively.
This difference suggested that the human UDG preferentially
recognized Ugi. Alternatively, these results could be explained if a
subpopulation of enzyme was incapable of forming a stable enzymeinhibitor
complex or if the concentration of the enzyme preparations were
miscalculated. To investigate these potential explanations, a defined quantity
of [35S]Ugi (300 pmol) was incubated with increasing molar amounts of E. coli
Ung or human UDG (75 to 3,000 pmol) in order to promote UngrSlUgi and370
Figure 72. Inhibition of E. coli and human UDG by uracil-DNA glycosylase
inhibitor protein. (A) Two standard uracil-DNA glycosylase inhibitor
reaction mixtures (900 ill) were prepared each containing 9 fmol of E. coli
(closed circles) or human (open circles) uracil-DNA glycosylase. Aliquots (75 p1)
of each reaction mixture were added to 25 11,1 samples of [35S]Ugi containing
the amounts indicated. Each assay mixture, containing 0.07 units of E. coli or
0.11 units of human uracil-DNA glycosylase, was incubated for 30 min at 37°C
and the amount of [31-1Juracil released from calf thymus [uracil-31-1JDNA (195
cpm/pmol) was determined as described under "Experimental Procedures".
The amount of enzyme activity detected was expressed as the percentage of
activity relative to the control lacking Ugi. E. coli and human uracil-DNA
glycosylase concentrations were determined using the molar extinction
coefficients e280.= 4.22 x 10' and 5.04 x 10', respectively. (B) Complex
formation between E. coli Ung and Ugi was examined in reaction mixtures
(130 p.1) containing 300 pmol of r SJUgi and 0, 75, 150, 225, 300, 375, 450, 600,
1,500, or 3,000 pmol of E. coli Ung (lanes C, 1-9, respectively). Samples were
incubated at 25°C for 10 min and 4°C for 20 min, loaded onto 12.5%
nondenaturing polyacrylamide gels, and electrophoresis and autoradiography
was performed. Arrows denote the location of [35S]Ugi andUngrSiUgi. (C)
Following autoradiography, radioactive bands containing [35S]Ugi and
UngrS1Ugi were excised from the gel and the 35S radioactivity was
measured. The amount of unbound [35S]Ugi (striped bars) and UngrSlUgi
complex (black bars) was measured as the percentage of the total amount of 35S
radioactivity detected as free or complexed Ugi, respectively. (D) Complex
formation between human uracil-DNA glycosylase and Ugi was similarly
examined in identical reactions containing 300 pmol of [35S]Ugi (lanes C, 1-9).
(E) The amount of unbound [35S]Ugi and Ung[35S]Ugi complex was
determined as described above.0
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UDG[35S]Ugi complex formation (Figure 72B and D, lanes 1-9).[35S]Ugi was
included as a control to indicate the position of uncomplexed [35S]Ugi (Figure
72B and D, lane C). The complexes were then resolved from their individual
components by nondenaturing polyacrylamide gel electrophoresis and
subjected to autoradiography. As both human UDG and E. coli Ung have
been shown to exhibit a 1:1 complex stoichiometry with Ugi (15, 167), [35S]Ugi
was expected to form a complex with both enzyme preparations in a manner
that was directly proportional to the enzymeinhibitor molar ratio.
Quantitation of the amount of [35S]Ugi in complex with Ung and UDG at an
Ung:Ugi molar ratio of 1:1 indicated that -66 `)/0 and -78 % of the [35S]Ugi was
in complex with the E. coli and human enzymes, respectively (Figure 72C and
E). Based on the complex stoichiometry, it was anticipated that 100 % of the
[35S]Ugi would be detected in complex for each enzyme at this ratio.
Assuming that both enzyme preparations were fully capable of forming a
stable enzymeinhibitor complex, it appeared that the concentration of
human UDG was slightly overestimated relative to that of the E. coli enzyme
and that both enzyme concentrations were underestimated relative to that of
[35S]Ugi.Inherent errors in protein concentration determination by
absorbance spectroscopy could have contributed to these differences. To
determine if a subpopulation of enzyme was incapable of forming complex,
the amount of [35S]Ugi detected in complex with human UDG was divided by
the amount detected in complex with E. coli Ung for Ung:Ugi molar ratios of
0.25:1, 0.50:1, 0.75:1, and 1:1 and values were calculated. It was estimated that
-1.10-, -1.23-, -1.24-, and -1.18-fold more [35S]Ugi was detected in complex
with human UDG than with E. co/i Ung at each respective ratio. Under
circumstances where a subpopulation of human UDG was incapable of
forming a stable complex, these values would be expected to decrease as the
molar ratio of Ung:Ugi increased. Conversely, these values would be
expected to increase proportionally to the Ung:Ugi molar ratio if a
subpopulation of E. co/i Ung was incapable of forming a stable complex. Thus,374
the similar excess amount of [35S]Ugi detected for each Ung:Ugi ratio
suggested that both enzyme preparations were equally capable of forming
complex with [35S]Ugi. Although the amount of human UDG relative to E.
coli Ung was overestimated by a factor of 1.1- to 1.2-fold in these experiments,
this does not account for the observed 3-fold higher ability of [35S]Ugi to
inhibit human UDG. This suggests that Ugi more readily binds human UDG
in the presence of a DNA substrate than it binds E. coli Ung and more
effectively competes DNA out of a human UDGDNA complex than out of
an E. coli UngDNA complex. Thus, the kinetics for the interactionof Ugi
with human UDG are more favorable than that observed for complex
formation with E. coli Ung. Defined kinetic measurements for the association
of Ugi with human UDG have yet to be determined.
In order to determine the structural basis for the interaction of Ugi
with human UDG, human placental recombinant UDG was obtained from
the laboratory of Dr. H.E. Krokan (University of Trondheim, Norway) and
UDGUgi complex was purified from its constitutive components and
concentrated in preparation for X-ray crystallography. The recombinant
human UDG enzyme used for this study lacked the N-terminal 84 amino
acids encoded by the UNG gene and contained three N-terminal residues
encoded by the vector. Specific amino acid contacts between UDG and Ugi
were determined by X-ray crystallography in the laboratory of Dr. J.A. Tainer
(Scripps Research Institute, La Jolla, CA) in order to provide details of the
human UDGUgi association and to understand how Ugi might mimic the
natural DNA substrate. The crystal structure of the UDGUgi complex solved
by Mol et al. (167) is illustrated in Figure 73. The 1.9 A crystal structure of PBS2
Ugi complexed with human UDG revealed that the tight association achieved
between UDG and Ugi was provided by complementarity shape and
electrostatic interactions, specific charged hydrogen bonds, and hydrophobic
packing of Leu-272 from the protruding UDG loop. Inhibition of UDG is375
Figure 73. Crystal structure of human uracil-DNA glycosylaseinhibitor
complex. The crystal structure of the human uracil-DNA
glycosylaseinhibitor complex was determined by using a combination of
molecular replacement and multiple isomorphous replacement (MIR)
methods (167). Uracil-DNA glycosylase (bottom) binds to Ugi (top) in a 1:1
stoichiometric fashion. In the tertiary structure of complexed enzyme, the (3-
strands are yellow, the a-helices are purple, and the random coil/loops are
green. In the tertiary structure of complexed Ugi, the 13-strands are orange, the
a-helices are blue, and the random coil/loops are red. f31- strand (orange arrow,
bottom) of the five-stranded anti-parallel Ugi 13 sheet inserts into the uracil-
DNA glycosylase active site groove roughly perpendicular to the four-
stranded parallel uracil-DNA glycosylase 13 sheet. The sequence-conserved
(His-268, Pro-269, Ser-270, Pro-271, Leu-272, and Ser-273) uracil-DNA
glycosylase active site loop (green tube, right) protrudes upwards into a
hydrophobic pocket formed by a2-helix (blue coil, right) and the curved 13 sheet
of Ugi.377
achieved by insertion of the Ugi (31-strand into the conservedDNA binding
groove of the enzyme to occlude the active-siteuracil-binding pocket. This
interaction effectively prevents DNA binding and catalysis.
The UDGUgi interface buries -1200 A2 of Ugi and contains 18
hydrogen bonds, involving 12 enzyme and 14 inhibitor side chains.Ugi
residues involved in the UDGligi interface include the following:Asn-3
from the N-terminus; two residues from the loop connecting theal-helix
and 131-strand (Ile-18 and Gln-19); the entire 131-strand (Glu-20,Ser-21, Ile-22,
Leu-23, and Met-24); three residues in the a2-helix (Glu-28,Glu-31, and Val-
32); Thr-45 from the 132-strand; two residues from the (33- strand (Asn-54and
Met-56); three residues from the loop connecting the (33- and (34-strands (Asp-
61, Ala-62, and Tyr-65); and three residues from the loopbetween the (33- and
(34-strands (Gln-73, Gly-77, and Glu-78). Recently, human UDG has been co-
crystallized with a uracil-containing duplex DNA substrate (251). A
comparison of important protein-protein contacts between UDGand Ugi and
protein-DNA contacts between UDG and its DNA substrate is representedin
Table 14. Out of the 14 Ugi amino acid residues that interact withhuman
UDG, 8 of these interact with UDG amino acid residues that areimplicated in
DNA binding. These interactions are specific for the DNA bindingregion but
not the active-site uracil-binding pocket of UDG. These contactsinclude the
following hydrogen bond interactions: Gln-144 (UDG) and Leu-23 (Ugi); His-
148 (UDG) and Ser-21 (Ugi); Ser-169 (UDG) and Glu-20 (Ugi); Ser-247(UDG)
and Glu-28 (Ugi); His-268 (UDG) and Ile-22 (Ugi); and Leu-272 and Tyr-275
(UDG) with Asn-54, Gln-73, and Glu-78 (Ugi). An additional interaction
includes a salt bridge between Arg-276 (UDG) and Glu-31 (Ugi). Withregards
to the EDC/GEE modification study presented in this dissertation,three acidic
amino acid residues of the inhibitor protein are involved in hydrogen
bonding with conserved UDG residues (Glu-20, Glu-28, and Glu-78). An378
Table 14
Amino Acid Contacts of Uracil-DNA Glycosylase with Uracil-DNA and Ugi
Uracil-DNA Glycosylase Contacts Sites of DNA Interactions
Human E. coli Ugi DNA Site Interaction
Gln -144 Gln-63 + + Uracil (02) H-bond (MC)a
Asp-145 Asp-64 + Uracil (02) H-bond (SC)
+ AP-sugar (C1) H-bond (SC)
His-148 His-67 + + 3' PO4 H-bond (SC)
+ AP-sugar (04) H-bond (SC)
Gln-152 Gln-71 +
Phe-158 Phe-77 + Uracil Stacking
+ Uracil (04) H-bond (SC)
Pro-165 Ala-84 +
Ser-169
Asn-204
Ser-88
Asn-123
+ +
+
+
5' PO,
5' PO,
Uracil (04)
H-bond (SC)
H-bond (MC)
H-bond (SC)
+ Uracil (N3) H-bond (SC)
His-212 Gly-131 +
Ala-214 Ala-133 +
Asn-215 His-134 +
Ser-247 Ser-166 + + +2 (3' PO4) H-bond (SC)
+ +2 (3' PO4) H-bond (MC)
Val-248 His-167 +
His-268 His-187 + + Uracil (02) H-bond (SC)
+ +2 (3' PO4) H-bond (MC)
Ser-270 Ser-189 + 3' PO4 H-bond (SC)
Leu-272 Leu-191 + + AP-site insert H-bonds
Ser-273 Ser-192 + 3' sugar (04) H-bond (SC)
Tyr-275 His-194 + + +2 (3' sugar 04) H-bond (SC)
Arg-276 Arg-195 + + +3 (3' PO4) H-bond (SC)
aThe abbreviations, MC and SC, are indicative of main chain and side chain interactions
between interacting amino acids of UDG with DNA.379
additional interaction with a nonconserved UDGresidue involved a salt
bridge formed by Glu-31. Out of the 13 aminoacid residues of human UDG
that interact with DNA, 8 (-62 `)/0) are involved in stronginteractions with
Ugi. Taken together, these results indicate thatUgi appears to mimic duplex
DNA interactions with UDG by interacting withspecific residues involved in
DNA binding.